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Abstract 
 
The Impact of Regulating Social Science Research with Biomedical 
Regulations: A Qualitative Study 
 
by 
 
Brenda Durosinmi 
 
Gerald C. Kops, J.D., PhD, Committee Chair 
Professor of Educational Leadership 
University of Nevada, Las Vegas 
 
 Since 1974 Federal regulations have governed the use of human subjects 
in biomedical and social science research. The regulations are known as the 
Federal Policy for the Protection of Human Subjects, and often referred to as the 
―Common Rule‖ because 18 Federal agencies follow some form of the policy. 
The Common Rule defines basic policies for conducting biomedical and social 
science research. Almost from the inception of the Common Rule social 
scientists have expressed concerns of the policy‘s medical framework of 
regulations having its applicability also to human research in the social sciences. 
The purpose of this dissertation was to investigate the impact of regulating social 
science research with the framework of biomedical research regulatory 
standards.   
 Qualitative methodology is used to analyze the Office of Human Research 
Protection‘s Determination Letters, to facilitate in-depth interviews of human 
research protection program administrators, and to evaluate the Common Rule 
policy.  
iv 
 
 
 The researcher reviewed 763 letters with 43 letters determined to be 
associated with social science research projects. The 763 determination letters 
represented a time span of 10 years, from 2000 to 2010. The letters were 
reviewed for indications of noncompliance or deficiencies to regulations specified 
in the Federal Regulations 45 CFR 46, Subpart A, (the Common Rule). 
Noncompliance or deficiencies by the IRB and HRPP support staff represented 
the majority of determination letter findings. 
 In-depth interviews were conducted with HRPP administrators. The lack of 
flexibility of the Common Rule in its application to social science disciplines was 
a common theme in the responses of HRPP administrators. Evaluation of the 
Common Rule suggested the policy was effective and efficient for the IRB and its 
administrative support staff, but was less effective and not efficient for social 
science research projects.  
 The assessment of the impact of regulating social science with biomedical 
regulations highlights the need for additional education and training of IRBs and 
their administrative support staff to more effectively apply a biomedical model of 
research regulation to the review and approval of social science research activity. 
The assessment additionally suggests the need for an ―update‖ of the Common 
Rule to address the specificity of new areas of social science research in which 
IRBs deliberate scrupulously with no regulatory guidance. 
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Chapter 1 
Introduction 
Human research can be traced as far back as the sixth century B.C. 
Sharav  (n. d.) details in A Chronology of Human Research (see Appendix A) 
vegetable and meat experimentation with young Jewish prisoners.1,2  As 
research continued during the Age of Enlightenment, medical human 
experimentation sought prisoners as research subjects with routine frequency 
(Jones, 1993). Eighteenth century research procedures included offers of free 
pardon to inmates who agreed to be inoculated with infectious small pox in 
variolation experimentation 3 (Lederer, 1995; Sharav, n.d.). Variolation 
experimentation resulted in disease and death for many of those inoculated with 
small pox. (Moreno, 2000; Faden & Beauchamp, 1986; Gibelman & Gelman, 
2005).4  In most, if not all cases, prisoners were subjected to variolation 
experimentation without their consent or offer of free pardon. Vollman & Winau 
(1996) puts forward that human research should not put subjects at risk to benefit 
others. They further suggest human subjects should receive a quotient of benefit 
from their participation in research. 
                                            
1
     No date is mentioned for the compilation of Human Experiments: A Chronology of Human Research 
by Vera Hassner Sharav  
2
     Katz (2008) suggests Sharav is referring to the Book of Daniel, 1:3-5, 8, 11-13 in which the king 
requests the presence of some of the Israelites of royal blood and nobility. The king allotted them a daily 
portion of food and wine from the royal table…But, Daniel was resolved not to defile himself with the kings 
food or wine…Then Daniel said …‖Please test your servants for ten days. Give us vegetables to eat and 
water to drink…Then see how we look in comparison with the other young men who ate from the royal 
table.‖ 
3    Variolation is an obsolete method of immunizing humans against smallpox by infecting them with the 
pustules of infected humans.  The method was popularized in England in 1721-1722.  In America, Cotton 
Mather (1663-1728) used the method on slaves. During that time variolation continued to be opposed by 
religious groups and most physicians, who were not convinced of the safety of the method. It was replaced 
by vaccination in 1799. In 1842 an act of Parliament in England made the practice of variolation a felony in 
that country. 
4
    Philip S. Hench Walter Reed Yellow Fever Collection details historical accounts of Walter Reeds 
experimentation with small pox research. See: http://yellowfever.lib.virginia.edu/reed/commission.html.   
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Vollman & Winau (1996) suggest that in 1900, as scientific information 
expanded so too did questions of unethical medical research practices. In Berlin, 
prostitutes were subjected to syphilis serum treatment without their knowledge or 
consent. The serum from patients recovering from syphilis was administered to 
the prostitutes by way of injection. The procedure was administered with the 
belief that the practice was a discovery in the cure for syphilis. An immeasurable 
epidemic among prostitutes and their customers resulted from the experimental 
procedures. The epidemic laid grounds for public outrage (Vollman & Winau, 
1996). The authors suggest that the outraged public demanded action to be 
taken to halt unethical experimentation.  
Early Human Research Regulatory Codes 
Berlin Code 
As a result of public outrage for unethical medical syphilis experiments, 
the Berlin Code of 1900 (the Code) was developed (see Appendix B). The Berlin 
Code was the first and strongest Code of that time to specify the conditions of 
ethical experimental procedures while conducting medical research with human 
subjects (Vollman & Winau, 1996).  The Code required: 
 unambiguous consent, after thorough explanation of possible negative 
consequences of participation in study;  
 the study be conducted or directed by the institute‘s medical 
administrator;  
 of minors or incompetent subjects be excluded;  
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 documentation of fulfillment of the Code requirements in subjects 
medical records; and that 
 the research not interfere with standard diagnostics, care and 
prophylaxis. 
Accounts of unethical human medical experimentation by world famous 
and revered doctors continued throughout the 1920s and beyond, forcing the 
medical community, courts, and the public to consider additional protections for 
human research subjects in addition to those protections stated in the Berlin 
Code of 1900. Examples of continued unethical treatment of human research 
subjects are documented in the historical events of medical experimentation by 
the Nazi regime.5 Nazi regime doctors performed many series of unethical 
medical experiments on hundreds of prisoners held in concentration camps6 
during World War II (1939-1945).  
Annas & Grodin (1992) suggests that camp prisoners were coerced and 
forced into participating in the medical research experiments. The experiments 
conducted resulted in harmful and often deadly consequences for the subjects 
(see Appendix C, Appendix D; Appendix E; Appendix F; and Appendix G). The 
harmful and deadly medical experiments were never accompanied by informed 
                                            
5
    The National Socialist German Workers' Party, known in German as the Nationalsozialistische Deutsche 
Arbeiterpartei and commonly known in English as the Nazi Party, was a political party in Germany between 
1919 and 1945. The party's last leader, Adolf Hitler, was appointed Chancellor of Germany in 1933 and 
established a totalitarian regime known as the Third Reich. Nazi ideology stressed the failures of 
communism, liberalism, and democracy.  They supported the "racial purity of the German people" and that 
of other Northwestern Europeans. The Nazis persecuted those they perceived as either race enemies or 
those with "life unworthy of living". This included Jews, Slavs, Communists, homosexuals, the mentally and 
physically disabled, and others. Source: http://en.wikipedia.org/wiki/Nazi_human_experimentation. 
6
    The Oxford English Dictionary, 2nd ed. defines concentration camp as: a camp where non-combatants of 
a district are accommodated, such as those instituted by Lord Kitchener during the South African war of 
1899-1902; one for the internment of political prisoners, foreign nationals, etc., especially as organized by 
the Nazi regime in Germany before and during the war of 1939-45. 
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consent.7 Public awareness of the medical research atrocities being performed 
in the camps surfaced.  Doctors and scientists that had engaged in the human 
experiments were put on trial for war crimes, including ―violations of the laws or 
customs of war‖ (Annas & Grodin, 1992, p. 95). 
Nuremberg Code 
In 1946 Nazi doctors and scientists that conducted harmful and fatal 
experiments were indicted for war crimes before the International Military 
Tribunal in Nuremberg, Germany. Shelton and Cengage (2005, para. 1) state 
that: 
The trial of the Nazi doctors, known as the United States of 
America vs. Karl Brandt et al. the Medical Case, or the Nazi 
Doctors Case, was based on the Agreement for the 
Prosecution and Punishment of the Major War Criminals of 
the European Axis, signed in London on August 8, 1945 by 
the United States, the United Kingdom, France, and the 
Soviet Union, which created the International Military 
Tribunal (IMT). The Nazi doctors were not tried by the IMT, 
but rather by a U.S. tribunal acting pursuant to Control 
Council Law No. 10, signed on 20 December 1945. 
 
The U.S. tribunal condemned all such harmful and fatal experiments and 
classified the experiments as crimes against humanity. These crimes were the 
result of Nazi doctors and scientists performing vile and potentially lethal 
medical experiments on concentration camp inmates and other living humans. 
The trials resulted in the conviction of 16 of the 23 physician defendants. Seven 
of those indicted were sentenced to death (Selton & Cengage, 2005). 
                                            
7
    Informed consent represents giving the research subject a clear appreciation and understanding of the 
facts of the research, the implications, and any foreseeable future consequences of the research 
procedures. In order to give informed consent, the individual concerned must have adequate reasoning 
faculties and have all relevant facts at the time consent is given. 45 CFR 46.116 of the Common Rule 
addresses informed consent. This term was first used in a 1957 medical malpractice case by Paul G. 
Gebhard. See  Salgo v. Leland Stanford etc. Bd. Trustees, 154 Cal.App.2d 560 [Civ. No. 17045. First Dist., 
Div. One. Oct. 22, 1957.]  
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 Shelton & Cengage further suggest the tribunal resulted in the judgment of 
principles that must be observed by medical researchers to satisfy moral, ethical, 
and legal concepts of research. The principles, as shown in Table 1, are known 
as the Nuremberg Code (see Appendix H). The tribunal espoused ten principles 
by which physicians must conform to when carrying out experiments on human 
subjects. The Nuremberg Code established additional standards of ethical 
medical behavior for the post-World War II human rights era (Annas & Grodin, 
1992)  
 Grodin (1992) suggests that the Nuremberg Code was the cornerstone of 
modern human experimentation ethics. Whereas, Rothman (2003) suggest there 
were little if any impact of the Nuremburg Trials on medical experimentation in 
the U.S. The harmful scientific research performed on humans in Germany had 
little, if any, impact on improving medical research practices in the U.S. 
(Rothman 2003). Rothman acknowledges that although twenty-three medical  
doctors and scientists were indicted for the atrocities, with seven of them being 
executed, the majority of American medical researchers did not find the German 
doctors‘ engagement in the unethical experimentation of human research 
subjects to be unscrupulous. 
 Annas & Grodin (1992) and Rothman (2003) put forward that German 
scientists and research doctors were trusted and revered scientists. Oakes 
(2002, p. 444) suggests that: 
Americans believed that its physician-researchers 
acted in accordance with their Hippocratic ideals and 
voluntary consent was unnecessary in a society with a 
long and untarnished history of medical research. 
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Table 1 
 
Principles of the Nuremberg Code 
 
1. 
Voluntary consent of the human subject is absolutely 
essential 
 
2. 
The experiment should be such as to yield fruitful 
results for the good of society 
 
3. 
The experiment should be so designed and based on 
the results of animal experimentation 
 
4. 
The experiment should be so conducted as to avoid 
all unnecessary physical and mental suffering and 
injury 
 
5. 
No experiment should be conducted where there is 
an a priori reason to believe that death or disabling 
injury will occur 
 
6. 
The degree of risk to be taken should never exceed 
that determined by the humanitarian importance of 
the problem to be solved by the experiment 
 
7. 
Proper preparations should be made and adequate 
facilities provided to protect the experimental subject 
against even remote possibilities of injury, disability, 
or death 
 
8. 
The experiment should be conducted only by 
scientifically qualified persons 
 
9. 
The human subject should be at liberty to bring the 
experiment to an end 
 
10. 
The scientist in charge must be prepared to 
terminate the experiment at any stage 
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American ethicists justified human research without the protections of informed 
consent given to subjects as unnecessary due to the need of experimentation for 
the persons own therapy; experimentation for the good of humanity in general, 
and experimentation to advance science (Oakes, 2002; Moreno, 2000; Vollman 
& Winau, 1996).  
Unethical Human Research in the United States 
Tuskegee Syphilis Study 
Jones (1993), Reverby (2009) and Washington (2006) suggest the forty 
year Tuskegee Syphilis Study conducted from 1932 until 1972, captures the 
unethical medical experimentation with humans in the United States after 
regulatory guidance of the Berlin Code and the aftermath of the Nuremberg 
Trials and the Nuremberg Code. The authors further suggest that the United 
States Public Health Service (PHS) continued to conduct unethical medical 
research.   
The Tuskegee Syphilis Study included medical research on 399 indigent 
men infected with syphilis. The men, black illiterate sharecroppers in Alabama, 
were never told by the medical researchers what disease they were suffering 
from or the seriousness of the disease. The research subjects became enrolled 
in the study without their knowledge or consent (Reverby, 2009; Jones, 1993; 
Moreno, 2000; Oakes, 2002; Washington 2006). Medical researchers told the 
men they were suffering from ―bad blood‖ instead of the disease of syphilis. 
The research doctors had no intention of treating the men for their illnesses 
(Jones, 1993; Washington, 2006; Oakes, 2002). Jones, Moreno and 
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Washington suggest that the men were left to expire with their disease in order 
that data could be collected from autopsies of their diseased bodies. One of the 
medical research team involved in the study explained, referring to the 
research subjects, ―As I see it we have no further interest in these patients until 
they die‖ (Washington, 2006, p. 164).  
The men died a slow and painful death without treatment being 
administered for their disease although penicillin had proven to be an effective 
treatment for syphilis in 1946 8 (Jones, 1993; Moreno, 2000). Medical research 
funding by the U.S. Public Health Office had been greatly increased for human 
subject research, although increased protections for subjects had not yet had 
been also put in place (LaFollette, 1994; Dubois, 2008). 
Increased Funding for Medical Research 
 Major Federal government financing of medical research appeared during 
World War II. Research funding escalated from $4 million to more than $100 
million between 1947 and 1957 while the National Institutes of Health (NIH), an 
agency of the Public Health Service, had grown from a budget of $8 million to 
over $1 billion by 1966 (Schrag, 2009). Under the same legislation that grew 
NIH‘s budget, the legislation also authorized the opening of a Clinical Center to 
―specifically provide researchers with people, some of them not even sick, on 
whom to experiment‖ (Schrag, 2009, p. 5). 
                                            
8
    In 1946, extensive trials with penicillin had demonstrated that the antibiotic was successful in curing 
syphilis. Supervising Physicians of the Tuskegee Study made certain that the experimental group were 
never to be given penicillin so as not ―to contaminate‖ the study as it was designed to determine the natural 
evolution of untreated chronic syphilis. 
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Schrag suggests Institutional Review Boards (IRBs) were formed to 
respond to the increased amount of medical research taking place in the United 
States. Although, as Schrag further suggests, the NIH had required their studies, 
having increased risk to subjects, be approved by their medical review committee 
with participating patients to be given written consent to participants in the 
studies. The NIH did not require signed informed consent from subjects 
participating in minimal risk studies as a condition for research institutions to 
receive Federal funding for their medical research projects. A comparable system 
of human research protection was recommended to be applied to all programs 
financially sponsored by NIH during the 1960s (Schrag, 2009).  
In 1966 medical research funded by the Public Health Service was 
required to undergo ―prior review‖ by institutional associates to insure research 
participants‘ protection of their rights and welfare (Gray, 1978). Pattullo (1985), 
Schrag (2009), and Oakes (2002) suggest that prior review was the first Federal 
prerequisite placed on institutions conducting research outside of the Federal 
government‘s agencies. Currently, all institutions receiving Federal funding are 
now required to have an institutional review committee (IRB) review and approve 
all medical and social science research projects before implementation of the 
research.  
Research with Vulnerable Populations in the United States  
In the United States biomedical researchers believed they were far 
removed from participating in unethical research atrocities as those perpetuated 
by Nazi doctors and scientists (Vanderpool, 1996). Vanderpool points out that 
10 
 
 
between 1946 and 1966 U.S. biomedical researchers ―resisted ethical and 
regulatory oversight‖ (p. 8). Beecher (1966) brought unprecedented attention to 
research practices in the United States involving unethical research practices in 
general and more specifically unethical research on children. Criticisms of 
unethical medical research practices involving children gained new attention 
(Vanderpool, 1996). The Willowbrook State Hospital study, as Rothman & 
Rothman (1984) note, is the most widely known unethical study on children. The 
Willowbrook Study involved children diagnosed with mental retardation, living at 
the Willowbrook State Hospital as patients from 1956 to 1971 (Levine, 1988). 
Researchers infected the otherwise healthy children with hepatitis to gauge its 
natural history, prevention, and treatment of the disease.  A public uncovering of 
the Willowbrook Study forced researchers to suspend the hepatitis research.  
Other fragile populations continued to be enrolled in unethical research 
studies in the U.S. (Faden & Beauchamp, 1986). The Jewish Chronic Disease 
Hospital Study, undertaken in 1963 included live cancer cells being injected into 
22 senile patients. The purpose of the research was to determine how a 
weakened immune system influenced the spread of cancer (Jones, 1993; 
Lederer, 1995). Patients were not informed of the research or asked to give their 
consent by the researchers about the experimental procedures of receiving live 
cancer cells. Researchers also neglected to get approval from the hospital‘s 
research committee or the patients‘ physicians or patients‘ legal guardians.  
According to Jones (1993) part of the researchers‘ defense was that there 
was no need to unnecessarily frighten the patient and their family with the details 
11 
 
 
of the research study.  The researchers conducting this study were tried and 
found guilty of fraud, deceit, and unprofessional conduct (Jones, 1993; Lederer, 
1995; Dubois, 2008). Still, unethical medical research practices continued 
(Dubois, 2008, Vanderpool, 1996). 
Congressional hearings produced the Kefauver-Harris Bill of 1962 as a 
result of pregnant women given birth to deformed infants in the United States, 
Canada, and Europe after being given the drug thalidomide. The experimental 
drug was given to women without their knowledge or consent. Originally 
developed to relieve nausea during pregnancy, the drug‘s birth defects of the 
fetus from the drug resulted in more than 12,000 severely deformed infants, 
many without limbs (National Center for Juvenile Justice [NCJJ]), n.d.). The 
Kefauver-Harris Bill required researchers to inform all subjects about impending 
risks and benefits of experimental drugs and to acquire consent from participants 
prior to taking part in the study (NCJJ, n.d.).  NCJJ notes that this bill was the first 
U.S. statute requiring informed consent. 
The NCJJ suggest the requirements of the Kefauver-Harris Bill did not 
―address the capacity of minors or adults with limited decision-making skills to 
make an informed decision‖ (para. 7) to participate in research activity. To 
address this issue, the World Medical Association issued the Declaration of 
Helsinki ( Appendix 1) in 1964, which required ―surrogate consent when the 
participant is incapable of decision-making (para.7). The Declaration of Helsinki 
(the Declaration) requires surrogate consent if minors and adults are to be 
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enrolled in a study  and, ―lack cognitive ability or emotional maturity to 
understand potential risk or harm associated with research participation‖ (para.8). 
The 1970s brought about much controversy over unethical medical 
research practices in general, and specifically the 40 year Tuskegee Syphilis 
Study (Caplan, 1992; Lederer & Grodin, 1994). Negative publicity of the studies 
garnered publication in medical journals, major newspapers, and discussions in 
Congress (Field & Berman, 2004; Goldman, 1973; Faden & Beauchamp, 1986; 
Lederer & Grodin, 1994). 
Human Research Regulatory Statutes in the United States 
National Research Act 
―While the 1947 Nuremberg Code was the world‘s reaction to Nazi war 
crimes, the 1974 National Research Act Public Law 93-348 (see Appendix J)  
was the response of the United States to the Tuskegee Syphilis Study‖ (NJCC, 
para. 8). The National Research Act established the IRB process requiring formal 
peer review and approval of all Department of Health and Human Services 
(DHHS) research involving human subjects (NCJJ, National Bioethics Advisory 
Committee (NBAC), 2001). 
NJCC and NBAC suggest that the 1974 National Research Act (Public 
Law 93-348) legislation also created the National Commission for the Protection 
of Human Subjects of Biomedical and Behavioral Research (National 
Commission).  The National Institutes of Health  
One of the charges to the Commission was to identify the 
basic ethical principles that should underlie the conduct 
of biomedical and behavioral research involving human 
subjects and to develop guidelines which should be 
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followed to assure that such research is conducted in 
accordance with those principles. In carrying out the 
above, the Commission was directed to consider: (i) the 
boundaries between biomedical and behavioral research 
and the accepted and routine practice of medicine, (ii) the 
role of assessment of risk-benefit criteria in the 
determination of the appropriateness of research 
involving human subjects, (iii) appropriate guidelines for 
the selection of human subjects for participation in such 
research and (iv) the nature and definition of informed 
consent in various research settings  
 (http://ohsr.od.nih.gov/guidelines/belmont.html, para. 1). 
The Belmont Report 
The Belmont Report serves as a statement of basic ethical principles and 
guidelines to assist in resolving ethical problems related to the conduct of 
research with human subjects. The basic tenets of the Belmont Report (see 
Appendix K) include three fundamental principles, respect for persons, 
beneficence, and justice.  
As a result of the 40 year Tuskegee Syphilis Study by the U.S. Public 
Health Service the Belmont Report was developed. The National Commission for 
the Protection of Human Subjects of Biomedical and Behavioral Research, 1974 
to 1978 revised and expanded 45 CFR 46 Subpart A (see Appendix L) to include 
principles of the Belmont Report. The National Commission's Report of ethical 
principles and guidelines for the protection of human subjects was published and 
was given the name, the Belmont Report for the Belmont Conference Center 
where the National Commission met to draft the report. Institutional peer review 
became a formal process to ensure compliance with the basic principles of the 
Belmont Report. 
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 However, the Belmont Report did have its critics regarding its applicability 
to nonmedical research. Schrag (2010) suggests that Albert Reiss, a prominent 
sociologist who participated in the 1976 conference that resulted in the National 
Commission‘s creation of the Belmont Report, ignored objections by social 
scientists participating in the recommendations to the document. Schrag notes 
that although the Belmont Report ―is a notable achievement in the exploration of 
the ethical challenges raised by medical research, but which serves as a poor 
guide to research in the social sciences and humanities …‖ (para. 2). The impact 
of the Belmont Report is discussed further in the section, Protecting Human 
Subjects Using Regulatory Standards. 
The Common Rule 
The National Commission recognized the need for a common Federal 
policy by recommending in 1991 that all Federal departments and agencies 
adopt a common core of regulations governing research with human subjects 
which was to be issued by the Department of Health and Human Services.  NCJJ 
suggested that the adoption of these ―common‖ regulations by 17 Federal 
departments and agencies became known as the Common Rule. The Code of 
Federal Regulations, Title 45 Public Welfare Department of Health and Human 
Services Part 46, Protection of Human Subjects (45 CFR 46) was adopted by 17 
Federal agencies and became known as the Common Rule because the rules 
are common to many Federal departments and agencies conducting human 
subjects research. Unethical use of human subjects in biomedical research in the 
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United States brought intervention from the Federal government that provided 
better protection for human research subjects (Pattullo, 1985).  
Although historical accounts of medical experimentation with human 
subjects identifies a history embedded in horrific pain, disfigurement, and death,9 
Muller (2007) suggests the literature does not bare the same historical unethical 
events for human subjects participating in social science research. 
Human Research Regulations and the “New Sciences” 
Although medical research was the initial focus of human research 
protection intervention by the Federal government, the ―new sciences,‖ 
anthropology, sociology, economics, and political science were also under 
scrutiny (Pattullo, p. 527). Tropp (1978) suggests that additional Federal policy to 
protect human research subjects emerged in the early 1970‘s regulating not only 
medical human research but also research activity of the social sciences. Yet, 
Singer & Levine (2002, p. 18) puts forward: 
Unlike clinical research, which at times involves the risk 
of physical injury and even death as a direct result of a 
research intervention, the most severe harms likely to 
befall subjects in social science research arise from 
potential breaches of the confidentiality of the data 
collected. Thus, for example, loss of job, criminal 
prosecution, and public humiliation are all potential 
consequences of revealing damaging information that a 
research subject has disclosed to an investigator. 
 
The authors suggest the kinds of limited harm social science research 
engenders is far less detrimental than that of biomedical research. Seemingly 
                                            
9
    Vivien Spitz. (2005). Doctors from Hell: The Horrific Account of Nazi Experiments on Humans. During the Nazi 
doctors‘ military tribunals Spitz, then a 22-year-old court reporter recounts the atrocities of 20 doctors and medical 
assistants‘ use of prisoners for horrific experimentation in German prisons. 
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―over-zealous medical scientist‖ has brought an increased level of scrutiny to 
social science research evidenced by governmental regulations (Patullo, 1985, p. 
524). Among noted social science unethical research includes: 
 The Harvard Drug Study (Weil, 1963) 
o Psychedelic drug research with students at Harvard University. 
 Tearoom Trade (Humphreys, 1970,) 
o Research to investigate who seeks quick, impersonal sexual 
gratification and the motives for doing so? 
 Stanford Prison Experiment (Zimbardo, 2007) 
o Investigation of the psychological effects of becoming a prisoner or 
prison guard. 
 Stanley Milgram Obedience Study (Milgram, 1974) 
o Research of the effect of authority on obedience 
 The literature suggests the amount of harm experienced by those 
participating in social science research has been negligible (Pattullo, 1985, 
Gunsalus et.al., 2004). Additionally, it is put forward that the fields of 
anthropology, journalism, oral history, ethnography and other social science 
fields already had well-established ethical research guidelines for their profession 
(Gunsalus et.al., 2004; Haggerty, 2004)). 
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Social Scientists’ Concerns of Overregulation 
As a result of the 1974 National Research Act, and the establishment of 
the National Commission for the Protection of Human Subjects of Biomedical and 
Behavioral Research both disciplines (biomedical and the social sciences) were 
subject to increased scrutiny. The Code of Federal Regulations, Title 45 Public 
Welfare Department of Health and Human Services Part 46, Protection of Human 
Subjects, the Common Rule10 (Subpart A of 45 CFR 46) in 1979 formally 
proposed that all human research including social science research be regulated 
by the same standards as biomedical research practice (Seiler & Murtha, 1980).  
The 1979 Federal Register (see Appendix M) proposed guidelines requiring all 
Federal funded social science research to receive institutional review board (IRB) 
review comparable to that of biomedical research. The Federal Register 
suggests that social science be included in the Federal regulations (Oakes 2002, 
p. 448; 44 FR 47688).  
Although the Federal Register includes social science research in the 
human subject research regulations, a number of social scientists saw the 
applicability of the federal regulations for the protection of research subjects to 
social science as ―being included by mistake‖ because there were no social 
scientist involved in the decision-making process to advocate for less restrictive 
regulatory standards of minimal and less than minimal research practices of 
social science researchers (Seiler & Murtha, 1980, p. 47). Seiler & Murtha 
                                            
10    The Common Rule which has been adopted by 17 government agencies proposes procedures for 
Institutional Review Boards, including the kinds of research which is exempt from their purview, and the 
kinds of research that should receive expedited review given there is minimal risk to participants.  Felice 
Levine of the American Sociological Association pointed out in recent testimony, there are ―growing fault 
lines in the system that protects human participants," and a ―gap has developed between law and policy on 
the books and in action. 
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suggest that there was ambiguity about how social science research became 
included for oversight in the federal human subject protection regulations. The 
authors note that documentation of discussions held did not address issues 
related to the less than minimal risk projects of social science research, including 
interviews, surveys, or oral history projects.  
The NBAC in 2001 proposed various efforts to strengthen the protection of 
humans participating in research regulated by the Common Rule, applying the 
tenets of biomedical human research protection to social science research. 
Gordon (2003) suggests that while these efforts to provide increased protections 
for human research participants reflect a laudable goal, the regulations do not 
necessarily apply or translate well to all disciplines of research, particularly social 
science research. Gordon further suggests that social science researchers 
commonly perceive the current and proposed human subjects regulations as 
obstacles to research for social scientists. Anthropologists and other social 
scientists typically encounter these obstacles at the point of obtaining IRB review 
and approval of their research protocol. As an example, IRBs require that human 
subjects research studies comply with the Common Rule by ensuring primarily 
that the benefits of participation in research outweigh the risks to subjects, and 
that subjects are consented by way of written informed consent in most cases 
prior to participation in the research. For anthropological projects and other social 
science projects these requirements can present unattainable conditions (White, 
2007; Hamberger, 2005).   
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Seiler & Murtha (1980) suggests that regulations and interpretations of the 
regulations are modeled heavily in the biomedical standards of research. The 
authors propose that the biomedical model of human research protection does 
not necessarily conform to social science approaches toward research. White 
(2007, p. 548) articulates the concerns of social science researchers in stating: 
The government‘s continued reliance on monopolistic, 
one-size-fits-all institutionalized solutions such as the 
IRB process clearly threatens the future of behavioral 
science, if not of biomedical science, by overloading the 
system with paperwork and by wasting the time, effort 
and resources of everyone involved, including 
researchers, board members, students, teachers and 
government officials. 
 
Social scientists puts forward that the Common Rule may not be fully applicable 
to anthropological and other social science research (Mueller, 2007; De Vries; 
DeBruin & Goodgame, 2000). They suggest that there is no evidence of 
enhanced safety for research participants of social science research when the 
one- size-fits-all regulations of the Common Rule are applied to the review and 
approval of their research projects.   
 Mueller (2007) suggests dissatisfaction and frustration with the system of 
applying biomedical regulations of research to social scientist research projects. 
Much of the frustration he suggest, centers on describing how risk is interpreted 
in biomedical terms, thereby making it difficult to apply the Common Rule to 
social science research. Social science researchers express high levels of 
concern of overregulation and mission creep as a result of applying biomedical 
regulations to social science research (White, 2007; Schrag, 2009; Mueller, 
2007; De Vries et al., 2004).   
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Haggerty (2004) suggests that IRBs are the instruments of a system of 
licensing in which scholars, students and other researchers must get permission 
to conduct research with human subjects. He suggests that IRBs are far more 
dangerous than the research they review and they offer little if any protection for 
human subjects. Rothman (1995) suggests that IRB‘s and their staff may not 
have adequate education and training in pertinent regulations; therefore 
inappropriate burdens may be placed on researchers. Similarly, excessive 
documentation procedures rather than providing guidance in the interpretation of 
the regulations amount to the overregulation and less protection for research 
subjects (Hamilton, 2004; Gunsalus, 2004).   
 Burris & Welsh (2007) characterize IRBs as a regulatory system that often 
distracts from rather than focus on key ethical concerns. Zywicki (2007) suggests 
that ―IRBs have become a ubiquitous presence on the landscape of America‘s 
higher education system‖ using a system of review of research projects which 
suggests a one-size-fits-all approach (p. 861). Zywicki proposes that IRBs have 
been extensively criticized as inefficient, obstructionist, and indifferent to the 
researchers‘ needs. He suggests that IRBs are ineffective at protecting the safety 
and ethical concerns of research participants because of excessive regulations 
required in biomedical and behavioral research.  
De Vries et al. (2004, October) propose that although the Common Rule at 
§46.117(c) state that the IRB may waive the requirement for the investigator to 
obtain a signed informed consent for some or all subjects if it finds that either: 
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(1) That the only record linking the subject and the research would 
be the consent document and the principal risk would be potential 
harm resulting from a breach in confidentiality. Each subject will be 
asked whether the subject wants documentation linking the subject 
with the research, and the subject's wishes will govern; or  
(2) That the research presents no more than minimal risk of harm to 
subjects and involves no procedures for which written consent is 
normally required outside of the research context.   
 De Vries; Debruin; & Goodgame propose that although the waiver of 
signed informed consent included in the regulation is a useful exception, 
beneficial to carrying out social science research, the institutions‘ administrative 
bureaucracy of legal cover insists that documented written consent be obtained 
from participants, even if they cannot write their names. The authors also 
suggest that documentation of legal consent is to cover the institution, not to 
provide additional protection for the research participant. Similarly, White (2007) 
agrees that the waiver is useful to accommodate minimal risk research projects, 
as most social behavioral research represent; however, some human research 
protection programs are reluctant to utilize such provisions as the waiver of 
signed documentation in the protocol review and approval process. 
Agreeing with some of the criticisms of social science researchers, the 
NBAC in 2001 criticized Institutional Review Boards for being grossly 
overwhelmed by tremendous workloads, scarce resources, and by a regulatory 
system that routinely distracts from, rather than focuses on more relevant and 
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important ethical issues. Criticisms by researchers of the practices of their IRB 
have appeared repeatedly in the literature for the last four decades as 
documented by the authors cited. The NBAC (2001) suggest that federal 
regulators‘ emphasis on procedure and documentation as contributing factors for 
the creation of a climate of hostility and noncompliance in which the review of 
research becomes an exercise in avoiding sanctions and liability rather than in 
maintaining appropriate ethical standards and protecting human research 
participants.  
De Vries et al. (2004); Gunsalus et al. (2004); and Wax (2000) also 
suggests that IRBs may be overly zealous in their interpretation and application 
of federal guidelines for conducting research with human subjects, exacerbating 
the challenges faced by social science researchers seeking IRB approval for 
their research projects. Professor of anthropology, Murray Wax, in his testimony 
before President Clinton's National Bioethics Advisory Commission stated:  
The gravest ethical problem facing the people 
studied by anthropological research is posed by 
unknowing and overzealous IRBs and by 
governmental regulators attempting to force 
qualitative ethnographic studies into a biomedical 
mold (NBAC, 2000, p. 95). 
 
White (2007) suggests that patterns of noncompliance and litigation are 
not seen in social science research as in biomedical or clinical research. He 
suggests that applying similar rules of biomedical research, with no subject being 
harmed, amounts to IRB mission creep. White further suggests that mission 
creep is due to OHRP‘s oversight based in the need for documented 
administrative procedures, not explicit unethical researcher implementation of the 
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research project. Gunsalus et al. (2007) refers to mission creep as detailed in the 
Illinois White Paper, Improving the System for Protecting Human Subjects: 
Counteracting IRB “Mission Creep” as a crisis being caused by the increased 
workload for IRBs and HRPP‘s inability to handle the workload effectively. 
Therefore, the emphasis is placed on the less difficult path of focusing more on 
procedures and documentation rather than difficult ethical issues presented in 
research studies.  
Gunsalus et al. suggest that the institutions‘ efforts to comply with federal 
requirements, even when research is minimal risk, amounts to exaggerated 
precautions to protect against program shutdowns, and efforts to protect the 
institution and institutional review boards against lawsuits. The concerns of social 
science researchers of overregulation and mission creep, permeates the 
literature. These concerns have given impetus to investigate the impact of 
regulating social science research with biomedical regulations.  
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Research Problem 
The literature supports the premise of protecting research participants 
from the risks and harms of research. Regulatory policy has provided guidelines 
to ensure research risk is minimized, although it is widely perceived that the 
system of human research protection needs improvement. The literature has 
consistently revealed social scientists‘ concern of regulating social science 
research using research standards assembled from for biomedical research 
practices. The Common Rule in its application to social science research, social 
scientists suggests, result in overregulation and mission creep. 
The research problem is to test the critical assessment of the Common 
Rule‘s impact of applying biomedical research standards for minimal risk social 
science research. 
Research Questions 
The research questions for this study include the following: 
1. What are the findings of deficiencies and findings of 
noncompliance indicated in OHRP determination letters (DL) for 
social science research projects?  
2. What impact does the Common Rule have on social science 
research protocol review by human research protection 
programs? 
3. Has the Common Rule achieved its intended purpose of 
protecting human research subjects participating in social 
science research? 
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Research Method 
Data collection and analysis include three research methods  
1. Content analysis of public documents (determination letters) 
issued by the Office of Human Research Protection; 
2. In-depth interviews of human research protection program 
administrators; and 
3. Policy evaluation of Federal Policy 45 CFR 46, Subpart A, the 
Common Rule. 
Content Analysis 
Gathering and analyzing documents that are produced in the course of 
everyday events is what Marshall & Rossman (1999) proposes as unobtrusive 
research.  Babbie (2004) suggests unobtrusive research is a method of studying  
social behavior without affecting it. Bogden & Biken (2003, p. 128) suggests that 
external documents like those available to the public are more effective for the 
researcher if it is known who produced the documents and for what reason they 
were produced. Having this knowledge can better place documents in social 
context. Babbie (2004) further suggests that content analysis is used to study 
human communication that has been recorded.  He provides as an example, 
letters. Letters are documents well suited to content analysis, giving the 
researcher the ability to answer: "Who says what, to whom, why, how, and with 
what effect (p. 314).  
Qualitative content analysis method is used to analyze OHRP public 
documents (determination letters). The goal of content analysis is to provide 
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knowledge and understanding of the phenomenon (Weber, 1990). Weber 
additionally suggests that qualitative content analysis is one of many research 
methods used to analyze text data and that it can be used to examine and 
classify large amounts of text into efficient number of categories. Qualitative 
content analysis is the study of human communications in the forms art, songs, 
collections and a host of categories of texts such as newspapers, books, letters, 
speeches (Weber 1990).  
Cavanagh (1997) suggests that researchers find content analysis a 
flexible method for analyzing text data. Conversely, Tesch (1991) suggests that 
the flexibility that has made content analysis useful on one hand provides 
constraints to a firm definition of procedures resulting in limited application of 
content analysis. Whereas, Weber (1990) suggest, the specific type of content 
analysis approach used by the researcher depends on the theoretical and 
substantive interests and the problem being studied by the researcher. 
Additionally, Holsti (1969, p. 608) legitimizes the methods of content analysis as 
a ―technique for making inferences by systematically and objectively identifying 
special characteristics of messages." Thus, content analysis is reasonable 
method for conducting inquiry (Weber, 1990; Babbie, 2004; Holsti, 1969; Lincoln 
& Guba, 2000).  
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In-Depth Interviews 
 In-depth interviewing is a qualitative research technique that involves 
conducting individual interviews with a small number of respondents to explore 
their perspectives on a particular idea, program, or situation (Boyce & Neale, 
2006). The authors suggest that in-depth interviews are useful when detailed 
information about a person‘s experiences and behaviors are sought (p. 3). 
Additionally, Boyce & Neale (2006) and Patton (2002) suggest that in-depth  
interviews are used to provide context to other data to assist in providing 
additional information to complete the picture of what is happening in a particular 
phenomenon.  Marshall & Rossman, 1999 suggest that in-depth interviewing 
may be the overall research method or one of several methods used in a study 
and the researcher must understand the advantages as well as disadvantages to 
in-depth interviewing.  
The purpose of the in-depth interviews implemented in this study is to 
better comprehend HRPP administrators experiences in applying the tenets of 
the Common Rule to minimal risk social science research.  Marshall and 
Rossman suggest that in-depth interviews are like conversations that ―uncover 
the participants views but otherwise respects how the participant frames and 
structures the responses" (p. 108). Although some systematization may be 
necessary to guide the questioning, it is the participant‘s perspective of the 
phenomenon of interests that should become apparent as the interview unfolds 
(Marshall & Rossman, 1999). In-depth interviews allow the researcher to 
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investigate complex topics and allow for ideas to emerge that have not been 
predetermined by the researcher (Berg, 2006; Denzin & Lincoln, 2005). 
Policy Evaluation 
  Torgerson (1985) and Shapiro & Schroeder (2008) identify Lasswell as 
the founder of the policy science field. Lasswell, defined policy science 
orientation utilizing three characteristics (1) a multi- disciplinary approach, (2) 
problem oriented focus that is contextual in nature and (3) and explicitly 
normative orientation. These characteristics provide the additional framework of 
foundation to utilize Fischer‘s interrelated discourses for policy evaluation 
In Fischer‘s Four Discourses of Policy Evaluation, Fischer (1995) suggest 
that regardless if one seeks to document accomplishments of a policy or criticize 
its failures, policy evaluation has emerged as an important component of the 
policymaking process in American government. Bryne (1987) and Fischer (1995) 
suggest that policy analysis asks the question of whether or not a policy 
accomplishes its stated purposes. Fischer (2003) posits that policy evaluation 
can also take the form of cost benefit analysis. He suggests that the logic of cost-
benefit analysis involves a compilation of costs and benefits of a policy to 
determine its net value. Although, he suggests that cost-benefit analysis has 
been the subject of theoretical and practical disagreement because of its difficulty 
in quantifying policy inputs and policy outputs. Fischer (2003) further suggests 
that ―the technique systematically underplays social objectives that cannot easily 
be measured in quantitative terms‖ (p. 116).  
Utilizing Fischer's (1995) framework of practical informal logic of policy 
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deliberation (which he uses synonymously with the ‗logic of policy evaluation‘), 
this descriptive study is organized around the basic discursive components of 
four interrelated discourses being viewed from a qualitative lens.  
 Technical/Analytic Discourse (Program Verification): does the 
program empirically fulfill its stated objectives? 
 Contextual Discourse (Situational Validation [Objectives]): are the 
program objectives relevant to the program situation? 
 Systems Discourse (Societal Vindication [Goals]): does the policy 
goal have instrumental or contributive value for the society as a 
whole? 
 Ideological Discourse (Social Choice [Values]): do the fundamental 
ideas (or ideology) that organizes the accepted social order provide 
a basis for a legitimate resolution of conflicting judgments?  
Title 45 CFR 46, Subpart A, the Common Rule is the focus of policy evaluation 
utilizing Fischer's Four Steps of Analysis.  
Complementary Analysis Research Method Application (CARMA) 
 The literature suggest, Putney, Wink & Perkins (2006) originally 
implemented Critical Action Research Matrix Application also called CARMA as 
an inquiry tool to assess transparency of practices and the implementation of 
classroom activities (p. 4). Putney suggest that CARMA can be used to evaluate 
programs for their effectiveness as shown in Table 2). Jezierska (2009) in 
collaboration with the principal author, Putney (2008) adapted the Critical Action 
Research Matrix Application as the Complementary Analysis Research Method 
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Application (CARMA) for use in policy assessment. It is Jezierska‘s work in 
collaboration with Dr. Putney that lays the foundation for using the  
Complementary Analysis Research Method Application tool to assess the 
implementation and viability of the qualitative research method of analyzing the 
Common Rule. 
CARMA is a flexible and natural tool to assist in the analysis process of 
the target populations intended to utilize the Common Rule and to assist the 
researcher to perceive the tangential impact of the Common Rule on social 
science and to identify elements of the Common Rule to support the tenets of 
social science research. Using a four tier matrix including; 1) Policy Expectations; 
2) Evident Implementation; 3) Results; 4) Recommendations, information is input 
into the CARMA Matrix in combination with the framework of Fischer‘s Four 
Discourses of Policy Evaluation to be analyzed. Putney (2008) suggests  
flexibility of CARMA lends its evaluation technique to components of this 
investigation.  
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Table 2 
 
Complementary Analysis Research Method Application (CARMA) 
 
1 
Determination 
Letter 
Expectations 
 
NOTE-
TAKING 
2 
Evident 
Implementation 
 
 
NOTE-TAKING 
3 
Results 
 
 
 
NOTE-
MAKING 
4 
Conclusions/ 
Recommendation
s 
 
 
NOTE-
REMAKING 
Initiators  Users/ 
Participants  
Compare/ 
Contrast 
expected with 
evident  
 
Evaluator 
Interpretations  
Who is being 
served?  
Who is 
involved?  
Who are evident 
participants?  
Expected vs. 
Evident  
What are the 
implications?  
Modify or 
maintain 
program?  
 
How are 
participants to 
be served?  
How are 
participants 
using the 
service?  
Expected vs. 
Evident  
What are the 
implications?  
Modify or 
maintain 
program?  
 
What will be 
produced by 
participants in 
the program?  
What was 
produced by 
participants in 
the program?  
Expected vs. 
Evident  
What are the 
implications?  
Modify or 
maintain 
program?  
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Limitations of the Study  
Researcher bias is a threat to the validity of conclusions drawn from the 
data of this qualitative study. For nearly 10 years the researcher of this study has 
served in the role of HRPP Administrator of a doctoral granting academic 
research institution which conducts biomedical and social science research. In 
addition the researcher has conducted social science research, having the 
projects reviewed and approved by the IRB at a doctoral granting academic 
research institution. Miles & Huberman (1994, p. 263) suggests that qualitative 
data that fit the existing theory and preconception of the data selected and the 
data that ―stand out‖ to the researcher is a threat to qualitative conclusions.   
Although the researcher‘s theories, beliefs and perceptual lens can never 
be fully eliminated, it is the explanation of the possible biases and how they will 
be dealt with nonetheless that should be revealed in the study (Maxwell, 2005). 
Berg and Smith (1988) puts forward that qualitative researchers have  a 
responsibility to science and their research participants which includes  
examining and reexamining their studies for their connection with their research 
as they ―formulate ideas, collect and interpret data and build theory‖ (p. 11). It is 
with these understandings that the researcher pursues this study. 
The additional limitations of this study are presented in a three pronged 
methodological approach of 1) content analysis of determination letters, 2) in-
depth interviews of HRPP Administrators and 3) policy, analysis of the Common 
Rule.  
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 Content analysis of determination letters: Tesch (1991) suggests 
that the flexibility that has made content analysis useful on one 
hand provides constraints to a firm definition of procedures 
resulting in limited application of content analysis. Determination 
letters most often address ethical violations and deficiencies of 
federal agency funded research projects, whether biomedical or 
social science research projects. A large portion of social science 
research is unfunded. As the intent of the qualitative content 
analysis is to identify determination letters applicable to the social 
sciences which contain research violations or deficiencies, the 
sample may be small and not generalizable.  
 In-depth Interviews: The limitation created by inclusive bias can 
impact the analysis of the data. Inclusive bias occurs when samples 
are selected for convenience. This type of bias is often a result of 
convenience where samples tend to fit a narrow demographic 
range. In this study HRPP Administrators are a narrow 
demographic range. Inclusive bias samples do not present concern, 
as long as the researcher is aware that the results cannot be 
extrapolated to fit the entire population of that demographic. 
Therefore the information extrapolated is not generalizable.  
 Evaluation of the Common Rule policy: Fischer (1995) suggests 
that although the policy evaluation process may be narrowed to 
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specific facets of the policy no absolute criterion exists to ensure 
the position of the evaluation method.  
The characteristics which limit and delimit the scope of this research 
project and define its boundaries and serve to enhance the overall quality of the 
data to be analyzed. These include the practice of OHRP in providing 
determination letters to institutions and researchers in many disciplines. OHRP 
regularly corresponds with hospitals, pharmaceuticals, medical teaching 
institutions, academic institutions and others. Correspondence to academic 
institutions from January 2000 to June 2010 is a delimitation to the study, I‘m 
ready used to the exclusion of other agencies or institutions OHRP sends 
determination letters. With the focus of this study concerned with social science 
research projects, these projects can be found in greater numbers at doctoral, 
profession dominant institutions (Doc/Prof).   
The Carnegie Foundation classifies Doc/Prof institutions as those 
institutions that award doctoral degrees in a range of fields such as education, 
public policy, and social work. The institutions may also offer professional 
education in law, and medicine11. Doc/Prof institutions are a delimitation to this 
study. Therefore, some entities are omitted for the reason that they are not 
directly relevant to this study. Furthermore, human research administrators are 
recruited from academic institutions sent determination letters reviewed in this 
study. An additional administrator is recruited from a DOC/Prof institution. 
                                            
11
    Carnegie classifications can be found at: 
(http://classifications.carnegiefoundation.org/descriptions/grad_program.php) 
35 
 
 
Six HRPP administrators are selected for the study. All HRPP 
administrators have more than five years training and experience in the human 
research protections field of work and are considered to have adequate 
knowledge of the tenets of the Common Rule. Over a five year period knowledge 
gained from professional conferences and workshops, and day to day duties in 
the role of HRPP administrator is considered adequate to garner understanding 
of the Common Rule in its application to social science research.12  HRPP 
administrators are selected due to their knowledge of the Common Rule by way 
of their professional training, their consistent contact with social scientists and 
social science research projects submitted to their HRPP to be reviewed and 
approval by the IRB. HRPP administrators are obligated to pursue a course of 
action in creating a culture of research compliance to assist the IRB by 
developing institutional human research compliance policies based on the 
policies of the Common Rule. HRPP administrators using the Common Rule as 
the basis for their institutional policies, could reasonably be a population in which 
the results of this study could be generalizable to the specific group. 
  
                                            
12
 The IRB Forum (at: http://irbforum.org) routinely post job positions for HRPP 
Directors/Administrators that require five years or more experience to be considered for the 
position.  prior experience to be success. 
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Definitions 
Assurance: A formal written, binding commitment that is submitted to a 
federal agency in which an institution agrees to comply with applicable 
regulations governing research with human subjects and stipulates the 
procedures through which compliance will be achieved, (Office of 
Human Research Protection)  
Behavioral and social science research: The Office of Behavioral and 
Social Science Research13 defines behavioral and social research in 
part as an assortment of methodological approaches including: 
surveys and questionnaires, interviews, direct observation, 
physiological manipulations and recording, descriptive methods, 
laboratory and field experiments, standardized tests, economic 
analyses, statistical modeling, ethnography, and evaluation. Social 
science is used interchangeably with behavioral science. 
Belmont Report: A statement of basic ethical principles governing 
research involving human subjects, issued in 1978 by the National 
Commission for the Protection of Human Subjects of Biomedical and 
Behavioral Research.  
Biomedical Science: ―the application of the principles of the natural 
sciences to medicine‖ (Bankert & Amdur, 2006, p. 87)  
Human Subjects: Individuals whose physiologic or behavioral 
characteristics and responses are the object of study in a research 
                                            
13
   The Office of Behavioral and Social Sciences Research (OBSSR) established by Congress opened in 
1995. 
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project. The Federal Regulations define human subjects: living 
individual(s) about whom an investigator conducting research obtains: 
(1) data through intervention or interaction with the individual; or (2) 
identifiable private information.  
Informed Consent: A person's voluntary agreement, based on adequate 
knowledge and understanding of relevant information, to participate in 
research or to undergo a diagnostic, therapeutic, or preventive 
procedure. In giving informed consent, subjects may not waive or 
appear to waive any of their legal rights, or release or appear to 
release the investigator, the sponsor, the institution or agents thereof 
from liability for negligence (Amdur & Bankert, 2006). 
Institutional Review Board (IRB): A specially constituted, federally 
mandated review body established or designated by an entity to 
protect the welfare of human subjects recruited to participate in 
biomedical or behavioral research (Amdur & Bankert, 2006).  
Minimal Risk: The Common Rule describes minimal risk as the probability 
and magnitude of harm or discomfort anticipated in the proposed 
research are not greater, in and of themselves, than those ordinarily 
encountered in daily life or during the performance of routine physical 
or psychological examinations or tests. For example, the risk of 
drawing a small amount of blood from a healthy individual for research 
purposes is no greater than the risk of doing so as part of routine 
physical examination. 
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Mission Creep: Defined by Gunsalus et al. (2007) as the result of the 
workload of IRBs that has expanded ―beyond their ability to handle 
effectively.‖ Mission creep they suggest is caused by ―rewarding wrong 
behaviors, such as focusing more on procedures and documentation 
than difficult ethical questions; unclear definitions, which lead to 
unclear responsibilities; efforts to comply with unwieldy federal 
requirements even when research is not federally funded; exaggerated 
precautions to protect against program shutdowns; and efforts to 
protect against lawsuits (p. 2). 
Protocol: The formal design or plan of an experiment or research activity; 
specifically, the plan submitted to an IRB for review and to an agency 
for research support. The protocol includes a description of the 
research design or methodology to be employed, the eligibility 
requirements for prospective subjects and controls, the treatment 
regimen(s), and the proposed methods of analysis that will be 
performed on the collected data. 
Research: A systematic investigation (i.e., the gathering and analysis of 
information) designed to develop or contribute to generalizable 
knowledge (the Common Rule). 
Risk: The probability of harm or injury (physical, psychological, social, or 
economic) occurring as a result of participation in a research study. 
Both the probability and magnitude of possible harm may vary from 
minimal to significant. Federal Regulations define only "minimal risk."  
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Social Science: Branches of social science include anthropology; 
economics; education; geography; history; law; linguistics; political 
science; public administration; psychology; sociology (Rule, 1997).    
Significance of the Study 
The significance of the study is to provide increased knowledge of the 
impact of the Common Rule for social science research. This study may ground 
criticisms of a ―one-size-fits-all‖ regulatory policy (the Common Rule) as well as 
determine the merit to the assertion. This study can provide the basis for 
additional research to recommend policy changes as a result of the findings of 
this study for more adaptable regulatory standards for social science research. 
Additionally, the study can provide a foundation for further research in the area of 
human research protection policy for federal agencies and academic research 
institutions. This research is needed to assess public documents held by the 
regulating authority OHRP and associated with their determination and findings 
of social science research projects. HRPP Administrative Administrators‘ 
assessment of utilizing a biomedical human research approach to evaluate the 
ethicality of social science research regulatory standards provide insight to the 
criticism of overregulation and mission creep. Finally this study can assist in 
better clarification of the Common Rule's applicability to and impact on social 
science research. 
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Summary 
 The Introduction of this study provides the historical framework of human 
subject research and human research protections from 6 B.C. to the present. The 
research problem of the study suggests there is a need to test the critical 
assessment of the Common Rule in its application to the social science research. 
The research questions of 1) what are the findings of deficiencies and findings of 
noncompliance indicated in OHRP determination letters (DL) for social science 
research projects,  2) what impact does the Common Rule have on social 
science research protocol review by human research protection programs,  
 and 3) has the Common Rule achieved its intended purpose of protecting 
human research subjects participating in social science research.  
 The methods used to address the research questions are, content analysis of 
public documents, in-depth interviews of human research protection program 
administrators and policy evaluation of Federal Policy 45 CFR 46, Subpart A 
using Fischer‘s (1994) Four Discourses of Public Policy Evaluation, and Putney‘s 
(2008) Complementary Analysis Research Method Application.  
The study includes a small sample size of HRPP directors which is not 
generalizable to an entire population but could be generalizable to the specific 
population of HRPP Directors, and researcher bias. Researchers suggest having 
social science research viewed through the regulatory eyes of biomedical 
expectations of risks has implications of unnecessary time barriers and cost to 
researchers, high workload for IRBs and their administrative support staff, as well 
as offering little if any additional protection for research subjects of behavioral 
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research14. The significance of the study is to provide increased knowledge of the 
impact of the Common Rule for social science research. Additionally, the study 
can provide a foundation for further research in the area of human research 
protection policy for federal agencies and academic research institutions.  
This research is needed to assess public documents held by the 
regulating authority OHRP, as they are related to the determination and findings 
of social science research projects. HRPP Administrators‘ assessments of 
utilizing a biomedical human research approach to evaluate the ethicality of 
social science research regulatory standards are assessed. Finally this study can 
assist in better clarification of the Common Rule's applicability to and impact on 
social science research.  
Although there has been much anecdotal comment in the literature on the 
topic of the application of a one-size-fits-all approach to regulating social science 
research with biomedical regulations, it is not apparent in the literature that 
empirical research has been conducted to substantiate the regulatory premise 
that social science research participants are better protected as a result of the 
one- size- fits-all Common Rule. 
                                            
14
    The Illinois White Paper out of the Center for Advanced Study at the University of Illinois at Urbana-
Champaign resulted in much controversy of IRB‘s and mission creep ,see Gunsalus, 2005. 
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Chapter 2 
Review of Literature 
 This Chapter presents a review of the literature related to social scientists‘ 
concerns of what in the literature is called over-regulation and mission creep in 
its application to the Common Rule. The Chapter will document the historical 
perspectives of unethical human experimentation as well as the regulatory 
standards put in place to protect human subjects. In addition, the Chapter will 
discuss prior research related to researcher and institutional human research 
compliance while outlining the necessity to investigate the impact of social 
science research that is regulated by a medical model of human research 
protections. 
 Gunsalus et al. (2007) puts forward that ―IRBs blizzard of paperwork is 
getting in the way of the fundamental mission: to protect the dignity and well-
being of human subjects‖ (p. 4). Institutional Review Board (IRB) workloads have 
expanded beyond their ability to handle, due to focusing much more on 
procedures and documentation, unclear definitions, leading to unclear 
responsibilities and efforts to comply with the standards of human research 
requirements even when research is not federally funded (Schrag, 2009, Lincoln 
& Tierney, 2002).  
 The overzealous responses and exaggerated precautions to protect 
against program shutdowns and lawsuits is what Gunsalus et al. have referred to 
as mission creep. Shweder (2006) posits that projects that are not federally 
funded and ―are not mandated for IRB review are under the federal surveillance 
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system‖ by IRBs (p. 507). Moreover, the increased scrutiny indirectly ―generates 
a bias favoring overregulation or mission creep‖ (p. 515).  
The concerns of social science researchers reflect the premise of 
overregulation. Gunsalus et al. suggests that: 
Without any systematic data or evidence of a problem, or 
even a thoughtful analysis of costs and benefits, the 
application of the human participant review system within 
universities is overreaching at the same time that some risky 
experimentation on humans outside of universities is 
unregulated… In too many cases, the focus is on form over 
ethical substance: counting what can be counted, rather than 
focusing instead on what counts. Some disciplines—oral 
history and journalism, for example—simply do not belong 
within the scope of institutional review board jurisdiction. 
Others, such as survey research, informational interviews, 
and informal interactions, call for a shift from centralized 
review to more departmentally based (i.e., rooted in 
disciplinary ethics) oversight, and clearer guidelines on what 
requires advance review as opposed to provision of post hoc 
complaint systems.        
 
Fox (1994), Faden & Beauchamp (1986), and Schrag (2009) concur with 
Gunsalus (2007) in his interpretation of the concerns related to overregulation. 
Although substantial social benefits have been produced by scientific research, it 
has also posed troubling ethical issues of noncompliance and deficiencies 
(Oakes, 2002; Jones, 1993; Edwards & Mauther, 2002; Dubois, 2008). Medical 
research has presented an abundance of physical and ethical risks to human 
subjects (Dubois, 2008; Advisory Committee on Human Radiation Experiments, 
1995; Ashcroft & Kirchin, 2004).  To address the physical and ethical violations 
once seen in medical research the regulatory standards by which appointed 
Institutional Review Boards review, approve and oversee human research is the 
Common Rule (Alvino, 2003; Schrag, 2009).  
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Aita & Richer (2005) suggests that the foundations of research ethics has 
been a result of the biomedical and social sciences fields, saying that the ―ethical 
principles related to human subjects‘ well-being emerged mostly with biomedical 
research while issues related to human rights are from the social sciences‖ (p. 
120). Although there is little question that those involved in social science 
research do not want the human rights of their research participants abdicated 
and that there must be protections against unethical research, social scientists 
have found that utilizing the current biomedical system of human research 
protections result in incongruence of the application of biomedical regulations for 
social science research projects (Gunsalus et al., 2004; Braxton & Bayer, 1994; 
De Vries et al., 2004).  
Social science researchers characterize their concerns as overregulation 
and mission creep resulting from the application of a regulatory process created 
for medical research being applied to non-invasive and minimal risk social 
science research, that usually is unfunded or privately funded (Oakes, 2002; 
Gunsalus et al., 2007). The authors suggest the premise of overregulation put 
forward by social science researchers, lays foundation for inquiry of regulating 
behavioral science research with biomedical science regulatory standards. 
Gunsalus et al. (2007) suggest the result human research overregulation 
can and do result in unintended consequences for the researcher and their 
institution‘s human research protection program (HRPP). Social science 
researchers express increased concern of overregulation and mission creep, 
putting forth that increased documentation requirements by HRPPs appears to 
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have no additional protections for human participants of social science research, 
but serve to delay and even deny research projects (Gunsalus et al., 2007; 
White, 2007; Candilis et al., 2006; Coleman, 2004). 
To better understand the impetus for the emergence of Federal 
Regulations to protect human research participants, historical perspectives on 
human experimentation are presented. The historical accounts of human 
experimentation provide background for additional perspective of the ethical 
concerns involved in human experimentation and research regulation in the 
United States.  The majority of social science researchers‘ concerns focused on 
overregulation and mission creep suggests the need to evaluate the impact of 
the Common Rule on social science research. The review of literature applicable 
to this study include the following topics: 
 Historical Perspectives on Unethical Human Experimentation  
 Protecting Human Subjects with Regulatory Standards 
 Berlin Code 
 Nuremberg Code 
 Declaration of Helsinki 
 Belmont Report 
 Common Rule 
 National Commission for the Protection of Human Subjects of 
Biomedical and Behavioral Research  
 National Bioethics Advisory Commission  
 Office of Human Research Protection (OHRP) 
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 Determination Letters 
 Human Research Protection Program (HRPP) 
 Institutional Review Boards (IRB) 
 IRB Administrative IRB Support Staff  
 Social Science Research 
 Overregulation/ Mission Creep   
 Intent and Impact of Policy  
Historical Perspectives of Unethical Human Experimentation 
 Throughout the centuries human experimentation has been constant, as 
shown in Table 3. Human experimentation in the eighteenth century included 
regular offers of free pardon to inmates to participate in human experiments 
(Sade, 2003). One such experiment included the inoculation of prisoners with 
infectious smallpox in variolation experimentation (Morgan & Parker, 2007). 
Variolation was a method of immunizing humans against smallpox by infecting 
them with the pustules of infected human subjects. The method was popularized 
in England in 1721-1722.   
 In America, Cotton Mather (1663-1728) used variolation experimental 
method on slaves (Washington, 2006, p. 72). Selgelid (2003) suggests that in 
1900 as scientific information expanded, questions of unethical medical research 
practices emerged with regularity. In Berlin, Germany, the medical practice of  
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Table 3   
Historical Events in Unethical Human Experimentation 
 
Date Event 
1796 Edward Jenner injects healthy eight-year-old first with cowpox then three 
months later with smallpox and is hailed as discoverer of smallpox vaccine 
1845-
1849 
J. Marion Sims, "the father of gynecology" performed multiple experimental 
surgeries on enslaved African women without the benefit of anesthesia. After 
suffering unimaginable pain, many lost their lives to infection 
1900 Walter Reed injects 22 Spanish immigrant workers in Cuba with the agent for 
yellow fever paying them $100 if they survive and $200 if they contract the 
disease 
1919-
1922 
Walter Reed injects 22 Spanish immigrant workers in Cuba with the agent for 
yellow fever paying them $100 if they survive and $200 if they contract the 
disease 
1932-
1972 
The Tuskegee Syphilis Study, sponsored by the U.S. Department of Health. 
Studied the effects of untreated syphilis in 400 African American men. 
Researchers withheld treatment even when penicillin became widely available. 
Researchers did not tell the subjects that they were in an experiment. Most 
subjects who attended the Tuskegee clinic thought they were getting treatment 
for "bad blood." 
1939-45 German scientists conduct research on concentration camp prisoners. 
1940‘s Chicago doctors infect nearly 400 prisoners with Malaria to develop new drugs 
to fight the disease during World War II. I 
Inmates given general information that they were helping with the war effort, but 
not informed about the nature of the experiment. Nazi doctors on trial at 
Nuremberg cited the Chicago studies as precedents to defend their own 
research aimed at aiding the German war effort 
1944-
1980 
The U.S. government sponsors secret research on the effects of radiation on 
human beings. Subjects were not told that they were participated in the 
experiments. Experiments were conducted on cancer patients, pregnant women, 
and military personnel 
1956-
1980 
Saul Krugman, Joan Giles and other researchers conduct hepatitis experiments 
on mentally disabled children at The Willowbrook State School. They 
intentionally infected subjects with the disease and observed its natural 
progression. The experiments were approved by the New York Department of 
Health 
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Table 3  
  
Historical Events in Unethical Human Experimentation (continued) 
 
1950-
1963 
The CIA begins a mind control research program, which includes administering 
LSD to unwitting subjects. 
1972 Stanley Milgram conducts his "electric shock" experiments, which proved that 
many people are willing to do things that they consider to be morally wrong 
when following the orders of an authority. He publishes Obedience to Authority 
in 1974 
1982 William Broad and Nicholas Wade publish Betrayers of Truth, claiming that there 
is more misconduct in science than researchers want to admit. Their book helps 
to launch an era of "fraud busting" in science 
1992 National Academy of Science publishes Responsible Science: Ensuring the 
Integrity of the Research Process. The book estimates the incidence of 
misconduct, discusses some of the causes of misconduct, proposes a definition 
of misconduct, and recommends some strategies for preventing misconduct 
1994 The Clinton Administration declassifies information about secret human radiation 
experiments conducted from the 1940s-1980s and issues an apology 
1999 Jessie Gelsinger dies in a human gene therapy experiment at the University of 
Pennsylvania. The event triggers heightened scrutiny of conflicts of interest in 
human subjects research, including institutional conflicts of interest. Penn settles 
with the Gelsinger family for an undisclosed amount of money 
1999 Administrator of National Institute of Mental Health suspends 29 clinical trials 
that failed to meet either ethical or scientific standards 
2001 Ellen Roche, a healthy 27-year old volunteer, dies in study at Johns Hopkins 
University in Baltimore, Maryland. 
2001 Maryland Court of Appeals renders a landmark decision affirming "best interest 
of the individual child" as a standard for medical research involving children. The 
Court unequivocally prohibited nontherapeutic experimentation on children. 
(Higgins and Grimes v. Kennedy Krieger Institute).The case involved exposure 
of babies and small children to lead poisoning in EPA funded experiment. 
(http://www.courts.state.md.us/opinions/coa/2001/128a00.pdf) 
2004 Liem Scheff authors article on AIDS research project of ―Guinea Pig Kids‖ toxic 
drugs given to NY Black, Hispanic and poor orphans. The orphan children 
become subjects of drug trials sponsored by National Institute of Allergies and 
Infectious Disease, a division of the NIH, the National Institute of Child Health 
and Human Development in conjunction with some of the world‘s largest 
pharmaceutical companies – GlaxoSmithKline, Pfizer, Genentech, 
Chiron/Biocine and others. 
             
Sources: Human Experiments: A Chronology of Human Research by Vera Hassner Sharav 
http://www.ahrp.org/history/chronology.php, Research Ethics Timeline (1932-2004) by David B. 
Resnik, JD, PhD http://www.niehs.nih.gov/research/resources/bioethics/timeline.cfm.  Table does 
not represent an exhaustive list of unethical human experimentation. 
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injecting prostitutes with serum from patients recovering from syphilis, with the 
belief that the protocol was a discovery for the cure of syphilis, laid grounds for 
public outrage as an immeasurable epidemic among prostitutes and their 
customers and partners surfaced (Gibelman & Gelman, 2001; Vollman & Winau, 
1996). 
Despite public concern of unethical research practices questionable 
research practices continued. The 1920s and 1930s revealed physicians‘ acts of 
routinely sterilizing Americans without their consent (Emanuel, 2002). Victoria 
Nourse‘s work, In Reckless Hands examines the case of Skinner versus 
Oklahoma (2008).15  Nourse details a history of America's experiment with 
eugenics16 resulting in thousands of incarcerated men and women having been 
sterilized. American ethicists at that time readily justified human research without 
the protections of informed consent as unnecessary due to the need of 
experimentation for the persons own therapy, experimentation for the good of 
humanity in general, and experimentation to advance science (Vollman & Winau, 
1996).  
American human research practices during the 1920s and 1930s would 
prove to be ambiguous in the effort to attain ethical research standards arising 
from the uncertainty of using experimental research methods for providing 
medical therapy, protecting the rights and welfare of research subjects and  
furthering scientific knowledge (Vanderpool, 1996; Moreno, 2000). Questionable 
medical research practices continued to proliferate.  
                                            
15
     Skinner v. State of Oklahoma,1942, the United States Supreme Court ruling held that compulsory sterilization 
could not be imposed as a punishment for a crime.  
16
     Eugenics is the study and practice of human selective breeding. The aim is to improve the species. 
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The Willowbrook hepatitis studies and the Tuskegee Syphilis study remain 
two of the United States most noted human research experiments failing to 
―adequately protect human research participants‖ (DuBois, 2008, p. 14). The 
Willowbrook hepatitis study carried out at the Willowbrook State Mental facility in 
New York City began in 1963 and was halted in 1966 as a result of public uproar 
(DuBois, 2008). Although the crowded mental institution had been closed to new 
patients, parents that agreed to have their child participate in various medical 
research studies were given placement for their child (Levine, 1988). The 
experiment, conducted on otherwise healthy children ―deliberately infected with 
the hepatitis virus, fed stool from infected individuals … and received injections 
from more purified virus preparations‖ (Levine, p. 70). Researchers defended the 
studies, suggesting that the children would become infected in the hospital 
anyway, and by being in the study the children would have better care in ―well-
staffed‖ units that would protect the children from more harmful infectious 
diseases (Beauchamp & Childress, 2001, p. 428).  
The 40 year Tuskegee Study of Untreated Syphilis in the Negro Male 
(1932-1972) is substantiated as the longest nontherapeutic experiment on 
human beings in history (Heintzelman, 2003; Vanderpool, 1996; Washington, 
2006). Jones (1981, p. 179) notes that when John Heller , U.S. Public Health 
Service Administrator was questioned about the ethical obligation on the part of 
the Public Health Service toward the participants in the syphilis study he stated 
that  ―The men‘s status did not warrant ethical debate. They were subjects, not 
patients, clinical material, not sick people.‖  
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Washington (2006); Oakes (2002); DuBois (2008); Caplan (1992) suggests 
the Tuskegee Study is considered by human scientists as one of the pivotal events 
leading to the regulation of human research in the United States. Emanuel (2002) 
posits that the Tuskegee Study led directly to the appointment of a National 
Commission for the Protection of Human Subjects of Biomedical and Behavioral 
Research in 1974. As a result of the work of the Commission, it was required that 
all federal funded studies using human subjects to be reviewed by an institutional 
review board (Jones, 1993; Iltis, Matsuo, & DeVader, 2008). 
In 1997 President Clinton encouraged federal human research protections 
programs to be extended to all Americans. The president stated that "science 
must respect the dignity of every American. We must never allow our citizens to 
be unwitting guinea pigs in scientific experiments" (NBAC, 2001, p. 145).  
Protecting Human Subjects Using Regulatory Standards 
Early human research regulation focused on medical experimentation. 
The Berlin Code of 1900, one of the earliest documents to address the outrage of 
medical research and its unethical practices in general and more specifically the 
outrage of the Berlin prostitute syphilis research (Harnett, 2004; Annas & Grodin, 
1992; Vollman & Winau, 1996). Murders, brutalities, tortures, and other inhuman 
acts were carried out daily as a result of Nazi medical experiments on World War 
II prisoners, on gypsies, the mentally disabled, and others (Washington, 2006; 
Jones, 1993; Baumrind, 1971).  Although the Code was in place, continued 
accounts of human experimentation by world famous and revered Nazi doctors 
forced the medical community, courts, and the public to consider additional 
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protections for human subjects (Oakes 2002; Harnett & Neuman, 2009).  
Nuremberg Trials 
After WW II, the Nuremberg Medical Trials (October, 1946 until August 
1947) resulted in twenty-three German physicians and scientists being convicted 
of performing vile and potentially lethal medical experiments on concentration 
camps inmates and other living human subjects between 1933 and 1945. Due to 
the trials, the Nuremberg Code was established as a set of ethical research 
principles.  The Code includes principles of informed consent and condemns 
coercion, as well as it promotes that the study must be a properly formulated 
scientific experiment, and must include beneficence toward experiment 
participants. The elements of the Nuremberg Code include that: The voluntary 
consent of the human subject is absolutely essential.  
 The experiment should be so designed and based on the results 
of animal experimentation and knowledge of the natural history 
of the disease or other problem under study that the anticipated 
results will justify the performance of the experiment.  
 The experiment should be so conducted as to avoid all 
unnecessary physical and mental suffering and injury.  
 The degree of risk to be taken should never exceed that 
determined by the humanitarian importance of the problem to be 
solved by the experiment.  
 Proper preparations should be made and adequate facilities 
provided to protect the experimental subject against even 
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remote possibilities of injury, disability, or death.  
 The experiment should be conducted only by scientifically 
qualified persons. The highest degree of skill and care should 
be required through all stages of the experiment of those who 
conduct or engage in the experiment. A complete list of the 
Code is found at Appendix H 
Although the legal force of the Nuremberg Code was not established, and 
the document was not incorporated directly into either American or German law, 
the Nuremberg Code and related Declaration of Helsinki are the basis for the 
Code of Federal Regulations, Title 45 Subpart 46 (45 CFR 46). The Federal 
Regulations were issued by the United States Department of Health and Human 
Services which governs federally funded research in the United States. 
Oakes (2002) acknowledges, although forty-two doctors were indicted, 
resulting from the Nuremberg Trials, the majority of American medical 
researchers did not find the unethical treatment of human subjects appalling 
(Rothman, 1995). Oakes points out that during that time Americans believed ―its 
physician-researchers acted in accordance with their Hippocratic Oath and that 
voluntary consent was unnecessary in a society with a long and untarnished 
history of medical research‖ (p. 444). The similar contention was pervasive 
among American physician-researchers.  
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Declaration of Helsinki 
The Declaration of Helsinki (Declaration) of 1964, revised in 1975,  was 
developed by the World Medical Association (WMA), as a set of ethical principles 
for the medical research community regarding human experimentation. Although 
the WMA developed the Declaration for the medical community it encourages 
other researchers conducting medical research to adopt the principles. The 
Declaration is not a legally binding instrument in international law, instead, draws 
its authority from the degree to which it has been codified in, or influenced in 
national or regional legislation and regulations (Dubois, 2008).  There have been 
eight amendments to the Declaration.  
Belmont Report: An Ethical Foundation 
The National Commission for the Protection of Human Research Subjects  
task was to consider: 
 the boundaries between biomedical and behavioral research 
and be accepted and routine practice of medicine; 
 the role of assessing risks criteria in the determination of the 
appropriateness of research involving human subjects;  
 appropriate guidelines for the selection of human subjects for 
dissipation in such research; 
 the nature and definition of informed consent in various 
research setting. 
The tasks resulted in the Belmont Report. The statement of basic ethical 
principles and guidelines to assist in resolving ethical problems related to the 
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conduct of research with human subjects laid another foundation for protection of 
research subjects. The tenets of the Belmont report include three fundamental 
principles: respect for persons, beneficence, and justice as shown in Table 4.  
 The Belmont report is the guiding document of ethical framework for 
protecting human subjects in the United States (NBAC, 2001).  
The Common Rule and Social Science 
Williams‘ (2005) Congress of Research Service Report (CRS) suggests 
that the Common Rule was designed with a focus on biomedical research, and 
submits that most social science researchers have questioned whether the 
Common Rule should apply to social science research. ―These regulatory 
concerns voiced by those in the social science community have focused primarily 
on the impact of the Common Rule‖ (p. 24). CRS suggest that social science 
research researchers ―have expressed a desire to have regulations regarding 
their research carved out from the Common Rule‖ (p. 24) noting that social 
science researcher, Joan S. Sieber‘s presentation ―Social and Behavioral 
Research with Human Subjects: Key Issues for SACHRP17 and OHRP to 
Consider‖18 represented the sentiments of an overwhelming number of social 
science researchers in their concerns of biomedical regulatory standards being 
applicable to social science research.  
  
                                            
17
     In July 2004, Secretary’s Advisory Committee on Human Research Protections (SACHRP) heard a 
series of presentations on protecting human subjects in Social Science Research. Presenters raised 
concerns for having regulations for social science separate from biomedical research regulations. Joan 
Sieber, an esteemed social science researcher, represented the views of her colleagues. 
18
    Presentation to the U.S. Secretary’s Advisory Committee on Human Research Protections, Washington, 
D.C., Aug. 8, 2004. 
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Table 4 
 
Key Concepts of the Belmont Report 
 
Principle Application 
Respect for Persons: 
Individuals should be 
treated as autonomous 
agents • Persons with 
diminished autonomy are 
entitled to protection  
Informed consent: 
Subjects, to the degree that they are 
capable, must be given the opportunity to 
choose what shall or shall not happen to 
them. The consent process must include 
three elements:  information, 
comprehension, and voluntariness 
  
Beneficence:  
Human subjects should 
not be harmed. 
Research should 
maximize possible 
benefits and minimize 
possible harms  
 
Assessment of risks and benefits:  
The nature and scope of risks and benefits 
must be assessed in a systematic manner  
 
Justice:  
The benefits and risks of 
research must be 
distributed fairly  
Selection of subjects:  
There must be fair procedures and 
outcomes in the selection of research 
subjects  
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The CRS suggest that IRBs are assembled with biomedical expertise, and 
a review process focused on that research may not be well suited to review 
social science research. Social science researchers argue that unnecessary 
delays in the review and approval of their protocols are due to lack of familiarity 
with social science research (Oakes, 2002, Gunsalus, 2004). The CSR finds that 
the IRB review process, in their use of the Common Rule as the standard of 
regulatory compliance, often does not place protocols in the category acceptable 
in the Common Rule. As an example, protocols exempt from IRB review are 
often placed in the expedited category which then does require IRB approval, 
costing unnecessary time for the researcher and unnecessary documentation for 
the IRB. The report details that protocols are place in a higher category of risk 
although the protocol would be ―commensurate with the protocols‘ level‖ and type 
of risk described in the Common Rule. Williams (2005) suggest that ―risk may be 
physical in biomedical research but is usually limited to the areas of 
confidentiality and privacy for social science research‖ (p. 24).  
In concurrence with, the CRS Report (2005); Oakes (2002); Bosk (1998); 
and Gunsalus (2004) suggest that IRBs‘ requirements for obtaining informed 
consent in social science research are overly cumbersome and ineffective due to 
the consent process required by the Common Rule. The process of consenting 
as illuminated in the Common Rule focuses on ―documenting consent instead of 
ensuring informed, voluntary decision making‖ (CRS, p. 24). In spite of long held 
concerns of the Common Rule, Federal agencies, many which conduct only 
social science research, have adopted Subpart A (see Appendix L). 
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The Common Rule, adopted by 16 federal departments and agencies in 
1991 is currently the regulatory framework for protecting human subjects for 17 
federal agencies. It requires all federally funded research conducted by any of 
the 17 federal agencies as shown in Table 5 to be reviewed by an institutional 
review board. Although, the Common Rule is not required to be the regulatory 
standard of human research protection for nonfederal funded research, human 
research protection programs at academic institutions have opted to apply the 
Common Rule also to research that is not federally funded (Oakes, 2004, 
Gunsalus, 2007, Williams, 2005).  
The Common Rule, developed in response to recommendations made by 
the President's Commission for the Study of Ethical Problems in Medicine and 
Biomedical and Behavioral Research in 1981(Presidents Commission) called for 
the adoption by all federal agencies of the Department of Health and Human 
Services. Until 1991, federal departments and agencies that conduct, support, or 
regulate research used a variety of policies and procedures to protect human 
research subjects. To promote uniformity of the rules applicable to human 
research subjects, each of the 17 departments and agencies, as shown in Table 
5, adopted as regulation, a common Federal Policy for the protection of human 
research subjects (NBAC, 2001, p. 5). 
Gordon (2003) suggests that significant revisions have been made to the 
Common Rule. These revisions have been primarily under the supervision of the 
National Bioethics Advisory Commission (NBAC). Gordon posits that the NBAC 
(2001) proposed various suggestions to strengthen the protection of humans  
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Table 5 
 
Federal Agencies Subject to the Common Rule 
 
1. Social Security Administration 
 
2. Central intelligence agency  
3. Consumer Product Safety  
4. Department of Agriculture  
5. Department of Commerce  
6. Department of Defense  
7. Department of Education  
8. Department of Energy  
9. Department of Health and Human Services  
10. Department of Housing and Urban Development  
11. Department of Justice   
12. Department of Transportation  
13. Department of Veterans Affairs  
14. Environmental Protection Agency  
15. National Aeronautics and Space Administration  
16. National Science Foundation  
17. Office of Science and Technology Policy  
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participating in research but the suggestions did not apply or translate well to 
social science research. Social science researches commonly perceive the 
current and proposed human subjects regulations as impediments to research 
(Gordon, 2003). 
The Common Rule‘s focus on concerns of risk from a biomedical 
viewpoint makes it difficult to apply the rules to social science research, Gordon 
suggests. However, the Common Rule does provide revisions for research that 
poses minimal risk. As such, the Common Rule states that minimal risks are 
those that are ordinarily encountered in daily life. Gunsalus (2006), and Gordon 
(2003) are among those who suggest, although minimal risk research is eligible 
for exemption according to the Common Rule, the general trend for IRBs is to 
incorporate a level of perceived risk. The perceived risk assessment most often 
calls for additional explanatory documentation, adding additional time to the 
review and approval process for the researchers, IRB's and their administrative 
support staff.  
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Office of Human Research Protection 
The Office for Human Research Protections (OHRP) is an agency of 
DHHS, that provides leadership and oversight for the protection of the rights, 
welfare, and wellbeing of subjects involved in research conducted or supported 
by the United States Department of Health and Human Services (DHHS) (Oakes, 
2002, Burris & Welsh, Borror et al., 2003). Prior to 2000 OHRP was called the 
Office for the Protection of Research Risk (OPRR), at that time an agency under 
The Office Of Extramural Research in the National Institute of Health (NIH).  
In 2000 OHRP was relocated from under NIH to the Office of Public 
Health and Science within the Office of The Secretary of the Department of 
Health and Human Services (DHHS). Amdur & Bankert (2002, p. 27) suggest 
that the administrative location of OHRP was changed to eliminate what could be 
viewed as a conflict of interest in which the research regulatory office reported to 
the administrator of an agency having research duties as their primary mission. 
―The status of the OHRP Administrator was upgraded to the Senior Executives 
Service, which is the highest level of nonpolitical civil servant‖ (p. 28). OHRP‘s 
mission continues to be toward providing clarification and guidance to institutions 
and researchers, by maintaining regulatory oversight, providing advice related to  
ethical and regulatory issues in biomedical and behavioral research and 
developing educational programs and materials.  
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The Federalwide Assurance 
The OHRP establishes a contract with institutions called Federalwide 
Assurance (FWA). The FWA (see Appendix N) establishes the standards by 
which institutions are to conduct research. So that institutions may qualify to 
receive federal funding for research, the institution must have a Federalwide 
Assurance on file with the OHRP (45 CFR 46.103). The assurance requires that: 
 Each agency provide written assurance satisfactory to the 
department or agency head that it will comply with the 
requirements set forth in the policy, 
 The institution must have an approved assurance, and the 
research must be approved by an IRB provided for in the 
assurance and the research will be subject to continuing review 
by the IRB.  
 Assurances applicable to federally funded support or conducted 
research shall at minimum include a statement of principles 
attesting to be the institutions responsibilities for protecting the 
rights and welfare of human subjects. Despite whether the 
research is subject to Federal Regulation designation of one or 
more IRB's established within the requirements of 45 CFR 46. 
 A list of IRB members identified by name, earned degrees, 
representative capacity, indications of experience such as board 
certifications and licenses etcetera, sufficient to describe each 
member's chief anticipated contribution to IRB deliberations. 
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 Written procedures for which the IRB will follow for conducting 
its initial and continuing review of research and for reporting its 
findings and actions to the investigator an institution, for 
determining which projects require review more often than 
annually, and for ensuring prompt reporting to the IRB of 
proposed changes in research activity. 
 Written procedures for ensuring prompt reporting to the IRB, the 
appropriate institutional officials, and the department or agency 
head of any unanticipated problems involving risk to subjects or 
others, or any serious or continuing noncompliance, and any 
suspension or termination of IRB approval. 
 Obtain written informed consent from research participants, 
unless the written informed consent is waived by the IRB. 
 The institutional signatory official, the IRB chair, and the human 
protections administrator must have adequate training. 
 Adequate educational and oversight mechanisms must be in 
place for documenting the training of investigators. 
 The IRB must have adequate knowledge of local research 
regulations. 
 Although an FWA is not required to conduct research that is not funded by 
a federal agency, Cohen (2002, p. 313) suggests there are many institutions that 
have elected to hold all research, even research that is not federally funded, to 
the same standards of the Common Rule. Many social scientists consider this to 
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be the impetus for institutional review boards to assert unnecessary regulation of 
minimal risk research projects (White, 2007). Some institutions are have recently 
revised their FWA to only include research that is federally funded to be 
applicable to the Common Rule.  
The FWA requires the institution to have a human protections 
administrator. The administrator is an employee of the institution and serves as 
an agent of the FWA exercising the day-to-day operations of the human research 
protections program. In most cases the IRB human protections administrator is 
also the Director of the institution‘s human research protection program and 
supervisor of the HRPP staff. Cohen (2002) suggests that the human protections 
administrator be extremely knowledgeable of the institutions systematic 
protections for human subjects. In addition to the human protections 
administrator, the FWA must also designate an Institutional Signatory Official 
who has the legal authority to represent the institution named in the FWA. The 
FWA ―formalizes‖ an institution's commitment to protect human subjects (Cohen, 
2002). 
The OHRP‘s Division of Compliance Oversight evaluates all written 
substantive indications of noncompliance or deficiency of the institution or 
researcher related to the Common Rule. OHRP requests the institution involved, 
to investigate the allegations and to provide OHRP with a written report of its 
investigation. OHRP then determines what, if any, regulatory action needs to be 
taken to protect human research subjects19. However, the NBAC suggests that 
                                            
19
     OHRP provides information fact sheets to the public relation to their mission, duties and expectations 
at: http://www.hhs.gov/ohrp/about/ohrpfactsheet.htm. 
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OHRP takes the lead as a de facto reference point and consensus builder among 
federal agencies although; it has no congressional or executive authority to do 
so. Additionally, some agency departments have not established offices 
comparable to OHRP for interpreting and implementing the regulations. 
Oversight activities in most of these cases are the responsibility of a single 
individual, therefore, ―the ability to coordinate oversight among the departments 
is weak, leaving departments and agencies to interpret the Common Rule 
potentially differently‖ (NBAC, 2001, p. 9).  
Determination Letters 
One of the available indicators of accounts of noncompliance and 
deficiencies resulting in increase of risk to research participants, researcher 
violation, IRB violations or institution violations is via the publicly available portal 
maintained by OHRP. OHRP memorializes its findings of noncompliance and 
deficiencies in determination letters sent to the institution for investigation. The 
letters outline concerns of OHRP relating to an approved research project. The 
project can be biomedical or social science research, and are usually federally 
funded. OHRP does not regulate unfunded research unless the institution‘s FWA 
document indicates that all research conducted at the institution will be under the 
interpretation of the FWA. Many institutions have opted out of the FWA regulating 
all research by unchecking the box on the form that previously indicated the FWA 
would be subject to all research. Only federally funded research is then regulated 
for those institutions.  
The determination letters specifically outline what actions must be taken 
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by the institution to return to, a compliant state, rectify a deficiency, or resume 
research activity. The communication from OHRP to the institution is publicly 
available. The letters have been routinely available to the public since 2000 on 
the OHRP Internet portal. Sieber (2004) posits that OHRP‘s publicized 
determination letters, and the costly sanctions handed down to a few institutions 
and the negative publicity to the institution makes it understandable that IRBs 
and research administrators have considered it in their self-interest to enact 
highly conservative decisions. As an example, IRB‘s have the authority to waive 
documentation of informed consent, but often neglect to do so although the 
Common Rule offers such flexibility (White, 2007). 
The Food and Drug administration (FDA) has a similar mechanism in 
place called Warning Letters. The Warning Letter is issued when the FDA has 
reason to believe deficiencies and or violations have been committed in an 
approved research project. The letters are also considered voluntary action 
letters. The voluntary action letters request voluntary correction of minor issue 
and deficiencies found by OHRP. The process is usually ended when all 
concerns raised in the letter has been addressed. Warning letters can and do 
carry sanctions for the institution and the investigator (Chadwick, 2002). The FDA 
oversees research involving drugs, biologics, and medical devices and does not 
oversee social science research, therefore, only OHRP determination letters are 
the focus of this discussion.  
The literature of determination letters studies is scarce, although the 
literature did reveal three similar research studies, one conducted by Borror et al. 
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(2003), Burris and Welsh (2007) and Weil et al.(2010). In each case their 
research revealed the numbers of citations of noncompliance (determination 
letters) sent to institutions. Borror et al. found 1120 citations of noncompliance 
and deficiencies and Burris & Welsh found 648 letters of noncompliance and 
deficiencies were sent from OHRP.  The research projects did not investigate 
which institutions or agencies were involved in the citations of noncompliance nor 
did the project delineate the numbers of biomedical or social science citations of 
noncompliance or deficiencies. The authors focused on the kinds and numbers of 
noncompliance and deficiencies found in determination letters.  The focus was 
not on the discipline in which those noncompliance and deficiencies were found. 
In the studies conducted by Borror et al. (2003) and Burris & Welsh (2007) they 
addressed, the percentage of institutions cited by OHRP, problems and remedies 
based on review of determination letters, and the regulatory requirements of the 
Common Rule.  
Borror et al. (2003) explains that over the last several years OHRP has 
developed a list of determinations of noncompliance that that include: 
 Initial and Continuing Review 
 Expedited Review Procedures 
 Reporting of Unanticipated Problems 
 Noncompliance, 
 Suspension of Protocol Changes 
 Application Of Exemptions 
 Informed Consent 
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 IRB Membership, Expertise, Staff, Support And Workload 
 IRB Documentation, Findings, and Procedures 
 Other 
Determination letters, also referred to as compliance oversight letters by 
Borror et al. (2003), are issued by OHRP in response to substantive allegations 
or indications of noncompliance with the Department of Health and Human 
Services (DHHS) regulations (45 CFR  46). Borror et al. acknowledges in their 
research of determination letters that allegations of noncompliance can come 
from various sources including research subjects, their family members, whistle-
blowers, patient/subject advocates, as well as OHRP staff based on the staff's 
review of data published in professional journals. Borror et al. reports that 269 
letters contained 1120 citations of noncompliance and deficiencies. One hundred 
and forty-two of the 155 institutions in which determination letters were issued 
had at least one citation of non-compliance.   
In a similar study conducted by Burris and Welsh (2007) 271 letters within 
the timeframe of January 1, 2002, and June 30, 2004, with 5 letters being issued 
before the study period, were reviewed for their study. Burris and Welsh‘s data 
set consisted of 174 letters being studied. Although Borror et al. (2003) and 
Burris (2007) conducted similar analysis of determination letters, their analysis 
resulted in divergent interpretation of the findings.  
Borror‘s analysis indicated that institutions did not have adequate IRB 
policies and procedures and did not maintain records according to regulatory 
requirements. Borror‘s findings focused on the gaps in documentation of 
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researchers‘ written materials including informed consent documentation and the 
process of the research project. While Burris & Welsh‘s qualitative study four 
years later also reviewed determination letters and focused on the lack of 
adequate information in consent documents, the level at which consent 
documents were written and wording issues in the informed consent.   
The later study by Weil et al. (2010) reviewed 235 determination letters 
that the Office of Human Research Protection issued to 146 institutions between 
August 1, 2002, and August 31, 2007. Weil et al.‘s examination of OHRP 
determination letters revealed 762 citations of noncompliance and deficiencies. 
However, similar to their first study of determination letters Weil et al. did not 
focus on the discipline specifically of biomedical or social science research in 
which the citations of noncompliance and deficiencies represented. 
Burris & Welsh‘s study focused on patterns of noncompliance. They 
concluded that although there were patterns of noncompliance no subjects were  
harmed. Burris and Welsh puts forward that their research suggests that 
documented procedures not explicit researcher unethical implementation of the 
research projects has been cause for excessive documentation burdens for 
human research protection programs and researchers. They refer to this process 
as mission creep as detailed in the Illinois White Paper, Improving the System for 
Protecting Human Subjects: Counteracting IRB Mission Creep (White Paper) by 
Gunsalus et al. (2005) as a crisis being caused by the increased workload of 
IRBs and their inability to handle the workload effectively efficiently. Thereby, the 
focus is placed on the less difficult path of procedures and documentation rather 
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than identifying difficult ethical issues which may be presented in research 
studies. The authors of the White Paper (Gunsalus et al., 2007) suggest that the 
institutions‘ efforts to comply with federal requirements even when research is 
minimal risk amounts to exaggerated precautions to protect against program 
shutdowns, and efforts to protect the institution against lawsuits.  
Notably, Borror et al.‘s findings focused on the gaps in documentation of 
written materials including informed consent documentation and process. Fifty-
two percent of noncompliance or deficiency citations were a result of institutional 
review board approval of informed consent document/process (27%) or the initial 
review process (25%). Four percent of overall citations were considered the most  
serious form of noncompliance putting research subjects at risk if not at serious 
risk.  
Burris and Welsh‘s study, four years later, focused on what OHRP 
determination letters consistently detailed. The letters included reference to the 
lack of adequate information in consent documents, the level at which documents 
were written and other grammatical misuse of wording in the consent form.  
Burris and Welsh also suggest: 
Very, very few researchers investigated by OHRP appear 
to have deliberately broken or disregarded the rules. 
Very, very few researchers conducted their studies in a 
way that endangered their subjects. The rate of serious 
problems—cases in which subjects were put at serious 
risk or suffered harm—was low, especially when the 
denominator is not the number of letters, complaints, or 
audits but the far greater number of studies going on in 
this period. Most of the violations uncovered involved the 
failure to document something that may actually have 
been done, or a failure to do something that, while 
required by the regulations, does not appear to have 
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exposed anyone to any harm or even put anyone at any 
appreciable risk (p. 671) 
 
The literature has presented the studies of Borror et al., and Burris & 
Welsh as reviewing the contents of the determination letters but their research 
nor other research studies in the literature has suggested what portion of the 
citations can be attributed to social science research. Additional research is 
warranted to address the gap in the literature of the impact of regulating social 
science research with biomedical regulations. standards.   
Scarce data exists in the literature documenting whether OHRP‘s citations 
of noncompliance are the result of biomedical or social science research 
projects. Knowing if the attributes of noncompliance and deficiencies have its 
place in biomedical or the social science discipline may assist in better defining 
the utility of the Common Rule to social science research projects. Additional 
research in this area will assist in the discourse for continued research of the 
applicability of IRBs using biomedical standards of research to address social 
science research. A qualitative content analysis of determination letters will add 
to the body of literature in this area. 
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National Bioethics Advisory Commission 
 The National Bioethics Advisory Committee (NBAC) was established by 
Executive Order 12975 signed by President Clinton on October 3, 1995. NBAC 
advises the President on bioethical issues that may emerge from advances in 
biomedicine and related areas of science and technology. NBAC‘s functions 
were defined as follows: 
a)  NBAC shall provide advice and make recommendations to the 
national Science and Technology Council and to other 
appropriate government entities regulating the following matters: 
1. the appropriateness of departmental, agency, and other 
governmental programs, policies, assignments, missions, 
guidelines, and regulations related to bioethical issues 
arising from research on human biology and behavior, and 
2. applications, including the clinical applications, of that 
research. 
b) NBAC shall identify broad principles to govern the ethical 
conduct of research, citing specific projects only as illustrations 
of such principles. 
c) NBAC shall not be responsible for the review and approval of 
specific projects. 
d) In addition to responding to requests for advice and 
recommendation from the national science and technology 
Council, NBAC may also accept suggestions of issues for 
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consideration from both the Congress and the public. NBAC 
may also identify bioethical issues for the purpose of providing 
advice and recommendations, subject to the approval of the 
national science and technology Council (NBAC, 2001). 
By 1997, the NBAC required that no person in the United States should be 
enrolled in research without the double protections of informed consent by an 
authorized person and independent for review of the risk and benefits of the 
research (NBAC, 2001). In 1999 the White House issued orders for the NBAC to 
compile a report on the concerns related to the human research enterprise. 
Several areas of concern were indicated to the White House in 1999 that 
included: 
 not all research participants are protected by the federal 
oversight system, 
 several federal departments and agencies that sponsor primarily 
non-biomedical research or modest amounts of research has 
failed to  implement fully the federal protections available,  
 the federal protections do not always include specific provisions 
for individuals who are especially vulnerable, and 
 the federal protections are difficult to enforce and improve 
effectively across the government, in part, because no single 
authority or office oversees research protections across all 
agencies and departments (NBAC, 2001, p. 1).  
The NBAC expressed concern stating, "the oversight system for protecting 
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research participants is losing credibility among some investigators, IRB's, 
institutions, and, perhaps most important, the public, causing more frustration 
and less willingness to commit time and resources to the system‖ (p. 16). The 
NBAC well aware that the current system for protecting human research subjects  
in need of reform was in agreement with social science researchers that the 
system of protection "was often burdened by excessive bureaucracy, confusing 
or conflicting interpretations of rules and an inability to respond to emerging 
areas of research" (p. viii). 
Human Research Protection Programs 
Chodosh (2006) puts forward that human research history has been 
marred with examples of ethical principles of human research being ignored. 
Although, most human research scientist have followed the basic tenets of 
ethical research, those scientists who were the exceptions created a necessity 
for legal measures formed to avoid future problems. Chodosh proposes that the 
Western society produced scientists that would not engage or permit the human 
research atrocities as seen in the World War II Nazi experiments. Although it was 
factual in most cases that medical researchers would abide by ethical research 
standards, the western academic world also produced risky biomedical research. 
The oversight that clinical administrative chiefs provided as guidance to the 
investigators became much more tenuous as the clinical services expanded and 
research generated much more operating funding.  
Chodosh (2006), Dyer & Dermeritt (2009), Jones (1993) suggests that the 
Tuskegee Syphilis Study and other unethical research practices brought about a 
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realization by the scientific community that better means for protecting human 
research subjects was needed. No longer was just peer review of research 
protocol enough. Federal agencies now required more intense review of research 
protocols. Institutional Review Boards now provided the oversight of research 
projects once held by department supervisors. Edgar & Rothman (1995) suggest 
that there are two goals which are the focus of IRBs: to determine if the benefits 
of the project outweigh the risks; and to ensure that all the relevant information is 
provided in the informed consent document.  
The volume and complexity of research protocols increased as did 
regulatory demands. Chodosh (2006) further suggests that additional resources 
did not always keep up with the demands. ―The IRB's primary role in protecting 
human subjects often became secondary to meeting regulatory requirements. 
The institution‘s need to meet the conditions of their assurance and continue the 
income and prestige of the institutions research program became the primary 
IRB function" (p. 14).  
Increased federal funding for research projects increased regulatory 
demands, and the need to create a culture of research integrity within the 
campus investigators brought about the need for the three components of the 
human research protection program that include the investigators; the IRB; and 
the institution (see Figure 1) to become congruent with protecting human 
research subjects, Chodosh (2006).  
Zywicki (2007) suggests that the size and expense of administrative such 
as HRPPs have grown substantially in recent decades. He points to the ―growing 
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accumulation of government regulation‖ which has required the creation of new 
administrative staff to take care of the regulatory responsibilities. Zywicki 
suggests, some of the growth of IRBs has been spurred by superfluous 
governmental regulations (p. 872). In addition, Zywicki proposes that ―the 
preoccupation of IRBs with paperwork and forms has been promoted by a regime 
of ―fear‖ of governmental oversight, ―fear by the institution that it will be ‗out of 
compliance‘ with one or more aspects of the paperwork, and subject to penalty 
upon audit, be that by the NIH, the OHRP, the U.S. Department of Agriculture, or 
whatever other organization is involved‖ (p. 875).  
 
 
Figure 1.  Components of Human Research Protections Program 
  
Investigators 
IRB Institution 
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Institutional Review Board 
Our IRB system is endangered by excessive paperwork 
and expanding obligations to oversee work that poses 
little risk to subjects. The result is that we have 
simultaneous overregulation and under protection‖ IRBs' 
burdens have grown to include studies involving 
interviews, journalism, secondary use of public-use data, 
and similar activities that others conduct regularly without 
oversight. Most of these activities involve minimal risks--
surely less than those faced during a standard physical 
or psychological examination, the metric for everyday risk 
in the federal regulations. And IRBs are pressured to 
review an expanding range of issues from research 
design and conflicts of interest to patient privacy. These 
are beyond the scope of research protection and are best 
left to others (Gunsalus, 2006, p. 1441). 
 
With the end of WW II bringing large amounts of federal funding for 
medical research projects, medical research projects escalated substantially.  
Institutional review boards (IRB) gained a larger role in the review and approval 
of human research. Haggarty (1966) suggests IRBs were primarily to determine 
the medical benefits of federally funded research projects. Later some IRBs 
began reviewing nonmedical research. In the United States, regulations 
protecting human subjects first became effective on May 30, 1974.  The 
regulations established the IRB as one mechanism through which human 
research subjects would be protected (Edwards, Ashcroft, & Kirchin, 2004).  
The National Research Act passed in July, 1974, established the National 
Commission for the Protection of Human Subjects of Biomedical and Behavioral 
Research (the Commission). Peckman (2001) suggests that prior to 1938 the 
United States placed no restrictions on human experimentation. The Hippocratic 
Oath of ―do no harm,‖ was the guiding principle of research ethics for 
78 
 
 
experiments on humans, suggests Peckman. Operating in sync with the 
proponents of ―do no harm‖ was the ―cultural bias that relied upon and trusted the 
expertise of professionals‖ (Peckman, 2001, p. K-3). However, the acts of 
unethical experimentation with human subjects lead to the creation of peer 
review committees (Levine, 1988; Peckman, 2001; Candilis et al., 2006; Advisory 
Committee on Human Radiation Experiments, 1995). By February, 1966 
institutions that received federal funding for biomedical research, were required 
to create an institutional committee to review their colleagues grant applications 
including protocol for involvement of human subjects (Peckman, 2001). 
By 1974 IRB‘s became more formalized (Chadwick, 2000; NBAC, 1999; 
Edgar & Rothman, 2004). They became committees to oversee the responsible 
conduct of biomedical and social science research, protect the rights of research 
participants, reduce their risks, and increase the benefits of the research (Levine,  
2001; Gilbert, 2006).  The Common Rule provides the structure of institutional 
review boards in the United States. The Common Rule includes explicit reference 
to the operations of the institutional review board.  IRB operations are found in 
the following Federal Regulations: 
§46.107 IRB membership. 
§46.108 IRB functions and operations. 
§46.109 IRB review of research. 
 §46.110 Expedited review procedures for certain kinds of  
§46.111 Criteria for IRB approval of research. 
§46.112 Review by institution. 
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§46.113 Suspension or termination of IRB approval of research. 
 For more than 10 years Institutional Review Boards (IRBs) have been 
placed under intensive scrutiny as a result of the Office of Inspector General 
(OIG) of the Department of Health and Human Services report, Institutional 
Review Boards: A Time for Reform (1998).  The report represented a one-year 
study by OIG. The key findings of the report‘s concluded that: 1) IRBs face major 
changes in the research environment as a result of increases in the quantity of 
research, the commercialization of research, and the number of multicenter trials; 
2) IRBs conduct minimum continuing review of approved research; 3) IRBs are 
overworked; 4) IRBs often lack sufficient scientific expertise to review protocols 
adequately; 5) IRBs face conflicts of interest that may undermine their 
independence, and 6) IRBs provide little education or training to members. 
The report recommended that: 
 IRBs should be held more accountable;  
 continuing protections for human subjects, such as data safety 
monitoring boards and adverse event reporting, should be 
strengthened; 
 federal requirements should be enacted to promote education 
on research ethics for IRB members and investigators; 
 steps should be taken to insulate IRBs from conflicts of interest,  
 more institutional resources should be devoted to IRBs, and  
 the federal oversight process should be revamped. 
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 Extensive criticism has permeated the IRB review and approval process 
(Dyer & Demeritt, 2009; Gordon, 2003, Oakes, 2004, AAUP, 2000). Dubois 
(2004) depicts IRBs as the instruments of a system of licensing in which 
scholars, students and other researchers must get permission to conduct 
research with human subjects.  He suggests that IRBs are far more dangerous 
than the research they review and they offer little if any protection for human 
subjects.  
Although, IRBs have garnered much of the negative criticism from 
researchers, the IRB staff has also contributed to the concerns researchers have 
with human research protection programs. Menikoff (2007) suggests that the 
―IRB staff may not be adequately educated about applicable regulations, and 
may be placing inappropriate burdens on researchers, or there may be 
insufficient staffing leading to inappropriate delays in the review of studies‖  
(p. 798). Rothman (1995) suggests that staff require excessive documentation 
rather than providing guidance in the interpretation of the regulations. 
 Burris & Welsh (2007), details IRBs as a regulatory system that often 
distracts from rather than focus on key ethical issues. The sentiments of DeVries 
et al. (2004 p. 234) suggests that IRBs have been extensively criticized as 
inefficient, obstructionist, and indifferent to the researchers needs and ineffective 
at protecting human research safety and ethical concerns because of excessive 
regulations required in biomedical research that impacts social science research. 
Brendel‘s (2008) writings from the biomedical point of view suggest that there 
must be a pragmatic approach to IRBs review and approval of clinical research. 
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The author notes that, the IRB focus should be using case-by-case moral 
problem solving as ―how to balance the drive toward scientific discovery with the 
need to protect human subjects in clinical research‖ (p. 25). The sentiments of 
Zywicki (2007) suggests that ―IRBs have become a ubiquitous presence on the 
landscape of America‘s higher education system‖ using a system of review of 
research projects which suggests a one-size-fits-all approach (p. 861). 
Social scientists routinely encounter impediments to their research when 
navigating Institutional Review Board (IRB) review process to obtain approval for 
their research studies. Gordon (2003) suggests that the Common Rule and the 
interpretation of the Common Rule by the IRB, which is modeled heavily on 
biomedical research, is not effective for social scientists and especially ineffective 
in its applicability to anthropological approaches to research (p. 300) concurs 
with social science scholars having similar concerns of the overregulation in 
social science research for more than 35 years. Burris, Buehler & Lazzarini 
(2003); Burris et al. (2003, Winter) propose that good regulations must be 
effective and efficient. They suggest that the Common Rule may not achieve the 
―desired behavior among regulated and protected at the lowest possible cost‖ 
(Burris, Buehler, & Lazzarini, 2003, p. 650).  
 Social science researchers point out that research procedures associated 
with biomedical research cannot be transplanted into the procedures for 
conducting social science research. Seiler and Murtha (1980) suggested that the 
federal regulatory efforts censor social research more prominently in federally 
funded research projects. Seiler and Murtha further argued more than 30 years 
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ago that the increased documentation and paperwork required by federal 
oversight agencies and, institutional review boards added no additional 
protections for human subjects. They proposed that using the biomedical model 
of protecting research subjects offers no evidence to show that the "swirl of 
paperwork either protects research participants or substantially changes the 
quality of social research‖ (p. 154).  
 Additionally, Seiler and Murtha put forward that the increase bureaucracy 
has made for increased delays for researchers, increased workloads and loss of 
control of even their work situation ―leading to a variety of unintended 
consequences‖ (p. 154). The consistency of this argument continues to resonate 
with social science researchers with little if any difference in contention.  
 In 2001,  the National Bioethics Advisory Commission (NBAC) complained 
that Institutional Review Boards (IRBs) were overwhelmed not only 
by high workloads generated by the amount of actions to process just one 
research project (see Figure 2) and limited resources but also by ―a regulatory 
system that often distracts from rather than focuses on key ethical issues‖  (p. A 
14). NBAC attributed ―emphasis by regulators on procedure‖ for contributing to 
―an atmosphere in which review of research becomes an exercise in avoiding 
sanctions and liability rather than in maintaining appropriate ethical standards 
and protecting human participants‖  (p. 22).  The procedure-prone regulator of 
greatest concern to NBAC was the federal Office for Human Research Protection 
(NBAC, 2001).  
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Protocols submitted to the IRB for: 
Review and Approval 
IRB staff review protocols to ensure all requirements of federal regulations are addressed, 
and protocol is ready for IRB review. If needed protocol is returned for revision and 
resubmission as necessary 
IRB conducts a review to: 
Identify risk and potential benefits to participants and others. 
IRB‘s ethical analysis of risk and potential benefits after risk identified and minimized, 
possible benefits identified 
Components designed solely to answer 
the research question(s 
Components that also offer the prospect 
of direct benefits to participants 
Are the Risks Reasonable in Relation 
to Potential Benefits of Knowledge? 
 
 Requires assessment of the 
study's objective. 
 May require input from experts 
and community representatives. 
Are the risk reasonable and in relation to 
potential benefits for participants? 
 
 Assessment of risk and potential 
benefits separately from experimental 
and control procedures. 
 The study pass test of research at 
equipoise? 
o Sufficient data exist to validate  
control or experimental 
procedure?  
o May require input from experts 
and community representatives. 
STUDY ACCEPTABLE ONLY IF ALL COMPONENTS PASS 
ETHICAL TEST. 
Figure 2.  Process of IRB Review including analysis of Risk and Potential 
Benefits   
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IRB Administrative Support Staff 
 The IRB Administrative support staff is critical to an institution‘s human 
research review system. Although as McGough (2002) points out, the Common 
Rule at 45 CFR 46.103(b)(2) does not specifically state that staffing is to be hired 
to support an institutional review board. However, for IRBs to function adequately 
they must have staff to assist them with administrative duties (Chodosh, 2002). 
The staff should have appropriate training and expertise and have access to 
needed resources. McGough (2002) adds that the positions the members serve 
on the IRB are as volunteers that cannot be expected to provide the 
administrative work necessary for IRB review of human subject research and 
daily oversight of the administrative duties required. Additionally, McGough 
suggests that in order to manage these tasks and many others needed by the 
IRB, for the mission of protecting those participants in human research, there 
must be qualified administrative IRB staff support in place with resources 
provided by the institution to support IRB functions.  
The IRB review process can be burdened with excessive paperwork 
required by Federal Regulations (NBAC, 2001, Gunsalus, 2005, King, 1999; 
Pattullo, 1985). Although the paperwork fulfills procedural rule requirements of 
the federal oversight agencies, and is designed to ensure compliance with ethical 
standards, the paperwork requirements have little relevance to ethical standards 
or the protection of participants (NBAC, 2001). IRB's also lack the resources 
suggested by the Office of Human Research Protection, including meeting 
space, adequate staff and equipment to support IRB functions. They have 
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increasingly large workloads with inadequate staff and inadequate resources that 
inhibit the protocol review and approval process (Sugarman, 2000). 
Social Science Research Regulation 
Almost no one believes the social sciences should be  
utterly free from oversight. The history of psychology,  
for example, is studded with experiments whose designers 
gave too little thought to the well-being of their subjects. 
 Shea (2000, p. 4) 
 
Prior to 1974 social science research was unregulated by the federal 
government (Seiler & Murtha, 1980). The authors suggest that the 1974 National 
Commission for the Protection of Human Subjects of Biomedical and Behavioral 
Research would require the social sciences to undergo federal scrutiny for 
research funded by the federal government. Seiler & Murtha suggests there was 
no concern of ethical violations reported of social science research during that 
time, making increased scrutiny of social science research unnecessary. Patullo 
(1979) agrees, saying that ―the record of social scientists is remarkably good‖ (p. 
531).  
 Although, as with biomedical research, there is always a possibility of 
harm to those participants of social science research projects through 
carelessness or ignorance or lack of character or those who abuse the 
standards, suggests Pattullo. The author further suggests that the possibility of 
injury in social science research is rare. The concern of social science research 
harms originated with the Surgeon General's concern at that time for "insuring 
the integrity of research his agency financed‖ (p. 533). 
 Oakes (2002) and Keith-Spiegel & Koocher (2005) suggest that social 
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scientists are undisturbed by federal regulatory oversight. However, the authors 
suggest, it is IRB's that have increased their scrutiny of research projects 
including social science research projects unnecessarily. The increased scrutiny 
has caused frustration to many social scientists because it results in excessive 
documentation to address the IRB concerns of perceived risks to research 
participants (Gunsalus et al., 2004; White, 2007). There is little debate regarding 
the need to protect volunteers in social science research (Bozeman, 2003; 
Braxton, 1994; Malone 2003) but social scientists posits that there continues to 
be a need for improvement of system, improvement that appropriately represents 
the risks of social science research (Dyer & Demeritt, 2009; Citro et al., 2003; 
Pittenger, 2003; White, 2007).  
Oakes (2002) suggests that as a result of the guidelines proposed by the 
Department of Health Education and Welfare (DHEW) in August 1979, social 
research has been made to undergo IRB review despite funding source, and 
requiring the same rigor as biomedical research. Social scientists, as evidenced 
by the literature, have argued for decades that the increased scrutiny, identical to 
that of biomedical research had no foundation of evidence of physical harm 
occurring in social science research (Pattullo, 1980, Seilar & Murtha, 1980).  
Oakes (2002) and Pattullo (1984) puts forward that social scientists were 
not involved in the development of the Common Rule. Without social scientists 
involvement in the development process, there was little applicability of the 
Common Rule to social science research thereby resulting in inappropriate 
regulations for the social sciences.  
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However, Amdur & Bankert (2002, p. 105) suggests: 
There is no legal or regulatory basis for making the 
distinction between social science and biomedical 
research from the IRB standpoint. Specifically, the U.S. 
Dept. of Health and Human Services (HHS) regulations 
that focus on the IRB do not mention the terms social 
science, behavioral science, or biomedical science. The 
regulations describe ethical standards for research based 
on the specific characteristic of the risk to research 
participants. Not on the academic field into which 
research may be classified. The fact that the regulations 
do not distinguish between social science and biomedical 
science emphasizes the similarities between these two 
general types of research in terms of ethical standards 
and research regulation (p. 105). 
 
Amdur and Bankert (2002) suggest that as a result of physical harm 
imposed on research subjects, ethical codes were developed. The risk of 
physical harm is not a component of social science research, causing some 
researchers to not fully understand the applicability of the Common Rule to both 
biomedical and social science research. The authors point out that social science 
research does, in fact, have a potential for social harms.  
Social harms can include a decrease in quality of life resulting from 
―information being created or used in a way that is damaging to the individual‖ 
causing ―loss of employability, loss of insurability and criminal or civil litigation‖ (p. 
106). Often social harm takes the form of disruption of personal relationships, 
causing embarrassment, humiliation, discrimination or stigmatization. Amdur & 
Bankert further suggest that social harm is just as much a threat to the rights and 
welfare of research participants as physical harm (p. 106).  
Sieber (2004) suggest that the system of protecting human subjects has 
been enacted in response to high profile conflicts between the values and 
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activities of scientists and the values of society as a whole (p. 402). As an 
example the author also refers to the 40 year of study of untreated syphilis by the 
U.S. Public Health Service in which informed consent and ethical oversight of 
research became the requirement. Sieber further suggest that regulations should 
not be confused with ethics. Ethics have a duty to address the unique 
characteristics of a circumstance, ―regulations are specific requirements, the 
wording may seem to imply that one size fits all (p. 403).‖ Although most 
regulations are written in a way that may be interpreted with some flexibility, the 
flexibility has not always been extended, causing problems for social scientist, 
Sieber suggests.  
Mission Creep and Overregulation 
Marshall (2003) acknowledges that IRBs have had a profound impact on 
the regulation of research with human participants. The author further 
acknowledges that the OHRP has shut down research at several United States 
institutions because of violations of human subjects' protections. Marshall 
suggests that there is a place for the work of OHRP, although they are 
overzealous in their approach. The majority of criticisms from researchers concur 
with Marshall in the observation that regulatory oversight entities are useful and 
needed, however federal regulatory entities are overzealous in their interpretation 
and application of federal guidelines, exacerbating the challenges faced by 
researchers in all fields of human research seeking approval of their research 
studies (Mosher, 1988).  
Kahn, Mastrianni & Sugarman (1998); Emanuel, Wendler & Grady (2000); 
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and Beyrer & Kass (2002) suggest that in recent years there has been increased 
debate in both public and professional arenas about a range of ethical concerns 
involving research with human participants. The authors agree, IRBs play 
critically important roles in evaluating and managing the risks inherent in 
research while they protect the rights and welfare of human research 
participants. Resnick‘s (2004) concurs with Marshall (2003) and Oakes (2002) in 
their opinion that IRBs have been placed under intense scrutiny. In 1998, the 
Office of Inspector General (OIG) of the Department of Health and Human Services 
issued its report, Institutional Review Boards: A Time for Reform. The report 
suggests that the regulatory system of protecting human subjects has 
weaknesses that threaten the effectiveness of the system. This, researchers 
suggest, has been a major factor in the increased documentation called for by 
IRBs from researchers and performed by human research protection programs. 
This progression of documentation has had an adverse effect on researchers, 
while affording little if any additional protections for research subjects. 
NBAC (2001) suggests that an IRB‘s assessment of risks and potential 
benefits is central to determining that a research study is ethically acceptable and 
would protect participants of the study. However, with no clear criteria for IRBs to 
use in judging whether the risks of research are reasonable in relation to what 
might be gained by the research participant or society, the ambiguity of 
measuring reasonable risks is left to individual interpretation. The lack of 
consistency and continuity of the review process is of grave concern to social 
scientists (Gunsalus, 2006). Zywicki (2007) puts forward that ―IRB decisions on a 
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vague and capacious metric of ‗harm‘ amounts to making decisions according to 
no predictable rules‖ (p. 892). Researchers put forward that investigators and 
IRBs must be more effective and efficient in carrying out their responsibilities, in 
that way, improving research protections and increasing public trust in research.  
Indications of noncompliance resulting in risk of harm to those 
participating in social science research remains minuscule compared to  OHRP 
findings of noncompliance in biomedical research activity (Braxton, 1994). 
Although there has been much anecdotal comment in the literature on the topic 
of the application of a one-size-fits-all approach to regulating social science 
research with biomedical regulations, there seems to be no abundance of 
literature of the research to substantiate the assertions that research participants 
are better protected in social science research studies resulting from the 
biomedical regulatory model of the Common Rule (Gunsalus, 2007 Mueller, 
2007). Similar to others in the literature, Zywicki (2007) states that:  
The requirement of IRB preapproval for research applies 
only to federally funded research. Nonetheless, universities 
have extended the mandate to all research involving human 
subjects, even though the vast majority of social science 
research is not federally funded. This requirement is typically 
justified by belief that IRBs are a necessary part of a system 
of checks and balances to curb the self-interest of 
researchers, whose natural inclinations may lead them to 
discount improperly the dangers to human subjects from 
their research. But the argument that IRBs are necessary to 
counterbalance the self-interest of researchers is somewhat 
ironic in that there are no institutional checks to balance the 
self-interested expansionist tendencies of IRB 
administrators. Thus, in a classic example of the problem of 
―who watches the watchers,‖ IRB administrators arrogate to 
themselves the power to oversee all research involving 
human subjects, even the vast majority of social science 
research that is not federally funded (p. 888).  
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De Vries et al. (2004) suggests social science researcher may be over 
scrutinized for the harms that may result from their research based on the 
amount of risk in typical social science research, including surveys, interviews, 
oral history research and others. The imposed regulations by OHRP on social 
science research continue to weigh heavily on institutions as they attempt to 
balance the need for protecting human subjects in research, the need to support 
their researchers‘ scholarly efforts and the need to minimize any untoward 
liability claims on the institution. Gunsalus et al. (2007) suggests that the 
increased workload burden of the IRB and administrative staff provide a negative 
impact on high-risk research needing to be reviewed and approved.   
The Common Rule - Intent and Impact of Policy  
 ―All compliance systems require the buy-in and collaboration of the 
regulated, and it will be a sad day if scholars come to see human protection in 
research as the source of frustrating delays and expensive paperwork‖ 
(Gunsalus, 2006, p 26). The literature does not reveal prodigious support for the 
regulatory system of protecting human subjects in the social sciences with 
biomedical regulatory standards. Governments translate their political agendas 
and programs through policymaking to deliver outcomes desired to reflect 
change (Fischer, 1995). The Common Rule was the United States answer to 
protecting human subjects in a uniform manner, representing a 10 year 
collaboration that resulted in 17 federal departments and agencies adopting one 
set of regulations to include biomedical and social science research (NBAC, 
2001). To obtain a more consistent form of protection for research subjects, in 
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1995 the NBAC surveyed agency's policies and procedures focused on the 
protection of human subjects research.  
The survey instrument was to assess "each department's activities to 
protect human subjects in research and the structure's, policies, and procedures 
in place for the review and oversight of human subjects protections‖ (NBAC, p. J-
2). The survey tool was designed to assess department‘s compliance level with 
the Common Rule and any difficulties arising from the implementation of the 
Common Rule. The data collected suggested concerns in the following areas: 
 Federal protections for persons serving as subjects in research 
do not extend to all Americans. 
 Despite widespread implementation of Federal Regulations by 
those departments and agencies sponsoring substantial 
amounts of biomedical research on a number of departments 
and agencies that sponsor primarily non-biomedical research or 
little research over all, have failed to implement fully, the federal 
protections. 
 Many federal agencies find the interpretation and 
implementation of the Common Rule unnecessarily 
burdensome. 
 Federal protections are difficult to enforce and improve the 
effect of the lead throughout the federal government, in part 
because no single authority or office oversees research 
protections across all government agencies and departments. 
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 New techniques are needed to ensure implementation at the 
local level. 
Although many federal agencies reported improvement in the way they 
addressed protecting human research subjects, years later problems still 
remained. Some problems as noted by the National Bioethics Advisory 
Commission in 2001 included: 
1. Appropriateness of the Common Rule  
Nonclinical nonmedical research communities reported 
having the greatest difficulty in the interpretation and 
application of the Common Rule especially as it applies to 
the finding minimal risks. 
Although the vast majority of agencies support nonclinical 
research, many of the agencies challenged the biomedical 
model of the Common Rule for addressing the unique 
concerns raised by behavioral, social science and 
educational research (p. J. 14). 
2. Lack of a knowledgeable IRB 
Agencies that do not have effective IRBs in place to assess 
research proposals prior to their funding may not have the 
appropriate information in place to adequately request 
revisions or even disapprove greater than minimal risk 
research, leaving  protections for human subjects lacking. 
3. Determining exemptions 
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The interpretations of exemption categories across agencies 
vary as well as who the designated entity will be to interpret 
the exemption categories. 
4. Adequacy of Administrative Structures 
Federal agencies are responsible for communicating policies 
to relevant research institutions and IRB's, establishing a 
structure of peer review for scientific merit of research 
proposals. In addition, negotiating assurances with research 
institutions verifying that IRB's and researchers comply with 
Federal Regulations and in investigating and providing 
follow-up on any complaints of noncompliance 
The data suggested that agencies did not devote sufficient 
resources to administrative structures. 
The concerns raised by the NBAC in 2001 reflect many similar concerns 
of social science researchers recently such as that of Coleman (2009); Kotzer & 
Milton (2007); Dyer & Dermeritt (2009). In particular, their concerns reflect the 
findings of the NBAC regarding the interpretation and implementation of the 
Common Rule as confusing and, or, unnecessarily burdensome. The literature 
provides a profusion of social science researchers‘ concern that the Common 
Rule provides overregulation for social science research. As discussed, social 
scientists suggest that the biomedical regulatory framework of protecting human 
research subjects is not congruent with social sciences.  
Byrne (1987) suggest that cost-benefit calculations play a role in policy 
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decisions, although, the value of cost-benefit analysis is in the discipline that 
brings to the policy process the ability to address social problems in a systematic 
and efficient manner. Earlier in this discussion details of the basis for federal 
intervention in unethical research practices funded by the federal government 
were highlighted detailing Federal intervention, due to unethical research 
practices, led to the development of Common Rule protection of human research 
subjects.  
The federal policy is a guide for the research practices of biomedical and 
social science research. The policy is based on a biomedical model of human 
research protections that also is the basis for protections in social science 
research. Social Science researchers puts forward that the cost of the federal 
policy has been in overregulation, human research protection programs deluged 
in unnecessary paperwork and documentation, having little benefit to research 
participants and that a reasonable solution has not been achieved for protecting 
human participants of social science research (Oakes, 2002; White, 2007; 
Vanderpool, 1996; Pattullo, 1985; Malone, 2003; Marshall, 2003). 
Fischer (1987) suggests that cost-benefit analysis in the policy process 
was institutionalized through the Office of Management and Budget (OMB) 
during the Reagan administration. Economy and efficiency is the focus of cost-
benefit analysis, and "politicians have found cost-benefit analysis to be 
conveniently compatible with their own biases" (p. 116). Gunsalus (2004), calls 
for refinements to the regulatory system that will provide a set of policy 
regulations designed for non-biomedical research. Gunsalus puts forward that 
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the challenges of the application of the policy (the Common Rule) must be better 
understood and implemented.  Better understanding will assist the IRB and their 
support staff to ―direct attention to the areas of greatest risk, while intentionally 
scaling back oversight in areas of lesser risk‖ (Gunsalus, p. 86).  
Levine‘s (2001, January) testimony to The Committee on Assessing the 
System for Protecting Human Research Subjects (see Appendix O ) suggested 
even then that there were ―growing fault lines in the system that protects human 
participants and that a gap has developed between law and policy on the books 
and in action‖ in the author‘s testimony to the American Sociological Association 
(p. 2). Levine states, ―For the social and behavioral sciences, the overall problem 
with the system is the attempt to fit our research into a framework that was over 
specified and designed for biomedical-clinical research.‖ 
 Seiler and Murtha (1980, p 147) suggest that the 1974 National Research 
Act that was ―signed under pressure of Congress to complete the task prior to the 
next administration coming in‖. The authors suggest that in the haste for 
completion of the regulations, there was no mechanism in place to inform the 
social science community of the new rules that would apply to them or to get their 
input or feedback (p. 148). The regulations produced were a product of mainly 
extensive drafting by the NIH staff. Tropp (1978) suggests that: 
Under the gun of imminent congressional passage of the 
National Research Act, and in order to preempt a 
possible Senate move to include in it mandatory ethical 
standards governing federally sponsored research, the 
secretary of HEW on May 22, 1974, signed a regulation 
on ―Protection of Human Subjects‖ which essentially 
transformed the predecessor NIH guidelines into 
department policy. The regulation was largely a product 
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of the ―H‖ part of HEW, drafted without participation by 
those HEW agencies which customarily commission 
social science research products and maintain daily 
conduct with the social science research world. (p. 391) 
 
Having little participation in the construction of development of the policy 
to regulate human subject research, social scientists need additional 
mechanisms to address their concerns and to insure that the Common Rule as a 
tool for protecting human subjects is the most effective and efficient mechanism 
for doing so (Haggerty, 2004).  
The Common Rule, from its inception was formed and charged with the 
responsibility of insuring research protection for those participating in federally 
funded research projects, using the Common Rule as the federal regulatory 
stance for the institution‘s human research policy foundation (Aronson, 2008; 
Payne, 2000; Coleman, 2009). In 1985, Patullo suggests that institutions had 
adopted policies much more restrictive for protecting human subjects than they 
need to be, stating that, ―outraged by a few excesses we have responded like 
one who burns down a house to rid the attic of squirrels‖ (p. 524). Nearly 30 
years later social science researchers are still critical of the overregulation of a 
one-size-fits-all model of applying biomedical standards to social science 
research.  
White (2007) and Bozeman & Hirsch (2005) suggests the negative 
publicity of institutions appearing in the OHRP database of determination letters 
has made for increased institutional scrutiny, overregulation and mission creep of 
human research projects submitted for review and approval. White points out that 
deficiencies in research protocols recorded by the institution‘s HRPP, that 
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prevents approval of social science projects, mainly represent documentation 
concerns that have little or nothing to do with the safety and risk to human 
subjects. Gunsalus et al. (2005) concurs, that HRPPs have increased 
documentation practices to the extent that researchers see the increased 
documentation practices as overregulation and mission creep.  
The concerns expressed by social scientists about overregulation includes 
as Wagener et al. (2004, October) points out , HRPPs are requesting much more 
additional safeguards to be included in minimal risk research projects. Mission 
creep in Institutional Review Boards permeates the literature of institutional 
review mission, practice and oversight related to the IRB system of protecting 
human research subjects. Although, IRBs are a critical safeguard in the system 
of protecting human research subjects, and social scientists give them credit for 
such, researchers suggest the system of human research protection is devoid of 
effective control that does little in protecting human subjects (Coleman, 2004; 
Resnik, 2004; Oakes, 2002; Burris & Welsh 2007; Marshal, 2003).  
Moreno (2000) suggests that IRB members should have more training to 
understand the regulatory issues that arise in research projects when 
collaborating with other institutions. The assertion is that research studies are 
delayed because of the uncertainty of a process to address collaborative 
projects. Recommendations for increased training and education are also 
included in the findings of Borror et al. (2003) and Burris & Welsh (2007) along 
with increased funding for IRB activities. Good practice guidelines for diverse 
areas of research are highlighted in reports on ethical and policy issues in human 
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subjects' research published by the Institute of Medicine (2000 & 2001), the 
National Bioethics Advisory Commission (2001a, 2001b), Similar 
recommendation, has been proposed by the National Academy of Science's 
panel on IRBs and social science research. While there is consensus about the 
general purpose of IRBs, significant problems remain in the applicability of the 
review process for social science research protocols (Edgar & Rothman, 1995; 
Ferraro and Orvedal, 1998; Marshall, 1998; Chadwick and Dunn, 2000).  
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Summary 
The history of research violations that brought about the intervention of 
formal codes and regulations to protect the safety and well-being of human 
research participants is well documented in the literature. Social science 
researchers are concerned with the applicability of biomedical research 
standards to their minimal and less than minimal research. The challenges faced 
by an oversight system for protecting the rights and welfare of human subjects 
have resulted in overregulation and under protection of the Common Rule, 
suggest social scientists. The concerns raised by social scientists mirror similar 
concerns of the in the NBAC. The over emphasis on procedural requirements 
has been a major concern of social science researchers as is excessive 
paperwork requirement of the IRB and its support staff to fulfill the policy 
requirements of the Common Rule that provides little added protection for human 
subjects suggest researchers. The quandary of what additional policies need to 
be put in place continues to be unanswered after more than three decades of 
contention with utilizing a biomedical model of protecting those human research 
participants involved in social science research.  
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Chapter 3 
Methods 
 The Code of Federal Regulations, 45 CFR 46 is not separately 
distinguished by applicability to the disciplines of biomedical or social science 
research. The Federal Regulations at 45 CFR 46 contain Subparts A-E (see 
Figure 3). Subpart A is the basic HHS Policy for the Protection of Human 
Subjects. Additional protections for vulnerable populations involved in research 
are included in Subparts B through D. Subpart B provides additional protections 
for pregnant women, human fetuses and neonates. Subpart C provides 
additional protections for research involving prisoners, and Subpart D provides 
additional protections for children. Added to 45 CFR 46 within 2009, Subpart E 
provides instruction for registration of IRBs. This research study focuses on 
Subpart A, the Basic HHS Policy for the Protection of Human Research Subjects. 
 The literature identifies challenges for social science researchers that 
range from excessive time delays in the implementation of their research projects 
to disapproval of the projects based on standards applicable to biomedical 
research projects. Social scientists contend that the current review process 
applicable to biomedical research may not fit social science methodological 
research practices. Researchers in the literature provide antidotal experiences 
that include what they perceive as over-regulatory practices and mission creep.  
As a result of some over-regulatory practices and mission creep, researchers 
suggest that some researchers do not seek IRB review and approval for research 
activity prior to conducting the research study. Although, conducting research 
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without IRB approval could have an adverse impact on the research subjects 
depending on the level of risk associated with the project (Dyer & Dermeritt, 
2009).  
 
 
Figure 3. Subparts A - E of HHS Federal Regulation 45 CFR 46. 
 
 
 Gunsalus (2005) suggest the requirement for documentation of social 
science research projects remains the same as that of biomedical research 
projects. As a result, the university‘s human research protection program 
becomes entangled in a bottleneck of protocols that requires excessive 
documentation of minimal risk and less than minimal risk research. Imitating the 
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identical review and approval process for social science research projects as for 
biomedical research projects may present challenges for all concerned, including 
the researcher, the human research protection program, as well as the university 
or college exercising the tenets of their human research protection program to 
comply with federal agency funding requirements.  
 To receive federal research funding, universities and colleges must abide 
by an Assurance from The Office of Human Research Protection (OHRP). The 
Assurance (see Appendix N) is a document administered by OHRP, signed by an 
institutional signatory official committing the institution to abide by the regulatory 
statutes overseeing the conduct of human research as specified in the Common 
Rule as well as to the Subparts of 45 CFR 46. OHRP requests institutions to 
investigate concerns of noncompliance or deficiency with the regulatory statutes 
overseeing human research protection. The institution receives a document 
called a determination letter detailing issues that must be addressed by the 
institution. 
 To provide additional understanding of the impact of regulating social 
science research with biomedical regulations this qualitative study describes and 
analyze the contents of OHRP determination letters, analyze in-depth interviews 
of human research protection program administrators and evaluates the 
Common Rule policy.  
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Theoretical Framework 
 Denzin & Lincoln (2005) suggest that qualitative research can be viewed 
as ―interpretive activities‖ having ―no single methodological practice over another‖ 
(p. 6). They suggest that qualitative research is void of a ―theory or paradigm that 
is distinctly its own‖ and does not belong to a single discipline having its own 
methods or practices. Merriam (1998) suggests the theoretical framework of a 
qualitative study is "the structure, the scaffolding, the frame of your study" (p. 5). 
As suggested by Merriam, the theoretical framework encompasses "concepts, 
terms, definitions, models and theories of a particular literature or base and 
disciplinary orientation" (p. 46). The combination of these, she suggests, affects 
all features of the study including articulating the purpose and problem of the 
study, to how we interpret the data collected.  
Miles & Huberman (1994) are in agreement with Merriam(1998) 
suggesting, ―any researcher, no matter how unstructured or inductive‖ comes 
with some orienting ideas (p. 17) being necessitated by the need to structure the 
process, the gathering of data, interpreting data, and reporting data in ways that 
is understandable. The authors suggest that the conceptual (theoretical) 
framework is a combination of theoretical understandings and experiences of the 
researcher in order to conceptualize the study. Anfara and Mertz (2006) posits 
that the researchers‘ use of any framework or theory is appropriate, considering 
that it allows the researcher to see and comprehend particular aspects of the 
phenomenon being studied. The authors suggest that ―no theory, or theoretical 
framework, provides a perfect explanation of what is being studied" (p. 27). With 
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that said, the theoretical framework to accomplish the goals of this study includes 
a qualitative methodology of study for content analysis, in-depth interviews and 
policy analysis.  
Research Questions 
 Based on the statement of the problem as discussed in Chapter 1, the 
research questions are: 
1. What are the findings of deficiencies and findings of 
noncompliance indicated in OHRP determination letters (DL) for 
social science research projects?  
2. What impact does the Common Rule have on social science 
research protocol review by human research protection 
programs? 
3. Has the Common Rule achieved its intended purpose of 
protecting human research subjects participating in social 
science research?  
Research Design 
 This study encompasses a three prong qualitative methodological 
approach to answer the research questions above using content analysis, in-
depth interviews, and policy evaluation. 
Content Analysis of Documents 
 Determination letters alert the institution and public of any noncompliance 
or deficiency issues resulting from research conducted by the institutions‘ faculty, 
students and staff. Determination letters range from communicating to the 
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institution that minor deficiencies in a research protocol might have occurred, to 
notification of shut down of the institutions‘ research projects. Availability to 
OHRP determination letters when viewed by the public can result in bad publicity 
for an institution. The threat of bad publicity for institutions may in turn promote 
human research protection programs (HRPPs) to surpass the regulatory 
mandates of the Common Rule and impose extended institutional policies for 
reviewing and approving research projects, subjecting research protocol to 
increased institutional policies for protecting human subjects (Gunsalus, 2005). 
The overly copious policies and regulations can provide additional workload for 
HRPPs, time delays for the review and approval of research studies, and in many 
cases,  as suggested by the literature, without adding any increased protections 
for human subjects, but providing better protections for the institution. 
 Qualitative content analysis of documents encompass a theoretical 
framework having an approach of empirical, methodological controlled analysis 
of texts within the context of communication, using systematic content analytical 
scientific methodology. Krippendorff (1969) suggests that "content analysis is a 
research technique for making replicable and valid inferences from texts (or other 
meaningful matter) to the context of their use. The author suggests specialized 
procedures are used with content analysis that can provide ―new insights, 
increase the researchers understanding of particular phenomena, or informs 
practical actions‖ (p. 18). Krippendorff suggests that ―content analysis is a 
scientific tool‖ (p. 18), as it is ―a replicable and valid method for making specific 
inferences from text to other states or properties of its source" (p. 103) 
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 Marshall and Rossman (1999) suggests that content analysis can be a 
supplement to additional forms of research including participant observation,  
interviewing, and analyzing documents used in the course of everyday events as 
well as those documents specifically constructed for the research at hand. As 
appropriate for this study, content analysis can render deeper understanding 
when used with in-depth interviews of human research protection program 
administrators and evaluation of the Common Rule policy. Qualitative content 
analysis of documents, being rich in ―portraying the values and beliefs of 
participants in the setting‖ is an unobtrusive method of compiling information and 
data (p. 116). In addition, the authors note that content analysis should be linked 
to research questions in the theoretical framework for the study. Marshall and 
Rossman note that: 
Although content analysis was once viewed as an objective and 
natural way of obtaining a detailed description of the contents of 
various forms of communication, thus counting the mention of  
specific items was important has evolved, it is viewed more  
generously as a method for describing and interpreting the  
artifacts of a society or social group (p. 117). 
 
Content analysis is nonreactive and can be conducted without disturbing 
the natural setting in any way (Babbie, 2004). It is the researcher that determines 
where to place the greatest emphases after the data has been compiled (Schutt, 
2006; Babbie, 2004; Marshall & Rossman, 1999). However, the researcher can 
be a potential weakness for the interpretation of the data. Marshall and Rossman 
suggest that "care should be taken in displaying the logic of interpretation used in 
inferring meaning from the artifacts" (p. 162) 
108 
 
 
McBurney & White  (2009) credits Lasswell (1951) for formulating  the 
core questions of content analysis: "Who says what, to whom, why, to what 
extent and with what effect?" Formulating this line of discourse is appropriate 
when studying the communication of determination letters, because this line of 
query can supply rich and deep insight. Holsti (1969) offers a broad definition of 
content analysis as "any technique for making inferences by objectively and 
systematically identifying specified characteristics of messages" (p. 14) The 
objective inferences systematically taken from determination letters assists in 
putting forward a rigorous scientific method for analyzing the texts applicable to 
the federal regulation of the Common Rule, Subpart A. 
Data Collection 
 The Office Of Human Research Protections (OHRP) is responsible for 
overseeing compliance with the Department of Health and Human Services 
(DHHS) regulations governing human subject research. OHRP has made 
determination letters available to the public via their Internet portal since 2000. 
These letters detail noncompliance and deficiencies of approved federally funded 
research studies. Letters were collected from January 2000 until December 
2010. Letters are collected that reference academic institutions. The address 
block in the letters identifies the specific organization. Those organizations that 
appear to be academic institutions are separated from those organizations and 
institutions that appear to be by name medical.  
The collection phase of data collection identifies in the body of the letter, 
reference to social science research projects. When a letter determined to 
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address social science research the letters were separated for further review. 
When determination letters seeming to reference social science research 
projects have been separated, they were reviewed for the following: 
 Institution name 
 Project title 
 Reason for correspondents from OHRP 
 Response from institution 
 Initial finding of OHRP 
 Final finding of OHRP 
The results of the review of determination letters are compiled using 
Complementary Analysis Research Method Application (CARMA).  
Telephone Interviews 
 Morgan (1988) suggests that an interview is a purposeful conversation 
with the purpose to obtain information from the other. Marshall and Rossman 
(1999) note that in-depth interviews focus on the individual‘s lived experience. 
This phase of the study focuses on human research protection program (HRPP) 
administrators. Marshall and Rossman suggest that in-depth interviews are used 
as a strategy to capture the deep meaning of the individual‘s experienced in his 
or her own words. HRPP Administrators are recruited for this phase of the study.  
 HRPP Administrators must process specific skills and knowledge of 
protecting human subjects. Their knowledge includes a high level of proficiency 
in regulations that oversee ethical standards of human research. In-depth 
knowledge of the Federal policy (45 CFR 46) which governs human research 
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protection standards is the paramount expectation for the HRPP Administrator, 
as the Common Rule (Subpart A) is the basic policy for the protection of human 
research subjects. Comprehensive knowledge and understanding of the Federal 
policy is required of the HRPP Administrator to perform adequately in the position 
(Bankert and Amdur, 2006). The authors suggest the HRPP Administrator has 
complex responsibilities of understanding, interpreting, and documenting 
research regulations as well as hold the position of the institution‘s chief authority 
on regulations pertinent to the IRB whose primary function is to protect human 
research subjects.   
The HRPP Administrator ensures the IRB is operating in full compliance 
with Federal and institutional research compliance regulations. The IRB 
Administrator provides leadership in establishing and modifying IRB policies and 
procedures including developing ways to improve the IRB functions, policy 
changes, criteria for classifying projects as research, forms for documentation of 
IRB activities, as well as develops standard wording in the consent document 
(Bankert & Amdur, 2004, p. 70). The authors suggest HRPP administrators often 
are advisers to risk-management and compliance officials for institutional 
research policies, and advise the institution‘s teaching professionals on the 
standards for research compliance for those conducting human research.  The 
HRPP Administrator is also required to develop a structured education program 
for IRB members and researchers related to human research regulation and the 
facets of IRB review and approval of research protocols.  
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Amdur & Bankert further suggest that HRPP Administrators devote 
―considerable amount of time to continuing education‖ and their profession 
because of new regulations being circulated and existing regulations ―being 
interpreted in new ways‖ (p. 71). The authors additionally put forward that many 
HRPP Administrators engage in professional organizations specific to their 
profession, subscribe to professional IRB journals, attend conferences and 
become members of IRB forums. HRPP administrators are consistently aware of 
social science research projects submitted and can be in daily contact with the 
project‘s investigators. Therefore, HRPP administrators can offer noteworthy 
insight for this study.  
In-depth interviewing is used as a technique to gather descriptive data in 
the subjects‘ own words for the purpose of developing insight as to how the 
HRPP Administrator interprets some portion of their professional world. Bogdan 
& Biklen (2003) put forward that, although qualitative interviews are relatively 
open-ended and can vary in the degree to which they are structured, the 
interviews can be focused on a specific topic and may be guided by general 
questions. Bogdan & Biklen furthermore, suggest that semi-structured interviews 
can ensure the researcher of obtaining comparable information across 
respondents. 
 Babbie (2004, p. 300) suggests that the qualitative interviewer must be 
completely familiar with the questions to be asked, allowing the interview to have 
a natural and smooth progression. The interviewer in this study has more than 10 
years‘ experience in human research protections as a Director and IRB 
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Administrator.  This research project includes a mode of semi-structured 
questions. Follow-up questions are asked as appropriate to the participants‘ 
response.   
 The qualitative research technique of in-depth interviewing involves 
individual interviews with a small number of respondents to investigate their 
perspectives on a particular idea, program, or situation (Creswell, 2007). As 
noted by Marshall and Rossman (1999) "the participant‘s perspective on the 
phenomenon of interest should unfold as the participant views it, not as the 
researcher views it. Boyce and Neale (2006, p. 3) suggest that "in-depth 
interviewing is a qualitative research technique that involves conducting 
intensive individual interviews with a small number of respondents to explore 
their perspectives on a particular idea, program, or situation.‖  They posit that 
those associated with the program may be interviewed about their experiences 
and expectations in regard to the program, including program operations, 
processes, outcome, and any changes they perceive they have experienced in 
the program. Six participants were interviewed for this phase of the study. 
 Boyce and Neale‘s perspective parallel with the intent of this phase of the 
research project which involves interviewing HRPP administrators about their 
experiences in the duties they perform and oversee. The emphasis of the 
interview questions is to compile data of their experiences, and expectations of 
their program to protect human research subjects. 
 The primary advantage of in-depth interviews is that they provide more 
detailed extensive information than what is available through other data collection 
113 
 
 
methods, although there can also be disadvantages. Qualitative data from 
interviews can be ambiguous which may result in a more difficult analysis 
process. In-depth interviews are useful when detailed information about a 
person‘s thoughts and behaviors are to be explored. Interviews are often used to 
provide context to other data such as the content analysis approach being used 
in this study for additional understanding of the impact of regulating social 
science research with biomedical regulations.  
 However, there are limitations and weaknesses to in-depth interviews. 
Marshall and Rossman (1999) suggest that interviews involve personal 
interaction and cooperation is essential. Interviews have particular strengths. 
According to Marshall and Rossman, in-depth interviews can result in large 
amounts of data quickly with the possibility of immediate follow-up and 
clarification. Marshall and Rossman further suggests that there are limitations 
and weaknesses to the interview process. "Interviews involve personal 
interaction and cooperation is essential. Interviewees may be unwilling or may be 
uncomfortable sharing all that the interview hopes to explore, or they may be 
unaware of recurring patterns in their lives" that may cause the respondent 
concern (p .110). Although large amounts of data can be acquired through 
interviewing, the data are very time consuming to analyze.  
In-depth interviews are flexible in that they can be presented in a number 
of ways, having no specific format to follow. In-depth interview data may stand 
alone or be included in a larger evaluation report (Patton, 2002). The author 
suggests when presenting results of in-depth interviews, care must be taken in 
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presenting the data by the use of qualitative descriptors rather than try to quantify 
the information.  
Therefore, with the understanding that in-depth interviews are effective as 
a tool to use in combination with other research methods, in depth interviews are 
appropriate for this study. The purpose of the interviews is to explore the HRPP 
administrators‘ point of view as it relates to protecting human research subjects, 
specifically those involved in social science research projects. Using open ended 
questions in a semi-structured format, the goal of this phase of the project is to 
interpret what is being said in order to explore the respondent‘s viewpoint, 
position and perspectives (Creswell, 1997 and Guion, 2006).  
 Creswell (1997); Denzin and Lincoln (2005); Kvale (1996); Babbie (2004) 
posits that there must be a positive rapport with the respondent keeping in mind 
that the researchers paramount duty is to listen and observe what is being 
articulated. Guion (2006) and Babbie (2004) suggests strategies to improve the 
quality of the in-depth interview experience include rephrasing and, allowing the 
respondent to speak freely as the researcher guides the conversation to ensure 
issues of interest are covered, to be open to deficiencies from the topic but using 
care to return the conversation back to the topic (see Figure 4). For increase 
accuracy and reference, audio record the conversation when possible. In-depth 
interviewing is used in combination with content analysis and policy evaluation. 
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 Figure 4. Strategies for In-Depth Interviewing 
 
 
Telephone Interview Questions 
1. What is your role in your institution‘s human research protection 
program?  
How long have you worked in this role? 
2. What has been the role of the HRPP in protecting human 
research    subjects involved in social science research? 
3.  If your institution has ―un-checked‖ the box on the Federalwide 
Assurance, how has un-checking the box affected the review 
and approval of social science research projects? 
4. The Common Rule is based on a biomedical regulatory model 
of human research protections.  How are the components of the 
In-depth 
Interviewing 
Actyive 
Listing 
Patience 
Audio 
Recording 
Flexibility 
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biomedical regulatory model working for social science research 
projects?  
5. What, if any, concerns have social science researchers reported 
to your HRPP related to the review and approval of their 
research projects?  
a. How does the Common Rule address some of these 
concerns?  
b. What do you (if you do) see as the major impediment in 
applying the Common Rule to social science research project 
review? 
6. How would you characterize the regulation of social science 
research? 
7. If you could modify the Common Rule to be specific to social 
science research projects, what would the change/s look like? 
Policy Evaluation 
 The system of protecting human participants in social science research 
studies relies on federal regulatory standards imposed in the policy of the 
Common Rule. Relying on Fischer‘s work on policy evaluation method, this 
phase of the study is focused on the author‘s four interrelated discourses of 
policy evaluation including: program verification; situational validation; societal 
level vindication, and social choice, aligned with CARMA as shown in Table 6.  
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 Jezierska (2009), in collaboration with the author Putney successfully 
applied CARMA to an evaluation of policy. A similar application of alignment of 
CARMA with Fischer‘s‘ Four Steps of Inquiry is used in this study.  
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TABLE 6 
 
CARMA Aligned with Fischer’s Four Steps of Inquiry/Four Interrelated 
Discourses 
Source: Putney (2008) & Jezierska (2009)  
  
 
Policy 
Expectations 
 
 
Evident 
Implementation 
 
 
Results 
 
 
Conclusions and 
Recommendations 
 
Initiator's Users/Participants Compare/Contrast 
expected with 
evident 
 
Evaluate 
Interpretations 
Who is being 
served? Who 
is involved? 
 
All are evident 
participants? 
Expected versus 
evident 
What are the 
implications? 
Modify or maintain 
program 
How are 
participants to 
be served? 
 
How are 
participants using 
the service? 
Expected versus 
evident 
What are the 
implications? 
Modify or maintain 
program 
What will be 
produced by 
participants in 
the program? 
What was 
produced by 
participants in the 
program? 
Expected versus 
evident 
What are the 
implications? 
Modify or maintain 
program 
    
Step 1 Step 2 Step 3 Step 4 
Verification: 
Intended 
Outcomes 
 
Policy fulfills its 
stated 
objective? 
 
 
Validation: 
Objectives 
 
Program objective 
relevant to the 
problem 
situation? 
Societal 
Vindication: 
Goals 
 
Instrumental or 
contributive value 
to society? 
 
Social Choice 
Values 
 
Provides for a 
legitimate 
resolution for 
conflicting 
judgments? 
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 Fischer (1995) suggests that policy evaluation is also referred to as policy 
analysis or policy science. Fischer (2003) indicates that Harold Lasswell‗s 
influential approach to policy analysis include assumptions of empiricist and post 
empiricist thought as a visionary in the evolution of the policy analysis. Quade 
(1982) denotes that policy analysis is "a form of applied research carried out to 
acquire a deeper understanding of sociotechnical issues and to bring about 
better solutions‖ (p. 5). Yanow (1996, p. 2) suggests that policy analysis is 
"designed to supply information about complex social and economic problems 
and to assess how a policy or program is formulated and implemented." 
Wagener (2003) maintains that policy analysis, as Fischer also suggests, is 
fundamentally interpretive and reflexive (p. 30). Therefore, to evaluate the 
Common Rule for better understanding of its effectiveness for the social 
sciences, policy analysis is appropriate as an investigation technique for this 
study. 
Policy analysis emerged in the 1960s and the 1970s with the practice now 
being used throughout governmental institutions and political organizations with  
the emphasis on producing and transforming information and arguments relevant 
to policy problems. In 1987 Byrne suggested that values are not easily quantified 
and can often be in conflict, but although a definite solution may not be achieved, 
a reasonable solution can be achieved, provided there is informed understanding 
of the general levels of costs and benefits and their distributions (p. 73). 
 Fischer indicates that the logic of cost-benefit analysis involves a 
compilation of costs and benefits of a policy to determine its net value. Fischer 
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further suggests that cost-benefit analysis has been the subject of theoretical and 
practical disagreement due to its difficulty to quantify ―policy inputs‖ and ―policy 
outputs,‖ stating ―the technique systematically underplays social objectives that 
cannot easily be measured in quantitative terms." (p. 116). Writing in 1987, John 
Byrne also suggests that cost benefit analysis was the tool of public policy 
making and evaluation. Dunn suggests that ―policy analysis can be formally 
defined as an applied social science discipline, which uses multiple methods of 
inquiry and arguments to produce and transform policy relevant information that 
may be utilized in political settings to resolve policy problems‖ (1981, p. 35). As 
previously discussed, there are many instances in which biomedical research 
policy has benefited from the Common Rule Policy. Social scientists have 
concerns that the Common Rule policy does not have similar benefit or have 
similar impact on research in their disciplines because the policy is geared 
towards the biomedical model of research.   
Lasswell, identified as the founder of the policy field, defined policy 
science orientation utilizing three characteristics (1) a multidisciplinary 
approach,(2) problem oriented focus that was contextual in nature and (3) and 
explicitly normative orientation (Fischer, 2003, p. 3). Yet another way of 
assessing policy is asking the question, is the policy accomplishing its stated 
purpose or not (Fischer, 1995)? The question asked by Fischer is also asked in 
in the analysis using the CARMA methodology.  
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Validity 
 Klenke (2008) suggests that the terms of validity in qualitative paradigms 
are the terms credibility, which parallels internal validity, transferability which 
parallels external validity, dependability which parallels reliability and 
confirmability which parallels objectivity. Lincoln and Guba (1985) suggests that 
trustworthiness of qualitative research methods consist of credibility, 
dependability, transferability, and confirmability. 
Credibility/Internal Validity 
 Credibility is the extent to which the results as indicated in qualitative 
research are credible or are believable from the standpoint of the participant. 
Credibility can be a test when there is the presence of multiple realities to insure 
the realities are represented adequately. Credibility is seen as the greatest 
available estimate to the truth of intentions. Internal validity in qualitative research 
concerns the findings of the research study and its approximate match to the 
reality espoused (Patton, 1990, Merriam, 2001). It is the degree in which 
interpretations and concepts share mutual meanings. While, Lincoln and Guba 
(1985) state that "the determination of such isomorphism is in principle 
impossible" (p. 294) since ―the precise nature of that reality‖ (p. 295) is not known 
whereas, Kvale (1996) suggests that validity can apply to qualitative 
methodology given that, in a broader concept validity can pertain to whether a 
method of observations reflect the phenomenon or variables of interest, thereby 
in principle qualitative research can lead to valid scientific knowledge..   
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 Patton (1990) suggests credibility of qualitative data can be enhanced 
through the use of triangulation of research methods used. As discussed, a three 
pronged methodological approach consisting of content analysis of documents, 
in-depth interviews and policy evaluation is used. ―Member checks‖ as posed by 
Lincoln and Guba (1985, pp. 313-316) can also be used to address credibility. 
Member checks are used with participants of in-depth interviews along with 
making the data available for others to analyze.  
Transferability/External Validity 
 Transferability is the extent to which results of the findings can be 
transferred to additional contexts or settings. In qualitative research although the 
researcher is unable to specify if the results of the study can be transferred to a 
larger population ,it can be conceded that the information can be extrapolated to 
determine if it fits a particular situation (Lincoln and Guba, 1985; Patton, 1990).  
Dependability/Reliability 
 Dependability in qualitative research aligns closely with reliability in 
quantitative research suggests Lincoln and Guba (1985, p. 300). The authors 
puts forward that dependability is achieved when independent investigators can 
obtain similar results of the study. Lincoln and Guba further suggests the use of 
an ―inquiry audit‖ to enhance dependability of qualitative research (p. 317).  The 
man in his own ―inquiry audit‖ is achieved by reviewers‘ examination of the data 
for consistency of the process and the product of the research study (p. 317). All 
data from this study will be available for the minimum of three years for 
reviewers‘ to perform an inquiry audit. 
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Confirmability/Objectivity 
 Lincoln and Guba (1985) propose that confirmability is the extent to which 
an audit inquiry of raw data, analysis notes, reconstruction and synthesis 
products, process notes, personal notes and preliminary development 
information can be confirmed by another. All data will be made available for 
confirmation.  
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Summary 
Social science researchers have suggested, the components of their 
research activity contained much less risk to human research subjects than that 
of biomedical research. Institutions are required to follow the policies of the 
Common Rule for federally funded research projects, as they are also required to 
follow their institutions‘ policies for human subject research. Social scientist 
suggest that using the Common Rule to review and approve their research that is 
minimal and less than minimal risk amounts to overregulation and mission creep 
by institution‘s HRPP (Schrag, 2009; Pittenger, 2003; Lincoln, 2005).  
 To better understand the impact of the Common Rule on social science 
research activity three methods of inquiry are applied in this qualitative study. 
Content analysis of OHRP determination letters, in-depth interviews of human 
research protection program administrators and policy evaluation of the Common 
Rule will provide a better understanding of the impact of the Common Rule for 
social science research activity.  
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Chapter 4 
Findings of the Study 
 The findings of three qualitative research methods are presented in this 
chapter. Content analysis of OHRP determination letters using CARMA as a tool 
of analysis, in-depth interviews of human research protection program 
administrators, and policy evaluation of the Common Rule utilizing CARMA 
aligned with Fischer‘s Four Steps of Inquiry were the methods used to address 
the following research questions: 
1. What are the findings of deficiencies and findings of 
noncompliance indicated in OHRP determination letters (DL) for 
social science research projects?  
2. What impact does the Common Rule have on social science 
research protocol review by human research protection 
programs? 
3. Has the Common Rule achieved its intended purpose of 
protecting human research subjects participating in social 
science research?  
Content Analysis of OHRP Determination Letters Using CARMA 
 CARMA is used as an analysis tool to address Question 1: What are the 
findings of deficiencies and findings of noncompliance indicated in OHRP 
determination letters (DL) for social science research projects? Steps in 
preparation to gather the sample for the analysis of the OHRP determination 
letters are described below.   
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 Determination letters are publically available and located on the OHRP 
Internet website at: http://www.hhs.gov/ohrp/compliance/letters/index.html . The 
public access site contains letters sent to institutions beginning, July 2000. A total 
of 763 letters (the initial sample) were sent to institutions from OHRP between 
2000 and 2010 (see Appendix P). A total of 763 letters were reviewed in Step 
One of the content analysis of OHRP determination letters.  
 In Step Two of the content analysis, the researcher further reviewed from 
the sample letters addressed to colleges and universities within the United States 
(U.S.). The vast majority of colleges and universities that were sent determination 
letters fall within the Carnegie Foundation‘s Classification Description of RU/VH: 
Research Universities (very high research activity); RU/H: Research Universities 
(high research activity); and DRU: Doctoral/Research Universities.20 These 
research institutions conduct social science, and or biomedical research. 
However, it was beyond the purview of this research project to definitively 
calculate which institutions conducted social science research projects, 
biomedical research projects or both social science and biomedical research 
projects. RU/VH, RU/H and DRU institutions within the U.S. were included in the 
sample. Letters sent to what appeared by name to be medical centers, medical 
companies, hospitals, pharmacies, clinics and other medical facilities were not 
included in the sample because social science research projects were the focus 
of this study. There was a high probability that determination letters sent to 
                                            
20
    The Carnegie Foundation appointed the Carnegie Commission on Higher Education in 1970 to develop 
a classification of colleges and universities to support its program of research and policy analysis. The 
classification system was derived from empirical data on colleges and universities. The Carnegie 
Classification was originally published in 1973, and has been updated in 1976, 1987, 1994, 2000, 2005, and 
2010 to reflect changes among colleges and universities. 
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medical facilities and universities reflected noncompliance or deficiencies in 
medical research projects. Therefore, in Step Two, the revised sample included 
288 determination letters. 
 In Step Three, the determination letters were reviewed for project 
information contained in the Reference (RE:) section of the letter. If the 
determination letters did not reference a Project Title in the ―RE:‖ section of the 
determination letter, the letter was not included in the sample. Project titles that 
suggest biomedical research projects were excluded. Samples of biomedical and 
social science research project titles are shown in Table 7. Two hundred and 
forty-five determination letters, with what appeared to be biomedical projects 
were excluded from the sample. Forty-three letters representing social science 
research projects remain in the new sample.  
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Table 7 
 
Examples of Social Science and Biomedical Research Project Titles from 
OHRP determination letters 
 
             
Social Science 
 
 
Biomedical 
Examples 
of  
Research 
Project 
Title 
 Socio-Cultural 
Determinants of 
Utilization of Breast 
Cancer Awareness and 
Prevention Services  
 
 The Impact of 
Education in Navajo 
Nation Border 
Community Public 
Schools  
 
  Study of HIV/AIDS 
Perception, Attitudes, 
and Knowledge Among 
University Students 
 
 Research Investigating 
How Restaurants 
Handle Food-
Poisoning Complaints 
 
 
 Dynamical Studies in 
Frontal and Temporal 
Lobe Epilepsy 
 
 A Phase I/II Study of 
Sequential Vaccinations 
with ALVAC-CEA with 
the Addition of IL-2 and 
GM-CSF in Patients 
with CEA Expressing 
Tumors  
 
 A Dose Response 
Study of Inhaled Nitric 
Oxide in the Treatment 
of Adult Respiratory 
Distress Syndrome 
 
 Study of 4% Lidocaine 
Intranasally to Treat 
Migraine 
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 In Step Four, the contents of the remaining sample of 43 OHRP 
determination letter were analyzed for noncompliance and deficiency matters 
related to social science research projects. The sample of 43 documents were 
analyzed for noncompliance and deficiencies containing reference to the 
Common Rule, Subpart A, §101-124 using Complementary Analysis Research 
Method Application (CARMA), as shown in Table 8. A determination letter that 
appears to be a social science research study (in reviewing the project title) can 
be found at Appendix Q.  
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Table 8 
 
Complementary Analysis Research Method Application (CARMA) 
 
1 
Determination 
Letter 
Expectations 
NOTE-TAKING 
2 
Evident 
Implementation 
NOTE-TAKING 
3 
Results 
 
NOTE-
MAKING 
4 
Conclusions 
and 
Recommendati
ons 
NOTE-
REMAKING 
 
Initiators  Users/Participa
nts  
Compare/Contr
ast expected 
with evident  
 
Evaluator 
Interpretations  
Who is being 
served?  
Who is 
involved?  
Who are 
evident 
participants?  
Expected vs. 
evident  
What are the 
implications?  
Modify or 
maintain 
program? 
 
How are 
participants to 
be served?  
How are 
participants 
using the 
service?  
Expected vs. 
evident  
What are the 
implications?  
Modify or 
maintain 
program? 
  
What will be 
produced by 
participants in 
the program?  
What was 
produced by 
participants in 
the program?  
Expected vs. 
evident  
What are the 
implications?  
Modify or 
maintain 
program?  
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 The CARMA process of analysis consists of first, Note-Taking. Note-
Taking is used in this study in two ways. First, in Table 9, Column 1, Note-Taking 
represents the expectations of the program and then compares the expectations 
of the program with what is evident in how the program functions. The researcher 
examined what the program initiator (OHRP) expected to accomplish with the 
determination letter program. 
 
Table 9 
 
Note-Taking Expectations of Initiators and Participants of OHRP 
Determination Letter Program 
 
1 
Determination Letter 
Expectations 
Note taking 
 
Note-Taking 
Initiators  
 
The Office Of Human research Protection (OHRP) initiates 
correspondence to institutions that have obtained an FWA 
from OHRP. Institutions are notified when OHRP finds that 
there may be a matter of noncompliance or a deficiency with 
the approved research study. The determination letter 
details date-specific required action by the institution and 
responds to the action taken by the institution. 
Who is being served?  
Who is involved?  
The institution is ultimately involved as a result of being 
engaged in research that is covered by the Common Rule 
and has an approved Federalwide Assurance. Specifically, 
the institutional review board having approved the research 
project, human research protection program which provides 
administrative assistance to the institutional review board, 
and the social science researcher, who implements the 
research project are served by the correspondence from 
OHRP.  
How are participants 
to be served?  
OHRP provides leadership in the protection of the rights, 
welfare, and wellbeing of subjects involved in research by 
providing oversight and guidance to institutions. OHRP does 
this in one way by the issuance of determination letters.  
What will be produced 
by participants in the 
program?  
The institutional review boards, human research protection 
programs, researchers and institutions, as a result of the 
correspondence from OHRP address concerns of 
noncompliance and deficiencies stated in the determination 
letter as applicable to the Common Rule in an attempt to 
provide protection of the rights, welfare, and wellbeing of 
subjects involved in the research project. 
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 Second, the researcher then compared the expectations to what is 
Evident Implementation (how the program is being carried out) of the 
determination letters being sent by OHRP and received by the participants (the 
institution) as shown in Table 10.  
 
 Table 10 
Note-Taking Evident Implementation 
 
2 
Evident 
Implementati
on 
 
Note-Taking 
Users/Particip
ants 
 
Institutions respond to Federal requirements as 
documented in the determination letters. HRPPs 
revise and add additional policies and procedures in 
reference to the findings of the determination letters. 
IRBs revise their review and approval process to 
address the determination letters findings of 
noncompliance and/or deficiencies. Researchers 
revised their research study to address issues of 
noncompliance, and or deficiencies.  
Who are 
evident 
participants?  
Same 
How are 
participants 
using the 
service?  
Institutions implemented additional policies and 
procedures, increased human research educational 
programs for researchers, institutional officials, and 
human research protection program staff. All changes 
were related to the regulations of the Common Rule 
as indicated in the findings of noncompliance, and or 
deficiencies detailed in the determination letter sent to 
the institution by OHRP.  
What was 
produced by 
participants in 
the program?  
To ensure that research subjects are fully protected 
from harm and that research funding is not withdrawn 
from the institution by Federal agency sponsors, 
additional policies, and increased procedures, with an 
increased level of scrutiny in the research protocol 
review process commenced. 
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suggests the Note-Taking strategy in this phase is to discern what is evident in 
the actions of participants. In Table 10 the researcher has described the evident 
implementation of the program from the researcher‘s point of view.  
 Although the entire response from institutions responding to the 
correspondence from OHRP is not publicly available, the subsequent response 
from OHRP referencing portions of the institutions response is publicly available. 
It is the subsequent response information from OHRP that is used for Note-
Making as shown in Table 11 to further analyze the reactions to the 
determination letter by the participants. The Expectations are then compared with 
the Evident Implementations for interpretation of the data and thereby changing 
the Note-Taking phase to the Note-Making phase to ascertain whether 
congruence or divergence exists as shown in Table 11. During the Note-Making 
stage the researcher sought to determine if the Evident Implementation fit the 
expectation of response from the institution to OHRP.   
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Table 11 
 
Note-Making Results of Expectations and Implementations of OHRP 
Determination Letters 
 
3 
Results 
 
Note making 
 
Compare/Contrast 
expected with 
evident 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Modify or 
maintain? 
 
Institutions respond to Federal requirements as 
requested by OHRP in the determination letters. 
Institutions revise and add additional policies and 
procedures in reference to the findings of the 
determination letters. IRBs revise their review 
and approval process to address the 
determination letter‘s notation of noncompliance 
and, or deficiencies. Researchers revised their 
research protocol to address issues of 
noncompliance or deficiencies.  
 
OHRP‘s resubmittal of correspondence in reply to 
the institution‘s corrective actions taken in the 
determination letter indicated that the issues of 
noncompliance and or deficiencies indicated was 
slated to be addressed by the institution 
immediately. In all cases the expectation of the 
correspondence was addressed by the institution.  
 
In all cases institutions and their human research 
protection programs, institutional review boards, 
and researchers complied with requests in the 
determination letter made by OHRP. It would 
appear that OHRP‘s publicly available 
determination letters should be maintained.  
Expected vs. 
evident  
Same 
Expected vs. 
evident  
 
 
 
 
 
 
 
 
Social science researchers are expected to 
safeguard the welfare and rights of those that 
volunteer in their research projects. From the 
indications of corrective action requested by 
OHRP as noted in the determination letters, 
research subjects were not in imminent danger of 
being harmed based on the determination letters. 
It was evident that social science researchers 
were protecting the welfare and safety of their 
research subjects since determination letters did 
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not indicate that there had been incidents of 
imminent danger to the research subjects. 
 
Administrative procedural deficiencies of the 
institution were the major focus of determination 
letters sent to institutions regarding approved 
social science research projects. Based on the 
information contained in the determination letters 
it‘s supported that institutions needed additional 
guidance in promulgating the Common Rule. 
 
Determination letters served as an educational 
tool for institutions and should be maintained. 
Expected vs. 
Evident  
Institutions and their human research protection 
program, institutional review boards and 
researchers provide additional documentation 
and practices to address the concerns cited in 
the determination letter. OHRP acknowledged 
the corrective action that has been addressed. In 
all cases from the review of each determination 
letter it was evident that the corrective action was 
in the process of being addressed, or had been 
addressed by the institution. 
 
 The final stage of the analysis was Note-Remaking as shown in Table 12. 
The researcher‘s interpretation from Expectations and Evident Implementation 
was determined, resulting in the subsequent step, Recommendations. The 
analysis clearly indicates the evident and expected were aligned.  
Forty-three cases of noncompliance and or deficiencies from June 2000 to 
January 2011 represented social science research projects as determined by the 
project name listed in the determination letter on the OHRP publicly available  
Internet portal. In all cases OHRP indicated that institutions were taking 
corrective action or had taken corrective action to mitigate the concerns of the 
agency. 
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Table 12 
 
Note-Remaking Results of Expectations and Implementations of OHRP 
Determination Letters 
 
4 
Results 
 
Note Remaking 
Maintain or modify 
program in terms of 
who is being served  
Of 763 determination letters reviewed from 2000 to 
2010 43 letters appear to be related to social science 
research projects in which OHRP cited issues of 
noncompliance or deficiencies. Seven hundred and 
twenty (720) letters were sent to institutions which 
referenced biomedical research projects. 
 
As a result of the corrective actions requested by 
OHRP, biomedical research projects should be the 
main focus of the regulatory elements of the Common 
Rule. 
Maintain or modify 
program in terms of 
how systems are 
being served 
The number of social science research projects (43) as 
compared to the number of biomedical projects (720) to 
receive determination letters may indicate there are far 
fewer incidents of noncompliance or deficiency in social 
science research than biomedical research. It may also 
indicate that biomedical research is funded by federal 
agencies at much greater rates than social science 
research. Also the disparity of the disciplines‘ numbers 
could suggest that social science has most of its 
research falling into the exempt or expedited categories 
of the Common Rule. 
 
The program should be modified to address the unique 
differences of social science research projects due to 
the level of risk involve in the majority of it research 
activity.  .  
Maintain or modify 
program in terms of 
outcomes being 
produced by them 
Biomedical research projects in general contain a 
higher level of risk to the subjects than that of social 
science research as indicated in a corrective action 
requests by OHRP. Research implemented at a much 
lower level of risk to the research subject may not 
warrant the identical regulatory standards and scrutiny 
of the institution‘s IRB as biomedical research projects. 
The regulatory oversight by OHRP of social science 
projects should be modified to accommodate research 
which contains much less risk than that of biomedical 
research projects. 
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 The concerns of OHRP as documented in determination letters of social 
science projects were overwhelmingly focused on inadequacies of the review 
and approval process completed by the IRB, and administrative errors 
representing noncompliance or deficiencies as shown in Table 13. Based on the 
specific Federal regulation of the Common Rule, OHRP requested that the 
institution address findings of noncompliance, and deficiencies involving the 
particular research study, policies and procedures directly related to the 
institutional review board, administrative procedures, and institutional human 
research policies.  
 The majority of OHRP concerns raised in determination letters were 
directly related to the functioning of the IRB and their administrative support staff. 
Very few OHRP concerns raised in the determination letters could be directly 
attributed social science researchers increasing the risk of harm to subjects 
participating in their studies. A selection of OHRP‘s determination letters detailing 
Required Actions are found in Appendix Q. The database of determination letters 
can be viewed at http://www.hhs.gov/ohrp/compliance/letters/index.html. 
 Risk of imminent harm or danger to research subjects did not appear to be 
the focus of noncompliance or deficiency indicated in the correspondence of the 
determination letter referencing social science research projects. 
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Table 13 
 
Noncompliance or Deficiencies Cited In Social Science 
Determination Letters from 2000-2010 
  
Federal 
Regulation 
 
OHRP Reference to the Section Of The Common Rule 
 
46.101(b) IRB has applied an exemption to research activities that exceeded these 
categories. 
 
46.103(a)   assurance regulations not documented properly in IRB policy 
 
46.103(b)  study conducted without IRB approval  
 
46.103(b)(2) IRB did not have a duly constituted, functioning IRB and the IRB did not 
conduct initial or continuing review of the protocol review and recordkeeping 
duties 
 
46.103(b)(4)  no written procedures conducting initial and continuing review  
 
46.103(b)(4) & (5): written IRB policies and procedures do not provide specifics of operational 
details (i.e., initial review, conducting continuing review, etc.) 
 
46.103(b)(4)(iii) protocol changes were initiated to the approved protocol without further IRB 
review and approval 
46.103(b)(5) no written policies for unanticipated problems involving risks to subjects or 
others or any serious or continuing noncompliance 
 
46.103(f) IRB does not have written procedures adequately describing IRB activities 
 
46.103(f)  IRB did not review grant application referenced in protocol prior to the initiation 
of research  
 
46.107 (e) chair and associate chair have conflicting interest – staff of Office of 
Sponsored Programs  
 
46.107(a) IRB not sufficiently qualified regarding race, gender, cultural background, and 
sensitivity to community attitudes 
 
46.109(a) HRPP sent letter of approval to the investigator prior to getting modifications 
as requested by IRB move 
  
46.109(e) regulations make no provision for any grace period extending the conduct of 
the research beyond the expiration date of IRB approval 
 
46.110(b) expedited review procedures failed to be carried out by the IRB chairperson or 
by one or more experienced reviewers designated by the chairperson from 
among members of the IRB 
 
46.110(b)(1) 
 
 
IRB inappropriately compounds the concept of minimal risk and expedited 
review 
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Table 13 
 
Noncompliance or Deficiencies Cited In Social Science 
Determination Letters from 2000-2010 (continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
46.110(b)(2 ) inappropriate use of expedited review procedures  
 
46.110( C ) IRB did not keep all IRB members advised of the approval of expedited 
protocol 
 
46.111 IRB approval of the proposed research not deferred, pending subsequent 
review by the convened IRB of responsive material., IRB lacked sufficient 
information to make determinations required for approval of research 
 
46.111(a)(7) there are no adequate provisions to protect the privacy of subjects and to 
maintain the confidentiality of data 
 
46.115(a)(1) difficult to reconstruct a complete history of all IRB actions related to the 
protocols, copies of research proposals and backup materials and other 
documents not available to OHRP 
 
46.115 (a)(2) IRB meeting minutes not documented 
 
46.115(a)(2) vote of IRB actions including number of members voting for, against, and 
abstaining not recorded in the minutes 
 
46.115(b) signed parental permission forms must be retained for at least three years 
after completion of the research (no mention of time-frame in protocol) 
 
46.116  
 
IRB failed to require legally effective informed consent or parental permission, 
and/or document waiver of informed consent Informed consent not presented 
in language understandable to the subject 
 
46.116(a)  study did not include basic elements of informed consent that was reviewed 
and approved by the IRB 
 
46.116(a)(1) IRB did not review adequate explanation of purposes of the research and 
complete description of procedures to be followed 
 
46.116(a)(2) adequate description of risk and benefits not described in protocol that was 
reviewed and approved by the IRB 
46.116(b) informed consent documents and parental permission forms that reviewed and 
approved by IRB did not include all of the elements outlined in the regulations 
that was reviewed and approved by the IRB 
 
46.116(d) no documentation or procedure which alters or waives the requirements for 
informed consent 
 
46.117( C ) no documentation of IRB waiver of signed informed consent form 
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Analysis of Determination Letters 
 To answer the Research Question 1: what are the findings of deficiencies 
and findings of noncompliance indicated in OHRP determination letters (DL) for 
social science research projects, a qualitative approach to content analysis of 
documents (DL) was utilized in this study. Seven hundred and sixty three (763) 
letters were reviewed by the researcher in order to identify nonmedical academic 
research institutions that had received a DL from OHRP. Two hundred and 
eighty-eight (288) DL were identified from the sample of 763 DL as being 
nonmedical institutions. The 288 DL project title was reviewed for wording that 
appeared to denote a social science research project.  
 Forty-three (43) letters were found to have reference to what appeared to 
be social science research projects. The sample of 43 letters were further 
reviewed for OHRP reference to the Common Rule, Subpart A, §101-124. Using 
CARMA to analyze the contents of the sample, Note-Taking (1) (Table 9) 
identified the expectations of the OHRP DL program. OHRP was identified as the 
initiator of the DL program, with the institution including the IRB, and the HRPP 
administrative staff identified as the participants that are being served by the 
OHRP DL program.  
 The next stage (2) of Note-Taking in Table 10 identified how the program 
is implemented and what was produced by the program participants including the 
institution), the HRPP, the IRB and social science researchers. The next stage 
(3) Note-Making, in Table 11, was used to determine the expected response from 
the participants (the institution) versus the evident response related to the 
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requests of OHRP in the DL. In all cases program participants responded to the 
requests noted in the DL. The expected and evident response was congruent. 
 The last stage (4) of CARMA was Note-Remaking. Note-Remaking 
focuses on assessing whether the program should be maintained or modified. 
The findings of the Note-Remaking stage suggests the OHRP determination 
letters program indicate that noncompliance and, or deficiencies to the Common 
Rule were attributed overwhelmingly to IRBs and their support staff, but not 
specifically to social scientists‘ research projects. The concerns of OHRP as 
documented in the DL of social science projects were overwhelmingly focused on 
inadequacies of the review and approval process completed by the IRB, and 
administrative errors of the HRPP. Therefore CARMA suggests that the vast 
majority of OHRP determination letters were effective in providing guidance and 
oversight to HRPPs in general, the OHRP determination letter program did not  
reveal a profusion of non-compliance  or deficiencies that could be specifically 
attributed to social science research projects.  
  Telephone Interviews of HRPP Administrators 
 Telephone interviews consisted of identifying and contacting human 
research protection program administrators (HRPP administrators).HRPP 
administrators were identified from determination letters sent to the institutions 
HRPP administrators within the last 7 years. OHRP make determination letters 
available to the public, thereby publicizing the name and title of the HRPP 
administrator for the institution notified of non-compliance and or deficiency to the 
Common Rule. Determination letters (DL) are publically available on the OHRP 
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internet portal found at: http://www.hhs.gov/ohrp/compliance/letters/index.html. 
Contact information for the HRPP administrator was available on the institution‘s 
employee directory site.  
 Five HRPP administrators were contacted as a result of the determination 
letter. One HRPP administrator was chosen at random from the list of universities 
found on the Carnegie Foundations website at: 
http://www.carnegiefoundation.org/ . A total of six HRPP administrators were 
interviewed by telephone. HRPP Administrator‘s identity remains confidential in 
this report. Interviewees‘ names were replaced by identification numbers and 
their institution is not referred to in this analysis. All participants in the study 
expressed concern that their institution remain confidential for the purposes of 
this study. Confidentiality and privacy was maintained in this study. Table 14 
shows questions and responses from the interviewees conducted on March 25, 
and March 28, 2011.  
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Table 14 
 
Telephone Interviews - Questions and Responses 
  
 
Question 1: What is your role in your institution‘s human research 
protection   program? How long have you worked in this role? 
 
Interviewee 
000-050 
IRB Administrator.   
6 years 
 
Interviewee  
052-093 
IRB Director and voting member of the committee.  
23 years  
 
Interviewee  
095-179 
Administrative Director, Social Behavioral IRB.   
8 years 
 
Interviewee  
181- 227 
HRPP Program Director 
11 years 
 
Interviewee  
233-286 
Director, Institutional Research and Effectiveness.    
9 years 
 
Interviewee  
291-342 
Director of Research Compliance.  
8 years 
 
 
Question 2:  What has been the role of the HRPP in protecting human 
research subjects involved in social science research 
 
Interviewee 
000-050 
We’ve done a lot of enhancements in terms of our 
procedures of our guidance documents and 
educational outreach to educate our investigators. 
We now have a stronger program 
 
Interviewee  
052-093 
We protect subjects involved in all types of 
research 
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Table 14 
 
Telephone Interviews - Questions and Responses (continued) 
 
Interviewee  
095-179 
The university has worked very hard to be 
progressive where the federal regulations allow 
particularly for social and behavioral research. We 
have unchecked the boxes on our FWA, for 
research that is federally sponsored that fall under 
social and behavioral sciences IRB. We have 
created demonstration projects, we have issued 2 
year approval periods, we have created a new 
exemption category, and we have done a lot of 
work to try and maintain a superior level of 
protection for our subjects but also implemented 
some different procedures that decrease 
administrative burden while keeping subjects safe. 
 
Interviewee  
181- 227 
As far as social science we have provided some 
education but not nearly enough for researchers to 
fully understand the Federal rules and regulations 
including why what seems to him to be minimal risk 
research still needing to go through that process. 
We have done a better job in providing education 
for the IRB. We constantly try to keep up with the 
new types of social science research we’re seeing. 
Some of it is now collaborative research with 
biomedical  
Interviewee  
233-286 
We have a lot of workshops with the IRB and 
researchers. I have a staff person that provides 
education for researchers and the IRB. This has 
helped us with the review process to insure 
research participants are safe and we have a much 
faster turnaround time for social science protocols 
since researchers know what the IRB is looking for 
in providing an ethically sound study. 
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Table 14 
 
Telephone Interviews - Questions and Responses (continued) 
 
Interviewee 
291-342 
Our role is not unlike that of biomedical. But I think 
it may be a little more difficult for the IRB to 
address some of the issues related to social 
science and the Common Rule. We just had a 
qualitative study that was very difficult since most 
of our members do not have experience in 
qualitative research. The protocol was combined 
with medical records review and blood draws. So 
you see how that can be cause for lots of 
deliberation. Sometimes there is no clear path 
except common sense. We provided education for 
the campus and the IRB but we have lots of empty 
seats.  
 
 
Question 3: If your institution has ―un-checked‖ the box on the Federalwide 
Assurance how has un-checking the box affected the review and approval 
of social science research projects? 
 
Interviewee 
000-050 
We have unchecked the box. We still review 
everything the same way but I think the one thing it 
may have done is given us more flexibility in terms 
exempt category 1 vs. expedited category 7. So if 
we’re on the fence we can be a little more lenient 
than we would be otherwise. 
 
Interviewee  
052-093 
No, our committee reviews social science and 
biomedical research. We treat the review process 
the same. 
 
Interviewee  
095-179 
By unchecking the box you are able to get flexibility 
in how you can create equivalent protections for 
human subjects, so we are trying to take 
advantage of that by creating different procedures 
where we are able to, where there is not federal 
sponsorship or where the research is not held to 
the Common Rule by contract. 
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Table 14 
 
Telephone Interviews - Questions and Responses (continued) 
 
Interviewee  
181- 227 
We have just unchecked the box. I think it will 
mainly help in the review of unfunded research 
especially student research projects. The expedited 
reviewer and the IRB will have more flexibility in the 
approval of minimal risk research. 
 
Interviewee  
233-286 
We unchecked the box two years ago. Review of 
protocol and now be done much faster. The 
protocol receives this same amount of scrutiny it 
did prior to the box being unchecked but the IRB 
can now use more latitude in the review process. 
 
Interviewee 
291-342 
We have not unchecked the box yet. I expect we 
will get to it in the next few months. The IO is on 
board but there are still members of the IRB that 
believe unchecking the box will have an impact on 
how we are perceived to our constituents, although 
we know that the system of review will not change. 
We will get to it I am sure. It can only help with the 
speed in getting protocols approved for the 
researcher 
 
 
Question 4:  The Common Rule is based on a biomedical regulatory model 
of human research protections. How are the components of the biomedical 
regulatory model working for social science research projects? 
 
Interviewee 
000-050 
I think there are some gaps, one is the exempt vs. 
the expedited particularly in that area with kids and 
in the other areas some of the regulations need to 
be updated in regards to what we see in the social 
sciences in Internet research and newer research 
areas like that. So we have tried to have templates 
for each area and we try to use the common sense 
approach since the Common Rule is written for the 
biomedical area. 
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Table 14 
 
Telephone Interviews - Questions and Responses (continued) 
 
Interviewee  
052-093 
I guess I disagree I think the regulations of the 
Belmont report applies to all research and can be 
affectively applied to all research 
 
Interviewee  
095-179 
That’s a fabulous question.  I think social scientists 
and the IRB have had to work creatively to fit 
certain social science models into those 
regulations because as you mentioned they really 
were contemplated for the biomedical arena so it 
does take some creativity to do that.  I think more 
recently across three to five years we have noticed 
a change in the perspective of social science 
research. For example there is much more bio-
specimen and bio-banking collection associated 
with social science research so, it has more of a 
biomedical flavor to it than it use to. I also think 
another emerging research portfolio is research 
involving the internet research and social 
networking. That has actually been a challenge to 
try and find places for that type of research model 
within the Common Rule because it was clearly not 
contemplated several decades ago. So on one 
hand you have a component to social science 
research getting more of a biomedical flavor on the 
other hand you have some research diverging 
even more from those regulations.  
 
Interviewee  
181- 227 
They could be working better for social and 
behavioral science research projects. With so 
many different areas that are not addressed (in the 
Common Rule) it can be difficult for us in the pre-
review process and for the IRB 
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Table 14 
 
Telephone Interviews - Questions and Responses (continued) 
 
Interviewee  
233-286 
I think researchers the IRB and all involved in 
conducting research want to have to safe studies. 
The Common Rule does provide components that 
work for social science research but it is up to the 
HRPP to provide education for increased 
understanding of the flexibility within the 
regulations. The biomedical model used for social 
science may not accommodate or address the 
aspects of social science research. The exempt 
and expedited categories are trying to address 
some of the aspects but new areas of research 
including social media, is challenging for the IRB. A 
revamping of the Common Rule is really needed to 
support our researchers and the IRB better.  
 
Interviewee 
291-342 
It has worked relatively well here since we began 
workshops a couple of years ago to address areas 
of social science research studies with the IRB, 
staff and our researchers. We are still spending a 
lot of time on some projects and have no clear 
guidance like that of biomedical studies. Most of 
our research here is social and behavioral science. 
 
 
 
Question 5:  What, if any, concerns have social science researchers 
reported to your HRPP related to the review and approval of their research 
projects.  
 
Interviewee 
000-050 
Of course everyone wants their projects approved 
yesterday. Chairs and committee members change 
and the researcher questions why a protocol was 
approved on day and not approved the next? So I 
think there are questions about continuity and 
disapprovals so they get pretty upset with this. 
Interviewee  
052-093 
They (social science investigators) felt they had to 
do it (go through the IRB process) because they 
are at a medical institution 
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Table 14 
 
Telephone Interviews - Questions and Responses (continued) 
 
Interviewee  
095-179 
I think savvy researchers realize the Common Rule 
was not written with social scientists in the forefront 
of the feel of those regulations, and I think the 
savvy researchers find the IRBs need to kind of fit 
a square peg into a round hole troublesome for 
them because they feel it limits their flexibility, 
probably the biggest concern for us. 
 
Interviewee  
181- 227 
Investigators frequently remind us that the approval 
process is too long and that they are required to 
make revisions to the protocol that protect the 
institution and not their research participants. Of 
course we provide training sessions from 
completing the protocol form to understanding 45 
CFR 46 but they still are very frustrated for the 
most part when the protocol has to conform to the 
standards of the regulations.  
  
Interviewee  
233-286 
Turn-around time is always a big issue. Exempt 
protocols are another one. We have an exempt 
reviewer that turns the study around rather quickly. 
Most of our researchers don’t have a lot of 
concerns with our office they just want to begin the 
research as soon as possible. 
  
Interviewee 
291-342 
We have recently had a few calls about additional 
documentation needed for internet studies. Chat 
room research has become very popular here. The 
concern is that we review it mainly as expedited 
research and there is some concern that it should 
be an exempt review.  
 
 
Question 5a:  How does the Common Rule address some of these 
concerns?  
 
Interviewee 
000-050 
It doesn’t. 
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Table 14 
 
Telephone Interviews - Questions and Responses (continued) 
 
Interviewee  
052-093 
It’s pretty clear that it (the regulations) applies to 
everything, all types of research. 
 
Interviewee  
095-179 
There are so many different models of social 
science research. I think it (the concerns) is not 
being addressed. I think the IRB has had to work 
very hard to make it (the Common Rule) fit the 
research models. For example some of the issues 
around waver of documentation of informed 
consent can be particularly challenging. For 
example, for more than minimal research you can’t 
always issue a waiver of documentation because 
that is prohibited by the regulations. That is exactly 
the time you would want to issue it (the waiver). 
You don’t want the subjects name connected to the 
research or on a piece of paper of informed 
consent because it’s a risky for the subjects but we 
are prohibited from waiving that documentation. 
 
Interviewee  
181- 227 
I’m not sure it does. But maybe the key is to 
understand what is allowable in the  regulations 
during the review process 
 
Interviewee  
233-286 
It doesn’t that I am aware of. 
  
Interviewee 
291-342 
There is no mention of Internet research in the 
regulations. This is one of the concerns we have in 
applying the regulations to the different kinds of 
research we have here. 
  
 
Question 5b:  What do you (if you do) see as the major impediment in 
applying the Common Rule to social science research project review?  
 
Interviewee 
000-050 
I think it’s just keeping up with the times because it 
(the Common Rule) just has not changed since it 
was written and there is so much need for its 
flexibility in  
terms of some of the investigators with research 
that just doesn’t meet the category of exemption 
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Interviewee  
052-093 
I don’t see an impediment. 
 
 
Interviewee  
095-179 
Some of the Common Rule elements have too 
much specificity and not enough flexibility for the 
IRB to make some of the determinations and that 
example I gave about when you could issue a 
waiver of documentation is a perfect one.  
 
Interviewee  
181- 227 
It just not the same fit as it is for biomedical. We 
spend a lot of time trying to make it fit. 
 
Interviewee  
233-286 
What I see is a lot of busy work that keeps us from 
doing the essential work of protecting participants.  
 
Interviewee 
291-342 
We have to have some guidelines and right now 
this is all we have. I don’t see so much of an 
impediment as I see in the need for a specific set of 
social and behavioral guidelines for human-subject 
protections. 
 
 
Question 6: How would you characterize the regulation of social science 
research? 
 
 Interviewee 
 000-050 
They could use some updating. The regulations are 
just not keeping up with the times, like internet 
research. 
 
Interviewee  
052-095 
I think the regulations are flexible enough to work 
for all research 
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Table 14 
 
Telephone Interviews - Questions and Responses (continued) 
 
Interviewee  
095-179 
It is awkward because the Common Rule has 
expectations that much of the work will be clinical 
in nature with the exception of the exemptions 
which clearly carve out educational research and 
some other components like that but, strict to Part 
A, it does not leave enough flexibility with the IRB. 
It makes it awkward. It makes it a challenge to fit all 
the different types of social science research 
models within that.  For example, It’s quite different 
when you are being asked to review an 
ethnography study from a study of children in a 
behavioral interventional kind of perspective one 
requires flexibility and the other requires additional 
protections for the children and neither one of 
those elements are contemplated well when those 
Common Rule elements do have such a 
biomedical focus.   
 
Interviewee  
181- 227 
It can be daunting. On one hand we want to make 
sure research participants are protected but we 
don’t want to instill unnecessary concern by 
including everything that might happen to them as 
a result of the study. The regulations address the 
necessity to be very specific for biomedical 
researchers by the very nature of the kinds of 
research. Many times it’s just over kill for social 
science research. IRBs want to make sure they 
adhere to their charge and require that which is 
required for biomedical studies.  
 
Interviewee  
233-286 
We have not had any major incidents so I guess 
that would speak to the effectiveness of the 
regulations. IRB deliberations can be very complex 
and time consuming but they get it right mainly.  
 
Interviewee 
291-342 
The regulations are very useful in protecting human 
subjects but it needs to be more specific to social 
and behavioral science projects  
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Table 14 
 
Telephone Interviews - Questions and Responses (continued) 
 
 
Question 7: If you could modify the Common Rule to be specific to 
social science research projects, what would the change/s look like? 
 
Interviewee 
000-050 
I would give it a facelift especially the exempt 
categories and also add more flexibility in terms of 
the continuations and the one-year rule. 
 
Interviewee  
052-093 
I think the regulations are flexible enough to work 
for all research 
Interviewee  
095-179 
As previous in my answer question I would ask that 
the IRB be given more flexibility to make additional 
determinations based on the nature of the project 
particularly if you are not talking about research 
with vulnerable subjects that would fall under the 
subparts. That would be really helpful because 
again I recognize that the government does not 
want to touch the regulations frequently and 
change them. Then if that’s their model they should 
either issue guidance more frequently to allow IRB 
to make certain determinations or expand the 
determinations possible under the regulations or 
give the IRB more flexibility to do that themselves 
with more latitude than the Common Rule currently 
offers that way we can adapt to new models. 
 
Interviewee  
181- 227 
I would look into disciplines of the social sciences 
and not group them under the same umbrella of 
regulation. Research in education may be much 
different than research in oral history. The 
humanities are much different than economics. It 
can be difficult at times for staff and the IRB to 
reconcile how the regulations best serve a study in 
these fields. I would just like to make the 
regulations more in line with social science 
research. 
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Table 14 
 
Telephone Interviews - Questions and Responses (continued) 
 
Interviewee  
233-286 
Increase the exempt categories to reflect more of 
the work that social and behavioral science 
conducts. I would make specific reference in the 
regulations to things like Internet research. 
  
Interviewee 
291-342 
Two separate set of regulations would make the 
process of review and approval so much more 
efficient and effective for all concerned. We spend 
so much time in meetings discussing protocols that 
should be expedited but are not clearly defined as 
such in the regulations.   
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Analysis of Telephone Interviews of HRPP Administrators 
 Six human research protection program administrators (HRPP 
administrators) were recruited to be interviewed for this study. HRPP 
administrators were identified from determination letters that had been sent to 
their institution by OHRP. Carbon copies of determination letters are sent to the 
institution‘s HRPP administrators, thereby publicizing the name and title of the 
HRPP administrator for that institution. Since determination letters (DL) are 
publically available on the OHRP internet portal found at: 
http://www.hhs.gov/ohrp/compliance/letters/index.html the researcher had access 
to the contact information for the HRPP administrator from  the institution‘s 
employee directory. Five HRPP administrators were contacted as a result of the 
determination letter. One HRPP administrator was chosen at random from the list 
of universities found on the Carnegie Foundations website at: 
http://www.carnegiefoundation.org/ . A total of six HRPP administrators were 
interviewed by telephone. HRPP Administrator‘s identity remains confidential in 
this report. Interviewees‘ names were replaced by identification numbers and 
their institution is not referred to in this analysis. Interviewees were conducted on 
March 25, and March 28, 2011. 
 The role of all HRPP administrators suggested the leadership position in 
the HRPP, although titles were somewhat different. Titles included IRB 
Administrator, IRB Director, Administrative Director, Program Director, Director, 
Institutional Research and Effectiveness and Director of Research Compliance. 
Years of leadership service in the role was from 6-23 years. HRPP administrators 
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reported enhancing the procedures in their program and documents and revising 
documents (HRPP policies) for a stronger program of protection for human 
research subjects.  
 Interviewee 095-179 reported that the university had worked hard to be 
progressive especially where the federal regulations allow for social and 
behavioral research. The administrator had unchecked the boxes on the FWA, to 
disallow research that is not federal funded from being under the purview of the 
Common Rule. This being especially beneficial for social science projects that 
are not federally funded projects. Demonstration projects have been created, and 
unlike research which falls under the purview of the Common Rule, 2 year 
approval periods have been issued instead of one year approval periods. 
Administrator 095-179 also reports that they have ―created a new exemption 
category, and we have done a lot of work to try and maintain a superior level of 
protection for our subjects but also implemented some different procedures that 
decrease administrative burden while keeping subjects safe,‖ as shown in Table 
14, Question 2. 
 Administrators report additional human research compliance education for 
the IRB and researchers as well as the HRPP keeping abreast of new areas of 
social science research such as social media. Social media is a concern for 
HRPPs, in that the Common Rule does not directly address this form of research. 
Interviewees also reported that there are ―gaps‖ in the Common Rule which 
needs updating to address newer research areas. The lack of flexibility was 
another concern of administrators. An additional concern as stated by 
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Interviewee 291-342, in Table 14, Question 2, IRB members ―do not have 
experience in qualitative research‖ to be efficient in the review and approval 
process.  
 Five out of six interviewees expressed concern that the Common Rule did 
not accommodate social science research practices and that IRB‘s struggle in 
deliberation with the review and approval process for social science projects 
often this resulted in excessive documentation, revision requests of the 
researcher to conform to the standards of the Common Rule while creating time 
delays for the approval of the researcher‘s study. Administrators suggest that the 
concerns of the IRB and researchers related to qualitative research, level of 
review for social media and other new areas of research studies is not addressed 
in the Common Rule. The lack of regulatory guidance for social science research 
projects continue to be a large concern for HRPPs providing regulatory guidance, 
for IRB‘ in their deliberation processes and for the social science researchers 
needing approval for their research projects while protecting human research 
subjects and avoiding overregulation and mission creep. 
 Findings from the phone interviews included comments from HRPP 
Administrators suggesting the need for additional human research compliance 
education for the IRB and researchers, as well as for the HRPP staff to keep 
abreast of new research areas of social science research. Some administrators 
had already begun additional educational components to their programs but 
others needed to provide more education. The additional education was useful 
for HRPP staff and the IRB. The administrators reported that social media is a 
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concern for HRPPs, in that the Common Rule does not directly address this form 
of research. Interviewees also reported that there are ―gaps‖ in the Common 
Rule which needs updating to address newer research areas. The lack of 
flexibility of the Common Rule was recurring concern reported by administrators. 
Administrator 291-342, Question 2 in Table 14 reported that IRB members ―do 
not have experience in qualitative research‖ to be efficient in the review and 
approval process for social science qualitative research projects.  
 The finding in the chapter also included interviewees expressed concern 
that the Common Rule did not accommodate social science research practices 
and that IRB‘s struggle in deliberation with the review and approval process for 
social science projects often resulting in excessive documentation, revision 
requests of the researcher to conform to the standards of the Common Rule 
while creating time delays for the approval of the researcher‘s study. The lack of 
regulatory guidance for social science research projects was found to be a large 
concern for HRPPs providing regulatory guidance for IRB‘ in their deliberation 
processes and for the social science researchers needing approval for their 
research projects while protecting human research subjects and avoiding 
overregulation and mission creep. 
Policy Evaluation Using CARMA Aligned with Fischer’s 
Four Steps of Inquiry 
 
 This section of the research study addresses the Research Question 3: 
has the Common Rule achieved its intended purpose of protecting human 
research subjects participating in social science research? Fischer suggests that 
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policy related ideas are mainly arguments favoring various ways of looking at the 
world, which results in resolving the problem and therefore policy should be 
evaluated in terms of efficiency or effectiveness. In determining efficiency or the 
effectiveness of a policy, Fischer suggests four interrelated discourses can be 
used to evaluate the policy: 1) technical analytic discourse or program verification 
(outcomes), 2) contextual discourse or situational validation systems (objectives), 
3) systems discourse or social vindication (goals), and 4) ideological discourse or 
social choice (values).  
 Program Verification: The aim of program verification is to understand how 
the program fulfills its objectives efficiently and effectively. Program verification 
assesses if the program has fulfilled its objective/objectives, are there secondary 
or unanticipated effects that offset program objectives and does the program 
fulfill objectives more efficiently than alternative means available.  
 Situational Validation: Situational validation focuses on if the program 
objectives are relevant to situation at hand. Validation has its concern in 
understanding if the program objective is relevant to the situation, are there 
circumstances that may require exception to the objectives, and are their two or 
more conditions that are also relevant to the problem situation. 
 Societal Vindication: The focus of societal vindication is on the societal 
system in its entirety, and the consequences of the policy to the societal system. 
The concerns of societal vindication are deliberated in concerns of instrumental 
or contributive value for society, and does the policy goal result in unanticipated 
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problems with important societal consequences, and does the policy goal lead to 
consequences that are judged to be equitably distributed.   
 Social Choice: Social choice is discerned by assessing whether the social 
order is essentially provided with a basis for a legitimate and equitable resolution 
of judgments that may be in conflict, and is there evident support for an 
alternative ideology to the policy.  
 Putney‘s (2008) qualitative evaluation tool, Complementary Analysis 
Research Method Application (CARMA) is similarly an evaluation tool to describe 
and interpret efficiency or effectiveness of a program or in this case, the 
Common Rule policy.  Therefore, to assess efficiency or effectiveness of the 
Common Rule CARMA was aligned with Fischer‘s (1999) framework of public 
policy evaluation. Aligning both qualitative methods assisted in the assurance of 
credibility of this study. 
 CARMA and Fischer‘s framework for public policy evaluation contained 
four essential steps. Each step of CARMA; (Expectations, Implementation , 
Results and Conclusions /Recommendations) was aligned with each of the four 
steps of Fischer‘s framework for public policy evaluation (Verification, Validation, 
Vindication, and Social Choice). The alignment of CARMA with Fischer‘s 
interrelated discourses produced the following results as shown in Table 15.  
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Table 15 
 
The Common Rule Policy aligned with CARMA and Fischer’s 
Four Steps of Inquiry  
 
1. Program Expectations 
Note-Taking  
1. Verification  
Outcomes 
Program initiator : Office of Human 
Research Protections (OHRP)   
 
 
Who is being served? Who is 
involved?    
Institutions, HRPPs, IRBs, 
Researchers are being served and 
are involved in the program. 
 
 
How are participants to be served? 
Notified by OHRP of 
noncompliance or deficiencies in 
the approved research project of 
actions and requests that ought to 
be taken to insure the safety and 
welfare of research subjects.  
 
 
What will be produced by 
participants in the program? 
Requests made by OHRP including 
revision of institutional human 
research policies, additional 
documentation in research 
protocols, additional education for 
HRPP staff, IRB, and researchers, 
additional time investment in the 
review and approval of research 
protocols. 
 
Program: Common Rule policy 
with oversight by OHRP‘s of 
institutions having an FWA and 
conducts human subject 
research regulated by the 
Common Rule  
 
Does the program empirically 
fulfill its stated objectives?  
The Common Rule instructs 
institutional review boards to 
ensure that ―risks to subjects are 
minimized‖ and ―risks to subjects 
are reasonable in relation to 
anticipated benefits, if any, to 
subjects, and the importance of 
the knowledge that may be 
reasonably expected to result (45 
CFR 46.111(a)(1, 2).  
 
Does the empirical analysis 
uncover secondary or 
unanticipated effects that offset 
the program objectives? 
The regulations of the Common 
Rule may in some cases 
increase the risks of those 
participating in social science 
research projects (i.e., 
anthropological studies). The 
doctrine of signed informed 
consent may not be applicable to 
all disciplines within social 
science.   
 
Does the program fulfill the 
objectives more efficiently than 
alternative means available?  
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Disciplines of social science are 
guided by their own professional 
ethics to protect human subjects. 
However, to qualify for Federal 
funding for research projects the 
institution must hold an 
assurance with OHRP and agree 
to abide by all regulations of the 
Common Rule. Therefore it has 
not been established if the 
program fulfill the objectives 
more efficiently than alternative 
means available seeing that 
alternative means would not elicit 
the funding needed to complete 
the research project. Additionally, 
most institutions have opted to 
follow the regulations of the 
Common Rule and regardless of 
funding source 
2. Evident implementation 
Note-Taking 
2. Situational Validation  
Objectives 
Users/participants. 
The institution consisting of its 
HRPP, the IRB, social science 
researchers.   
 
 
Who are evident participants? 
Same  
 
 
How are the participants using the 
service? Required actions by 
OHRP to fulfill the requirements of 
the Common Rule result in 
corrective actions being taken by 
the institution. 
 
 
What will be produced by 
participants in the program?  
Implementation of additional 
policies and procedures may 
suggest that risks to subjects are 
Is the program objective relevant 
to the problem situation?  
The objective of OHRP is to 
protect the rights, welfare, and 
wellbeing of subjects involved in 
research conducted or supported 
by the U.S. Department of Health 
and Human Services (DHHS) 
based on the regulatory 
provisions of the Common Rule. 
However, in order to accomplish 
their objectives OHRP regulators 
suggest that the institution, its 
HRPP, the IRB and social 
science researchers must define 
their research practices in the 
Common Rule. 
 
Are there circumstances in the 
situation that require an 
exception to be made to the 
objectives? 
There are no exceptions made to 
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minimized. 
 
 
 
 
the objectives of the Common 
Rule in its protection of human 
research subjects. However, 
§46.110 espouse expedited 
review procedures for certain 
kinds of research involving no 
more than minimal risk, and for 
minor changes in approved 
research. 
3. Results  
Note-Making 
3. Societal Vindication 
Goals 
Who are the participants?  
Same  
 
 
How are they working together? 
Expected vs. evident, alignment or 
departure?   
Federal agencies supporting social 
science research studies, 
institutions and their researchers 
work together to provide a culture of 
research compliance for the safety 
and welfare of research participants 
as indication in the determination 
letters. They appear to be aligned 
to provide ethical research 
practices articulated in the Common 
Rule.  
 
 
Modify or maintain?   
This practice should be maintained 
given that it appears from the 
determination letters that 
participants are working together to 
protect human research subjects. 
 
What was produced?  
Additional practices were 
implemented as detailed in the 
institution‘s revised policies and 
procedures for protecting human 
subjects. Amended policies and 
procedures included ethical 
Systems discourse: Does the 
policy goal have instrumental or 
contributive value for the society 
as a whole. 
The Common Rule is comprised 
of a shared system of 
responsibility for protecting 
human research subjects as 
indicated in corrective action 
taken by institutions when 
notified of incidents of 
noncompliance or deficiencies. 
The shared system includes the 
institution, the institutional review 
board with its administrative 
support staff (HRPP) and 
researchers. The Common Rule 
lays the foundation for ethical 
research practices contributing to 
the safety and welfare of 
research subjects. The policy 
goal has a contributive value for 
the society as a whole. 
 
Does the policy goal result in 
unanticipated problems with 
important societal 
consequences?  
OHRP‘s publicly available 
information regarding research 
studies that have issues of 
noncompliance or deficiencies 
cause institutions to act swiftly in 
order to continue with the 
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research education and training for 
IRBs, administrative staff and 
researchers. 
  
 
Expected vs. evident, alignment or 
departure?   
These factors are in alignment. The 
goal of the OHRP program, 
institutions and their researchers is 
to protect the safety and welfare of 
research participants.  
 
Modify or maintain?  
Although the program appears to 
be working, it is doing so since 
there are no other alternatives. The 
institution, HRPPs, the IRB and 
social scientists have little options 
to alternative programs.  
research, and mitigate bad 
publicity that can occur to the 
institution and ensure continued 
funding for the project. By acting 
swiftly institutions may only be 
able to provide the minimum 
remedy to address the 
determination letter when 
remediation in different ways 
could have additional impact on 
the system of social science 
research.  
 
4. Recommendations 
Note-ReMaking 
4. Social Choice  
Values 
Researcher  
The Common Rule policy of 
regulating Social science research 
by the same standards as 
biomedical research appears on 
the surface to be working. 
However, facets of the biomedical 
model of human research 
protection cannot always be 
applicable to social science 
research.  
 
 
Informed consent is an essential 
element of the Common Rule. 
Informed consent can be approved 
by the IRB as signed informed 
consent or verbal consent, as in 
telephone interviews. Social 
scientists have concerns that the 
IRB may not utilize the flexibility of 
the Common Rule in the 
application of verbal consent, 
Do the fundamental ideas (or 
ideology) that organizes the 
accepted social order provide a 
basis for a legitimate resolution 
of conflicting judgments?  
The Common Rule provides a 
medium for shared meanings of 
the ethical standards by which 
human research must be guided. 
The Common Rule effectively 
provides guidelines in which this 
can be accomplished. The 
Common Rule also provides 
flexibility in the usage of the 
ethical standards and guidelines 
applicable to human research. 
Social scientists contend that 
flexibility of the Common Rule‘s 
usage is not made readily 
available to them; thereby social 
scientists see a need for specific 
regulations to address social 
science research. 
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causing cumbersome and time 
consuming measures for the 
researcher and the research 
subjects.  
 
 
Modify or maintain program?   
The Common Rule should be 
modified to specifically address 
new areas of social science 
research. 
 
Analysis of Policy Evaluation 
 To answer Research Question 3: has the Common Rule achieved its 
intended purpose of protecting human research subjects participating in social 
science research, Fischer‘s (1995) four interrelated discourses   consisting of:  
1) program verification (outcomes), 2) contextual discourse or situational 
validation systems (objectives), 3) systems discourse or social vindication 
(goals), and 4) ideological discourse or social choice (values) was aligned with 
CARMA, Putney (2008). CARMA consists of four areas of evaluation, 1) program 
expectations, 2) evident implementation, 3) results, and  4) recommendations. 
The alignment was used to interpret efficiency and effectiveness of the Common 
Rule policy. Disciplines of social science are guided by their own professional 
ethics to protect human subjects. However, to qualify for Federal funding for 
research projects the institution must hold an assurance with OHRP and agree to 
abide by all regulations of the Common Rule. Therefore it has not been 
established if the program fulfill the objectives more efficiently than alternative 
means available seeing that alternative means would not elicit the funding 
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needed to complete the research project. Additionally, most institutions have 
opted to follow the regulations of the Common Rule regardless of funding source. 
 Alignment 1 consists of program expectations (note-taking) with program 
verification (outcomes). The Office of Human Research Protections (OHRP) 
oversees the Common Rule policy as operational human research subject policy 
and guidelines for Institutions, HRPPs, IRBs, and researchers. The Common 
Rule instructs institutional review boards to ensure that ―risks to subjects are 
minimized‖ and ―risks to subjects are reasonable in relation to anticipated 
benefits, if any, to subjects, and the importance of the knowledge that may be 
reasonably expected to result‖ (45 CFR 46.111(a)(1, 2). Requests made by 
OHRP as a result of noncompliance or deficiency to the Common Rule are 
documented to the institution. Requests can include revision of institutional 
human research policies, additional documentation in research protocols, 
additional education for HRPP staff, IRB, and researchers.  
 Secondary or unanticipated effects that offset the program objectives 
include, as an example the doctrine of signed informed consent may not be 
applicable to all disciplines within social science and additional time investment in 
the review and approval of research protocols are produced by the participants. 
The regulations of the Common Rule may in some cases increase the risks of 
those participating in social science research projects (i.e., anthropological 
studies). 
 Alignment 2, evident implementation (note-taking) and situational 
validation (outcomes) suggests the institution consisting of its HRPP, the IRB, 
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and social science researchers fulfill required actions requested by OHRP 
consistent with the Common Rule. The objective of OHRP is to protect the rights, 
welfare, and wellbeing of subjects involved in research conducted or supported 
by the U.S. Department of Health and Human Services (DHHS) based on the 
regulatory provisions of the Common Rule. However, in order to accomplish their 
objectives OHRP regulators suggest that the institution, its HRPP, the IRB and 
social science researchers must define their research practices with the 
regulations of the Common Rule, not necessarily by social scientists professional 
code of ethics. There are no exceptions made to the objectives of the Common 
Rule in its protection of human research subjects. However, §46.110 espouse 
expedited review procedures for certain kinds of research involving no more than 
minimal risk, and for minor changes in approved research. 
 Alignment 3 of results (note-making) and societal vindication (goals) 
suggest Federal agencies supporting social science research studies, institutions 
and their researchers work together to provide a culture of research compliance 
for the safety and welfare of research participants as indication in the 
determination letters appear to be aligned to provide ethical research practices 
articulated in the Common Rule. The Common Rule is comprised of a shared 
system of responsibility for protecting human research subjects as indicated in 
corrective action taken by institutions when notified of incidents of noncompliance 
or deficiencies. The shared system includes the institution, the institutional review 
board with its administrative support staff (HRPP) and researchers. The Common 
Rule lays the foundation for ethical research practices contributing to the safety 
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and welfare of research subjects. The policy goal has a contributive value for the 
society as a whole.  
 OHRP‘s publicly available information regarding research studies that 
have issues of noncompliance or deficiencies cause institutions to act swiftly in 
order to continue with the research, and mitigate bad publicity that can occur to 
the institution and that may cancel federal funding for the research project. By 
acting swiftly institutions may only be able to provide the minimum remedy to 
address the determination letter when remediation in different ways could have 
additional impact. Based on the analysis of alignment the program should be 
modified to address additional research areas that impact social science such as 
social media, qualitative research, anthropological research, and areas specific 
to social science. 
 Alignment 4 Recommendations (note-Taking) and social choice (values) 
The Common Rule policy of regulating Social science research by the same 
standards as biomedical research appears on the surface to be working. 
However, facets of the biomedical model of human research protection cannot 
always be applicable to social science research, especially the new areas of 
research. Do the fundamental ideas (or ideology) that organizes the accepted 
social order provide a basis for a legitimate resolution of conflicting judgments?  
 The Common Rule provides a medium for shared meanings of the ethical 
standards by which human research must be guided. The Common Rule 
effectively provides guidelines in which this can be accomplished but may lack 
the flexibility needed by social scientists to conduct their research in an effective 
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and efficient manner. Although the Common Rule provides some flexibility in the 
usage of the ethical standards and guidelines applicable to human research, 
social scientists contend that flexibility of the Common Rule‘s usage is not made 
readily available to them by the IRB, leaving many social scientists to see a 
need for specific regulations to address social science research (Gunsalus et al., 
2006; Schrag, 2009). 
 The analysis of the alignment of CARMA with Fischer‘s Four Steps of 
Inquiry indicates that although the Common Rule is somewhat effective for social 
science research seeing that it is part of the only federal regulatory tool available, 
it is not efficient in its use by HRPPs, the IRB and importantly, social science 
researchers. The inefficiency presents itself in overregulation and mission creep 
(Gunsalus, 2006; Schrag, 2009). Following, Chapter 5 presents discussion of the 
findings, recommendations and chapter summaries of this study. 
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Chapter 5 
Discussion, Recommendations and Chapter Summaries  
Implications from the Results of Data 
Social science researchers suggest the components of their research 
activity contained much less risk to human research subjects than that of 
biomedical research. Social scientists conducing human research are required to 
follow the policies of the Common Rule for federally funded research projects. 
Using the Common Rule they suggest, to review and approve their research, 
most of which is minimal and less than minimal risk to research subjects amounts 
to overregulation and mission creep. To better understand the impact of the 
Common Rule on social science research, implications from the data of three 
methods of inquiry in this qualitative study is discussed. Three methods of inquiry 
include: 1) content analysis of OHRP determination letters, 2) in-depth interviews 
of human research protection program administrators, and 3) policy evaluation of 
the Common Rule, Subpart A.  
 OHRP oversees human research conducted with federal funding. When 
research projects are found to be in noncompliance to or deficient in the 
regulations governing human research, OHRP provides a determination letter to 
the institution. The determination letter contains findings of deficiency or 
noncompliance based on the regulations of the Common Rule that regulates 
biomedical and social science research. In an attempt to understand the impact 
of regulating social science human research with biomedical regulations this 
study sought to answer the Research Question 1: what are the findings of 
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deficiencies and findings of noncompliance indicated in OHRP determination 
letters (DL) for social science research projects? The qualitative approach to 
content analysis of documents revealed that of the 763 letters 43 were found to 
reference what appeared to be social science research projects. The sample of 
43 letters were further reviewed for OHRP reference to the Common Rule, 
Subpart A, §101-124. It was determined that deficiencies or noncompliance to 
the Common Rule was attributed overwhelmingly to IRBs and their support staff, 
but not specifically to social scientists‘ research projects.  
 The implication of the OHRP determination letter content analysis data 
suggests that participants of social science research activity reviewed by OHRP 
were not at risk of harm from the research activity. The data did however imply 
that in many cases the IRBs and their administrative staff did not handle 
procedural matters of the review and approval process correctly. Implications 
from the data suggest that additional education and training related to the 
Common Rule is necessary for the HRPP to develop better institutional human 
research protection policies and procedures. 
 Six human research protection program HRPP administrators were 
recruited for telephone interview for this study to answer the Research Question 
2:  What impact does the Common Rule have on social science research 
protocol review by human research protection programs?  The role of the HRPP 
administrators interviewed suggested they held a leadership position in the 
HRPP, with years of leadership service in the role ranging from 6-23 years. 
Consistently administrators reported that there was a need for additional human 
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research compliance education for the IRB and researchers as well as the HRPP 
staff to keep abreast of new areas of social science research such as social 
media. New research areas specifically was an expressed concern since 
Common Rule does not directly address social media as a form of research. 
Interviewees also reported that there are ―gaps‖ in the Common Rule which 
needs updating to address newer research areas. The lack of regulatory flexibility 
of the Common Rule was another consistent concern of administrators, as also 
was the IRB‘s lack of experience in qualitative research methods. The 
administrators also expressed concern that the Common Rule did not fully 
accommodate social science research practices as it did for biomedical 
researchers.  
 Implications from the interview data suggest that IRB‘s struggle in 
deliberation with the review and approval process for social science projects, 
often resulting in excessive documentation, revision requests of the researcher to 
conform to the standards of the Common Rule while creating time delays for the 
approval of the researcher‘s study. Lack of regulatory guidance for social science 
research can result in inconsistent review of research projects by the IRB during 
the deliberation process. Requiring additional documentation and revision to 
protocols when no clear regulatory procedure can be relied upon can contribute 
to overregulation and mission creep. 
 The fundamental notion of protecting human subjects whether in 
biomedical research or social behavioral research is consistent within the 
disciplines of human research as cited in the literature. However, the quandary of 
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how best to facilitate the highest levels of human research protection in the social 
science discipline remains vague. At the core of the issue is the Common Rule 
and its application to the review and approval process of social science research 
studies including what the literature suggests is minimal and less than minimal 
social science research.  
 The majority of cases of unethical scientific research have focused on 
biomedical investigations. As a result, federal regulations have provided 
guidelines to ensure ethical research standards. The Common Rule is the 
standard by which all federal human research is held, biomedical and social 
science research. Analysis of the data in this research study indicates the 
Common Rule does not have the flexibility of regulations to specifically regulate 
the facets of social science research. IRBs are left to participate in deliberations  
of social science research areas (with some being new areas of research such 
as social media) without adequate regulatory guidelines, albeit in an attempt to fit 
the social science research review and approval process within biomedical 
regulations of the Common Rule.  
 The question of, has the Common Rule achieved its intended purpose for 
social science research was analyzed via policy evaluation, aligning CARMA with  
Fischer‘s Four Steps of Inquiry for four interrelated discourses. The analysis 
indicates that the elements of biomedical research regulations do not translate to 
the tenets of social science research. Although, the Common Rule is somewhat 
effective for social science research it is not efficient in its use by researchers, 
IRBs and the HRPP to address the tenets of social science research.    
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 The implications from the data of this study also suggest that the Common 
Rule does not fully accommodate social science research practices. Partial 
accommodation of social science research practices my lead to partial 
protections for social science research subjects. However, implications of the 
data also suggest that researchers, IRBs and HRPPs may find flexibility in the 
Common Rule when the applicability of the Common Rule regulations is fully 
understood in its application to social science research. As an example, waiver of 
documentation of informed consent (45 CFR 46.117) may not be used to the 
extent allowable when there is ambiguity regarding its use. The implication from 
the data of the need for on-going education is prevalent in the data.  
Recommendation for Policy Consideration 
 Institutional review boards need better regulatory guidelines for the 
effective and efficient review and approve social science research. A separate 
regulatory policy applicable to the tenets of social science research should be 
developed for use by those conducting, reviewing and approving research 
projects.  Definitions must be included in the policy that adopts the language of 
the disciplines of the social science profession. The policy development should 
be undertaken by social scientists, vetted in the Federal Register and made 
applicable to funded as well as unfunded and privately funded research projects. 
Consistency of the application of the regulations social science research projects 
should be a priority in the development of the document.   
 Researchers need to be assured that a policy in whole is applicable to 
their research discipline. Categories of research applicable to the regulation 
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should be delineated within the policy as to add consistency throughout the 
social science research enterprise. The social science research policy should be 
a document that can be revised and updated as new research areas are 
identified. The policy should make provisions for all categories of exempt 
research listed to be reviewed at the department of the primary investigatory. The 
recommendations should serve as a beginning to removing a one-size-fits-all 
approach to protecting human research subjects participating in social science 
research activity. 
Recommendation for Further Research 
 This study has provided a foundation for additional qualitative inquiry to 
assess the impact of the Common Rule‘s biomedical standards being applicable 
to social science research from the lens of the OHRP determination letters, 
HRPPs and the Common Rule. Further research on IRB social science 
deliberation strategies applicable to exempt, expedited and full board strategies 
are needed to build on the foundation of the Common Rule‘s applicability to 
social science or the lack thereof. Continued research, from varied social science 
disciplines qualitatively investigating the impact of a one-size-fits-all regulatory 
approach to protecting human subjects is needed. This research focused on the 
basic policy for protection of human subjects, 45 CFR 46 Subpart A, additional 
Subparts including Subparts B - E should be invested to assess the applicability 
to social science research. Continued investigation of the current system of 
human research protections for social science research may warrant an overhaul 
to influence institutions, and politicians to revise institutional policies and 
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procedures and federal regulatory mandates that are effective and efficient for 
the varied disciplines of social science.   
Chapter Summaries 
Introduction - Chapter 1 
In Chapter 1 of this study vegetable and meat experimentation with young 
Jewish prisoners as early as the sixth century is reported as human research. 
Prior to and including the 18th, the 19th, 20th centuries and beyond, revealed 
human experimentation that has resulted in disease and death to some research 
subjects. This chapter reveals that only since the 20th century has protections for 
human research subjects been a requirement for ethical human research.  
Although ethical requirements have been embodied in various professions, a 
human research protection has taken a longer time frame to be embraced by 
researchers. As a result of public outrage for unethical medical syphilis 
experiments, the Berlin Code of 1900 (see Appendix B) was developed. Needing 
a stronger code of ethical conduct for human subject research, and as a result of 
the conviction of 16 of the 23 physician defendants, of which seven of those 
indicted were sentenced to death, the Nuremberg Code was established. The 
Nuremberg Code established additional standards of ethical medical behavior for 
the post-World War II human rights era. Although German scientists were found 
to have committed atrocious research experiments on human research subjects, 
U.S. medical researchers still considered the research doctors as trusted and 
revered scientists.  
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The United States had committed its own unethical medical research for 
many years without much concern for the human research subjects in their 
studies. One of the most infamous studies was conducted by the U.S. Public 
Health Office, was the Tuskegee Syphilis Study, conducted from 1932 until 1972, 
in which men diagnosed with syphilis were left untreated to study the natural 
progression of the disease. The Willowbrook State Hospital Study is the most 
widely known unethical study on children. The study involved children diagnosed 
with mental retardation, living at the Willowbrook State Hospital as patients from 
1956 to 1971. Researchers infected the otherwise healthy children with hepatitis 
to gauge the disease‘s natural history, prevention, and treatment.  
While the 1947 Nuremberg Code was the world‘s reaction to Nazi war 
crimes, the 1974 National Research Act Public Law 93-348 (see Appendix J) was 
the response of the United States to the Tuskegee Syphilis Study. The National 
Research Act established the IRB process requiring formal peer review and 
approval of all DHHS research involving human subjects. The 1974 National 
Research Act legislation also created the National Commission for the Protection 
of Human Subjects of Biomedical and Behavioral Research (Commission). 
Additionally, out of the Commission‘s Report came what was called the Belmont 
Report, named for the Belmont Conference Center where the Commission met to 
draft the report. The Belmont Report summarizes the basic ethical principles 
identified by the Commission as respect for persons, beneficence and justice in 
its application to informed consent, assessment to risk and benefits and the 
selection of subjects. However, the Belmont Report did have its critics regarding 
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its applicability to nonmedical research. It was noted that although the Belmont 
Report ―is a notable achievement in the exploration of the ethical challenges 
raised by medical research, but which serves as a poor guide to research in the 
social sciences and humanities …‖ Although medical research was the initial 
focus of human research protection intervention by the Federal government, the 
―new sciences,‖ anthropology, sociology, economics, and political science also 
came under scrutiny.  
Social scientists voiced concern and suggested that the kinds of limited 
harm social science research engenders is far less detrimental than that of 
biomedical research. They put forward that seemingly ―over-zealous medical 
scientist‖ has brought an increased level of scrutiny to social science research 
evidenced by governmental regulations. Additionally, it was put forward that the 
fields of anthropology, journalism, oral history, ethnography and other social 
science fields already had well-established ethical research guidelines for their 
profession. 
Social scientists suggests that while these efforts to provide increased 
protections for human research participants reflect a laudable goal, the 
regulations do not necessarily apply or translate well to all disciplines of 
research, particularly social science research. Social scientists further suggest 
that the current human subjects regulations are obstacles to their research 
studies and view the regulations as overregulation and mission creep because 
the patterns of noncompliance and litigation are not seen in social science 
research as in biomedical or clinical research. 
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 Therefore, the research problem of this study suggests there is a need to 
test the critical assessment of the Common Rule in its application to the social 
science research. The research questions of, 1) what are the findings of 
deficiencies and findings of noncompliance indicated in OHRP determination 
letters (DL) for social science research projects, 2) what impact does the 
Common Rule have on social science research protocol review by human 
research protection programs, and 3) has the Common Rule achieved its 
intended purpose of protecting human research subjects participating in social 
science research.  
Review of Literature – Chapter 2  
 Chapter 2 presents a review of the literature related to social scientists‘ 
concerns of what, in the literature is called, ―over-regulation and mission creep‖. 
The Chapter documents the historical perspectives of unethical human 
experimentation as well as the regulatory standards put in place to protect 
human subjects. In addition, the Chapter discusses prior research related to 
researcher and institutional human research compliance while outlining the 
necessity to investigate the impact of social science research that is regulated by 
a medical model of human research protections. 
 Chapter 2 details social scientists concerns of the IRBs ―blizzard of 
paperwork getting in the way of the fundamental mission to protect the dignity 
and well-being of human subjects‖. Discussed also in this chapter is institutional 
review board (IRB) workloads expanding beyond their ability to handle, due to 
focusing much more on procedures and documentation, unclear definitions, 
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leading to unclear responsibilities and efforts to comply with the standards of 
human research requirements even when research is not federally funded. Social 
science researchers characterize their concerns as overregulation and mission 
creep resulting from the application of a regulatory process created for medical 
research being applied to non-invasive and minimal risk social science research, 
that usually is unfunded or privately funded. The chapter details social science 
researchers increased concerns of the delay and even denial of their research 
projects. 
Historical perspectives of unethical human experimentation is documented 
in the literature and presented in Chapter 2. Human experimentation in the 
eighteenth century included regular offers of free pardon to inmates to participate 
in human experiments. Experiments that included the inoculation of prisoners 
with infectious small pox in variolation experimentation popularized in England in 
1721-1722 is discussed with the same procedures being used in America on 
slaves. Despite public concern of unethical research practices questionable 
research practices continued for many years. Victoria Nourse‘s work, In Reckless 
Hands, examines the case of Skinner versus Oklahoma (2008).21  Nourse details 
a history of America's experiment with eugenics22 resulting in thousands of 
incarcerated men and women having been sterilized. The ambiguity of American 
human research practices during the 1920s and 1930s to attain ethical research  
  
                                            
21
     Skinner v. State of Oklahoma,1942, the United States Supreme Court ruling held that compulsory sterilization 
could not be imposed as a punishment for a crime.  
22
     Eugenics is the study and practice of human selective breeding. The aim is to improve the species. 
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standards arising from the uncertainty of using experimental research methods is 
expounded.  
Research regulation including the Berlin Code of 1900, one of the earliest 
documents to address the outrage of medical research and its unethical 
practices, the Nuremberg Code (1947) established as a set of ethical research 
principles, the Declaration of Helsinki (Declaration) of 1964, revised in 1975, 
developed by the World Medical Association as a set of ethical principles for the 
medical research community is discussed. 
 Chapter 2 discusses the historical factors of the Common Rule having 
been designed with a focus on biomedical research, with social science 
researchers questioning whether the Common Rule should apply to social 
science research. The Chapter presents details of The Office for Human 
Research Protections (OHRP) as an agency of the Department of Health and 
Human Services that provides leadership and oversight for the protection of the 
rights, welfare, and wellbeing of subjects involved in research conducted or 
supported by HHS agencies. OHRP documentation of the finding of deficiencies 
and non-compliance in the form of determination letters is discussed. The 
determination letters specifically outline what actions must be taken by the 
institution to return to a compliant state, rectify a deficiency, or resume research 
activity. The communication from OHRP to the institution is publicly available. 
Research scientists posit that public availability of determination letters force 
institutions to enact highly conservative in their IRB deliberative decisions. 
 Previous research relevant to this study is identified and discussed. The 
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literature of determination letters studies revealed three similar research studies, 
conducted by Borror et al. (2003), Burris and Welsh (2007) and Weil et al.(2010). 
In each case their quantitative research revealed the numbers of citations of 
noncompliance. The research projects did not delineate the numbers of 
biomedical or social science citations of noncompliance or deficiencies. The 
authors focused on the categories and numbers of noncompliance and 
deficiencies found in determination letters. The focus was not on the discipline in 
which those noncompliance and deficiencies were found.  
 The chapter expounds on the components of human research protection 
program consisting of the investigators, the Institutional Review Board (IRB) and 
its administrative staff as well as the institution. The HRPP of an institution 
oversees the responsible conduct of biomedical and social science research, 
protect the rights of research participants, reduce their risks, and increase the 
benefits of the research. The literature review details concerns of social scientist 
with their institution‘s HRPP administrative staff as they routinely encounter 
impediments to their research when navigating Institutional Review Board (IRB) 
review process to obtain approval for their research studies. 
 In 2001, the National Bioethics Advisory Commission (NBAC) complained 
that Institutional Review Boards (IRBs) were overwhelmed not only 
by high workloads generated by the amount of actions to process just one 
research project (see Figure 2) and limited resources but also by a regulatory 
system that often distracts from rather than focuses on key ethical issues.  
Review of the literature in this chapter illustrated that investigators and 
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IRBs must be more effective and efficient in carrying out their responsibilities, in 
that way, improving research protections and increasing public trust in research.  
The literature indications of noncompliance resulting in risk of harm to those 
participating in social science research remains minuscule compared to OHRP 
findings of noncompliance in biomedical research activity. Although there has 
been much anecdotal comment in the literature on the topic of the application of 
a one-size-fits-all approach to regulating social science research with biomedical 
regulations, there seems to be no abundance of literature of the research to 
substantiate the assertions that research participants are better protected in 
social science research studies resulting from the biomedical regulatory model of 
the Common Rule. Therefore, leading to the assertion that the social science 
researcher may be over scrutinized for the harms that may result from their 
research based on the amount of risk in typical social science research, including 
surveys, interviews, oral history research and other types of minimal risk 
research. The chapter discusses the federal regulations in its application to social 
science research that continue to weigh heavily on institutions as they attempt to 
balance the need for protecting human subjects in research, the need to support 
their researchers‘ scholarly efforts and the need to minimize any untoward 
liability claims on the institution.  
Methods - Chapter 3  
 Chapter Three discusses the methods used to address three research 
questions, 1) what are the findings of deficiencies and findings of noncompliance 
indicated in OHRP determination letters (DL) for social science research projects,  
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 2) what impact does the Common Rule have on social science research protocol 
review by human research protection programs, and 3) has the Common Rule 
achieved its intended purpose of protecting human research subjects 
participating in social science research?  
 This study encompasses a three prong qualitative methodological 
approach to answer the research questions above respectively using, content 
analysis, in-depth interviews, and policy evaluation. To better understand the 
impact of the Common Rule on social science research activity three methods of 
inquiry are applied in this qualitative study. Content analysis of OHRP 
determination letters, in-depth interviews of human research protection program 
administrators and policy evaluation of the Common Rule is discussed as 
providing a better understanding of the impact of the Common Rule for social 
science research activity.  
 Relying on qualitative content analysis of documents to encompass a 
theoretical framework having an approach of empirical, methodological controlled 
analysis of texts within the context of communication and using systematic 
content analytical scientific methodology is used to study OHRP determination 
letters. The next phase of the study includes human research protection program 
(HRPP) administrators. In-depth interviewing is used as a technique to gather 
descriptive data in the subjects‘ own words for the purpose of developing insight 
as to how the HRPP Administrator interprets some portion of their professional 
world. In-depth interviews are used at this stage of the study as a strategy to 
capture the deep meaning of the administrators‘ ―lived experience‖ of the HRPP 
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administrator in his or her own words. Six HRPP administrators were recruited for 
this phase of the study due to their high level of knowledge of the Common Rule, 
are advisers to risk-management and compliance officials for institutional 
research policies, and advise the institution‘s teaching professionals on the 
standards for those conducting human research. 
 The final method discussed in Chapter 3 is policy evaluation.  This phase 
of the study is focused on the Fischer‘s Four Steps of Inquiry for four interrelated 
discourses of policy evaluation including: program verification; situational 
validation; societal level vindication, and social choice, aligned with Putney‘s 
Critical Analysis Research Method Application (CARMA). Policy analysis is used 
in this study to evaluate the Common Rule for better understanding of its 
effectiveness for the social sciences. 
Findings of the Study Summary - Chapter 4  
 Chapter 4 details the findings of this study. To answer the Research 
Question 1: what are the findings of deficiencies and findings of noncompliance 
indicated in OHRP determination letters (DL) for social science research projects, 
a qualitative approach to content analysis of documents (DL) was utilized in this 
study. Seven hundred and sixty three (763) letters were reviewed resulting in  
two hundred and eighty-eight (288) letters identified as nonmedical institutions. 
The 288 DL project title was reviewed for wording that appeared to denote a 
social science research project. Forty-three (43) letters were found to have 
reference to what appeared to be social science research projects.  
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 The sample of 43 letters were further reviewed for OHRP reference to the 
Common Rule, Subpart A, §101-124. Using CARMA to analyze the contents of 
the sample, Note-Taking (1) (Table 9) identified the expectations of the OHRP 
DL program. The findings suggest OHRP as the initiator of the DL program, with 
the institution including the IRB, and the HRPP administrative staff identified as 
the participants being served by the OHRP DL program.  
 The next stage (2) of Note-Taking in Table 10 found that the OHRP 
program provided guidance to HRPPs and researchers based on their findings to  
revise policies and procedures, and revise research protocol. The next stage (3) 
Note-Making, in Table 11, used to determine the expected response from the 
participants (the institution) versus the evident response related to the requests 
of OHRP in the DL found that in all cases program participants responded to the 
requests noted in the DL. The expected and evident response was congruent. 
 The last stage (4) of CARMA was Note-Remaking. Note-Remaking 
focused on assessing whether the program should be maintained or modified. 
The findings of the Note-Remaking stage suggests the OHRP determination 
letters program indicate that noncompliance and, or deficiencies to the Common 
Rule were attributed overwhelmingly to IRBs and their support staff, but not 
specifically to social scientists‘ research projects. The concerns of OHRP as 
documented in the DL of social science projects were overwhelmingly focused on 
inadequacies of the review and approval process completed by the IRB, and 
administrative errors of the HRPP. Therefore CARMA suggests that the vast 
majority of OHRP determination letters were effective in providing guidance and 
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oversight to HRPPs in general, the OHRP determination letter program did not 
reveal a profusion of non-compliance or deficiencies that could be specifically 
attributed to social science research projects.  
  To answer Research Question 2: what impact does the Common Rule 
have on social science research protocol review by human research protection 
programs six human research protection program administrators (HRPP 
administrators) were recruited and interviewed by phone for this study. Findings 
from the phone interviews included comments from HRPP Administrators 
suggesting the need for additional human research compliance education for the 
IRB and researchers, as well as for the HRPP staff to keep abreast of new 
research areas of social science research. Some administrators had already 
begun additional educational components to their programs but others needed to 
provide more education. The additional education was useful for HRPP staff and 
the IRB. The administrators reported that social media is a concern for HRPPs, in 
that the Common Rule does not directly address this form of research. 
Interviewees also reported that there are ―gaps‖ in the Common Rule which 
needs updating to address newer research areas. The lack of flexibility of the 
Common Rule was recurring concern reported by administrators.  
 The finding in the chapter also included interviewees expressed concern 
that the Common Rule did not accommodate social science research practices 
and that IRB‘s struggle in deliberation with the review and approval process for 
social science projects, often resulting in excessive documentation, revision 
requests of the researcher to conform to the standards of the Common Rule 
188 
 
 
while creating time delays for the approval of the researcher‘s study. The lack of 
regulatory guidance for social science research projects was found to be a large 
concern for HRPPs providing regulatory guidance for IRB‘ in their deliberation 
processes and for the social science researchers needing approval for their 
research projects while protecting human research subjects and avoiding 
overregulation and mission creep. 
 To answer Research Question 3: has the Common Rule achieved its 
intended purpose of protecting human research subjects participating in social 
science research, Fischer‘s (1995) four interrelated discourses  consisting of:  
1) program verification (outcomes), 2) contextual discourse or situational 
validation systems (objectives), 3) systems discourse or social vindication 
(goals), and 4) ideological discourse or social choice (values) was aligned with 
the CARMA, Putney (2008). The alignment was used to interpret efficiency and 
effectiveness of the Common Rule policy. Disciplines of social science are 
guided by their own professional ethics to protect human subjects. However, to 
qualify for Federal funding for research projects the institution must hold an 
assurance with OHRP and agree to abide by all regulations of the Common Rule. 
The findings of the alignment of CARMA with Fischer‘s Four Steps of Inquiry 
indicates that although the Common Rule is somewhat effective for social 
science research seeing that it is part of the only federal regulatory tool available, 
it is not efficient in its use by HRPPs, the IRB and importantly, social science 
researchers. The inefficiency presents itself in overregulation and mission creep 
(Gunsalus, 2006; Schrag, 2009).  
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Discussion, Recommendations and Chapter Summaries - Chapter 5 
 Chapter 5 discussed the implications of the data that suggests that OHRP 
determination letters contained findings of deficiencies and noncompliance could 
be attributed to procedural factors of the IRB and HRPP administration. In most 
cases determination letters referenced policies that needed to be developed or 
revision of the institutions existing human research policies, revealing that social 
science research projects specifically, did not increase risks to human subjects. 
Telephone interviews of HRPP administrators revealed that excessive 
documentation, lack of flexibility in the deliberation process and may contribute to 
overregulation and mission creep. 
 Recommendations for policy consideration included the need for better 
regulatory guidelines for effective and efficient review and approval of social 
science research. The findings of the research suggests that a separate 
regulatory policy for social science should be considered and undertaken by 
researchers representing various fields within the social science discipline. 
 Recommendations for further research included investigating deliberation 
strategies applicable to exempt, expedited and full board protocol review. 
Strategies are needed to build on the foundation of the Common Rule‘s 
applicability to social science as well as the lack thereof. Chapter 5 included the 
introduction to this author‘s research study, history of unethical research 
practices, a review of the literature applicable to this research study, methods of 
research to answer the research questions, findings, and finally, discussion of the 
research. 
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Epilogue 
 Research ethics and its impact continue to be a contemporary issue 
reaching into the past to rectify wrongs created by what could be seen as a lack 
of Federal oversight. On October 5, 2010 the New York Times reported that from 
―1946 to 1948 American public health doctors infected nearly 700 Guatemalans‖ 
that were comprised of ―prison inmates, mental patients and soldiers with 
venereal diseases in what was meant as an effort to test the effectiveness of 
penicillin.‖ It is not clear if the penicillin was effective and used to treat those that 
had been infected by the American medical researchers. Again, financed with 
American tax dollars the NIH ―even paid for syphilis-infected prostitutes to sleep 
with prisoners‖, since Guatemalan prisons allowed such visits.  
 When the prostitutes did not succeed in infecting the men, some prisoners 
had the bacteria poured onto scrapes made on their penises, faces or arms, and 
in some cases it was injected by spinal puncture.‖ The Secretary Of State Hillary 
Clinton and HHS Secretary Kathleen Sebelius ―offered an apology to the 
government and the survivors and descendants of those infected.‖ The complete 
article is found at: 
http://www.nytimes.com/2010/10/02/health/research/02infect.html?_r=2 
 A recent publicized example of the lack of flexibility in the application of 
the Common Rule is reported in Inside Higher Ed on March 25, 2011 as ―IRB 
Overreach‖ of social science research:  
 An associate professor of education has sued 
Brown University for barring her from using her own data 
because she paid her human research subjects different 
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amounts of money based on their economic status. The 
suit raises questions about the role of IRBs in regulating 
privately funded research, the fairness of their process 
and the tensions that arise when such boards govern the 
work of social scientists. 
 
 Based on the researchers recommendation discussed above this situation 
could have been avoided to the satisfaction of the IRB and the researcher using 
appropriate institutional and regulatory policies. On-going education for IRBs and 
their support staff lends itself to better understanding of the flexibility available in 
the Common Rule and regulatory procedures of protecting human subjects. 
Although the immediate future does not suggest revamping of the Common Rule 
to separately address social science research projects, the current literature 
continues to promote that a one-size-fits-all regulatory oversight for social 
science research and biomedical research may not be as effective or as efficient 
as it could be otherwise. The article in its entirety can be found at: 
http://m.insidehighered.com/layout/set/popup/news/2011/03/18/brown_professor
_sues_university_for_barring_her_from_using_her_research . 
 On July, 2011 the U.S. Department of Health and Human Services issued 
an Advance Notice of Proposed Rulemaking (ANPRM) that proposed changes to 
the Common Rule as of July 2011. DHHS suggests the proposal entitled: Human 
Subject Research Protections: Enhancing Protections for Research Subjects and 
Reducing Burden, Delay, and Ambiguity for Investigators has been proposed for 
two reasons, (1) the human subject research landscape has changed 
dramatically since the early 1980s when the current regulations were first being 
formulated and (2) in light of that, there is a need to address effectiveness and 
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the efficiency of the regulations for human subject protections in the current 
research environment. Proposed changes can be found at:  
http://www.hhs.gov/ohrp/humansubjects/anprmqanda.html .  
 This research study also suggested in the analysis of determination 
letters, interviews with human research protection administrators and analysis of 
the evaluation of the Common Rule, the need for change to the federal 
regulations given the identical reasons as indicated above. The most recent 
article from Inside Higher Ed by Doug Lederman on August 3, 2011 further 
affirms the timeliness of this study. The article suggests that this is ―the federal 
government's first major review of its so-called Common Rule governing the 
protection of human research subjects and  has the potential to ease if not 
resolve many of the concerns of scholars.‖  The article entitled ―Updating the 
Common Rule‖ can be found at: 
http://www.insidehighered.com/news/2011/08/03/u_s_review_of_human_subject
s_rules_could_ease_restrictions_on_researchers .  
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Appendix A 
 
HUMAN EXPERIMENTS: A CHRONOLOGY OF HUMAN RESEARCH 
 
by Vera Hassner Sharav 
 
6th century B.C.: Meat and vegetable experiment on young Jewish prisoners in Book of Daniel. 
5th century B.C.: "Primum non nocere" ("First do no harm"), medical ethics standard attributed to 
Hippocrates. This Oath became obligatory for physicians prior to practicing medicine in the 4th century AD 
1st century B.C. Cleopatra devised an experiment to test the accuracy of the theory that it takes 40 days to 
fashion a male fetus fully and 80 days to fashion a female fetus. When her handmaids were sentenced to 
death under government order, Cleopatra had them impregnated and subjected them to subsequent 
operations to open their wombs at specific times of gestation. 
[http://www.jlaw.com/Articles/NaziMedExNotes.html#1]  
12th century: Rabbi and physician Maimonides' Prayer: "May I never see in the patient anything but a fellow 
creature in pain." 
1796 Edward Jenner injects healthy eight-year-old James Phillips first with cowpox then three months later 
with smallpox and is hailed as discoverer of smallpox vaccine. 
1845-1849: J. Marion Sims, "the father of gynecology" performed multiple experimental surgeries on 
enslaved African women without the benefit of anesthesia. After suffering unimaginable pain, many lost their 
lives to infection. One woman was made to endure 34 experimental operations for a prolapsed uterus. 
http://www.coax.net/people/lwf/jm_sims.htm  
1865: French physiologist Claude Bernard publishes "Introduction to the Study of Human Experimentation," 
advising: "Never perform an experiment which might be harmful to the patient even though highly 
advantageous to science or the health of others."  
1896: Dr. Arthur Wentworth performed spinal taps on 29 children at Children's Hospital, Boston, to 
determine if the procedure was harmful. Dr. John Roberts of Philadelphia, noting the non-therapeutic 
indication, labeled Wentworth's procedures "human vivisection."  
1897: Italian bacteriologist Sanarelli injects five subjects with bacillus searching for a causative agent for 
yellow fever.  
1900: Walter Reed injects 22 Spanish immigrant workers in Cuba with the agent for yellow fever paying 
them $100 if they survive and $200 if they contract the disease.  
1900: Berlin Code of Ethics. Royal Prussian Minister of Religion, Education, and Medical Affairs guaranteed 
that: "all medical interventions for other than diagnostic, healing, and immunization purposes, regardless of 
other legal or moral authorization are excluded under all circumstances if (1) the human subject is a minor or 
not competent due to other reasons; (2) the human subject has not given his unambiguous consent; (3) the 
consent is not preceded by a proper explanation of the possible negative consequences of the intervention." 
http://www.geocities.com/artnscience/00berlincode.pdf  
1906: Dr. Richard Strong, a professor of tropical medicine at Harvard, experiments with cholera on prisoners 
in the Philippines killing thirteen.  
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1913: Pennsylvania House of Representatives recorded that 146 children had been inoculated with syphilis, 
"through the courtesy of the various hospitals" and that 15 children in St. Vincent's House in Philadelphia 
had their eyes tested with tuberculin. Several of these children became permanently blind. The 
experimenters were not punished.  
1915: A doctor in Mississippi, working for the U.S. Public Health Office produces Pellagra in twelve 
Mississippi inmates in an attempt to discover a cure for the disease  
1919-1922: Testicular transplant experiments on five hundred prisoners at San Quentin.  
1927: Carrie Buck of Charlottesville is legally sterilized against her will at the Virginia Colony Home for the 
Mentally Infirm. Carrie Buck was the mentally normal daughter of a mentally retarded mother, but under the 
Virginia law, she was declared potentially capable of having a "less than normal child." By the 1930s, 
seventeen states in the U.S. have laws permitting forced sterilization  
The settlement of Poe v. Lynchburg Training School and Hospital (same institution, different name) in 1981 
brought to an end the Virginia law. It is estimated that as many as 10,000 perfectly normal women were 
forcibly sterilized for "legal" reasons including alcoholism, prostitution, and criminal behavior in general.  
1931: Lubeck, Germany, 75 children die in from pediatrician's experiment with tuberculosis vaccine.  
1931: Germany adopts "Regulation on New Therapy and Experimentation" requiring all human experiments 
to be preceded by animal experiments. This law remained in effect during the Nazi regime.  
1931: Dr. Cornelius Rhoads, a pathologist, conducted a cancer experiment in Puerto Rico under the 
auspices of the Rockefeller Institute for Medical Investigations. Dr. Rhoads has been accused of purposely 
infecting his Puerto Rican subjects with cancer cells. Thirteen of the subjects died. A Puerto Rican physician 
uncovered the experiment an investigation covered-up the facts. Despite Rhoads' hand written statements 
that the Puerto Rican population should be eradicated, Rhoads went on to establish U.S. Army Biological 
Warfare facilities in Maryland, Utah, and Panama, and was later named to the U.S. Atomic Energy 
Commission. Rhoads was also responsible for the radiation experiments on prisoners, hospital patients, and 
soldiers. The American Association for Cancer Research honored him by naming its exemplary scientist 
award the Cornelius Rhoads Award.  
1932-1972: U.S. Public Health Service study in Tuskegee, Alabama of more than 400 black sharecroppers 
observed for the natural course of untreated syphilis.  
1932: Japanese troops invade Manchuria. Dr. Shiro Ishii, a prominent physician and army officer begins 
preliminary germ warfare experiments.  
1936: Japan's Wartime Human Bio warfare Experimentation Program.  
1938: Japan establishes Unit 731 in Pingfan, 25 km. from Harbin. Unit 731, a biological-warfare unit 
disguised as a water-purification unit, is formed outside the city of Harbin.  
1939: Third Reich orders births of all twins be registered with Public Health Offices for purpose of genetic 
research.  
1939: Twenty-two children living at the Iowa Soldiers' Orphans' Home in Davenport were the subjects of the 
"monster" experiment that used psychological pressure to induce children who spoke normally to stutter. It 
was designed by one of the nation's most prominent speech pathologists, Dr. Wendell Johnson, to test his 
theory on the cause of stuttering.  
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1940: Poisonous gas experiments at Unit 731. One experiment conducted September 7-10, 1940, on 16 
Chinese prisoners who were exposed to mustard gas in a simulated battle situation.  
1940-1941: Unit 731 used aircraft to spread cotton and rice husks contaminated with the black plague at 
Changde and Ningbo, in central China. About 100 people died from the black plague in Ningbo as a result.  
1940s: In a crash program to develop new drugs to fight Malaria during World War II, doctors in the Chicago 
area infected nearly 400 prisoners with the disease. Although the Chicago inmates were given general 
information that they were helping with the war effort, they were not informed about the nature of the 
experiment. Nazi doctors on trial at Nuremberg cited the Chicago studies as precedents to defend their own 
research aimed at aiding the German war effort.  
1941: Sterilization experiments at Auschwitz.  
1941-1945: Typhus experiments at Buchenwald and Natzweiler concentration camps.  
1941: Dr. William c. Black inoculated a twelve month old baby with herpes. He was criticized by Francis 
Payton Rous, editor of the Journal of Experimental Medicine, who called it "an abuse of power, an 
infringement of the rights of an individual, and not excusable because the illness which followed had 
implications for science." Dr. Rous rejected outright the fact that the child had been "offered as a volunteer."  
1942 –1945: Unit 731. Ishii begins "field tests" of germ warfare and vivisection experiments on thousands of 
Chinese soldiers and civilians. Chinese people who rebelled against the Japanese occupation were arrested 
and sent to Pingfan where they became human guinea pigs; there is evidence that some Russian prisoners 
were also victims of medical atrocities.  
"I cut him open from the chest to the stomach and he screamed terribly and his face was all twisted in 
agony. He made this unimaginable sound, he was screaming so horribly. But then finally he stopped. This 
was all in a day's work for the surgeons, but it really left an impression on me because it was my first time." 
NYT  
These prisoners were called 'maruta' (literally 'logs') by the Japanese. After succumbing to induced diseases 
- including bubonic plague, cholera, anthrax - the prisoners were usually dissected while still alive, their 
bodies then cremated within the compound. Tens of thousands died. The atrocities were committed by some 
of Japan's most distinguished doctors recruited by Dr. Ishii.  
1942: High altitude or low pressure experiments at Dachau concentration camp.  
1942: Harvard biochemist Edward Cohn injects sixty-four Massachusetts prisoners with beef blood in U.S. 
Navy-sponsored experiment.  
1942: Japanese sprayed cholera, typhoid, plague, and dysentery pathogens in the Jinhua area of Zhejian 
province (China). A large number of Japanese soldiers also fell victim to the sprayed diseases.  
1942-1943: Bone regeneration and transplantation experiments on female prisoners at Ravensbrueck 
concentration camp.  
1942-1943: Freezing experiments at Dachau concentration camp.  
1943 Refrigeration experiment conducted on sixteen mentally disabled patients who were placed in 
refrigerated cabinets at 30 degree Farenheit, for 120 hours, at University of Cincinnati Hospital., "to study 
the effect of frigid temperature on mental disorders."  
1942-1943: Coagulation experiments on Catholic priests at Dachau concentration camp.  
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1942-1944: U.S. Chemical Warfare Service conducts mustard gas experiments on thousands of 
servicemen.  
1942-1945: Malaria experiments at Dachau concentration camp on more than twelve hundred prisoners.  
1943: Epidemic jaundice experiments at Natzweiler concentration camp.  
1943-1944: Phosphorus burn experiments at Buchenwald concentration camp.  
1944: Manhattan Project injection of 4.7 micrograms of plutonium into soldiers at Oak Ridge.  
1944: Seawater experiment on sixty Gypsies who were given only saltwater to drink at Dachau 
concentration camp.  
1944-1946: University of Chicago Medical School professor Dr. Alf Alving conducts malaria experiments on 
more than 400 Illinois prisoners.  
1945: Manhattan Project injection of plutonium into three patients at Billings Hospital at University of 
Chicago.  
1945: Malaria experiment on 800 prisoners in Atlanta.  
1946: Opening of Nuremberg Doctors Trial by U.S. Military Tribunal.  
1945: Japanese troops blow up the headquarters of Unit 731 in final days of Pacific war. Ishii orders 150 
remaining ''logs'' (i.e., human beings) killed to cover up their experimentation. Gen. Douglas MacArthur is 
named commander of the Allied powers in Japan.  
1946: U.S. secret deal with Ishii and Unit 731 leaders cover up of germ warfare data based on human 
experimentation in exchange for immunity from war-crimes prosecution.  
1946-1953: Atomic Energy Commission sponsored study conducted at the Fernald school in 
Massachusetts. Residents were fed Quaker Oats breakfast cereal containing radioactive tracers.  
1946: Patients in VA hospitals are used as guinea pigs for medical experiments. In order to allay suspicions, 
the order is given to change the word "experiments" to "investigations" or "observations" whenever reporting 
a medical study performed in one of the nation's veteran's hospitals.  
1947: Colonel E.E. Kirkpatrick of the U.S. Atomic Energy Comission issues a secret document (Document 
07075001, January 8, 1947) stating that the agency will begin administering intravenous doses of 
radioactive substances to human subjects.  
1947: The CIA begins its study of LSD as a potential weapon for use by American intelligence. Human 
subjects (both civilian and military) are used with and without their knowledge.  
1947: Judgment at Nuremberg Doctors Trial sets forth "Permissible Medical Experiments" – i.e., the 
Nuremberg Code, which begins: "The voluntary consent of the human subject is absolutely essential."  
1949: Intentional release of radiodine 131 and xenon 133 over Hanford Washington in Atomic Energy 
Commission field study called "Green Run."  
1949: Soviet Union's war crimes trial of Dr. Ishii's associates.  
1949-1953: Atomic Energy Commission studies of mentally disabled school children fed radioactive isotopes 
at Fernald and Wrentham schools.  
1940s-1950s: "psychic driving" and "mental departterning" experiments conducted by Dr. Ewen Cameron, 
depriving patients of sleep, using massive ECT combined with psychoactive drugs such as, LSD. After his 
"treatments" patients were unable to function. In the 1950's Dr.Cameron's experiments were sponsored by 
the CIA.  
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1950: Dr. Joseph Stokes of the University of Pennsylvania infects 200 women prisoners with viral hepatitis.  
1950: U.S. Army secretly used a Navy ship outside the Golden Gate to spray supposedly harmless bacteria 
over San Francisco and its outskirts. Eleven people were sickened by the germs, and one of them died.  
1951-1960: University of Pennsylvania under contract with U.S. Army conducts psychopharmacological 
experiments on hundreds of Pennsylvania prisoners.  
1952-1974: University of Pennsylvania dermatologist Dr. Albert Kligman conducts skin product experiments 
by the hundreds at Holmesburg Prison; "All I saw before me," he has said about his first visit to the prison, 
"were acres of skin."  
1952: Henry Blauer injected with a fatal dose of mescaline at New York State Psychiatric Institute of 
Columbia University. U.S. Department of Defense, the sponsor, conspired to conceal evidence for 23 years. 
I  
1953 Newborn Daniel Burton rendered blind at Brooklyn Doctor's Hospital due to high oxygen study on RLF.  
1953-1957: Oak Ridge-sponsored injection of uranium into eleven patients at Massachusetts General 
Hospital in Boston.  
1953-1960: CIA brainwashing experiments with LSD at eighty institutions on hundreds of subjects in a 
project code named "MK-ULTRA."  
1953-1970: U.S. Army experiments with LSD on soldiers at Fort Detrick, Md.  
1954-1974: U.S. Army study of 2,300 Seventh-Day Adventist soldiers in 157 experiments code named 
"Operation Whitecoat."  
1950s –1972: Mentally disabled children at Willowbrook School (NY) were deliberately infected with hepatitis 
in an attempt to find a vaccine. Participation in the study was a condition for admission to institution.  
1956: Dr. Albert Sabin tests experimental polio vaccine on 133 prisoners in Ohio.  
1958-1962: Spread of radioactive materials over Inupiat land in Point Hope, Alaska in Atomic Energy 
Commission field study code named "Project Chariot."  
1962: Thalidomide withdrawn from the market after thousands of birth deformities blamed in part on 
misleading results of animal studies; the FDA thereafter requires three phases of human clinical trials before 
a drug can be approved for the market.  
1962 to 1966, a total of 33 pharmaceutical companies tested 153 experimental drugs at Holmesburg prison 
(PA) alone.  
1962-1980 Pharmaceutical companies conduct phase I safety testing of drugs almost exclusively on 
prisoners for small cash payments.  
1962: Injection of live cancer cells into 22 elderly patients at Jewish Chronic Disease Hospital in Brooklyn. 
Administration covered up, NYS licensing board placed the principal investigator on probation for one year. 
Two years later, American Cancer Society elected him Vice President.  
1962: Stanley Milgram conducts obedience research at Yale University.  
1963: NIH supported researcher transplants chimpanzee kidney into human in failed experiment.  
1963-1973: Dr. Carl Heller, a leading endocrinologist, conducts testicular irradiation experiments on 
prisoners in Oregon and Washington giving them $5 a month and $100 when they receive a vasectomy at 
the end of the trial.  
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 1964: World Medical Association adopts Helsinki Declaration, asserting "The interests of science and 
society should never take precedence over the well being of the subject."  
 1965-1966: University of Pennsylvania under contract with Dow Chemical conducts dioxin experiments on 
prisoners at Holmesburg.  
 1966: Henry Beecher's article "Ethics and Clinical Research" in New England Journal of Medicine.  
 1966: U.S. Army introduces bacillus globigii into New York subway tunnels in field study.  
 1966: NIH Office for Protection of Research Subjects ("OPRR") created and issues Policies for the 
Protection of Human Subjects calling for establishment of independent review bodies later known as 
Institutional Review Boards.  
 1967: British physician M.H. Pappworth publishes "Human Guinea Pigs," advising "No doctor has the right 
to choose martyrs for science or for the general good."  
 1969: Judge Sam Steinfield's eloquent dissent in Strunk v. Strunk, 445 S.W.2d 145, the first judicial 
suggestion that the Nuremberg Code should influence American jurisprudence.  
 1969. Milledgeville Georgia, investigational drugs tested on mentally disabled children. No institutional 
approval.  
 1969: San Antonio Contraceptive Study conducted on 70 poor Mexican-American women. Half received 
oral contraceptives the other placebo. No informed consent.  
 1973 Ad Hoc Advisory Panel issues Final Report of Tuskegee Syphilis Study, concluding "Society can no 
longer afford to leave the balancing of individual rights against scientific progress to the scientific 
community."  
 1974: National Research Act establishes National Commission for the Protection of Human subjects and 
requires Public Health Service to promulgate regulations for the protection of human subjects.  
 1975: The Department of Health, Education and Welfare (DHEW) raised NIH's 1966 Policies for the 
Protection of Human subjects to regulatory status. Title 45 of the Code of Federal Regulations, known as 
"The Common Rule," requires the appointment and utilization of institutional review boards (IRBs).  
 1976: National Urban League holds National Conference on Human Experimentation, announcing "We 
don't want to kill science but we don't want science to kill, mangle and abuse us."  
 1978: Experimental Hepatitis B vaccine trials, conducted by the CDC, begin in New York, Los Angeles and 
San Francisco. Ads for research subjects specifically ask for promiscuous homosexual men.  
 1979: National Commission issues Belmont Report setting forth three basic ethical principles: respect for 
persons, beneficence, and justice.  
1980: The FDA promulgates 21 CFR 50.44 prohibiting use of prisoners as subjects in clinical trials shifting 
phase I testing by pharmaceutical companies to non-prison population.  
1981: Leonard Whitlock suffers permanent brain damage after deep diving experiment at Duke University.  
1986: Congressional subcommittee holds one-day hearing in Washington, called by Rep. Pat Williams of 
Montana, aimed at determining whether U.S. prisoners of war in Manchuria were victims of germ-warfare 
experimentation. Hearing is inconclusive.  
1981-1996: Protocol 126 at Fred Hutchinson Cancer Center in Seattle.  
1987: Supreme Court decision in United States v. Stanley, 483 U.S. 669, holding soldier given LSD without 
his consent could not sue U.S. Army for damages.  
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1987:" L-dopa challenge and relapse" experiment conducted on 28 U.S. veterans who were subjected to 
psychotic relapse for study purposes at the Bronx VA.  
1990: The FDA grants Department of Defense waiver of Nuremberg Code for use of unapproved drugs and 
vaccines in Desert Shield.  
1991: World Health Organization announces CIOMS Guidelines which set forth four ethical principles: 
respect for persons, beneficence, nonmaleficence and justice.  
1991: Tony LaMadrid commits suicide after participating in study on relapse of schizophrenics withdrawn 
from medication at UCLA.  
1993: Kathryn Hamilton dies 44 days after participating in breast cancer experiment at Fred Hutchinson 
Cancer Center in Seattle.  
1994. The Albuquerque Tribune publicizes 1940s experiments involving plutonium injection of human 
research subjects and secret radiation experiments. Indigent patients and mentally retarded children were 
deceived about the nature of their treatment.  
1994. President Clinton appoints the Advisory Commission on Human Radiation Experiments (ACHRE) The 
ACHRE Report http://tis.eh.doe.gov/ohre/roadmap/achre/index.html  
1995. U.S. Department of Energy (DOE) published Human Radiation Experiments, listing 150 plus an 
additional 275 radiation experiments conducted by DOE and the Atomic Energy Commission, during the 
1940s-1970s. http://tis.eh.doe.gov/ohre/roadmap/experiments/0491doca.html#0491_List  
1995: 19-year-old University of Rochester student Nicole Wan dies after being paid $150 to participate in 
MIT-sponsored experiment to test airborne pollutant chemicals.  
1995. President Clinton appoints the National Bioethics Advisory Commission.  
1995: NYS Supreme Court rules (TD v NYS Office of Mental Health) against the state's policy of conducting 
nontherapeutic experiments on mentally incapacitated persons - including children - without informed 
consent. Justice Edward Greenfield ruled that parents have no authority to volunteer their children:  
"Parents may be free to make martyrs of themselves, but it does not follow that they may make martyrs of 
their children."  
1995: Thirty-four healthy, previously non-aggressive New York City minority children, boys aged 6 to 11 
years old, were exposed to fenfluramine in a nontherapeutic experiment at the New York State Psychiatric 
Institute. The children were exposed to this neurotoxic drug to record their neurochemical response in an 
effort to prove a speculative theory linking aggression to a biological marker.  
 1996. Cleveland Plain Dealer investigative report series, 'Drug Trials: Do People Know the Truth About 
Experiments,' December 15 to 18, 1996. The Plain-Dealer found: of the "4,154 FDA inspections of 
researchers testing new drugs on people [since 1977] . . . more than half the researchers were cited by FDA 
inspectors for failing to clearly disclose the experimental nature of their work."  
 1996: Yale University researchers publish findings of experiment that subjected 18 stable schizophrenia 
patients to psychotic relapse in an amphetamine provocation experiment at West Haven VA.  
1997. President Clinton issues a formal apology to the subjects of the Tuskegee syphilis experiments. NBAC 
continues investigation into genetics, consent, privacy, and research on persons with mental disorders.  
1997. Researchers at the University of Cincinnati publish findings of experiment attempting to create a 
"psychosis model" on human beings at the Cincinnati VA. Sixteen patients, experiencing a first episode 
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schizophrenia, were subjected to repeated provocation with amphetamine. The stated purpose was to 
produce "behavioral sensitization. This process serves as a model for the development of psychosis, but has 
been little studied in humans. Symptoms, such as severity of psychosis and eye-blink rates, were measured 
hourly for 5 hours."  
1997. U.S. government sponsored placebo-controlled experiment withholds treatment from HIV infected, 
pregnant African women. NY Times, Sept. 18.  
1997. Victims of unethical research at major U.S. medical centers - including the NIMH - testify before the 
National Bioethics Advisory Commission, Sept. 18.  
1997. FDA Modernization Act gives pharmaceutical companies a huge financial incentive - a 6 month patent 
exclusivity extension - if they conduct drug tests on children. The incentive can yield $900 million.  
1998. National Bioethics Advisory Commission (NBAC) Report. Research Involving Subjects with Mental 
Disorders That May Affect Decisionmaking Capacity. November 12, 1998 
http://bioethics.georgetown.edu/nbac/capacity/TOC.htm  
1998: The Japanese government has never formally apologized for Unit 731's activities, and did not even 
admit to its existence until August 1998, when the Supreme Court ruled that the existence of the unit was 
accepted in academic circles.  
1998. Complaint filed with OPRR about experiments that exposed non-violent children in New York City to 
fenfluramine to find a predisposition to violence.  
1998: Boston Globe (four part) series, "Doing Harm: Research on the Mentally Ill" shed light on the 
mistreatment and exploitation of schizophrenia patients who have been subjected to relapse producing 
procedures in unethical experiments.  
1999: Nine month-old Gage Stevens dies at Children's Hospital in Pittsburgh during participation in 
Propulsid clinical trial for infant acid reflux.  
1999: 18-year-old Jesse Gelsinger dies after being injected with 37 trillion particles of adenovirus in gene 
therapy experiment at University of Pennsylvania.  
1999: Administrator of National Institute of Mental Health suspends 29 clinical trials that failed to meet either 
ethical or scientific standards.  
2000: University of Oklahoma melanoma trial halted for failure to follow government regulations and 
protocol.  
2000: OPRR becomes Office of Human Research Protection ("OHRP") and made part of the Department of 
Health and Human Services.  
2000: President Clinton implement the Energy Employees Occupational Illness Compensation Act of 2000, 
which authorized compensation for thousands of Department of Energy workers who sacrificed their health 
in building the nation's nuclear defenses.  
2000: The Washington Post (6 part) series, "Body Hunters" exposes unethical exploitation in experiments 
conducted by U.S. investigators in underdeveloped countries. Part 4 dealt with U.S. government funded, 
genetic experiments conducted by Harvard University in rural China. 
http://www.washingtonpost.com/wp-dyn/articles/A26797-2000Dec19.html  
2001: A biotech company in Pennsylvania asks the FDA for permission to conduct placebo trials on infants 
in Latin America born with serious lung disease though such tests would be illegal in U.S.  
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2001: Ellen Roche, a healthy 27-year old volunteer, dies in challenge study at Johns Hopkins University in 
Baltimore, Maryland.  
2001: April 4, Elaine Holden-Able, a healthy retired nurse, consumed a glass of orange juice that had been 
mixed with a dietary supplement for the sake of medical research. This Case Western University Alzheimer's 
experiment, financed by the tobacco industry, wound up killing her in what was called a ''tragic human error.'' 
Federal Office of Human Research Protections did not interview hospital staff, mostly accepted hospital's 
internal report, imposed no penalty, and closed the case and did not mention the death in its letter of 
determination. http://ohrp.osophs.dhhs.gov/detrm_letrs/nov01f.pdf  
2001: Maryland Court of Appeals renders a landmark decision affirming "best interest of the individual child" 
as a standard for medical research involving children. The Court unequivocally prohibited nontherapeutic 
experimentation on children. (Higgins and Grimes v. Kennedy Krieger Institute).The case involved exposure 
of babies and small children to lead poisoning in EPA funded experiment. 
(http://www.courts.state.md.us/opinions/coa/2001/128a00.pdf)  
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Appendix B 
Berlin Code Of 1900 
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High-Altitude Experiments 
 
 
To investigate the limits of human endurance and 
existence at extremely high altitudes the victims were 
placed in the low-pressure chamber and thereafter the 
simulated altitude therein was raised. Many victims died as 
a result of these experiments and others suffered grave 
injury, torture, and ill-treatment. 
 
Appendix C 
 
 
 
 
 
 
 
 
 
 
 
 
Source: United States Holocaust Memorial Museum, Washington, D.C.: 
http//www.ushmm.org 
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Appendix D 
 
 
 
 
 
 
 
 
 
Source: United States Holocaust Memorial Museum, Washington, D.C.: 
http//www.ushmm.org 
 
 
Incendiary Bomb Experiments: 
 
 
To test the effect of various pharmaceutical 
preparations on phosphorous burns were inflicted 
on the victims with phosphorous matter taken from 
incendiary bombs, and caused severe pain, 
suffering, and serious bodily injury. 
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Appendix E 
 
 
 
 
 
 
 
 
Source: United States Holocaust Memorial Museum, Washington, D.C.: http//www.ushmm.org 
  
Freezing Experiments 
 
 
To investigate the most effective means of treating 
persons who had been severely chilled or frozen the 
victims were forced to remain in a tank of ice water 
for up to 3 hours. Extreme rigor developed in a short 
time. Numerous victims died in the course of these 
experiments. After the survivors were severely 
chilled, re-warming was attempted by various 
means. In another series of experiments, the victims 
were kept naked outdoors for many hours at 
temperatures below freezing. The victims screamed 
with pain as their bodies froze. 
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Appendix F 
 
 
 
 
 
 
 
 
 
 
 
Source: United States Holocaust Memorial Museum, Washington, D.C.: http//www.ushmm.org 
 
 
  
 
 
Sea-water Experiments 
 
To study various methods of making sea water 
drinkable the victims were deprived of all food and 
given only chemically processed sea water. Such 
experiments caused great pain and suffering and 
resulted in serious bodily injury to the victims. 
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Appendix G 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: United States Holocaust Memorial Museum, Washington, D.C.: http//www.ushmm.org 
  
Malaria Experiments: 
 
To investigate immunization for and treatment of malaria 
the victims were infected by mosquitoes or by injections 
of extracts of the mucous glands of mosquitoes. After 
having contracted malaria the victims were treated with 
various drugs to test their relative efficacy. Over 1,000 
victims were used in these experiments. Many died and 
others suffered severe pain and permanent disability. 
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Appendix H 
THE NUREMBERG CODE (1947) 
BRITISH MEDICAL JOURNAL NO 7070 VOLUME 313: P 1448, 
7 December 1996. 
 
Introduction 
 
The judgment by the war crimes tribunal at Nuremberg laid down 10 standards to which 
physicians must conform when carrying out experiments on human subjects in a new code that is 
now accepted worldwide. 
This judgment established a new standard of ethical medical behavior for the post World War II 
human rights era. Amongst other requirements, this document enunciates the requirement 
of voluntary informed consent of the human subject. The principle of voluntary informed consent 
protects the right of the individual to control his own body. 
 
This code also recognizes that the risk must be weighed against the expected benefit, and that 
unnecessary pain and suffering must be avoided. 
This code recognizes that doctors should avoid actions that injure human patients. 
 
The principles established by this code for medical practice now have been extended into general 
codes of medical ethics. 
Permissible Medical Experiments 
The great weight of the evidence before us to effect that certain types of medical experiments on 
human beings, when kept within reasonably well-defined bounds, conform to the ethics of the 
medical profession generally. The protagonists of the practice of human experimentation justify 
their views on the basis that such experiments yield results for the good of society that are 
unprocurable by other methods or means of study. All agree, however, that certain basic 
principles must be observed in order to satisfy moral, ethical and legal concepts: 
1. The voluntary consent of the human subject is absolutely essential. This means that 
the person involved should have legal capacity to give consent, should be so situated 
as to be able to exercise free power of choice, without the intervention of any element 
of force, fraud, deceit, duress, overreaching, or other ulterior form of constraint or 
coercion, and should have sufficient knowledge and comprehension of the elements 
of the subject matter involved as to enable him to make an understanding and 
enlightened decision. This latter element requires that before the acceptance of an 
affirmative decision by the experimental subject there should be made known to him 
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the nature, duration, and purpose of the experiment, the method and means by which 
it is to be conducted, all inconveniences and hazards reasonably to be expected, and 
the effects upon his health or person which may possibly come from his participation 
in the experiment. 
 
The duty and responsibility for ascertaining the quality of the consent rests upon 
each individual who initiates, directs, or engages in the experiment. It is a personal 
duty and responsibility which may not be delegated to another with impunity. 
2. The experiment should be such as to yield fruitful results for the good of society, 
unprocurable by other methods or means of study, and not random and unnecessary 
in nature. 
3. The experiment should be so designed and based on the results of animal 
experimentation and a knowledge of the natural history of the disease or other 
problem under study that the anticipated results justify the performance of the 
experiment. 
4. The experiment should be so conducted as to avoid all unnecessary physical and 
mental suffering and injury. 
5. No experiment should be conducted where there is an a priori reason to believe that 
death or disabling injury will occur, except, perhaps, in those experiments where the 
experimental physicians also serve as subjects. 
6. The degree of risk to be taken should never exceed that determined by the 
humanitarian importance of the problem to be solved by the experiment. 
7. Proper preparations should be made and adequate facilities provided to protect the 
experimental subject against even remote possibilities of injury, disability or death. 
8. The experiment should be conducted only by scientifically qualified persons. The 
highest degree of skill and care should be required through all stages of the 
experiment of those who conduct or engage in the experiment. 
9. During the course of the experiment the human subject should be at liberty to bring 
the experiment to an end if he has reached the physical or mental state where 
continuation of the experiment seems to him to be impossible. 
10. During the course of the experiment the scientist in charge must be prepared to 
terminate the experiment at any stage, if he has probable cause to believe, in the 
exercise of the good faith, superior skill and careful judgment required of him, that a 
continuation of the experiment is likely to result in injury, disability, or death to the 
experimental subject. 
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Appendix I 
DECLARATION OF HELSINKI (1964) 
 
[CIRP Note: Ethical research on human subjects into or about the effects of circumcision must be 
conducted under the provisions of this declaration and those of the Nuremberg Code.]  
Recommendations guiding physicians in biomedical research involving human subjects.  
Adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964, amended by the 
29th World Medical Assembly, Tokyo, Japan, October 1975, and the 35th World Medical 
Assembly, Venice, Italy, October 1983.  
 
Introduction 
It is the mission of the physician to safeguard the health of the people. His or her knowledge and 
conscience are dedicated to the fulfillment of this mission.  
The Declaration of Geneva of the World Medical Association binds the physician with the words, 
"The health of my patient will be my first consideration "and the International Code of Medical 
Ethics declares that, "A physician shall act only in the patient's interest when providing medical 
care which might have the effect of weakening the physical and mental condition of the patient. "  
 
The purpose of biomedical research involving human subjects must be to improve diagnostic, 
therapeutic and prophylactic procedures and the understanding of the audiology and 
pathogenesis of disease.  
In current medical practice most diagnostic, therapeutic or prophylactic procedures involve 
hazards. This applies especially to biomedical research.  
Medical progress is based on research which ultimately must rest in part on experimentation 
involving human subjects. In the field of biomedical research a fundamental distinction must be 
recognized between medical research in which the aim is essentially diagnostic or therapeutic for 
a patient, and medical research the essential object of which is purely scientific and without 
implying direct diagnostic or therapeutic value to the person subjected to the research.  
Special caution must be exercised in the conduct of research which may affect the environment, 
and the welfare of animals used for research must be respected.  
 
Because it is essential that the results of laboratory experiments be applied to human beings to 
further scientific knowledge and to help suffering humanity, the World Medical Association has 
prepared the following recommendations as a guide to every physician in biomedical research 
involving human subjects. They should be kept under review in the future. It must be stressed 
that the standards as drafted are only a guide to physicians all over the world. Physicians are not 
relieved from criminal, civil and ethical responsibilities under the law of their own countries.  
 
I. Basic Principles 
1. Biomedical research involving human subjects must conform to generally accepted 
scientific principles and should be based on adequately performed laboratory and animal 
experimentation and on a thorough knowledge of the scientific literature.  
2. The design and performance of each experimental procedure involving human subjects 
should be clearly formulated in an experimental protocol which should be transmitted to a 
specially appointed independent committee for consideration, comment and guidance.  
3. Biomedical research involving human subjects should be conducted only by scientifically 
qualified persons and under the supervision of a clinically competent medical person. The 
responsibility for the human subject must always rest with a medically qualified person 
and never rest on the subject of the research, even though the subject has given his or 
her consent.  
4. Biomedical research involving human subjects cannot legitimately be carried out unless 
the importance of the objective is in proportion to the inherent risk to the subject.  
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5. Every biomedical research project involving human subjects should be preceded by 
careful assessment of predictable risks in comparison with foreseeable benefits to the 
subject or to others. Concern for the interests of the subject must always prevail over the 
interests of science and society.  
6. The right of the research subject to safeguard his or her integrity must always be 
respected. Every precaution should be taken to respect the privacy of the subject and to 
minimize the impact of the study on the subject's physical and mental integrity and on the 
personality of the subject.  
7. Physicians should abstain from engaging in research projects involving human subjects 
unless they are satisfied that the hazards involved are believed to be predictable. 
Physicians should cease any investigation if the hazards are found to outweigh the 
potential benefits.  
8. In publication of the results of his or her research, the physician is obliged to preserve the 
accuracy of the results. Reports of experimentation not in accordance with the principles 
laid down in this Declaration should not be accepted for publication.  
9. In any research on human beings, each potential subject mustbe adequately informed of 
the aims, methods, anticipated benefits and potential hazards of the study and the 
discomfort it may entail. He or she should be informed that he or she is at liberty to 
abstain from participation in the study and that he or she is free to withdraw visor her 
consent to participation at any time. The physician should then obtain the subject's freely 
given informed consent, preferably inheriting.  
10. When obtaining informed consent for the research project the physician should be 
particularly cautious if the subject is in dependent relationship to him or her or may 
consent under duress. In that case the informed consent should be obtained by a 
physician who isn't engaged in the investigation and who is completely independent of 
this official relationship.  
11. In case of legal incompetence, informed consent should be obtained from the legal 
guardian in accordance with national legislation. Where physical or mental incapacity 
makes it impossible to obtain informed consent, or when the subject is a minor, 
permission from the responsible relative replaces that of the subject in accordance with 
national legislation. Whenever the minor child is in fact able to give a consent, the minor's 
consent must be obtained in addition to the consent of the minor's legal guardian.  
12. The research protocol should always contain a statement of the ethical considerations 
involved and should indicate that the principles enunciated in the present declaration are 
complied with.  
II. Medical Research Combined with Professional Care (Clinical Research) 
1. In the treatment of the sick person, the physician must be free to use a new diagnostic 
and therapeutic measure, if in his or her judgment it offers hope of saving life, re-
establishing health or alleviating suffering.  
2. The potential benefits, hazards and discomfort of a new method should be weighed 
against the advantages of the best current diagnostic and therapeutic methods.  
3. In any medical study, every patient- including those of a control group, if any- should be 
assured of the best proven diagnostic and therapeutic method.  
4. The refusal of the patient to participate in a study must never interfere with the physician-
patient relationship.  
5. If the physician considers it essential not to obtain informed consent, the specific reasons 
for this proposal should be stated in the experimental protocol for transmission to the 
independent committee (1, 2).  
6. The physician can combine medical research with professional care, the objective being 
the acquisition of new medical knowledge, only to the extent that medical research is 
justified by its potential diagnostic or therapeutic value for the patient.  
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III. Non-Therapeutic Biomedical Research Involving Human Subjects (Non-Clinical Biomedical 
Research) 
1. In the purely scientific application of medical research carried out on a human being, it is 
the duty of the physician to remain the protector of the life and health of that person on 
whom biomedical research is being carried out.  
2. The subjects should be volunteers- either healthy persons or patients for whom the 
experimental design is not related to the patient's illness.  
3. The investigator or the investigating team should discontinue the research if in his/her or 
their judgment it may, if continued, be harmful to the individual.  
4. In research on man, the interest of science and society should never take precedence 
over considerations related to the well-being of the subject.  
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Appendix J 
NATIONAL RESEARCH ACT 
PUBLIC LAW 93-348-JULY 12, 1974 - Public Law 93-348 July 12.1974  
JULY 12, 1974 - [H. R. 7724] 
 
 AN ACT  
 
To amend the Public Health Service Act to establish a program of National Research Service 
Awards to assure the continued excellence of biomedical and behavioral research and to provide 
for the protection of human subjects involved in biomedical and behavioral research and for other 
purposes.  
 
Be it enacted by the Senate and House of Representatives of the Re- United States of America in 
Congress assembled, search Act. 42 usc 2891-1 SECTION 1. This Act may be cited as the 
"National Research Act". note. National Re- TITLE I-BIOMEDICAL AND BEHAVIORAL 
RESEARCH search Service Award Act of 1974. TRAINING SHORT TITLE SEC. 101. This title 
may be cited as the '<National Research Service 42 U.S.C 28g1-1 Award Act of 1974". note. 
FINDINGS .AND DECLARATION OF PURPOSE 42 U.S.C 2891-1 note. SEC. 102. (a) Congress 
finds and declares that- (1) the success and continued viability of the Federal biomedical and 
behavioral research effort depends on the availability of excellent scientists and a network of 
institutions of excellence capable of producing superior research personnel ; (2) direct support of 
the training of scientists for careers in biomedical and behavioral research is an appropriate and 
necessary role for the Federal Government ; and (3) graduate research assistance programs 
should be the key elements in the training programs of the institutes of the National Institutes of 
Health and the Alcohol, Drug Abuse, and Mental Health Administration. (b) It is the purpose of 
this title to increase the capability of the institutes of the National Institutes of Health and the 
Alcohol, Drug Abuse, and Mental Health Administration to carry out their responsibility of 
maintaining a superior national program of research into the physical and mental diseases and 
impairments of man. BIOMEDICAL AND BEHAVIORAL RESEARCH TRAINING Ante, p. 135. 
SEC. 103. The part H of the Public Health Service Act relating to the appointment of the 
Administrators of the National Institutes of Health and the National Cancer Institute is 
redesignated as part I, section 461 of such part is redesignated as section 471, and such part is 
amended by adding at the end the following new sections: 42 U.S.C 289C1. "SEC. 472. (a) (1) 
The Secretary shall- "(A) provide National Research Service Awards for- "(1) biomedical and 
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behavioral research at and with the National Institutes of Health and the Alcohol, Drug Abuse, 
and Mental Health Administration in matters relating to the cause, diagnosis, prevention, and 
treatment of the disease (or diseases) or other health problems to which the activities of the 
Institutes and Administration are directed, "(ii) training at the Institutes and Administration of 
individual~ to undertake such research, PUBLIC LAW 93-348-JULY 12, 1974 - \ Public Law 93-
348 July 12.1974 AN ACT [H' R. 77241 TO amend the Public Health Service Act to establish a 
program of National Research Service Awards to assure the continued excellence of biomedical 
and behavioral research and to provide for the protection of human subjects involved in 
biomedical and behavioral research and for other purposes. Be it enacted by the Senate and 
House of Representatives of the Re- United States of America in Congress assembled, search 
Act. 42 usc 2891-1 SECTION 1. This Act may be cited as the "National Research Act". note. 
National Re- TITLE I-BIOMEDICAL AND BEHAVIORAL RESEARCH search Service Award Act 
of 1974. TRAINING SHORT TITLE SEC. 101. This title may be cited as the '<National Research 
Service 42 U.S.C 28g1-1 Award Act of 1974". note. FINDINGS .AND DECLARATION OF 
PURPOSE 42 U.S.C 2891-1 note. SEC. 102. (a) Congress finds and declares that- (1) the 
success and continued viability of the Federal biomedi- cal and behavioral research effort 
depends on the availability of excellent scientists and a network of institutions of excellence 
capable of producing superior research personnel ; (2) direct support of the training of scientists 
for careers in biomedical and behavioral research is an appropriate and necessary role for the 
Federal Government ; and (3) graduate research assistance programs should be the key 
elements in the training programs of the institutes of the National Institutes of Health and the 
Alcohol, Drug Abuse, and Mental Health Administration. (b) It is the purpose of this title to 
increase the capability of the institutes of the National Institutes of Health and the Alcohol, Drug 
Abuse, and Mental Health Administration to carry out their responsibility of maintaining a superior 
national program of research into the physical and mental diseases and impairments of man.  
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Appendix K 
 
THE BELMONT REPORT 
 
Ethical Principles and Guidelines for the protection of human subjects of 
research 
 
The Belmont Report  
 
Office of the Secretary  
 
Ethical Principles and Guidelines for the Protection of Human  
Subjects of Research  
 
The National Commission for the Protection of Human Subjects  
of Biomedical and Behavioral Research 
 
April 18, 1979 
 
AGENCY: Department of Health, Education, and Welfare.  
 
ACTION: Notice of Report for Public Comment.  
 
SUMMARY: On July 12, 1974, the National Research Act (Pub. L. 93-348) was signed into law, 
there-by creating the National Commission for the Protection of Human Subjects of Biomedical 
and Behavioral Research. One of the charges to the Commission was to identify the basic ethical 
principles that should underlie the conduct of biomedical and behavioral research involving 
human subjects and to develop guidelines which should be followed to assure that such research 
is conducted in accordance with those principles. In carrying out the above, the Commission was 
directed to consider: (i) the boundaries between biomedical and behavioral research and the 
accepted and routine practice of medicine, (ii) the role of assessment of risk-benefit criteria in the 
determination of the appropriateness of research involving human subjects, (iii) appropriate 
guidelines for the selection of human subjects for participation in such research and (iv) the 
nature and definition of informed consent in various research settings.  
 
The Belmont Report attempts to summarize the basic ethical principles identified by the 
Commission in the course of its deliberations. It is the outgrowth of an intensive four-day period of 
discussions that were held in February 1976 at the Smithsonian Institution's Belmont Conference 
Center supplemented by the monthly deliberations of the Commission that were held over a 
period of nearly four years. It is a statement of basic ethical principles and guidelines that should 
assist in resolving the ethical problems that surround the conduct of research with human 
subjects. By publishing the Report in the Federal Register, and providing reprints upon request, 
the Secretary intends that it may be made readily available to scientists, members of Institutional 
Review Boards, and Federal employees. The two-volume Appendix, containing the lengthy 
reports of experts and specialists who assisted the Commission in fulfilling this part of its charge, 
is available as DHEW Publication No. (OS) 78-0013 and No. (OS) 78-0014, for sale by the 
Superintendent of Documents, U.S. Government Printing Office, Washington, D.C. 20402.  
 
Unlike most other reports of the Commission, the Belmont Report does not make specific 
recommendations for administrative action by the Secretary of Health, Education, and Welfare. 
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Rather, the Commission recommended that the Belmont Report be adopted in its entirety, as a 
statement of the Department's policy. The Department requests public comment on this 
recommendation. 
 
National Commission for the Protection of Human Subjects 
of Biomedical and Behavioral Research 
Members of the Commission 
 
Kenneth John Ryan, M.D., Chairman, Chief of Staff, Boston Hospital for Women.  
Joseph V. Brady, Ph.D., Professor of Behavioral Biology, Johns Hopkins University.  
Robert E. Cooke, M.D., President, Medical College of Pennsylvania.  
*** Dorothy I. Height, President, National Council of Negro Women, Inc. 
Albert R. Jonsen, Ph.D., Associate Professor of Bioethics, University of California at San 
Francisco.  
Patricia King, J.D., Associate Professor of Law, Georgetown University Law Center.  
Karen Lebacqz, Ph.D., Associate Professor of Christian Ethics, Pacific School of 
Religion.  
*** David W. Louisell, J.D., Professor of Law, University of California at Berkeley.  
Donald W. Seldin, M.D., Professor and Chairman, Department of Internal Medicine, 
University of Texas at Dallas.  
***Eliot Stellar, Ph.D., Provost of the University and Professor of Physiological 
Psychology, University of Pennsylvania.  
*** Robert H. Turtle, LL.B., Attorney, VomBaur, Coburn, Simmons & Turtle, Washington, 
D.C. 
*** Deceased.  
 
Ethical Principles & Guidelines for Research Involving Human Subjects 
 
Scientific research has produced substantial social benefits. It has also posed some 
troubling ethical questions. Public attention was drawn to these questions by reported 
abuses of human subjects in biomedical experiments, especially during the Second 
World War. During the Nuremberg War Crime Trials, the Nuremberg code was drafted as 
a set of standards for judging physicians and scientists who had conducted biomedical 
experiments on concentration camp prisoners. This code became the prototype of many 
later codes(1) intended to assure that research involving human subjects would be 
carried out in an ethical manner.  
 
The codes consist of rules, some general, others specific, that guide the investigators or 
the reviewers of research in their work. Such rules often are inadequate to cover complex 
situations; at times they come into conflict, and they are frequently difficult to interpret or 
apply. Broader ethical principles will provide a basis on which specific rules may be 
formulated, criticized and interpreted.  
 
Three principles, or general prescriptive judgments, that are relevant to research 
involving human subjects are identified in this statement. Other principles may also be 
relevant. These three are comprehensive, however, and are stated at a level of 
generalization that should assist scientists, subjects, reviewers and interested citizens to 
understand the ethical issues inherent in research involving human subjects. These 
principles cannot always be applied so as to resolve beyond dispute particular ethical 
problems. The objective is to provide an analytical framework that will guide the 
resolution of ethical problems arising from research involving human subjects.  
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This statement consists of a distinction between research and practice, a discussion of 
the three basic ethical principles, and remarks about the application of these principles. 
 
Part A: Boundaries Between Practice & Research 
A. Boundaries Between Practice and Research  
It is important to distinguish between biomedical and behavioral research, on the one 
hand, and the practice of accepted therapy on the other, in order to know what activities 
ought to undergo review for the protection of human subjects of research. The distinction 
between research and practice is blurred partly because both often occur together (as in 
research designed to evaluate a therapy) and partly because notable departures from 
standard practice are often called "experimental" when the terms "experimental" and 
"research" are not carefully defined.  
 
For the most part, the term "practice" refers to interventions that are designed solely to 
enhance the well-being of an individual patient or client and that have a reasonable 
expectation of success. The purpose of medical or behavioral practice is to provide 
diagnosis, preventive treatment or therapy to particular individuals.(2) By contrast, the 
term "research' designates an activity designed to test an hypothesis, permit conclusions 
to be drawn, and thereby to develop or contribute to generalizable knowledge 
(expressed, for example, in theories, principles, and statements of relationships). 
Research is usually described in a formal protocol that sets forth an objective and a set of 
procedures designed to reach that objective.  
 
When a clinician departs in a significant way from standard or accepted practice, the 
innovation does not, in and of itself, constitute research. The fact that a procedure is 
"experimental," in the sense of new, untested or different, does not automatically place it 
in the category of research. Radically new procedures of this description should, 
however, be made the object of formal research at an early stage in order to determine 
whether they are safe and effective. Thus, it is the responsibility of medical practice 
committees, for example, to insist that a major innovation be incorporated into a formal 
research project.(3)  
 
Research and practice may be carried on together when research is designed to evaluate 
the safety and efficacy of a therapy. This need not cause any confusion regarding 
whether or not the activity requires review; the general rule is that if there is any element 
of research in an activity, that activity should undergo review for the protection of human 
subjects. 
 
Part B: Basic Ethical Principles 
B. Basic Ethical Principles  
The expression "basic ethical principles" refers to those general judgments that serve as 
a basic justification for the many particular ethical prescriptions and evaluations of human 
actions. Three basic principles, among those generally accepted in our cultural tradition, 
are particularly relevant to the ethics of research involving human subjects: the principles 
of respect of persons, beneficence and justice.  
 
1. Respect for Persons. -- Respect for persons incorporates at least two ethical 
convictions: first, that individuals should be treated as autonomous agents, and second, 
that persons with diminished autonomy are entitled to protection. The principle of respect 
for persons thus divides into two separate moral requirements: the requirement to 
acknowledge autonomy and the requirement to protect those with diminished autonomy.  
 
An autonomous person is an individual capable of deliberation about personal goals and 
of acting under the direction of such deliberation. To respect autonomy is to give weight 
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to autonomous persons' considered opinions and choices while refraining from 
obstructing their actions unless they are clearly detrimental to others. To show lack of 
respect for an autonomous agent is to repudiate that person's considered judgments, to 
deny an individual the freedom to act on those considered judgments, or to withhold 
information necessary to make a considered judgment, when there are no compelling 
reasons to do so.  
 
However, not every human being is capable of self-determination. The capacity for self-
determination matures during an individual's life, and some individuals lose this capacity 
wholly or in part because of illness, mental disability, or circumstances that severely 
restrict liberty. Respect for the immature and the incapacitated may require protecting 
them as they mature or while they are incapacitated.  
 
Some persons are in need of extensive protection, even to the point of excluding them 
from activities which may harm them; other persons require little protection beyond 
making sure they undertake activities freely and with awareness of possible adverse 
consequence. The extent of protection afforded should depend upon the risk of harm and 
the likelihood of benefit. The judgment that any individual lacks autonomy should be 
periodically reevaluated and will vary in different situations.  
In most cases of research involving human subjects, respect for persons demands that 
subjects enter into the research voluntarily and with adequate information. In some 
situations, however, application of the principle is not obvious. The involvement of 
prisoners as subjects of research provides an instructive example. On the one hand, it 
would seem that the principle of respect for persons requires that prisoners not be 
deprived of the opportunity to volunteer for research. On the other hand, under prison 
conditions they may be subtly coerced or unduly influenced to engage in research 
activities for which they would not otherwise volunteer. Respect for persons would then 
dictate that prisoners be protected. Whether to allow prisoners to "volunteer" or to 
"protect" them presents a dilemma. Respecting persons, in most hard cases, is often a 
matter of balancing competing claims urged by the principle of respect itself.  
 
2. Beneficence. -- Persons are treated in an ethical manner not only by respecting their 
decisions and protecting them from harm, but also by making efforts to secure their well-
being. Such treatment falls under the principle of beneficence. The term "beneficence" is 
often understood to cover acts of kindness or charity that go beyond strict obligation. In 
this document, beneficence is understood in a stronger sense, as an obligation. Two 
general rules have been formulated as complementary expressions of beneficent actions 
in this sense: (1) do not harm and (2) maximize possible benefits and minimize possible 
harms.  
The Hippocratic maxim "do no harm" has long been a fundamental principle of medical 
ethics. Claude Bernard extended it to the realm of research, saying that one should not 
injure one person regardless of the benefits that might come to others. However, even 
avoiding harm requires learning what is harmful; and, in the process of obtaining this 
information, persons may be exposed to risk of harm. Further, the Hippocratic  
 
Oath requires physicians to benefit their patients "according to their best judgment." 
Learning what will in fact benefit may require exposing persons to risk. The problem 
posed by these imperatives is to decide when it is justifiable to seek certain benefits 
despite the risks involved, and when the benefits should be foregone because of the 
risks.  
The obligations of beneficence affect both individual investigators and society at large, 
because they extend both to particular research projects and to the entire enterprise of 
research. In the case of particular projects, investigators and members of their institutions 
are obliged to give forethought to the maximization of benefits and the reduction of risk 
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that might occur from the research investigation. In the case of scientific research in 
general, members of the larger society are obliged to recognize the longer term benefits 
and risks that may result from the improvement of knowledge and from the development 
of novel medical, psychotherapeutic, and social procedures.  
 
The principle of beneficence often occupies a well-defined justifying role in many areas of 
research involving human subjects. An example is found in research involving children. 
Effective ways of treating childhood diseases and fostering healthy development are 
benefits that serve to justify research involving children -- even when individual research 
subjects are not direct beneficiaries. Research also makes it possible to avoid the harm 
that may result from the application of previously accepted routine practices that on 
closer investigation turn out to be dangerous. But the role of the principle of beneficence 
is not always so unambiguous. A difficult ethical problem remains, for example, about 
research that presents more than minimal risk without immediate prospect of direct 
benefit to the children involved. Some have argued that such research is inadmissible, 
while others have pointed out that this limit would rule out much research promising great 
benefit to children in the future. Here again, as with all hard cases, the different claims 
covered by the principle of beneficence may come into conflict and force difficult choices.  
 
3. Justice. -- Who ought to receive the benefits of research and bear its burdens? This is 
a question of justice, in the sense of "fairness in distribution" or "what is deserved." An 
injustice occurs when some benefit to which a person is entitled is denied without good 
reason or when some burden is imposed unduly. Another way of conceiving the principle 
of justice is that equals ought to be treated equally. However, this statement requires 
explication. Who is equal and who is unequal? What considerations justify departure from 
equal distribution? Almost all commentators allow that distinctions based on experience, 
age, deprivation, competence, merit and position do sometimes constitute criteria 
justifying differential treatment for certain purposes. It is necessary, then, to explain in 
what respects people should be treated equally.  
There are several widely accepted formulations of just ways to distribute burdens and 
benefits. Each formulation mentions some relevant property on the basis of which 
burdens and benefits should be distributed. These formulations are (1) to each person an 
equal share, (2) to each person according to individual need, (3) to each person 
according to individual effort, (4) to each person according to societal contribution, and 
(5) to each person according to merit.  
 
Questions of justice have long been associated with social practices such as punishment, 
taxation and political representation. Until recently these questions have not generally 
been associated with scientific research. However, they are foreshadowed even in the 
earliest reflections on the ethics of research involving human subjects. For example, 
during the 19th and early 20th centuries the burdens of serving as research subjects fell 
largely upon poor ward patients, while the benefits of improved medical care flowed 
primarily to private patients. Subsequently, the exploitation of unwilling prisoners as 
research subjects in Nazi concentration camps was condemned as a particularly flagrant 
injustice. In this country, in the 1940's, the Tuskegee syphilis study used disadvantaged, 
rural black men to study the untreated course of a disease that is by no means confined 
to that population. These subjects were deprived of demonstrably effective treatment in 
order not to interrupt the project, long after such treatment became generally available.  
 
Against this historical background, it can be seen how conceptions of justice are relevant 
to research involving human subjects. For example, the selection of research subjects 
needs to be scrutinized in order to determine whether some classes (e.g., welfare 
patients, particular racial and ethnic minorities, or persons confined to institutions) are 
being systematically selected simply because of their easy availability, their compromised 
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position, or their manipulability, rather than for reasons directly related to the problem 
being studied. Finally, whenever research supported by public funds leads to the 
development of therapeutic devices and procedures, justice demands both that these not 
provide advantages only to those who can afford them and that such research should not 
unduly involve persons from groups unlikely to be among the beneficiaries of subsequent 
applications of the research. 
 
Part C: Applications 
C. Applications  
Applications of the general principles to the conduct of research leads to consideration of 
the following requirements: informed consent, risk/benefit assessment, and the selection 
of subjects of research.  
 
1. Informed Consent. -- Respect for persons requires that subjects, to the degree that 
they are capable, be given the opportunity to choose what shall or shall not happen to 
them. This opportunity is provided when adequate standards for informed consent are 
satisfied.  
 
While the importance of informed consent is unquestioned, controversy prevails over the 
nature and possibility of an informed consent. Nonetheless, there is widespread 
agreement that the consent process can be analyzed as containing three elements: 
information, comprehension and voluntariness.  
Information. Most codes of research establish specific items for disclosure intended to 
assure that subjects are given sufficient information. These items generally include: the 
research procedure, their purposes, risks and anticipated benefits, alternative procedures 
(where therapy is involved), and a statement offering the subject the opportunity to ask 
questions and to withdraw at any time from the research. Additional items have been 
proposed, including how subjects are selected, the person responsible for the research, 
etc.  
 
However, a simple listing of items does not answer the question of what the standard 
should be for judging how much and what sort of information should be provided. One 
standard frequently invoked in medical practice, namely the information commonly 
provided by practitioners in the field or in the locale, is inadequate since research takes 
place precisely when a common understanding does not exist. Another standard, 
currently popular in malpractice law, requires the practitioner to reveal the information 
that reasonable persons would wish to know in order to make a decision regarding their 
care. This, too, seems insufficient since the research subject, being in essence a 
volunteer, may wish to know considerably more about risks gratuitously undertaken than 
do patients who deliver themselves into the hand of a clinician for needed care. It may be 
that a standard of "the reasonable volunteer" should be proposed: the extent and nature 
of information should be such that persons, knowing that the procedure is neither 
necessary for their care nor perhaps fully understood, can decide whether they wish to 
participate in the furthering of knowledge. Even when some direct benefit to them is 
anticipated, the subjects should understand clearly the range of risk and the voluntary 
nature of participation.  
 
A special problem of consent arises where informing subjects of some pertinent aspect of 
the research is likely to impair the validity of the research. In many cases, it is sufficient to 
indicate to subjects that they are being invited to participate in research of which some 
features will not be revealed until the research is concluded. In all cases of research 
involving incomplete disclosure, such research is justified only if it is clear that (1) 
incomplete disclosure is truly necessary to accomplish the goals of the research, (2) 
there are no undisclosed risks to subjects that are more than minimal, and (3) there is an 
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adequate plan for debriefing subjects, when appropriate, and for dissemination of 
research results to them. Information about risks should never be withheld for the 
purpose of eliciting the cooperation of subjects, and truthful answers should always be 
given to direct questions about the research. Care should be taken to distinguish cases in 
which disclosure would destroy or invalidate the research from cases in which disclosure 
would simply inconvenience the investigator.  
 
Comprehension. The manner and context in which information is conveyed is as 
important as the information itself. For example, presenting information in a disorganized 
and rapid fashion, allowing too little time for consideration or curtailing opportunities for 
questioning, all may adversely affect a subject's ability to make an informed choice.  
 
Because the subject's ability to understand is a function of intelligence, rationality, 
maturity and language, it is necessary to adapt the presentation of the information to the 
subject's capacities. Investigators are responsible for ascertaining that the subject has 
comprehended the information. While there is always an obligation to ascertain that the 
information about risk to subjects is complete and adequately comprehended, when the 
risks are more serious, that obligation increases. On occasion, it may be suitable to give 
some oral or written tests of comprehension.  
 
Special provision may need to be made when comprehension is severely limited -- for 
example, by conditions of immaturity or mental disability. Each class of subjects that one 
might consider as incompetent (e.g., infants and young children, mentally disable 
patients, the terminally ill and the comatose) should be considered on its own terms. 
Even for these persons, however, respect requires giving them the opportunity to choose 
to the extent they are able, whether or not to participate in research. The objections of 
these subjects to involvement should be honored, unless the research entails providing 
them a therapy unavailable elsewhere. Respect for persons also requires seeking the 
permission of other parties in order to protect the subjects from harm. Such persons are 
thus respected both by acknowledging their own wishes and by the use of third parties to 
protect them from harm.  
 
The third parties chosen should be those who are most likely to understand the 
incompetent subject's situation and to act in that person's best interest. The person 
authorized to act on behalf of the subject should be given an opportunity to observe the 
research as it proceeds in order to be able to withdraw the subject from the research, if 
such action appears in the subject's best interest.  
 
Voluntariness. An agreement to participate in research constitutes a valid consent only if 
voluntarily given. This element of informed consent requires conditions free of coercion 
and undue influence. Coercion occurs when an overt threat of harm is intentionally 
presented by one person to another in order to obtain compliance. Undue influence, by 
contrast, occurs through an offer of an excessive, unwarranted, inappropriate or improper 
reward or other overture in order to obtain compliance. Also, inducements that would 
ordinarily be acceptable may become undue influences if the subject is especially 
vulnerable.  
 
Unjustifiable pressures usually occur when persons in positions of authority or 
commanding influence -- especially where possible sanctions are involved -- urge a 
course of action for a subject. A continuum of such influencing factors exists, however, 
and it is impossible to state precisely where justifiable persuasion ends and undue 
influence begins. But undue influence would include actions such as manipulating a 
person's choice through the controlling influence of a close relative and threatening to 
withdraw health services to which an individual would otherwise be entitle.  
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2. Assessment of Risks and Benefits. -- The assessment of risks and benefits requires a 
careful arrayal of relevant data, including, in some cases, alternative ways of obtaining 
the benefits sought in the research. Thus, the assessment presents both an opportunity 
and a responsibility to gather systematic and comprehensive information about proposed 
research. For the investigator, it is a means to examine whether the proposed research is 
properly designed. For a review committee, it is a method for determining whether the 
risks that will be presented to subjects are justified. For prospective subjects, the 
assessment will assist the determination whether or not to participate.  
 
The Nature and Scope of Risks and Benefits. The requirement that research be justified 
on the basis of a favorable risk/benefit assessment bears a close relation to the principle 
of beneficence, just as the moral requirement that informed consent be obtained is 
derived primarily from the principle of respect for persons. The term "risk" refers to a 
possibility that harm may occur. However, when expressions such as "small risk" or "high 
risk" are used, they usually refer (often ambiguously) both to the chance (probability) of 
experiencing a harm and the severity (magnitude) of the envisioned harm.  
 
The term "benefit" is used in the research context to refer to something of positive value 
related to health or welfare. Unlike, "risk," "benefit" is not a term that expresses 
probabilities. Risk is properly contrasted to probability of benefits, and benefits are 
properly contrasted with harms rather than risks of harm.  
 
Accordingly, so-called risk/benefit assessments are concerned with the probabilities and 
magnitudes of possible harm and anticipated benefits. Many kinds of possible harms and 
benefits need to be taken into account. There are, for example, risks of psychological 
harm, physical harm, legal harm, social harm and economic harm and the corresponding 
benefits. While the most likely types of harms to research subjects are those of 
psychological or physical pain or injury, other possible kinds should not be overlooked.  
 
Risks and benefits of research may affect the individual subjects, the families of the 
individual subjects, and society at large (or special groups of subjects in society). 
Previous codes and Federal regulations have required that risks to subjects be 
outweighed by the sum of both the anticipated benefit to the subject, if any, and the 
anticipated benefit to society in the form of knowledge to be gained from the research. In 
balancing these different elements, the risks and benefits affecting the immediate 
research subject will normally carry special weight. On the other hand, interests other 
than those of the subject may on some occasions be sufficient by themselves to justify 
the risks involved in the research, so long as the subjects' rights have been protected. 
Beneficence thus requires that we protect against risk of harm to subjects and also that 
we be concerned about the loss of the substantial benefits that might be gained from 
research.  
 
The Systematic Assessment of Risks and Benefits. It is commonly said that benefits and 
risks must be "balanced" and shown to be "in a favorable ratio." The metaphorical 
character of these terms draws attention to the difficulty of making precise judgments. 
Only on rare occasions will quantitative techniques be available for the scrutiny of 
research protocols. However, the idea of systematic, nonarbitrary analysis of risks and 
benefits should be emulated insofar as possible. This ideal requires those making 
decisions about the justifiability of research to be thorough in the accumulation and 
assessment of information about all aspects of the research, and to consider alternatives 
systematically. This procedure renders the assessment of research more rigorous and 
precise, while making communication between review board members and investigators 
less subject to misinterpretation, misinformation and conflicting judgments. Thus, there 
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should first be a determination of the validity of the presuppositions of the research; then 
the nature, probability and magnitude of risk should be distinguished with as much clarity 
as possible. The method of ascertaining risks should be explicit, especially where there is 
no alternative to the use of such vague categories as small or slight risk. It should also be 
determined whether an investigator's estimates of the probability of harm or benefits are 
reasonable, as judged by known facts or other available studies.  
 
Finally, assessment of the justifiability of research should reflect at least the following 
considerations: (i) Brutal or inhumane treatment of human subjects is never morally 
justified. (ii) Risks should be reduced to those necessary to achieve the research 
objective. It should be determined whether it is in fact necessary to use human subjects 
at all. Risk can perhaps never be entirely eliminated, but it can often be reduced by 
careful attention to alternative procedures. (iii) When research involves significant risk of 
serious impairment, review committees should be extraordinarily insistent on the 
justification of the risk (looking usually to the likelihood of benefit to the subject -- or, in 
some rare cases, to the manifest voluntariness of the participation). (iv) When vulnerable 
populations are involved in research, the appropriateness of involving them should itself 
be demonstrated. A number of variables go into such judgments, including the nature and 
degree of risk, the condition of the particular population involved, and the nature and level 
of the anticipated benefits. (v) Relevant risks and benefits must be thoroughly arrayed in 
documents and procedures used in the informed consent process.  
 
3. Selection of Subjects. -- Just as the principle of respect for persons finds expression in 
the requirements for consent, and the principle of beneficence in risk/benefit assessment, 
the principle of justice gives rise to moral requirements that there be fair procedures and 
outcomes in the selection of research subjects.  
 
Justice is relevant to the selection of subjects of research at two levels: the social and the 
individual. Individual justice in the selection of subjects would require that researchers 
exhibit fairness: thus, they should not offer potentially beneficial research only to some 
patients who are in their favor or select only "undesirable" persons for risky research. 
Social justice requires that distinction be drawn between classes of subjects that ought, 
and ought not, to participate in any particular kind of research, based on the ability of 
members of that class to bear burdens and on the appropriateness of placing further 
burdens on already burdened persons. Thus, it can be considered a matter of social 
justice that there is an order of preference in the selection of classes of subjects (e.g., 
adults before children) and that some classes of potential subjects (e.g., the 
institutionalized mentally infirm or prisoners) may be involved as research subjects, if at 
all, only on certain conditions.  
 
Injustice may appear in the selection of subjects, even if individual subjects are selected 
fairly by investigators and treated fairly in the course of research. Thus injustice arises 
from social, racial, sexual and cultural biases institutionalized in society. Thus, even if 
individual researchers are treating their research subjects fairly, and even if IRBs are 
taking care to assure that subjects are selected fairly within a particular institution, unjust 
social patterns may nevertheless appear in the overall distribution of the burdens and 
benefits of research. Although individual institutions or investigators may not be able to 
resolve a problem that is pervasive in their social setting, they can consider distributive 
justice in selecting research subjects.  
 
Some populations, especially institutionalized ones, are already burdened in many ways 
by their infirmities and environments. When research is proposed that involves risks and 
does not include a therapeutic component, other less burdened classes of persons 
should be called upon first to accept these risks of research, except where the research 
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is directly related to the specific conditions of the class involved. Also, even though public 
funds for research may often flow in the same directions as public funds for health care, it 
seems unfair that populations dependent on public health care constitute a pool of 
preferred research subjects if more advantaged populations are likely to be the recipients 
of the benefits.  
 
One special instance of injustice results from the involvement of vulnerable subjects. 
Certain groups, such as racial minorities, the economically disadvantaged, the very sick, 
and the institutionalized may continually be sought as research subjects, owing to their 
ready availability in settings where research is conducted.  
 
Given their dependent status and their frequently compromised capacity for free consent, 
they should be protected against the danger of being involved in research solely for 
administrative convenience, or because they are easy to manipulate as a result of their 
illness or socioeconomic condition. 
 
(1) Since 1945, various codes for the proper and responsible conduct of human 
experimentation in medical research have been adopted by different organizations. The 
best known of these codes are the Nuremberg Code of 1947, the Helsinki Declaration of 
1964 (revised in 1975), and the 1971 Guidelines (codified into Federal Regulations in 
1974) issued by the U.S. Department of Health, Education, and Welfare Codes for the 
conduct of social and behavioral research have also been adopted, the best known being 
that of the American Psychological Association, published in 1973.  
 
(2) Although practice usually involves interventions designed solely to enhance the well-
being of a particular individual, interventions are sometimes applied to one individual for 
the enhancement of the well-being of another (e.g., blood donation, skin grafts, organ 
transplants) or an intervention may have the dual purpose of enhancing the well-being of 
a particular individual, and, at the same time, providing some benefit to others (e.g., 
vaccination, which protects both the person who is vaccinated and society generally). 
The fact that some forms of practice have elements other than immediate benefit to the 
individual receiving an intervention, however, should not confuse the general distinction 
between research and practice. Even when a procedure applied in practice may benefit 
some other person, it remains an intervention designed to enhance the well-being of a 
particular individual or groups of individuals; thus, it is practice and need not be reviewed 
as research.  
 
(3) Because the problems related to social experimentation may differ substantially from 
those of biomedical and behavioral research, the Commission specifically declines to 
make any policy determination regarding such research at this time. Rather, the 
Commission believes that the problem ought to be addressed by one of its successor 
bodies. 
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Appendix L 
CODE OF FEDERAL REGULATIONS 
 
TITLE 45 
PUBLIC WELFARE 
DEPARTMENT OF HEALTH AND HUMAN SERVICES 
PART 46 
PROTECTION OF HUMAN SUBJECTS 
Subparts A, B C D E 
Revised January 15, 2009 
Effective July 14, 2009 
 
 
 
 
Subpart A –
(Common 
Rule)- 
Basic HHS Policy for Protection of Human Research Subjects 
 
 
 
Section.  
 
46.101 
To what does this policy apply? 
46.102 Definitions. 
46.103 Assuring compliance with this policy--research conducted or supported by any 
Federal Department or Agency. 
46.104- 
46.106 
[Reserved] 
46.107 IRB membership. 
 
46.108 
IRB functions and operations. 
46.109 IRB review of research. 
46.110 Expedited review procedures for certain kinds of research involving no more 
than minimal risk, and for minor changes in approved research. 
46.111 Criteria for IRB approval of research. 
 
46.112 
Review by institution. 
 
46.113 
Suspension or termination of IRB approval of research. 
46.114 Cooperative research. 
46.115 IRB records. 
46.116 General requirements for informed consent. 
46.117 Documentation of informed consent. 
46.118 Applications and proposals lacking definite plans for involvement of human 
subjects. 
46.119 Research undertaken without the intention of involving human subjects. 
46.120 Evaluation and disposition of applications and proposals for research to be 
conducted or supported by a Federal Department or Agency. 
46.121 [Reserved] 
46.122 Use of Federal funds. 
46.123 Early termination of research support: Evaluation of applications and proposals. 
46.124 Conditions. 
  
226 
 
 
 
 
Subpart B -- 
 
 
Additional Protections for Pregnant Women, Human Fetuses and Neonates 
Involved in Research  
Sec.  
 
46.201  
To what do these regulations apply? 
46.202  Definitions. 
46.203  Duties of IRBs in connection with research involving pregnant women, fetuses, and 
neonates. 
46.204  Research involving pregnant women or fetuses. 
46.205  Research involving neonates. 
46.206  Research involving, after delivery, the placenta, the dead fetus or fetal material. 
 
46.207  
Research not otherwise approvable which presents an opportunity to understand, 
prevent, or alleviate a serious problem affecting the health or welfare of pregnant 
women, fetuses, or neonates. 
  
Subpart C -- Additional Protections Pertaining to Biomedical and Behavioral Research 
Involving Prisoners as Subjects 
Sec.  
46.301  Applicability. 
46.302  Purpose. 
46.303  Definitions. 
46.304  Composition of Institutional Review Boards where prisoners are involved. 
46.305  Additional duties of the Institutional Review Boards where prisoners are involved. 
46.306  Permitted research involving prisoners. 
 Subpart D -- Additional Protections for Children Involved as Subjects in Research 
Sec. 
 
46.401  To what do these regulations apply? 
46.402  Definitions. 
46.403  IRB duties. 
46.404  Research not involving greater than minimal risk. 
46.405  Research involving greater than minimal risk but presenting the prospect of direct 
benefit to the individual subjects. 
46.406  Research involving greater than minimal risk and no prospect of direct benefit to 
individual subjects, but likely to yield generalizable knowledge about the subject's 
disorder or condition. 
46.407  Research not otherwise approvable which presents an opportunity to understand, 
prevent, or alleviate a serious problem affecting the health or welfare of children. 
46.408  Requirements for permission by parents or guardians and for assent by children. 
46.409  Wards. 
 Subpart E -- Registration of Institutional Review Boards 
Sec.  
46.501  What IRBs must be registered? 
46.502  What information must be provided when registering an IRB? 
46.503  When must an IRB be registered? 
46.504  How must an IRB be registered? 
46.505  When must IRB registration information be renewed or updated? 
Authority: 5 U.S.C. 301, 42 U.S.C. 289(a). 
Editorial Note: The Department of Health and Human Services issued a notice of waiver 
regarding the requirements set forth in part 46, relating to protection of human subjects, as they 
pertain to demonstration projects, approved under section 1115 of the Social Security Act, which 
test the use of cost--sharing, such as deductibles, copayment and coinsurance, in the Medicaid 
program. For further information see 47 FR 9208, Mar. 4, 1982. 
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* * * 
Subpart A Basic HHS Policy for Protection of Human Research Subjects 
  Authority: 5 U.S.C. 301, 42 U.S.C. 289(a), 42 U.S.C. 300v-1(b). 
  Source: 56 FR 28012, 28022, June 18, 1991, unless otherwise noted. 
 
§46.101 To what does this policy apply? 
(a) Except as provided in paragraph (b) of this section, this policy applies to all research involving 
human subjects conducted, supported or otherwise subject to regulation by any Federal 
department or agency which takes appropriate administrative action to make the policy applicable 
to such research. This includes research conducted by Federal civilian employees or military 
personnel, except that each department or agency head may adopt such procedural 
modifications as may be appropriate from an administrative standpoint. It also includes research 
conducted, supported, or otherwise subject to regulation by the Federal government outside the 
United States. 
 
(1) Research that is conducted or supported by a Federal department or agency, whether or not it 
is regulated as defined in §46.102(e), must comply with all sections of this policy. 
 
(2) Research that is neither conducted nor supported by a Federal department or agency but is 
subject to regulation as defined in §46.102(e) must be reviewed and approved, in compliance 
with §46.101, §46.102, and §46.107 through §46.117 of this policy, by an institutional review 
board (IRB) that operates in accordance with the pertinent requirements of this policy. 
 
(b) Unless otherwise required by department or agency heads, research activities in which the 
only involvement of human subjects will be in one or more of the following categories are exempt 
from this policy: 
 
(1) Research conducted in established or commonly accepted educational settings, involving 
normal educational practices, such as (i) research on regular and special education instructional 
strategies, or (ii) research on the effectiveness of or the comparison among instructional 
techniques, curricula, or classroom management methods. 
 
(2) Research involving the use of educational tests (cognitive, diagnostic, aptitude, achievement), 
survey procedures, interview procedures or observation of public behavior, unless: 
(i) information obtained is recorded in such a manner that human subjects can be identified, 
directly or through identifiers linked to the subjects, and (ii) any disclosure of the human subjects' 
responses outside the research could reasonably place the subjects at risk of criminal or civil 
liability or be damaging to the subjects' financial standing, employability, or reputation. 
 
(3) Research involving the use of educational tests (cognitive, diagnostic, aptitude, achievement), 
survey procedures, interview procedures, or observation of public behavior that is not exempt 
under paragraph (b)(2) of this section, if: 
(i) the human subjects are elected or appointed public officials or candidates for public office, or 
(ii) Federal statute(s) require(s) without exception that the confidentiality of the personally 
identifiable information will be maintained throughout the research and thereafter. 
 
(4) Research involving the collection or study of existing data, documents, records, pathological 
specimens, or diagnostic specimens, if these sources are publicly available or if the information is 
recorded by the investigator in such a manner that subjects cannot be identified, directly or 
through identifiers linked to the subjects. 
 
(5) Research and demonstration projects which are conducted by or subject to the approval of 
department or agency heads, and which are designed to study, evaluate, or otherwise examine: 
228 
 
 
(i) Public benefit or service programs, (ii) procedures for obtaining benefits or services under 
those programs, (iii) possible changes in or alternatives to those programs or procedures, or (iv) 
possible changes in methods or levels of payment for benefits or services under those programs. 
 
(6) Taste and food quality evaluation and consumer acceptance studies, (i) if wholesome foods 
without additives are consumed or (ii) if a food is consumed that contains a food ingredient at or 
below the level and for a use found to be safe, or agricultural chemical or environmental 
contaminant at or below the level found to be safe, by the Food and Drug Administration or 
approved by the Environmental Protection Agency or the Food Safety and Inspection Service of 
the U.S. Department of Agriculture. 
(c) Department or agency heads retain final judgment as to whether a particular activity is 
covered by this policy. 
(d) Department or agency heads may require that specific research activities or classes of 
research activities conducted, supported, or otherwise subject to regulation by the department or 
agency but not otherwise covered by this policy, comply with some or all of the requirements of 
this policy. 
(e) Compliance with this policy requires compliance with pertinent Federal laws or regulations 
which provide additional protections for human subjects. 
(f) This policy does not affect any state or local laws or regulations which may otherwise be 
applicable and which provide additional protections for human subjects. 
(g) This policy does not affect any foreign laws or regulations which may otherwise be applicable 
and which provide additional protections to human subjects of research. 
(h) When research covered by this policy takes place in foreign countries, procedures normally 
followed in the foreign countries to protect human subjects may differ from those set forth in this 
policy. [An example is a foreign institution which complies with guidelines consistent with the 
World Medical Assembly Declaration (Declaration of Helsinki amended 1989) issued either by 
sovereign states or by an organization whose function for the protection of human research 
subjects is internationally recognized.] In these circumstances, if a department or agency head 
determines that the procedures prescribed by the institution afford protections that are at least 
equivalent to those provided in this policy, the department or agency head may approve the 
substitution of the foreign procedures in lieu of the procedural requirements provided in this 
policy. Except when otherwise required by statute, Executive Order, or the department or agency 
head, notices of these actions as they occur will be published in the FEDERAL REGISTER or will 
be otherwise published as provided in department or agency procedures. 
(i) Unless otherwise required by law, department or agency heads may waive the applicability of 
some or all of the provisions of this policy to specific research activities or classes or research 
activities otherwise covered by this policy. Except when otherwise required by statute or 
Executive Order, the department or agency head shall forward advance notices of these actions 
to the Office for Human Research Protections, Department of Health and Human Services (HHS), 
or any successor office, and shall also publish them in the FEDERAL REGISTER or in such other 
manner as provided in department or agency procedures.
1
 
 
1 
Institutions with HHS-approved assurances on file will abide by provisions of Title 45 CFR part 
46 subparts A-D. Some of the other departments and agencies have incorporated all provisions 
of Title 45 CFR part 46 into their policies and procedures as well. However, the exemptions at 45 
CFR 46.101(b) do not apply to research involving prisoners, subpart C. The exemption at 45 CFR 
46.101(b)(2), for research involving survey or interview procedures or observation of public 
behavior, does not apply to research with children, subpart D, except for research involving 
observations of public behavior when the investigator(s) do not participate in the activities being 
observed. 
 [56 FR 28012, 28022, June 18, 1991; 56 FR 29756, June 28, 1991, as amended at 70 FR 
36328, June 23, 2005] 
 
§46.102 Definitions. 
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(a) Department or agency head means the head of any Federal department or agency and any 
other officer or employee of any department or agency to whom authority has been delegated. 
(b) Institution means any public or private entity or agency (including Federal, state, and other 
agencies). 
(c) Legally authorized representative means an individual or judicial or other body authorized 
under applicable law to consent on behalf of a prospective subject to the subject's participation in 
the procedure(s) involved in the research. 
(d) Research means a systematic investigation, including research development, testing and 
evaluation, designed to develop or contribute to generalizable knowledge. Activities which meet 
this definition constitute research for purposes of this policy, whether or not they are conducted or 
supported under a program which is considered research for other purposes. For example, some 
demonstration and service programs may include research activities. 
(e) Research subject to regulation, and similar terms are intended to encompass those research 
activities for which a Federal department or agency has specific responsibility for regulating as a 
research activity, (for example, Investigational New Drug requirements administered by the Food 
and Drug Administration). It does not include research activities which are incidentally regulated 
by a Federal department or agency solely as part of the department's or agency's broader 
responsibility to regulate certain types of activities whether research or non-research in nature 
(for example, Wage and Hour requirements administered by the Department of Labor). 
(f) Human subject means a living individual about whom an investigator (whether professional or 
student) conducting research obtains 
(1) Data through intervention or interaction with the individual, or 
(2) Identifiable private information. 
Intervention includes both physical procedures by which data are gathered (for example, 
venipuncture) and manipulations of the subject or the subject's environment that are performed 
for research purposes. Interaction includes communication or interpersonal contact between 
investigator and subject. Private information includes information about behavior that occurs in a 
context in which an individual can reasonably expect that no observation or recording is taking 
place, and information which has been provided for specific purposes by an individual and which 
the individual can reasonably expect will not be made public (for example, a medical record). 
Private information must be individually identifiable (i.e., the identity of the subject is or may 
readily be ascertained by the investigator or associated with the information) in order for obtaining 
the information to constitute research involving human subjects. 
(g) IRB means an institutional review board established in accord with and for the purposes 
expressed in this policy. 
(h) IRB approval means the determination of the IRB that the research has been reviewed and 
may be conducted at an institution within the constraints set forth by the IRB and by other 
institutional and Federal requirements. 
(i) Minimal risk means that the probability and magnitude of harm or discomfort anticipated in the 
research are not greater in and of themselves than those ordinarily encountered in daily life or 
during the performance of routine physical or psychological examinations or tests. 
(j) Certification means the official notification by the institution to the supporting department or 
agency, in accordance with the requirements of this policy, that a research project or activity 
involving human subjects has been reviewed and approved by an IRB in accordance with an 
approved assurance. 
 
§46.103 Assuring compliance with this policy -- research conducted or supported by any Federal 
Department or Agency. 
(a) Each institution engaged in research which is covered by this policy and which is conducted or 
supported by a Federal department or agency shall provide written assurance satisfactory to the 
department or agency head that it will comply with the requirements set forth in this policy. In lieu 
of requiring submission of an assurance, individual department or agency heads shall accept the 
existence of a current assurance, appropriate for the research in question, on file with the Office 
for Human Research Protections, HHS, or any successor office, and approved for Federalwide 
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use by that office. When the existence of an HHS-approved assurance is accepted in lieu of 
requiring submission of an assurance, reports (except certification) required by this policy to be 
made to department and agency heads shall also be made to the Office for Human Research 
Protections, HHS, or any successor office. 
(b) Departments and agencies will conduct or support research covered by this policy only if the 
institution has an assurance approved as provided in this section, and only if the institution has 
certified to the department or agency head that the research has been reviewed and approved by 
an IRB provided for in the assurance, and will be subject to continuing review by the IRB. 
Assurances applicable to Federally supported or conducted research shall at a minimum include: 
 
(1) A statement of principles governing the institution in the discharge of its responsibilities for 
protecting the rights and welfare of human subjects of research conducted at or sponsored by the 
institution, regardless of whether the research is subject to Federal regulation. This may include 
an appropriate existing code, declaration, or statement of ethical principles, or a statement 
formulated by the institution itself. This requirement does not preempt provisions of this policy 
applicable to department- or agency-supported or regulated research and need not be applicable 
to any research exempted or waived under §46.101(b) or (i). 
 
(2) Designation of one or more IRBs established in accordance with the requirements of this 
policy, and for which provisions are made for meeting space and sufficient staff to support the 
IRB's review and recordkeeping duties. 
 
(3) A list of IRB members identified by name, earned degrees, representative capacity, 
indications of experience such as board certifications, licenses, etc., sufficient to describe each 
member's chief anticipated contributions to IRB deliberations, and any employment or other 
relationship between each member and the institution, for example: full-time employee, part-time 
employee, member of governing panel or board, stockholder, paid or unpaid consultant. Changes 
in IRB membership shall be reported to the department or agency head, unless in accord with  
§46.103(a) of this policy, the existence of an HHS-approved assurance is accepted. In this case, 
change in IRB membership shall be reported to the Office for Human Research Protections, HHS, 
or any successor office. 
 
(4) Written procedures which the IRB will follow (i) for conducting its initial and continuing review 
of research and for reporting its findings and actions to the investigator and the institution, (ii) for 
determining which projects require review more often than annually and which projects need 
verification from sources other than the investigators that no material changes have occurred 
since previous IRB review, and (iii) for ensuring prompt reporting to the IRB of proposed changes 
in a research activity, and for ensuring that such changes in approved research, during the period 
for which IRB approval has already been given, may not be initiated without IRB review and 
approval except when necessary to eliminate apparent immediate hazards to the subject. 
 
(5) Written procedures for ensuring prompt reporting to the IRB, appropriate institutional officials, 
and the department or agency head of (i) any unanticipated problems involving risks to subjects 
or others or any serious or continuing noncompliance with this policy or the requirements or 
determinations of the IRB, and (ii) any suspension or termination of IRB approval. 
(c) The assurance shall be executed by an individual authorized to act for the institution and to 
assume on behalf of the institution the obligations imposed by this policy and shall be filed in such 
form and manner as the department or agency head prescribes. 
(d) The department or agency head will evaluate all assurances submitted in accordance with this 
policy through such officers and employees of the department or agency and such experts or 
consultants engaged for this purpose as the department or agency head determines to be 
appropriate. The department or agency head's evaluation will take into consideration the 
adequacy of the proposed IRB in light of the anticipated scope of the institution's research 
activities and the types of subject populations likely to be involved, the appropriateness of the 
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proposed initial and continuing review procedures in light of the probable risks, and the size and 
complexity of the institution. 
(e) On the basis of this evaluation, the department or agency head may approve or disapprove 
the assurance, or enter into negotiations to develop an approvable one. The department or 
agency head may limit the period during which any particular approved assurance or class of 
approved assurances shall remain effective or otherwise condition or restrict approval. 
(f) Certification is required when the research is supported by a Federal department or agency 
and not otherwise exempted or waived under §46.101(b) or (i). An institution with an approved 
assurance shall certify that each application or proposal for research covered by the assurance 
and by §46.103 of this Policy has been reviewed and approved by the IRB. Such certification 
must be submitted with the application or proposal or by such later date as may be prescribed by 
the department or agency to which the application or proposal is submitted. Under no condition 
shall research covered by §46.103 of the Policy be supported prior to receipt of the certification 
that the research has been reviewed and approved by the IRB. Institutions without an approved 
assurance covering the research shall certify within 30 days after receipt of a request for such a 
certification from the department or agency, that the application or proposal has been approved 
by the IRB. If the certification is not submitted within these time limits, the application or proposal 
may be returned to the institution. 
(Approved by the Office of Management and Budget under Control Number 0990-0260.) 
 [56 FR 28012, 28022, June 18, 1991; 56 FR 29756, June 28, 1991, as amended at 70 FR 
36328, June 23, 2005] 
 
§§46.104--46.106 [Reserved] 
 
§46.107 IRB membership. 
(a) Each IRB shall have at least five members, with varying backgrounds to promote complete 
and adequate review of research activities commonly conducted by the institution. The IRB shall 
be sufficiently qualified through the experience and expertise of its members, and the diversity of 
the members, including consideration of race, gender, and cultural backgrounds and sensitivity to 
such issues as community attitudes, to promote respect for its advice and counsel in 
safeguarding the rights and welfare of human subjects. In addition to possessing the professional 
competence necessary to review specific research activities, the IRB shall be able to ascertain 
the acceptability of proposed research in terms of institutional commitments and regulations, 
applicable law, and standards of professional conduct and practice. The IRB shall therefore 
include persons knowledgeable in these areas. If an IRB regularly reviews research that involves 
a vulnerable category of subjects, such as children, prisoners, pregnant women, or handicapped 
or mentally disabled persons, consideration shall be given to the inclusion of one or more 
individuals who are knowledgeable about and experienced in working with these subjects. 
(b) Every nondiscriminatory effort will be made to ensure that no IRB consists entirely of men or 
entirely of women, including the institution's consideration of qualified persons of both sexes, so 
long as no selection is made to the IRB on the basis of gender. No IRB may consist entirely of 
members of one profession. 
(c) Each IRB shall include at least one member whose primary concerns are in scientific areas 
and at least one member whose primary concerns are in nonscientific areas. 
(d) Each IRB shall include at least one member who is not otherwise affiliated with the institution 
and who is not part of the immediate family of a person who is affiliated with the institution. 
(e) No IRB may have a member participate in the IRB's initial or continuing review of any project 
in which the member has a conflicting interest, except to provide information requested by the 
IRB. 
(f) An IRB may, in its discretion, invite individuals with competence in special areas to assist in 
the review of issues which require expertise beyond or in addition to that available on the IRB. 
These individuals may not vote with the IRB 
 
§46.108 IRB functions and operations. 
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In order to fulfill the requirements of this policy each IRB shall: 
(a) Follow written procedures in the same detail as described in §46.103(b)(4) and, to the extent 
required by, §46.103(b)(5). 
(b) Except when an expedited review procedure is used (see §46.110), review proposed research 
at convened meetings at which a majority of the members of the IRB are present, including at 
least one member whose primary concerns are in nonscientific areas. In order for the research to 
be approved, it shall receive the approval of a majority of those members present at the meeting 
 
 
 
§46.109 IRB review of research. 
(a) An IRB shall review and have authority to approve, require modifications in (to secure 
approval), or disapprove all research activities covered by this policy. 
(b) An IRB shall require that information given to subjects as part of informed consent is in 
accordance with §46.116. The IRB may require that information, in addition to that specifically 
mentioned in §46.116, be given to the subjects when in the IRB's judgment the information would 
meaningfully add to the protection of the rights and welfare of subjects. 
(c) An IRB shall require documentation of informed consent or may waive documentation in 
accordance with §46.117. 
(d) An IRB shall notify investigators and the institution in writing of its decision to approve or 
disapprove the proposed research activity, or of modifications required to secure IRB approval of 
the research activity. If the IRB decides to disapprove a research activity, it shall include in its 
written notification a statement of the reasons for its decision and give the investigator an 
opportunity to respond in person or in writing. 
(e) An IRB shall conduct continuing review of research covered by this policy at intervals 
appropriate to the degree of risk, but not less than once per year, and shall have authority to 
observe or have a third party observe the consent process and the research. High heat 
[56 FR 28012, 28022, June 18, 1991; 56 FR 29756, June 28, 1991, as amended at 70 FR 36328, 
June 23, 2005] 
 
§46.110 Expedited review procedures for certain kinds of research involving no more than 
minimal risk, and for minor changes in approved research. 
(a) The Secretary, HHS, has established, and published as a Notice in the FEDERAL 
REGISTER, a list of categories of research that may be reviewed by the IRB through an 
expedited review procedure. The list will be amended, as appropriate, after consultation with 
other departments and agencies, through periodic republication by the Secretary, HHS, in the 
FEDERAL REGISTER. A copy of the list is available from the Office for Human Research 
Protections, HHS, or any successor office. 
(b) An IRB may use the expedited review procedure to review either or both of the following: 
(1) some or all of the research appearing on the list and found by the reviewer(s) to involve no 
more than minimal risk, 
(2) minor changes in previously approved research during the period (of one year or less) for 
which approval is authorized. 
Under an expedited review procedure, the review may be carried out by the IRB chairperson or 
by one or more experienced reviewers designated by the chairperson from among members of 
the IRB. In reviewing the research, the reviewers may exercise all of the authorities of the IRB 
except that the reviewers may not disapprove the research. A research activity may be 
disapproved only after review in accordance with the non-expedited procedure set forth in 
§46.108(b). 
 (c) Each IRB which uses an expedited review procedure shall adopt a method for keeping all 
members advised of research proposals which have been approved under the procedure. 
 (d) The department or agency head may restrict, suspend, terminate, or choose not to authorize 
an institution's or IRB's use of the expedited review procedure. 
[56 FR 28012, 28022, June 18, 1991, as amended at 70 FR 36328, June 23, 2005] 
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§46.111 Criteria for IRB approval of research. 
(a) In order to approve research covered by this policy the IRB shall determine that all of the 
following requirements are satisfied: 
(1) Risks to subjects are minimized: (i) By using procedures which are consistent with sound 
research design and which do not unnecessarily expose subjects to risk, and (ii) whenever 
appropriate, by using procedures already being performed on the subjects for diagnostic or 
treatment purposes. 
(2) Risks to subjects are reasonable in relation to anticipated benefits, if any, to subjects, and the 
importance of the knowledge that may reasonably be expected to result. In evaluating risks and 
benefits, the IRB should consider only those risks and benefits that may result from the research 
(as distinguished from risks and benefits of therapies subjects would receive even if not 
participating in the research). The IRB should not consider possible long-range effects of applying 
knowledge gained in the research (for example, the possible effects of the research on public 
policy) as among those research risks that fall within the purview of its responsibility. 
(3) Selection of subjects is equitable. In making this assessment the IRB should take into account 
the purposes of the research and the setting in which the research will be conducted and should 
be particularly cognizant of the special problems of research involving vulnerable populations, 
such as children, prisoners, pregnant women, mentally disabled persons, or economically or 
educationally disadvantaged persons. 
(4) Informed consent will be sought from each prospective subject or the subject's legally 
authorized representative, in accordance with, and to the extent required by §46.116. 
(5) Informed consent will be appropriately documented, in accordance with, and to the extent 
required by §46.117. 
(6) When appropriate, the research plan makes adequate provision for monitoring the data 
collected to ensure the safety of subjects. 
(7) When appropriate, there are adequate provisions to protect the privacy of subjects and to 
maintain the confidentiality of data. 
(b) When some or all of the subjects are likely to be vulnerable to coercion or undue influence, 
such as children, prisoners, pregnant women, mentally disabled persons, or economically or 
educationally disadvantaged persons, additional safeguards have been included in the study to 
protect the rights and welfare of these subjects. 
 
§46.112 Review by institution. 
Research covered by this policy that has been approved by an IRB may be subject to further 
appropriate review and approval or disapproval by officials of the institution. However, those 
officials may not approve the research if it has not been approved by an IRB. 
 
§46.113 Suspension or termination of IRB approval of research. 
An IRB shall have authority to suspend or terminate approval of research that is not being 
conducted in accordance with the IRB's requirements or that has been associated with 
unexpected serious harm to subjects. Any suspension or termination of approval shall include a 
statement of the reasons for the IRB's action and shall be reported promptly to the investigator, 
appropriate institutional officials, and the department or agency head. 
(Approved by the Office of Management and Budget under Control Number 0990-0260.) 
[56 FR 28012, 28022, June 18, 1991, as amended at 70 FR 36328, June 23, 2005] 
 
 §46.114 Cooperative research. 
Cooperative research projects are those projects covered by this policy which involve more than 
one institution. In the conduct of cooperative research projects, each institution is responsible for 
safeguarding the rights and welfare of human subjects and for complying with this policy. With the 
approval of the department or agency head, an institution participating in a cooperative project 
may enter into a joint review arrangement, rely upon the review of another qualified IRB, or make 
similar arrangements for avoiding duplication of effort. 
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§46.115 IRB records. 
(a) An institution, or when appropriate an IRB, shall prepare and maintain adequate 
documentation of IRB activities, including the following: 
(1) Copies of all research proposals reviewed, scientific evaluations, if any, that accompany the 
proposals, approved sample consent documents, progress reports submitted by investigators, 
and reports of injuries to subjects. 
(2) Minutes of IRB meetings which shall be in sufficient detail to show attendance at the 
meetings, actions taken by the IRB, the vote on these actions including the number of members 
voting for, against, and abstaining, the basis for requiring changes in or disapproving research, 
and a written summary of the discussion of controverted issues and their resolution. 
(3) Records of continuing review activities. 
(4) Copies of all correspondence between the IRB and the investigators. 
(5) A list of IRB members in the same detail as described in §46.103(b)(3). 
(6) Written procedures for the IRB in the same detail as described in §46.103(b)(4) and 
§46.103(b)(5). 
(7) Statements of significant new findings provided to subjects, as required by §46.116(b)(5). 
(b) The records required by this policy shall be retained for at least 3 years, and records relating 
to research which is conducted shall be retained for at least 3 years after completion of the 
research. All records shall be accessible for inspection and copying by authorized representatives 
of the department or agency at reasonable times and in a reasonable manner. 
(Approved by the Office of Management and Budget under Control Number 0990-0260.) 
[56 FR 28012, 28022, June 18, 1991, as amended at 70 FR 36328, June 23, 2005] 
 
§46.116 General requirements for informed consent. 
Except as provided elsewhere in this policy, no investigator may involve a human being as a 
subject in research covered by this policy unless the investigator has obtained the legally 
effective informed consent of the subject or the subject's legally authorized representative. An 
investigator shall seek such consent only under circumstances that provide the prospective 
subject or the representative sufficient opportunity to consider whether or not to participate and 
that minimize the possibility of coercion or undue influence. The information that is given to the 
subject or the representative shall be in language understandable to the subject or the 
representative. No informed consent, whether oral or written, may include any exculpatory 
language through which the subject or the representative is made to waive or appear to waive 
any of the subject's legal rights, or releases or appears to release the investigator, the sponsor, 
the institution or its agents from liability for negligence. 
(a) Basic elements of informed consent. Except as provided in paragraph (c) or (d) of this section, 
in seeking informed consent the following information shall be provided to each subject: 
(1) A statement that the study involves research, an explanation of the purposes of the research 
and the expected duration of the subject's participation, a description of the procedures to be 
followed, and identification of any procedures which are experimental, 
(2) A description of any reasonably foreseeable risks or discomforts to the subject, 
(3) A description of any benefits to the subject or to others which may reasonably be expected 
from the research, 
(4) A disclosure of appropriate alternative procedures or courses of treatment, if any, that might 
be advantageous to the subject, 
(5) A statement describing the extent, if any, to which confidentiality of records identifying the 
subject will be maintained, 
(6) For research involving more than minimal risk, an explanation as to whether any 
compensation and an explanation as to whether any medical treatments are available if injury 
occurs and, if so, what they consist of, or where further information may be obtained, 
(7) An explanation of whom to contact for answers to pertinent questions about the research and 
research subjects' rights, and whom to contact in the event of a research-related injury to the 
subject, and 
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(8) A statement that participation is voluntary, refusal to participate will involve no penalty or loss 
of benefits to which the subject is otherwise entitled, and the subject may discontinue 
participation at any time without penalty or loss of benefits to which the subject is otherwise 
entitled. 
(b) Additional elements of informed consent. When appropriate, one or more of the following 
elements of information shall also be provided to each subject: 
(1) A statement that the particular treatment or procedure may involve risks to the subject (or to 
the embryo or fetus, if the subject is or may become pregnant) which are currently unforeseeable, 
(2) Anticipated circumstances under which the subject's participation may be terminated by the 
investigator without regard to the subject's consent, 
(3) Any additional costs to the subject that may result from participation in the research, 
(4) The consequences of a subject's decision to withdraw from the research and procedures for 
orderly termination of participation by the subject, 
(5) A statement that significant new findings developed during the course of the research which 
may relate to the subject's willingness to continue participation will be provided to the subject, and 
(6) The approximate number of subjects involved in the study. 
(c) An IRB may approve a consent procedure which does not include, or which alters, some or all 
of the elements of informed consent set forth above, or waive the requirement to obtain informed 
consent provided the IRB finds and documents that: 
(1) The research or demonstration project is to be conducted by or subject to the approval of 
state or local government officials and is designed to study, evaluate, or otherwise examine: (i) 
public benefit or service programs, (ii) procedures for obtaining benefits or services under those 
programs, (iii) possible changes in or alternatives to those programs or procedures, or (iv) 
possible changes in methods or levels of payment for benefits or services under those programs, 
and 
(2) The research could not practicably be carried out without the waiver or alteration. 
(d) An IRB may approve a consent procedure which does not include, or which alters, some or all 
of the elements of informed consent set forth in this section, or waive the requirements to obtain 
informed consent provided the IRB finds and documents that: 
(1) The research involves no more than minimal risk to the subjects, 
(2) The waiver or alteration will not adversely affect the rights and welfare of the subjects, 
(3) The research could not practicably be carried out without the waiver or alteration, and 
(4) Whenever appropriate, the subjects will be provided with additional pertinent information after 
participation. 
(e) The informed consent requirements in this policy are not intended to preempt any applicable 
Federal, state, or local laws which require additional information to be disclosed in order for 
informed consent to be legally effective. 
(f) Nothing in this policy is intended to limit the authority of a physician to provide emergency 
medical care, to the extent the physician is permitted to do so under applicable Federal, state, or 
local law. 
(Approved by the Office of Management and Budget under Control Number 0990-0260.) 
[56 FR 28012, 28022, June 18, 1991, as amended at 70 FR 36328, June 23, 2005] 
 
§46.117 Documentation of informed consent. 
(a) Except as provided in paragraph (c) of this section, informed consent shall be documented by 
the use of a written consent form approved by the IRB and signed by the subject or the subject's 
legally authorized representative. A copy shall be given to the person signing the form. 
(b) Except as provided in paragraph (c) of this section, the consent form may be either of the 
following: 
(1) A written consent document that embodies the elements of informed consent required by 
§46.116. This form may be read to the subject or the subject's legally authorized representative, 
but in any event, the investigator shall give either the subject or the representative adequate 
opportunity to read it before it is signed, or 
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(2) A short form written consent document stating that the elements of informed consent required 
by §46.116 have been presented orally to the subject or the subject's legally authorized 
representative. When this method is used, there shall be a witness to the oral presentation. Also, 
the IRB shall approve a written summary of what is to be said to the subject or the representative. 
Only the short form itself is to be signed by the subject or the representative. However, the 
witness shall sign both the short form and a copy of the summary, and the person actually 
obtaining consent shall sign a copy of the summary. A copy of the summary shall be given to the 
subject or the representative, in addition to a copy of the short form. 
(c) An IRB may waive the requirement for the investigator to obtain a signed consent form for 
some or all subjects if it finds either: 
(1) That the only record linking the subject and the research would be the consent document and 
the principal risk would be potential harm resulting from a breach of confidentiality. Each subject 
will be asked whether the subject wants documentation linking the subject with the research, and 
the subject's wishes will govern, or 
(2) That the research presents no more than minimal risk of harm to subjects and involves no 
procedures for which written consent is normally required outside of the research context. 
In cases in which the documentation requirement is waived, the IRB may require the investigator 
to provide subjects with a written statement regarding the research. 
 
(Approved by the Office of Management and Budget under Control Number 0990-0260.) 
[56 FR 28012, 28022, June 18, 1991, as amended at 70 FR 36328, June 23, 2005] 
 
§46.118 Applications and proposals lacking definite plans for involvement of human subjects. 
Certain types of applications for grants, cooperative agreements, or contracts are submitted to 
departments or agencies with the knowledge that subjects may be involved within the period of 
support, but definite plans would not normally be set forth in the application or proposal. These 
include activities such as institutional type grants when selection of specific projects is the 
institution's responsibility, research training grants in which the activities involving subjects remain 
to be selected, and projects in which human subjects' involvement will depend upon completion 
of instruments, prior animal studies, or purification of compounds. These applications need not be 
reviewed by an IRB before an award may be made. However, except for research exempted or 
waived under §46.101(b) or (i), no human subjects may be involved in any project supported by 
these awards until the project has been reviewed and approved by the IRB, as provided in this 
policy, and certification submitted, by the institution, to the department or agency. 
 
§46.119 Research undertaken without the intention of involving human subjects. 
In the event research is undertaken without the intention of involving human subjects, but it is 
later proposed to involve human subjects in the research, the research shall first be reviewed and 
approved by an IRB, as provided in this policy, a certification submitted, by the institution, to the 
department or agency, and final approval given to the proposed change by the department or 
agency. 
 
§46.120 Evaluation and disposition of applications and proposals for research to be conducted or 
supported by a Federal Department or Agency. 
(a) The department or agency head will evaluate all applications and proposals involving human 
subjects submitted to the department or agency through such officers and employees of the 
department or agency and such experts and consultants as the department or agency head 
determines to be appropriate. This evaluation will take into consideration the risks to the subjects, 
the adequacy of protection against these risks, the potential benefits of the research to the 
subjects and others, and the importance of the knowledge gained or to be gained. 
(b) On the basis of this evaluation, the department or agency head may approve or disapprove 
the application or proposal, or enter into negotiations to develop an approvable one. 
 
§46.121 [Reserved] 
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§46.122 Use of Federal funds. 
Federal funds administered by a department or agency may not be expended for research 
involving human subjects unless the requirements of this policy have been satisfied. 
 
§46.123 Early termination of research support: Evaluation of applications and proposals. 
(a) The department or agency head may require that department or agency support for any 
project be terminated or suspended in the manner prescribed in applicable program 
requirements, when the department or agency head finds an institution has materially failed to 
comply with the terms of this policy. 
(b) In making decisions about supporting or approving applications or proposals covered by this 
policy the department or agency head may take into account, in addition to all other eligibility 
requirements and program criteria, factors such as whether the applicant has been subject to a 
termination or suspension under paragraph (a) of this section and whether the applicant or the 
person or persons who would direct or has/have directed the scientific and technical aspects of 
an activity has/have, in the judgment of the department or agency head, materially failed to 
discharge responsibility for the protection of the rights and welfare of human subjects (whether or 
not the research was subject to Federal regulation). 
 
§46.124 Conditions. 
With respect to any research project or any class of research projects the department or agency 
head may impose additional conditions prior to or at the time of approval when in the judgment of 
the department or agency head additional conditions are necessary for the protection of human 
subjects. 
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Written Testimony 
 
Felice J. Levine, PhD 
American Sociological Association 
on behalf of the 
Consortium of Social Science Associations 
in Cooperation with the American Sociological Association 
 
Submitted to 
 
The Committee on Assessing the System for Protecting Human Research Subjects 
The Institute of Medicine 
The National Academies 
January 31, 2001 
Written Testimony Felice J. Levine, PhD American Sociological Association on behalf of 
the Consortium of Social Science Associations in Cooperation with the American 
Sociological Association Submitted to The Committee on Assessing the System for 
Protecting Human Research Subjects  
The Institute of Medicine  
The National Academies January 31, 2001  
 
Dr. Federman and Members of the Committee:  
Thank you very much for the opportunity to submit comments on the draft accreditation 
standards regarding the protection of human participants in research. As Executive 
Officer of the American Sociological Association and as a member of the Executive 
Committee of the Consortium of Social Science Associations (COSSA), I am pleased to 
be able to do so on behalf of COSSA. COSSA is an advocacy organization for the social 
and behavioral sciences, supported by over 105 professional associations, scientific 
societies, universities, and research institutes.  
 
COSSA appreciates the opportunity to talk about some of the issues and challenges for 
the social and behavioral sciences under the proposed standards of accreditation for the 
protection of human subjects in research. COSSA believes in promoting sound science 
with sound ethical practices. Most of our professional associations have developed 
ethical guidelines for researchers to follow in conducting their studies, particularly where 
human subjects are part of the research design. All embrace the Belmont Report's 
admonitions of respect for persons, beneficence, and justice. We are, however, 
concerned with the growing fault lines in the system that protects human subjects and by 
the gap that has developed between law and policy on-the-books and in-action. For 
example, researchers utilizing secondary data are being asked to seek approval by IRBs 
to use these data where the information is in anonymous form and where subjects are 
already protected under earlier protocols. We hope the Committee will examine such 
issues closely, not only in assessing these draft standards, but also in your larger study 
of the whole system of protecting human research participants.  
 
For the social and behavioral sciences, the overall problem with the system is the attempt 
to fit our research into a framework that was over specified and designed for biomedical-
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clinical research. The presence of IRBs in academic and other research organizations 
dates back to 1974 when Federal guidelines were established for the protection of human 
subjects. While social and behavioral science research was included from the outset, 
much of the impetus for such guidelines grew out of concerns about informed consent 
and risks involved in biomedical research. Despite the passage of time, this model of 
science continues to color the operations of the system, the understanding of best ethical 
practices, and the functioning of Institutional Review Boards (IRBs). The proposed 
standards that we are here to discuss today provide further evidence of this inherent 
problem. If these standards are intended to be universal and fit all research involving 
human participants, then they need to be framed in a way that meaningfully includes all 
research fields. Standing alone, for example, the very long mention at the beginning of 
Section 3 of Henry Beecher and his 1966 article on "Ethics and Clinical Research" 
focuses too exclusively on physicians and on "performing experiments" on humans. This 
type of preamble sends the wrong signal. We need to take this opportunity to send 
inclusive signals about a broader band of research involving humans.  
 
Before offering our specific observations of the draft accreditation standards, we address 
some general concerns about the standards and about the system for protecting human 
research subjects. We have framed our observations as a series of ten 
recommendations. Most are broadly applicable to accreditation and the overall system; 
some deal with issues that are particularly important for improving the ethical 
consideration of research in the social and behavioral sciences. We believe that these 
recommendations could and should usefully guide the IOM Committee in both the 
assessment of the system and the development of accreditation standards.  
 
GENERAL RECOMMENDATIONS  
1) Seize the Moment for Effective Leadership on Behalf of All Science. IOM has the 
opportunity to provide guidance on an accreditation system and a human research 
participant protection system that effectively reaches to all areas of scientific research 
and effectively serves all Federal funding agencies engaged in the support of such 
research-not just the biomedical sciences. The social and behavioral sciences have 
been committed to this system and its objectives, but often, in practice, the ethical 
requirements of our sciences have not been consistently and effectively understood.  
 
2) There is Virtue to Moving Ahead, but There is Also Virtue to Slowing the "Train" 
Sufficiently to Ensure We Can Turn a New Corner. If the standards for accreditation are 
to be more effective than the current process for obtaining assurances of compliance 
under the Common Rule, then the two important IOM studies yet to be undertaken 
should logically proceed before the final crafting and finalizing of accreditation 
standards. Simply put, perhaps the final accreditation standards should follow after 
studies two and three and not before.  
 
3) Where's the Fit? The proposed accreditation standards integrate many pieces of the 
Common Rule but use these regulations in a different context and often coupled with 
other ideas. Accreditation standards should accredit to the regulations in place; the goal 
of accreditation is to ensure that the regulations are followed, not to produce additional 
regulations. The disjuncture between the Common Rule and the accreditation standards 
needs careful analysis. It may be wisest to have accreditation standards that ensure the 
effective implementation of the Common Rule guidelines. Then, perhaps as part of 
introducing accreditation standards, an evaluation could be undertaken to assess 
whether the system is working effectively and what gaps exist. The problem in the past 
has been less the actual rules governing the human research protection system than 
implementation of them.  
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4) The Devil is in the Details. The proposed accreditation standards are not per se 
couched in the language of any one science or arena of research, but, when coupled 
with the Commentary, these standards are quite biomedical and heavily clinical and pay 
only lip service to other substantive arenas of work. This is especially problematic for the 
social and behavioral sciences. Will the Commentary be presented? If so, the role of the 
Commentary needs to be clear, and the examples across areas of research need to be 
specified.  
 
5) While Good Ethics Makes for Good Research, Judgments of Best Ethical Practices are 
Distinct from Judgments about the Quality of the Research. The proposed accreditation 
standards overreach to what constitutes quality science and do not sufficiently distinguish 
between those judgments and what constitutes ethical practices in science. Standards 
shift from the criteria for the accreditation of IRBs to the assessment of the research and 
the researcher. The standards need to emphasize accrediting the structure put in place 
and the procedures to be followed for the  
protection of human participants in research.  
 
6) Clarity, Simplicity, and Transparency are Fundamental to Accreditation Standards of 
Excellence. Many of the standards require judgments that are impossible to make. The 
standards should not tell an institution how it should achieve its goals, but should set 
forth what the standards or goals are. The standards should focus on the actual facts of 
what is required and not engage in standard setting or determinations that are highly 
subjective or elusive. The Commentary is often so detailed that, by omission, it is limiting 
in its scope; at other points, the standards are so vague as to be subject to widely 
different interpretations. Ironically, the movement to accreditation in large part aims to 
transcend such problems-with the promulgation of reproducible standards intended to be 
the backbone.  
http://www.cossa.org/humanparticipants.html  
 
7) The Educative Role of Accreditation Standards Can be More Powerful than its 
Regulatory or Enforcement Functions. We know from research on compliance and non-
compliance, that the primary power of a rule system is in its moral persuasion and 
educative effects. Yet, the proposed accreditation standards, especially the Commentary, 
provide little education for IRBs regarding how the human research protection system 
should operate-especially for the social and behavioral sciences.  
 
8) Less Can be More: Accreditation Standards Should Ensure that the Human Research 
Protection System Does Not Overreach Its Role and that it Stays on Task. The human 
research protection system needs to ensure that research proceeds and knowledge is 
advanced in accordance with the highest standards of ethical practice with respect to 
human subjects protection. The system needs also to ensure that work that comports to 
ethical standards is facilitated and not impeded by the process. For example, research 
involves risk at various levels-standards should hold IRBs to the task of effectively 
implementing what was intended to be exempt or expedited and what requires full review. 
Consent is another area where IRBs need to have knowledge about how to undertake 
research ethically. Studies of runaway youth, for example, raise different issues about 
parental consent than do observational studies of  
preschoolers in a classroom.  
 
9) Human Research Participants Refer to Actual Participation in a Study Underway or 
Being Proposed. The accreditation standards need to make clear to IRBs what the scope 
of the human research protection system is and is not. The analysis, for example, of 
public use data or public use files where information is maintained in anonymous form 
and without personal identifiers is research about people but not on people. The definition 
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of human subjects under the Common Rule defines the scope of its purview as research 
on living individuals when an investigator obtains data through an intervention or 
interaction or obtains identifiable private information. For a human research protection 
system to focus on this domain and to do it well-with appropriate attention to level of risk-
is to achieve an important goal.  
10) Focus on the Ethical Considerations regarding Human Research Participants in 
Various Types of Research. The answer to concerns in the social and behavioral 
sciences is not to create a dual human research protection system but to ensure a 
system that is more sophisticated about ethical practices across fields of science. Social 
and behavioral science research is increasingly interdisciplinary within fields and across 
especially biomedical, environmental, public health, and engineering fields. Separation 
of the review by field could create redundancy and limit researchers mutually benefiting 
from the ethical expertise of each other. But, this puts a burden on ensuring that an 
altered human research protection system includes the necessary and appropriate 
expertise on ethical practices in the social and behavioral sciences. The composition of 
IRBs is very important; other parts of the system also need to be savvy about ethical 
practices in the social and behavioral sciences.  
 
SPECIFIC ILLU.S.TRATIVE CONCERNS  
Our general recommendations raise questions that speak to the overall thrust, tone, 
scope, and reach-if not overreaching-of the accreditation standards as currently crafted. 
They also speak to how and when the IOM might be best situated to develop and 
recommend accreditation standards for Institutional Review Boards. Because our general 
concerns speak to each of the standards, we offer below some illustration of the type of 
revisions and development work that would be required in any revision process.  
 
Section on Principles Underlying . . . . should be expanded to set the tone of what is 
meant to be included within the scope of the Belmont Report and the Common Rule (45 
CFR Part 26). Note, for example, the reference in paragraph two to only "experimental 
subjects." This should be changed to "who agree to be research participants (subjects)" 
or similar language.  
 
Definitions should explicitly include "colleges and universities" not just "universities."  
Proposed Standard 1.7 calls for the review of the policies and procedures of the Human 
Research Protection Plan. We suggest that it include a clause that periodic review must 
include input from the scientific community and researchers as to whether the policies 
and procedures are effectively protecting research participants and enabling the progress 
of  
research.  
 
Proposed Standard 1.9 would benefit from explicit recognition of the social and 
behavioral sciences. The language and Commentary of 1.9 should be appropriately 
amended. Such a modification would make clear that the social and behavioral sciences 
are different from the biomedical/clinical sciences and that, in a meaningful protection of 
research participants, ethical principles need to be applied and implemented appropriate 
to the substance and methodologies of the work. We urge that the Human Research 
Protection Plan recognize that research in the social and behavioral sciences often 
involves different situations (from clinical experiments) regarding the protection of human 
subjects. The Plan could allows for specialty IRBs or certainly IRBs with appropriate 
expertise in the social and behavioral sciences and ethical practices therein.  
 
Proposed Standard 1.11 should make clear that expertise for the chair needs to include 
expertise regarding ethical issues as they pertain to human participants in social and 
behavioral science research. Language could be added to the effect of "across all fields 
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of science germane to the work of the IRB." As in the Commentary, perhaps the 
proposed standard should refer to both the chair and the members. The Commentary can 
make clear that every chair cannot be expert in the specifics of all arenas of inquiry, but 
that chairs need to display a breadth of interest and exposure that signals knowledge and 
openness across fields. Also, the reference to "organization culture" seems superfluous 
to an accreditation standard. It is not clear how one would measure "their [IRB chairs] 
contribution to the organization's culture." It is also unclear why this determination is 
included in the Commentary and the fit between this language and requirements for 
assurances under the Common Rule.  
 
Proposed Standard 1.14 focuses on the performance of an organization's HRPP-
emphasizing the importance of assessment and evaluation. The Commentary, however, 
should refer only to the HRPP overall and the IRBs, not to the investigator. The 
evaluation, of course, focuses on whether the HRPP is effectively performing its functions 
of protecting human participants in research and thus necessarily examines how the 
system identifies and deals with problems. The Commentary, however, should not imply 
that there is a further assessment of the performance of investigators beyond examining 
how the system operates with respect to the ethical monitoring of investigations. Also, the 
Commentary should not explicitly cite any group like PRIM&R and what roles it might 
perform because such roles are not mandated by the accreditation process. Also, the 
Commentary should allow for successful assessments  
and how they will be duly recorded and reported.  
 
Proposed Standard 1.15 does not recognize the breadth and nature of communities of 
research when it charges this function to the "organization." As currently written, the 
proposed standard seems also to confuse an implied "local" community with populations 
at risk and groups requiring special sensitivity because of their vulnerabilities. If it is to be 
retained as a standard, it needs to be clear how community is defined. Does it include 
international communities in multi-national research? Unlike in clinical trials where the 
subject population might be drawn from the proximal community, in the social and 
behavioral sciences, the sites for research and the locations of relevant research 
participants and research communities can be geographically wide ranging. Typically 
samples are drawn not based on geographic convenience to the investigator, but on the 
substantive ideas motivating the research. Researchers need to demonstrate sensitivity 
to relevant research communities, but it is unclear how or why the "organization" would 
be charged with doing so. Therefore, as an accreditation standard for HRPP, this should 
be deleted.  
 
Proposed Standard 2.3 has examples in the Commentary that could usefully be 
broadened. The Commentary should also use explicit language that signals the social 
and behavioral sciences. Here and throughout "i.e." is used when it seems that "e.g." is 
meant.  
 
Proposed Standard 2.4 seems to focus on traits beyond substantive expertise in relevant 
ethical areas embraced by the IRB. Why is this section necessary as an accreditation 
standard, how does it link to the assurances specified in the Common Rule, and what 
does it add beyond Proposed Standard 1.11? Especially in the Commentary, it reads far 
too much like a job description. The accreditation standards need to focus on required 
structures and processes; it seems unnecessary and unwise to frame the standards in 
terms of personality attributes of those who serve. The Standard itself talks about 
"sufficient respect" and other elusive traits which we believe are far too subjective and not 
very  
useful. Therefore, we recommend that this whole section should be eliminated.  
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Proposed Standard 2.5 and the Commentary could usefully signal the breadth of 
research involving human subjects. The text should read: The IRB administrator, staff, 
chair(s), and Board members must possess and maintain knowledge, skills and abilities 
appropriate to the actual conduct of research across all areas of study with human 
subjects. IRB chairs and members should be encouraged to attend scientific society 
meetings and their ethics workshops so that they understand the ethical requirements 
put on the researcher by his/her professional community. Language in Commentary 
should not explicitly privilege-even by example-any one certification process like CCIP. 
Standards should be neutral on their face and should not promote any specific 
programs.  
 
Proposed Standards 2.8 and 2.9 should be in reverse order. The appropriateness of the 
consent process should take precedence over the legibility of the consent documents.  
 
Proposed Standard 2.10 needs clarification. The Commentary is misguided. The IRB 
should not be determining who should serve as principal investigator and whether that 
person is qualified to lead a research project. That should be left to peer review of the 
substance of the research itself. The IRBs' attention should be directed to the processes 
and procedures to be followed for the protection of human research participants. The 
language could usefully be modified from "to be responsible for the research" to "to be 
responsible for the protection of human subjects involved in the conduct of the 
research." This standard is a further location where the breadth of the fields could be 
signaled and the  
social and behavioral sciences more explicitly included.  
 
Proposed Standard 2.11 and specifically its opening Commentary should include a wide 
array of examples that go beyond health and visibly include examples from the social 
and behavioral sciences on health and other issues. For example, written specific 
guidelines for IRBs would be useful in the area of survey research (including with 
respect to different populations), and IRBs would benefit from being better informed (and 
having greater expertise) regarding how risk or adverse circumstances may be different 
in survey research. As elsewhere, the current examples (after the "i.e.," are essentially 
all clinical or biomedical.)  
 
Proposed Standard 2.11 (E) (F) essentially has no Commentary. This is an area where 
the accreditation standards can ensure that the HRPP system and the operations of IRBs 
reach-not overreach-to what is meant to be included. The specification of Commentary 
here could usefully educate IRBs about human subjects protection with respect to a 
considerable amount of work in the social and behavioral sciences. Research qualified 
for exemption or expedited review needs to be explicitly stipulated and reference made to 
the Common Rule.  
 
Proposed Standard 2.12 and 2.13 could usefully be aligned with the Common Rule; in 
their present form, they are too prescriptive. They should be simplified so that the goals 
and purposes of the IRB record keeping are clear and so that someone not party to the 
process or the meeting could be expected to understand what has happened and why.  
Proposed Standard 3, as noted above, needs to have the General Commentary recast 
to explicit capture all fields of research, not just the biomedical and clinical fields. In 
Commentary about investigators, all researchers and all IRBs need to see that these 
accreditation standards includes social and behavioral science research and other 
germane fields.  
 
Proposed Standard 3.4 needs to explicitly account for exempt research and the 
alignment between the responsibility of the IRBs and the investigators. Also, the 
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Commentary gives final authority to the IRBs. We recommend that the IRB should not 
have the sole authority in the organization to determine what constitutes protection of 
human participants in research. There should be some avenue of appeal of IRB 
decisions. Thus, if an IRB determined that a given project, such as secondary analysis 
of data, should not be exempt, there needs to be another body where the researcher 
can make his/her case and which is charged with determining if the IRB operated 
consistent with regulations.  
Proposed Standard 3.5 substantially overlaps Standard 2.10, which, as noted earlier, 
needs clarification. The one difference is the emphasis on "delegation." Were this 
Standard to be retained, it should read: "Principal Investigators (PIs) may delegate 
responsibility for aspects of human subjects protection only to individuals who are 
qualified through training and experience for this role."  
Proposed Standard 3.7 is vague and unclear as to its purpose and intent. It sounds 
almost like a "litmus test" that goes well beyond the high level of ethical practices 
that an investigator may set for his or her own research. Furthermore, it is unclear 
how it would be measured. We recommend that it be eliminated.  
 
CONCLU.S.ION  
In addressing both our general recommendations and specific concerns, we in the social 
and behavioral sciences and in the scientific societies can be very useful. We stand 
ready to do so under the auspices of COSSA. Other key agencies outside of the health 
sciences that fund and support research with human participants can also help to bring 
appropriate knowledge to bear. The National Science Foundation is key in that regard. 
We believe that such guidance can help structure the next round of revisions for a final 
set of "testable" accreditation standards. We at COSSA as well as many, many top 
quality researchers behind us are eager to help in any way we can. Thank you for the 
opportunity to present our views.  
 
 
 
http://www.cossa.org/humanparticipants.html  
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Appendix P 
 
   
 
Office for Human Research Protections (OHRP) 
       Determination Letters 2000 – 2010 
 
1. 12/04/2000  University of South Florida 
2. 12/11/2000  Louisiana State University Medical Center of New Orleans 
3. 12/11/2000  The University of Alabama at Birmingham 
4. 12/11/2000  University of Wisconsin - Madison 
5. 12/12/2000  Yale University 
6. 12/12/2000  National Institutes of Health 
7. 12/12/2000  State University of New York 
8. 12/15/2000  Massachusetts Eye and Ear Infirmary 
9. 12/15/2000  Virginia Commonwealth University 
10. 12/18/2000  Vanderbilt University 
11. 12/20/2000  Yale University 
12. 12/20/2000  Washington University School of Medicine 
13. 12/22/2000  Wake Forest University 
14. 12/22/2000  The University of North Carolina at Chapel Hill 
15. 11/03/2000  National Institutes of Health 
16. 11/06/2000  University of Arkansas for Medical Sciences 
17. 11/08/2000  Yale University 
18. 11/13/2000  University of Florida 
19. 11/22/2000  University of Missouri - Columbia 
20. 11/17/2000  University of South Florida 
21. 11/27/2000  University of Rochester 
22. 11/27/2000  RAND 
23. 11/27/2000  Evanston Northwestern Healthcare Corporation 
24. 11/27/2000  Case Western Reserve University 
25. 11/27/2000  Raritan Bay Medical Center 
26. 11/27/2000  Brown University 
27. 11/29/2000  Temple University 
28. 11/30/2000  Charles R. Drew University of Medicine and Science 
29. 10/03/2000  The Johns Hopkins University 
30. 10/03/2000  State University of New York at Binghamton 
31. 10/03/2000  Brooke Army Medical Center 
32. 10/04/2000  Georgetown University 
33. 10/11/2000  Northeast Georgia Health Services 
34. 10/11/2000  Evanston Northwestern Healthcare Corporation 
35. 10/11/2000  St. Francis Health System 
36. 10/19/2000  University of Maryland 
37. 10/19/2000  Research Foundation for Mental Hygiene, Inc. 
38. 10/19/2000  East Tennessee State University 
39. 10/19/2000  The University of Oklahoma Health Sciences Center 
40. 10/23/2000  Kaiser Foundation Hospitals 
261 
 
 
41. 10/24/2000  University of South Florida 
42. 10/26/2000  University of Colorado Health Sciences Center 
43. 10/26/2000  Toxicology Associates 
44. 10/27/2000  Louisiana State University Medical Center 
45. 10/27/2000  The Pennsylvania State University 
46. 10/27/2000  George Mason University 
47. 09/07/2000  University of Florida 
48. 09/14/2000  University of Texas Medical Branch at Galveston 
49. 09/21/2000  University of Tennessee, Memphis 
50. 09/22/2000  Virginia Commonwealth University 
51. 09/26/2000  University of Texas Medical Branch at Galveston 
52. 09/28/2000  University of South Florida 
53. 08/02/2000  The University of Alabama at Birmingham 
54. 08/04/2000  Northeast Georgia Health Services 
55. 08/07/2000  Good Samaritan Regional Medical Center 
56. 08/07/2000  INOVA Institute of Research and Education, Fairfax Hospital 
57. 08/07/2000  Morehouse School of Medicine 
58. 08/07/2000  University of Cincinnati 
59. 08/11/2000  University of Wisconsin - Madison 
60. 08/23/2000  University of Pennsylvania 
61. 08/25/2000  The Cleveland Clinic Foundation 
62. 08/28/2000  The University of Alabama at Birmingham 
63. 08/28/2000  Memorial Health University Medical Center 
64. 08/28/2000  St. Francis Health System 
65. 08/28/2000  The Miriam Hospital 
66. 07/07/2000  University of Oklahoma Health Sciences Center 
67. 07/10/2000  University of Nebraska Medical Center 
68. 07/10/2000  University of Texas Medical Branch at Galveston 
69. 07/12/2000  University at Buffalo, State University of New York 
70. 07/13/2000  University of Oklahoma Health Sciences Center 
71. 07/13/2000  University of Illinois at Chicago 
72. 07/17/2000  State University of New York 
73. 07/18/2000  University of Illinois at Chicago 
74. 07/21/2000  Encino-Tarzana Regional Medical Center 
75. 07/27/2000  Yale University 
76. 07/28/2000  University of Miami 
77. 07/31/2000  University of Miami 
78. 07/31/2000  University at Buffalo, State University of New York 
79. 12/05/2001  Brooke Army Medical Center 
80. 12/11/2001  Thomas Jefferson University/Wills Eye Hospital 
81. 12/14/2001  John Hopkins University School of Medicine 
82. 12/14/2001  Memorial Medical Center, New Orleans 
83. 12/14/2001  University of Texas Health Science Center, Houston 
84. 12/20/2001  University of Cincinnati 
85. 12/21/2001  Columbia University 
86. 12/21/2001  Columbia University Health Sciences Division 
87. 11/16/2001  Brookhaven Science Associates, LLC 
88. 11/21/2001  Children's National Medical Center 
89. 11/26/2001  The Johns Hopkins University School of Medicine 
90. 11/29/2001  Virginia Mason Research Center 
91. 11/30/2001  Eastern Virginia Medical School 
92. 11/30/2001  Case Western Reserve University 
93. 10/03/2001  The Johns Hopkins University School of Medicine 
94. 10/03/2001  Suburban Hospital 
262 
 
 
95. 10/10/2001  Beth Israel Deaconess Medical Center 
96. 10/15/2001  The Johns Hopkins University School of Medicine and 
National Institute on Aging 
97. 10/15/2001  Thomas Jefferson University/Wills Eye Hospital 
98. 10/17/2001  Georgetown University 
99. 10/23/2001  St. Elizabeth's Medical Center of Boston 
100. 10/23/2001  The University of Texas Health Center - San Antonio 
101. 10/24/2001  Sturdy Memorial Hospital 
102. 10/24/2001  University of California - Los Angeles 
103. 10/24/2001  University of California - San Francisco 
104. 10/25/2001  National Institute on Drug Abuse (NIDA) 
105. 10/29/2001  Georgetown University 
106. 10/30/2001  Brown University 
107. 10/30/2001  State University of New York at Stony Brook 
108. 09/04/2001   Memorial Medical Center, New Orleans 
109. 09/21/2001   University of South Florida/Tampa General Healthcare 
110. 09/21/2001   Aaron Diamond AIDS Research Center 
111. 09/26/2001   University of Pennsylvania 
112. 08/01/2001   Thomas Jefferson University/Wills Eye Hospital 
113. 08/06/2001   Georgetown University 
114. 08/15/2001   Georgetown University 
115. 08/15/2001   National Institutes of Health 
116. 08/16/2001   University of Miami 
117. 08/17/2001   Michael Reese Hospital 
118. 08/17/2001   Rosewell Park Cancer Institute 
119. 08/17/2001   University of California, Irvine 
120. 08/17/2001   University of Michigan 
121. 08/17/2001   University of Washington 
122. 08/20/2001   University of Pennsylvania 
123. 08/21/2001   University of Iowa 
124. 08/21/2001   Okanagan Similkameen Health Region-Corporate 
125. 08/21/2001   South Georgia Medical Center 
126. 08/22/2001   St. Jude Children's Research Hospital 
127. 08/22/2001   National Institutes of Health 
128. 08/27/2001   University of California, San Francisco 
129. 08/28/2001   The University of Texas Health Science Center at San 
Antonio 
130. 08/29/2001   National Institutes of Health 
131. 08/29/2001   University of California, Davis 
132. 08/29/2001   Minnesota Department of Health 
133. 08/29/2001   State University of New York at Stony Brook 
134. 08/31/2001   Childrens Hospital Los Angeles 
135. 07/11/2001  University of Missouri - Columbia 
136. 07/12/2001  St. Elizabeth's Medical Center of Boston 
137. 07/12/2001  The University of Texas M.D. Anderson Cancer Center 
138. 07/13/2001  St. Judes Children's Research Hospital 
139. 07/19/2001  Johns Hopkins University School of Medicine/The Johns 
Hopkins Bayview Medical Center 
140. 07/20/2001  University of South Florida 
141. 07/22/2001  Johns Hopkins University School of Medicine/The Johns 
Hopkins Bayview Medical Center 
142. 06/01/2001  Florida Department of Children and Families 
143. 06/01/2001  Michael Reese Hospital 
144. 06/05/2001  Roswell Park Cancer Institute 
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145. 06/05/2001  Sturdy Memorial Hospital 
146. 06/06/2001  University of Pennsylvania 
147. 06/11/2001  Cleveland Clinic Foundation  
148. 06/11/2001  Scientific Analysis Corporation 
149. 06/11/2001  University of California, Irvine 
150. 06/11/2001  University of Michigan 
151. 06/14/2001  University of Arkansas for Medical Sciences & Arkansas 
Children's Hospital 
152. 05/03/2001  University of Colorado Health Sciences Center 
153. 05/07/2001  University of Pennsylvania 
154. 05/10/2001  University of Missouri-Columbia 
155. 05/29/2001  University of Colorado Health Sciences Center 
156. 05/31/2001  University of Texas M.D. Anderson Cancer Center 
157. 05/31/2001  Georgetoown University 
158. 04/13/2001  Mary Bridge Children's Hospital & Health Center 
159. 04/17/2001  University of Texas - Houston Health Science Center 
160. 04/19/2001  University of South Florida 
161. 04/20/2001  University of Washington 
162. 04/23/2001  Wills Eye Hospital - Thomas Jefferson University 
163. 04/30/2001  University of Cincinnati, Department of Veterans Affairs 
Medical Center and Shriners Burns Institute 
164. 04/30/2001  University of Cincinnati, Department of Veterans Affairs 
Medical Center and Shriners Burns Institute 
165. 04/30/2001  University of Cincinnati, Department of Veterans Affairs 
Medical Center and Shriners Burns Institute 
166. 04/30/2001  NIH Cancer Therapy Evaluation Program - Eastern 
Cooperative Oncology Group 
167. 03/26/2001  University of Southern California Health Sciences 
168. 03/27/2001  Indiana University 
169. 03/28/2001  Department of Veterans Affairs Medical Center, Philadelphia 
170. 03/28/2001  The University of Texas Southwestern Medical Center 
171. 03/29/2001  RAND 
172. 03/29/2001  Garden State Cancer Center 
173. 03/29/2001  St. Jude Children's Research Hospital 
174. 03/30/2001  St. Jude Children's Research Hospital 
175. 03/30/2001  University of Utah 
176. 03/30/2001  University of Illinois at Chicago 
177. 02/08/2001  Children's Hospital, Boston 
178. 02/12/2001  Louisiana State University Medical Center 
179. 02/15/2001  Baylor College of Medicine 
180. 02/15/2001  University of Cincinnati 
181. 02/15/2001  Department of Veterans Affairs Medical Center, Philadelphia 
182. 02/16/2001  Florida Dept. of Health/FDCF 
183. 02/22/2001  Yale University 
184. 02/28/2001  Raritan Bay Medical Center 
185. 02/28/2001  Brown University Graduate School 
186. 01/12/2001  Mary Bridge Children's Hospital & Health Center 
187. 01/17/2001  National Institutes of Health 
188. 01/17/2001  University of Texas Medical Branch at Galveston 
189. 01/19/2001  University of Miami 
190. 01/22/2001  The John Hopkins University School of Medicine 
191. 01/22/2001  McMaster University 
192. 01/22/2001  University of Pennsylvania 
193. 01/22/2001  National Institutes of Health 
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194. 01/23/2001  The University of Texas Southwestern Medical Center 
195. 01/23/2001  National Institutes of Health 
196. 01/24/2001  Garden State Cancer Center 
197. 01/24/2001  National Institutes of Health 
198. 01/25/2001  University of South Florida 
199. 01/25/2001  Cook Children's Medical Center 
200. 01/25/2001  St. Francis Health System 
201. 01/26/2001  University of South Florida 
202. 01/31/2001  Morehouse School of Medicine 
203. 01/31/2001  St. Luke's Medical Center 
204. 01/31/2001  The University of Memphis 
205. 12/03/2002 Columbia University Health Sciences 
206. 12/03/2002 Lawrence Berkeley National Laboratory/University of 
California, Berkeley 
207. 12/03/2002 National Institutes of Health 
208. 12/04/2002 Ohio State University 
209. 12/04/2002 University of Miami 
210. 12/10/2002 Oregon Health & Science University 
211. 12/20/2002 Lankenau Medical Research Center 
212. 12/27/2002 Wake Forest University School of Medicine 
213. 11/13/2002 Johns Hopkins University 
214. 11/14/2002 Lankenau Medical Research Center 
215. 11/14/2002 Loma Linda University 
216. 11/21/2002 New York City Department of Health and Mental Hygiene 
217. 11/21/2002 New York Hospital Medical Center of Queens 
218. 11/21/2002 University of Cincinnati 
219. 11/27/2002 University of Michigan, Ann Arbor 
220. 10/04/2002 Oregon Health & Science University 
221. 10/07/2002 Vanderbilt University 
222. 10/10/2002 New York City Department of Health and Mental Hygiene 
223. 10/24/2002 Oregon Health & Science University 
224. 10/28/2002 Uganda National Council of Science and Technology 
225. 10/28/2002 University of Louisville 
226. 10/30/2002 National Institutes of Health 
227. 09/04/2002 Beth Israel Deaconess Medical Center 
228. 09/04/2002 University of Florida 
229. 09/05/2002 Loyola University Chicago 
230. 09/16/2002 University of Michigan 
231. 09/24/2002 University of Louisville 
232. 08/05/2002 University of Hawaii 
233. 08/05/2002 University of Miami 
234. 08/19/2002 Johns Hopkins University School of Medicine/Kennedy 
Krieger Institute 
235. 08/19/2002 University of Chicago 
236. 08/19/2002 University of Utah 
237. 08/20/2002 Hawaii State Department of Health 
238. 08/23/2002 Johns Hopkins University School of Medicine 
239. 08/26/2002 University of Michigan 
240. 07/01/2002 Boston University Medical Center 
241. 07/01/2002 New York City Department of Health 
242. 07/11/2002 Walter Reed Army Medical Center 
243. 07/16/2002 National Institutes of Health 
244. 07/16/2002 Uganda National Council of Science and Technology 
245. 07/17/2002 Johns Hopkins University School of Medicine 
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246. 07/24/2002 Beijing Medical University 
247. 07/24/2002 Brigham & Women's Hospital 
248. 07/24/2002 Harvard School of Public Health 
249. 07/24/2002 Massachusetts Mental Health Center/Massachusetts 
Mental Health Research Corporation 
250. 07/24/2002 Shanghai No. 1 Textile Hospital 
251. 07/24/2002 Sun Yat-sen University of Medical Sciences 
252. 07/24/2002 Yunnan Institute for Drug Abuse 
253. 07/29/2002 Lankenau Hospital 
254. 07/29/2002 St. Louis University 
255. 07/31/2002 Duke University Health System, Inc. 
256. 07/31/2002 University of Washington 
257. 06/10/2002 Thomas Jefferson University 
258. 06/10/2002 University of Pennsylvania 
259. 06/18/2002 Johns Hopkins University 
260. 06/18/2002 New York University School of Medicine 
261. 06/26/2002 Vanderbilt University/Nashville Veterans Affairs Medical 
Center 
262. 06/27/2002 Columbia University, Health Sciences 
263. 05/07/2002 Mount Sinai School of Medicine 
264. 05/08/2002 New York University School of Medicine 
265. 05/09/2002 Columbia University College of Physicians and 
Surgeons/New York-Presbyterian Hospital 
266. 05/09/2002 Beth Israel Deaconess Medical Center 
267. 05/13/2002 Children's Hospital of Pittsburgh 
268. 05/13/2002 Ochsner Clinical Foundation 
269. 05/16/2002 Parker Hughes Institute 
270. 05/23/2002 University of California, San Francisco 
271. 05/31/2002 Johns Hopkins University School of Medicine 
272. 05/31/2002 State University of New York Downstate Medical Center 
273. 05/31/2002 Winifred Masterson Burke Medical Research Institute 
274. 04/02/2002 Indiana University 
275. 04/02/2002 Mayo Foundation 
276. 04/02/2002 Memorial Hospital of Rhode Island 
277. 04/02/2002 University of Kansas Medical Center 
278. 04/03/2002 LDS Hospital 
279. 04/03/2002 Massachusetts General Hospital 
280. 04/03/2002 Rush-Presbyterian-St. Luke's Medical Center 
281. 04/03/2002 Washington University School of Medicine 
282. 04/03/2002 University of Colorado Health Sciences Center 
283. 04/03/2002 University of Minnesota 
284. 04/04/2002 Baylor College of Medicine 
285. 04/04/2002 Cornell University Medical Center 
286. 04/04/2002 University of Texas Southwestern Medical Center 
287. 04/10/2002 Boston University Medical Center 
288. 04/11/2002 Cleveland Clinic Foundation 
289. 04/11/2002 University of California, San Francisco 
290. 04/12/2002 State University of New York at Stony Brook 
291. 04/17/2002 State University of New York Health Sciences Center at 
Brooklyn/Downstate Medical Center 
292. 04/17/2002 Walter Reed Army Medical Center 
293. 04/23/2002 Case Western Reserve University 
294. 04/23/2002 University of Chicago 
295. 04/25/2002 University of California, Davis 
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296. 04/29/2002 Johns Hopkins University, School of Medicine 
297. 04/29/2002 University of California, Irvine 
298. 04/29/2002 University of California, San Diego 
299. 04/29/2002 University of Michigan Ann Arbor 
300. 04/30/2002 Beth Israel Deaconess Medical Center 
301. 04/30/2002 Cleveland Clinic Foundation 
302. 04/30/2002 McLean Hospital 
303. 04/30/2002 University of Pennsylvania 
304. 03/12/2002 National Institutes of Health 
305. 03/18/2002 Suburban Hospital 
306. 03/19/2002 University of California, Los Angeles 
307. 03/21/2002 Duke University Health System, Inc. 
308. 03/25/2002 Emory University 
309. 03/25/2002 Southern Illinois University 
310. 03/25/2002 University of Kentucky 
311. 03/25/2002 University of Maryland, Baltimore 
312. 03/25/2002 University of Pittsburgh 
313. 03/25/2002 University of South Florida 
314. 03/25/2002 Walter Reed Army Medical Center 
315. 03/25/2002 Yale University 
316. 03/26/2002 Case Western Reserve University 
317. 03/27/2002 University of California, San Diego 
318. 03/28/2002 Brigham and Women's Hospital 
319. 03/28/2002 Harvard School of Public Health 
320. 03/28/2002 Massachusetts Mental Health Center 
321. 02/01/2002 Duke University Health System, Inc. 
322. 02/02/2002 Brookhaven Science Associates, LLC 
323. 02/04/2002 John Hopkins University School of Medicine 
324. 02/04/2002 LDS Hospital 
325. 02/04/2002 University of Maryland, Baltimore 
326. 02/04/2002 University of Washington 
327. 02/04/2002 Vanderbilt University/Nashville Veterans Affairs Medical 
Center 
328. 02/05/2002 University of Cincinnati 
329. 02/05/2002 Yale University 
330. 02/07/2002 Cleveland Clinic Foundation 
331. 02/08/2002 University of California, San Francisco 
332. 02/11/2002 University of California, San Diego 
333. 02/11/2002 University of Michigan, Ann Arbor 
334. 02/26/2002 University of Arkansas for Medical Sciences 
335. 02/27/2002 National Institutes of Health 
336. 01/07/2002 Beth Israel Deaconess Medical Center 
337. 01/07/2002 University of Colorado Health Sciences Center 
338. 01/08/2002 University of California, San Diego 
339. 01/10/2002 Baylor College of Medicine 
340. 01/11/2002 Thomas Jefferson University 
341. 01/14/2002 North Shore University Hospital 
342. 01/18/2002 Duke University Health System, Inc. 
343. 01/18/2002 John Hopkins University School of Medicine/Kennedy 
Krieger Institute 
344. 01/22/2002 Beth Israel Deaconess Medical Center 
345. 01/24/2002 John Hopkins University School of Medicine 
346. 01/29/2002 Children's National Medical Center 
347. 01/29/2002 Massachusetts General Hospital 
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348. 01/30/2002 Thomas Jefferson University 
349. 01/30/2002 University of Pennsylvania 
350. 01/31/2002 University of Colorado Health Sciences Center 
351. 12/01/2003 Columbia University Health Sciences 
352. 11/03/2003 Baystate Medical Center 
353. 11/03/2003 University of Maryland at Baltimore/Baltimore Veterans 
Affairs Medical Center 
354. 11/05/2003 Center for Molecular Medicine and Immunology 
355. 11/05/2003 Moses Cone Health System 
356. 11/10/2003 Duke University Health System 
357. 11/10/2003 Wake Forest University School of Medicine 
358. 11/17/2003 Louisiana State University Health Sciences Center 
359. 11/17/2003 Thomas Jefferson University 
360. 11/17/2003 University of Virginia 
361. 11/17/2003 Vanderbilt University 
362. 11/19/2003 University of California, San Francisco 
363. 10/01/2003 Ochsner Clinic Foundation 
364. 10/06/2003 Boston University Medical Center 
365. 10/06/2003 National Institutes of Health 
366. 10/06/2003 University of South Florida 
367. 10/20/2003 Cleveland Clinic Foundation 
368. 10/20/2003 University of Maryland 
369. 10/21/2003 The Cleveland Clinic Foundation 
370. 10/23/2003 Johns Hopkins University School of Medicine 
371. 10/30/2003 Parma Community General Hospital 
372. 09/03/2003 University of Rochester 
373. 09/05/2003 Parma Community General Hospital 
374. 09/15/2003 University of Michigan 
375. 09/29/2003 Ohio State University 
376. 8/07/2003 University of South Florida 
377. 8/21/2003 National Institutes of Health 
378. 8/28/2003 Garden State Cancer Center 
379. 07/01/2003 University of Florida 
380. 07/01/2003 University of Maryland 
381. 07/02/2003 University of Texas - Austin 
382. 07/03/2003 ARDS Network 
383. 07/15/2003 The University of Alabama at Birmingham 
384. 07/25/2003 Baystate Medical Center 
385. 07/25/2003 Case Western Reserve University 
386. 07/25/2003 The Cleveland Clinic Foundation 
387. 07/25/2003 Department of Veterans Affairs - New Orleans 
388. 07/25/2003 Duke University Health System, Inc 
389. 07/25/2003 Harris County Hospital District 
390. 07/25/2003 Intermountain Health Care - McKay-Dee Hospital Center 
391. 07/25/2003 Intermountain Health Care - Utah Valley Regional Medical 
Center 
392. 07/25/2003 Johns Hopkins University School of Medicine 
393. 07/25/2003 LDS Hospital 
394. 07/25/2003 Louisiana State University Health Sciences Center 
395. 07/25/2003 Moses Cone Health System 
396. 07/25/2003 Northwestern University 
397. 07/25/2003 Ochsner Clinic Foundation 
398. 07/25/2003 St. Anthony Central Hospital 
399. 07/25/2003 Thomas Jefferson University 
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400. 07/25/2003 Tulane University Hospital 
401. 07/25/2003 The University of British Columbia 
402. 07/25/2003 University of California, San Francisco 
403. 07/25/2003 The University of Chicago 
404. 07/25/2003 University of Colorado Health Sciences Center 
405. 07/25/2003 University of Maryland at Baltimore 
406. 07/25/2003 University of Michigan 
407. 07/25/2003 University of Pennsylvania 
408. 07/25/2003 University of Pittsburgh 
409. 07/25/2003 University of Texas Health Science Center at San Antonio 
410. 07/25/2003 University of Virginia 
411. 07/25/2003 University of Washington 
412. 07/25/2003 Vanderbilt University 
413. 07/25/2003 Veterans Affairs Medical Center - Denver 
414. 07/25/2003 Wake Forest University School of Medicine 
415. 06/02/2003 University of Arizona 
416. 06/04/2003 University of Texas - Austin 
417. 05/02/2003 Harvard School of Public Health 
418. 05/13/2003 Columbia University Health Sciences 
419. 05/15/2003 National Institutes of Health 
420. 05/30/2003 City of Hope National Medical Center 
421. 04/02/2003 Beth Israel Deaconess Medical Center 
422. 04/08/2003 Virginia Commonwealth University 
423. 04/17/2003 Oregon Health & Science University 
424. 04/21/2003 University of Cincinnati Medical Center 
425. 04/29/2003 Saint Joseph‘s University 
426. 03/17/2003 National Institutes of Health 
427. 03/21/2003 University of Washington 
428. 03/24/2003 Duke University Health Systems, Inc. 
429. 03/24/2003 Mary Imogene Bassett Hospital 
430. 03/24/2003 Uganda National Council of Science & Technology 
431. 03/26/2003 New York University School of Medicine 
432. 02/06/2003 University of California San Francisco 
433. 02/12/2003 Mount Sinai School of Medicine 
434. 02/12/2003 University of Colorado Health Sciences Center 
435. 02/12/2003 University of Michigan 
436. 02/13/2003 The Children‘s Hospital of Philadelphia 
437. 02/22/2003 University of California - Los Angeles 
438. 02/25/2003 Saint Joseph‘s University 
439. 01/07/2003 Washington University School of Medicine 
440. 01/13/2003 University of California, San Francisco 
441. 01/23/2003 Loma Linda University 
442. 01/29/2003 Saint Louis University Health Sciences Center 
443. 12/02/2004 Colorado Cancer Research Program, Inc. 
444. 12/06/2004 Evanston Northwestern Healthcare 
445. 12/06/2004 St. John's Health System 
446. 12/07/2004 M. D. Anderson Cancer Center 
447. 12/15/2004 University of Colorado Health Sciences Center 
448. 12/22/2004 Baptist Hospital of Miami, Inc. 
449. 11/03/2004 City of Hope National Medical Center and Beckman 
Research Institute 
450. 11/03/2004 University of Maryland Baltimore Professional Schools 
451. 11/04/2004 Baptist Hospital of Miami 
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452. 11/05/2004 University of Southern California - Health Science/Charles 
R. Drew University 
453. 11/22/2004 University of Arizona 
454. 10/13/2004 Florida Department of Health 
455. 10/15/2004 National Institutes of Health 
456. 10/15/2004 Virginia Commonwealth University 
457. 09/09/2004 Columbia University Health Sciences 
458. 09/16/2004 Scott & White Memorial Hospital 
459. 08/02/2004 Columbia University Health Sciences 
460. 08/03/2004 Association of American Medical Colleges 
461. 08/03/2004 Finch University Health Sciences/Chicago Medical School 
462. 08/03/2004 George Washington University 
463. 08/03/2004 University of California, Los Angeles 
464. 08/03/2004 University of Massachusetts Medical School 
465. 08/03/2004 University of Medicine & Dentistry of New Jersey - Newark 
Campus/New Brunswick Campus 
466. 08/03/2004 University of Miami 
467. 08/12/2004 Community Hospital of the Monterey Peninsula 
468. 08/19/2004 Tufts-New England Medical Center 
469. 08/20/2004 Virginia Commonwealth University 
470. 08/23/2004 City of Hope National Medical Center 
471. 08/26/2004 AIDS Research Alliance-Chicago/Saint Joseph Hospital 
472. 08/31/2004 Florida Department of Health 
473. 07/01/2004 Fred Hutchinson Cancer Research Center 
474. 07/06/2004 Evanston Northwestern Healthcare Research Institute 
475. 07/06/2004 Medical University of South Carolina 
476. 07/06/2004 Ohio State University 
477. 07/08/2004 Tufts-New England Medical Center 
478. 07/21/2004 Joan and Sanford I. Weill College of Medicine of Cornell 
University 
479. 07/22/2004 Texas Tech University Health Sciences Center 
480. 06/29/2004 Johns Hopkins University School of Medicine 
481. 06/29/2004 M. D. Anderson Cancer Center 
482. 06/29/2004 University of Michigan 
483. 05/03/2004 University of Pittsburgh/Carnegie Mellon University 
484. 05/10/2004 University of Colorado Health Sciences Center 
485. 05/24/2004 Joan and Sanford I. Weill College of Medicine of Cornell 
University 
486. 05/26/2004 Harvard Medical School 
487. 05/28/2004 Oregon Health & Science University 
488. 04/05/2004 AIDS Research Alliance-Chicago 
489. 04/05/2004 University of Cincinnati 
490. 04/15/2004 Intermountain Health Care/McKay-Dee Hospital Center 
491. 04/15/2004 Thomas Jefferson University 
492. 04/15/2004 University of Alabama - Birmingham 
493. 04/16/2004 Northwestern University 
494. 04/20/2004 Evanston Northwestern Healthcare Research Institute 
495. 04/21/2004 Medical University of South Carolina 
496. 04/23/2004 Baptist Hospital of Miami 
497. 03/10/2004 University of Alabama, Birmingham 
498. 03/26/2004 Harvard Medical School 
499. 02/13/2004 Denver Veterans Affairs Medical Center 
500. 02/13/2004 University of Texas Health Science Center at San Antonio 
501. 02/26/2004 University of California, San Francisco 
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502. 01/06/2004 Harris County Hospital District 
503. 01/06/2004 University of California, San Francisco 
504. 01/06/2004 University of Colorado Health Sciences Center 
505. 01/06/2004 University of Michigan 
506. 01/06/2004 University of Pennsylvania 
507. 01/07/2004 Children's Hospital and Regional Medical Center 
508. 01/12/2004 Ohio State University 
509. 01/15/2004 Oregon Health & Sciences University 
510. 01/20/2004 Johns Hopkins University School of Medicine 
511. 01/20/2004 University of Chicago 
512. 01/20/2004 University of Pittsburgh 
513. 01/21/2004 University of Pittsburgh 
514. 01/28/2004 Tulane University Hospital 
515. 01/30/2004 University of Washington 
516. December 13, 2005 Mid-Delta Family Practice Clinic 
517. November 22, 2005 Gothenburg University 
518. October 3, 2005 Gothenburg University 
519. October 19, 2005 National Institutes of Health 
520. October 20, 2005 University of South Florida/ All Children‘s Health 
System 
521. October 24, 2005 University of Washington 
522. October 27, 2005 Drexel University College of Medicine 
523. October 31, 2005 Gothenburg University 
524. October 31, 2005 Louisiana State University Health Science Center 
Shreveport 
525. September 9, 2005 University of Washington 
526. August 5, 2005 University of Miami 
527. August 18, 2005 University of Illinois at Urbana-Champaign 
528. August 18, 2005 University of Minnesota 
529. August 25, 2005 National Institutes of Health 
530. August 26, 2005 University of South Florida 
531. August 30, 2005 Northwestern University 
532. July 19, 2005 St. Joseph‘s Hospital Atlanta 
533. July 28, 2005 Oregon Health and Science University 
534. June 29, 2005 Northwestern University 
535. May 2, 2005 University of Maryland Baltimore Professional Schools 
536. May 19, 2005 St. Joseph‘s Hospital Atlanta, Inc. 
537. May 23, 2005 Columbia University Medical Center / New York 
Presbyterian Hospital 
538. April 1, 2005 University of Washington 
539. April 15, 2005 Joan and Sanford I. Weill College of Medicine of Cornell 
University 
540. April 27, 2005 University of Colorado Health Sciences Center 
541. April 28, 2005 National Jewish Medical and Research Center 
542. April 29, 2005 National Institutes of Health 
543. March 1, 2005 University of Colorado Health Sciences Center 
544. March 7, 2005 National Institutes of Health 
545. March 8, 2005 University Hospitals of Cleveland 
546. March 14, 2005 University of Illinois at Urbana-Champaign 
547. March 30, 2005 National Institutes of Health 
548. February 24, 2005 University of Maryland Baltimore Professional 
Schools 
549. February 25, 2005 St. John's Health System 
550. February 28, 2005 National Jewish Medical and Research Center 
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551. January 5, 2005 Saint Joseph Hospital 
552. January 6, 2005 Joan and Sanford I. Weill College of Medicine of Cornell 
University 
553. January 7, 2005 University Hospitals of Cleveland 
554. January 10, 2005 National Institutes of Health 
555. December 7, 2006 Medical College of Wisconsin 
556. December 13, 2006 New England Research Institute 
557. December 13, 2006 University of Washington 
558. December 20, 2006 University of Illinois at Urbana-Champaign 
559. December 21, 2006 Children's Hospital Oakland 
560. December 22, 2006 Anne Arundel Medical Center 
561. November 8, 2006 Lenox Hill Hospital 
562. November 17, 2006 San Antonio Metropolitan Health District 
563. November 22, 2006 Women & Infants Hospital of Rhode Island 
564. October 11, 2006 University of Utah 
565. October 12, 2006 University of Illinois at Urbana-Champaign 
566. October 19, 2006 Main Line Health Systems 
567. October 24, 2006 Scripps Health 
568. October 25, 2006 Illinois Institute of Technology 
569. September 6, 2006 Illinois Institute of Technology 
570. September 25, 2006 Women & Infants Hospital of Rhode Island 
571. August 15, 2006 Children‘s Hospital of Philadelphia 
572. August 16, 2006 University of Miami 
573. August 21, 2006 Main Line Health Systems 
574. August 24, 2006 Scripps Health 
575. August 28, 2006 Cook County Bureau of Health Services 
576. August 28, 2006 Drexel University College of Medicine 
577. August 29, 2006 New England Research Institutes, Inc. 
578. August 29, 2006 University of Washington 
579. July 6, 2006 University of Colorado at Boulder 
580. July 21, 2006 Custom Kynetics/Cardinal Hill Rehab 
581. July 21, 2006 San Juan City Hospital 
582. June 15, 2006 Eastern Virginia Medical School 
583. June 19, 2006 Bronx-Lebanon Hospital Center 
584. June 19, 2006 Universidad Central del Caribe 
585. June 19, 2006 Children's Hospital of the King's Daughters 
586. June 19, 2006 Children's Hospital and Research Center at Oakland 
587. June 19, 2006 University of Medicine and Dentistry of New Jersey 
588. June 19, 2006 Bellevue Hospital Center 
589. June 19, 2006 Children's Hospital and Regional Medical Center 
590. June 19, 2006 SUNY Upstate Medical University 
591. June 19, 2006 Drexel University College of Medicine 
592. June 19, 2006 Cook County Bureau of Health Services 
593. June 19, 2006 Children's Hospital of Philadelphia 
594. June 19, 2006 Duke University School of Medicine 
595. June 19, 2006 University of Miami 
596. June 19, 2006 University of Chicago 
597. June 19, 2006 Children's Hospital of Orange County 
598. June 19, 2006 Children's Memorial Hospital 
599. June 19, 2006 San Juan City Hospital 
600. June 19, 2006 University of California, San Francisco 
601. June 21, 2006 University of Miami 
602. June 26, 2006 University of Maryland Baltimore School of Medicine 
603. June 27, 2006 Scripps Health 
272 
 
 
604. June 28, 2006 University of Tennessee Health Science Center 
605. May 5, 2006 Research Foundation for Mental Hygiene, Inc 
606. May 17, 2006 The University of Tennessee Health Science Center 
607. May 23, 2006 University of California, Los Angeles 
608. April 10, 2006 Scripps Health 
609. April 11, 2006 Research Foundation for Mental Hygiene, Inc. 
610. April 11, 2006 University of Colorado at Boulder 
611. April 12, 2006 Delta Health Center 
612. April 26, 2006 Philadelphia Health and Education Corporation (Drexel 
University College of Medicine) 
613. March 3, 2006 State University of New York at Stony Brook 
614. March 27, 2006 University of Houston 
615. February 14, 2006 Delta Health Center 
616. February 14, 2006 Mid-Delta Family Practice Clinic 
617. February 14, 2006 University of California, Los Angeles 
618. February 17, 2006 Bellevue Hospital Center 
619. February 17, 2006 Bronx-Lebanon Hospital Center 
620. February 17, 2006 Children‘s Hospital - Denver 
621. February 17, 2006 Children's Hospital - Oakland 
622. February 17, 2006 Children's Hospital - Philadelphia 
623. February 17, 2006 Children's Hospital & Regional Medical Center 
624. February 17, 2006 Columbia University Medical Center/New York 
Presbyterian Hospital 
625. February 17, 2006 Cook County Bureau of Health Services 
626. February 17, 2006 H. Lee Moffitt Cancer Center and Research Institute 
627. February 17, 2006 Harbor-UCLA Medical Center 
628. February 17, 2006 Johns Hopkins Health System 
629. February 17, 2006 North Shore-Long Island Jewish Health System 
630. February 17, 2006 SUNY Stony Brook 
631. February 17, 2006 SUNY Upstate Medical University 
632. February 17, 2006 University of Chicago 
633. February 17, 2006 University of Maryland Baltimore Professional 
Schools 
634. February 17, 2006 University of Medicine and Dentistry New Jersey/New 
Brunswick 
635. February 17, 2006 University of Miami 
636. February 24, 2006 Philadelphia Health and Education Corporation 
(Drexel University College of Medicine) 
637. February 27, 2006 Gothenburg University 
638. January 25, 2006 Louisiana State University Health Science Center 
Shreveport 
639. January 25, 2006December 17, 2007 The J. David Gladstone Institutes/ 
University of California, San Francisco/San Francisco General Hospital Medical 
Center 
640. January 26, 2006 University of Tennessee Health Science Center 
641. December 17, 2007 University of Connecticut Health Center 
642. December 18, 2007 Interior Health Authority 
643. December 19, 2007 University of Arizona 
644. December 19, 2007 Carondelet Health Network 
645. December 20, 2007 New York University School of Medicine 
646. November 1, 2007 New Mexico State University 
647. November 6, 2007 Michigan Health & Hospital Association 
648. November 6, 2007 John Hopkins University School of Medicine/ Johns 
Hopkins Bloomberg School of Public Health/ Johns Hopkins University 
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649. November 28, 2007 Saint John's Health System 
650. October 15, 2007 Bridge Back Recovery Homes, Inc. 
651. September 14, 2007 Saint John's Health System 
652. September 14, 2007 University of Miami 
653. September 17, 2007 Bluefield State College 
654. September 24, 2007 Hawaii State Department of Health/ University of 
Hawaii 
655. August 9, 2007 University of Connecticut Health Center 
656. August 27, 2007 New Mexico State University 
657. July 9, 2007 Bluefield State College 
658. July 18, 2007 University of Miami 
659. July 19, 2007 Johns Hopkins 
660. July 24, 2007 Arizona State University 
661. June 22, 2007 University of Arizona 
662. June 25, 2007 Hawaii State Department of Health/ University of Hawaii 
663. June 29, 2007 University of California at Berkeley 
664. May 2, 2007 University of Florida/ Malcom Randall VA Medical Center 
665. May 15, 2007 Arizona State University 
666. May 16, 2007 University of Texas Health Science Center at Houston 
667. May 30, 2007 University of Florida 
668. April 10, 2007 University of Miami 
669. April 23, 2007 University of Washington 
670. March 7, 2007 New Mexico State University 
671. March 20, 2007 Bluefield State College 
672. February 5, 2007 Anne Arundel Medical Center 
673. February 6, 2007 Washington University School of Medicine 
674. February 13, 2007 HCA-HEALTHONE LLC 
675. January 3, 2007 University of Utah 
676. January 4, 2007 Cleveland Clinic Foundation/Case Western Reserve 
University 
677.  University of Houston 
678. December 1, 2008 YRG CARE India 
679. December 4, 2008 Mayo Clinic 
680. December 16, 2008 University of KwaZulu-Natal 
681. December 30, 2008 University of Puerto Rico 
682. November 24, 2008 Haverford College 
683. October 3, 2008 George Washington University 
684. September 15, 2008 YR Gaitonde Center for AIDS Research and 
Education 
685. September 15, 2008 Haverford College 
686. September 26, 2008 Interior Health Authority 
687. August 1, 2008 University of Washington 
688. August 13, 2008 University of KwaZulu-Natal 
689. August 21, 2008 Cook County Bureau of Health Services/ Rush 
University Medical Center 
690. July 3, 2008 The J. David Gladstone Institutes/ University of California, 
San Francisco 
691. July 17, 2008 Lehigh Valley Hospital & Health Network 
692. July 23, 2008 Mayo Clinic 
693. June 2, 2008 Columbia University Health Sciences 
694. May 1, 2008 Lehigh Valley Hospital & Health Network 
695. May 2, 2008 University of Arizona 
696. May 6, 2008 George Washington University 
697. May 13, 2008 Carondelet Health Network 
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698. May 19, 2008 The J. David Gladstone Institutes/ University of California, 
San Francisco 
699. April 21, 2008 University of California at Berkley 
700. April 28, 2008 University of Connecticut Health Center 
701. April 28, 2008 Saint John's Health System 
702. March 3, 2008 University of Connecticut Health Center 
703. March 5, 2008 New York University 
704. February 11, 2008 Charles R. Drew University of Medicine & Science 
705. February 14, 2008 John Hopkins University School of Medicine /Johns 
Hopkins Bloomberg School of Public Health /Johns Hopkins University 
706. February 14, 2008 Michigan Health & Hospital Association 
707. February 21, 2008 Bluefield State College 
708. February 25, 2008 Columbia University Medical Center 
709. February 25, 2008 Gothenburg University 
710. February 27, 2008 University of Washington 
711. January 2, 2008 Mount Sinai School of Medicine 
712. December 8, 2009 - Northern Arizona University 
713. December 16, 2009 - Carle Clinic Association/ Carle Foundation Hospital 
714. November 9, 2009 - University of California, San Francisco 
715. November 9, 2009 - Children's Hospital of Philadelphia 
716. November 9, 2009 - Cincinnati Children's Hospital Medical Center 
717. October 30, 2009 - Mt. Sinai Medical Center 
718. September 2, 2009 - The University of Iowa 
719. September 16, 2009 - Northern Arizona University 
720. September 21, 2009 - Carle Clinic Association/ Carle Foundation 
Hospital 
721. July 31, 2009 Howard University 
722. June 4, 2009 Weizmann Institute of Science 
723. June 5, 2009 Board of Regents of the University of Oklahoma Health 
Sciences Center 
724. June 9, 2009 Carle Clinic Association / Carle Foundation Hospital 
725. May 26, 2009 Scottsdale Healthcare 
726. May 27, 2009 Mount Sinai Medical Center/ Duke University Health 
System, Inc./ University of Miami 
727. April 15, 2009 University of Washington 
728. April 15, 2009 Northern Virginia Pelvic Surgery 
729. April 29, 2009 Duke University Health System, Inc. 
730. April 30, 2009 Weizmann Institute of Science 
731. March 2, 2009 Board of Regents of the University of Oklahoma Health 
Sciences Center 
732. March 17, 2009 Children's Hospital of Philadelphia 
733. March 17, 2009 University of California, San Francisco 
734. March 17, 2009 Cincinnati Children's Hospital Medical Center 
735. March 19, 2009 Cook County Bureau of Health 
736. March 25, 2009 Native American Cancer Research/ University of 
Colorado Denver 
737. March 30, 2009 Children's Hospital Oakland Research Institute 
738. March 30, 2009 Scottsdale Healthcare 
739. February 3, 2009 University of KwaZulu-Natal 
740. February 11, 2009 Indiana University 
741. February 17, 2009 Duke University Health System, Inc. 
742. February 19, 2009 Children's Hospital Oakland Research Institute 
743. February 19, 2009 Northern Virginia Pelvic Surgery Associate 
744. February 25, 2009 Rush University Medical Center 
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745. January 29, 2009 Mayo Clinic 
746. November 24, 2010 Drexel University/Philadelphia Health & Education 
Corp. 
747. October 4, 2010 University of California, Berkeley 
748. October 26, 2010 Drexel University/Philadelphia Health & Education 
Corp. 
749. September 2, 2010 Weill Cornell Medical Center and Mount Sinai 
School of Medicine 
750. September 6, 2010 Massachusetts General Hospital 
751. June 3, 2010 Board of Regents of the University of Oklahoma Health 
Sciences Center 
752. May 10, 2010 North Shore-Long Island Jewish Health System 
753. April 8, 2010 University at Buffalo - State University of New York 
754. April 8, 2010 University of California, San Francisco 
755. April 16, 2010 University of British Columbia 
756. April 30, 2010 Howard University 
757. March 29, 2010 University of California, San Francisco 
758. March 29, 2010 Intermountain Health Care 
759. February 25, 2010 Research Triangle Institute International/ University 
of Rochester 
760. February 25, 2010 University at Buffalo - State University of New York 
761. January 11, 2010 East Carolina University 
762. January 28, 2010 Intermountain Health Care 
763. January 29, 2010 Howard University 
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Appendix Q  
Determination Letter 
 DEPARTMENT OF HEALTH & HUMAN SERVICES    
        Office of the Secretary 
                   Office of Public Health and Science 
 ___________________________________________________________________________ 
Office for Human Research Protections  
The Tower Building 
 1101 Wootton Parkway, Suite 200 
 Rockville, Maryland 20852 
 Telephone: 240 453-8297  
FAX: 240 453-6909  
March 27, 2006  
Arthur C. Vailas, Ph.D.  
Vice President for Research   
University of Houston  
4800 Calhoun 316 East Cullen  
Houston, TX 77204-2015  
  
RE: Human Research Subject Protections Under Federalwide Assurance FWA-5994  
(1) Research Project: Investigation of Variables Involved in the Behavioral Treatment of  
Children with Autism  
Project Number: 03-097  
Principal Investigator: Gerald Harris, Ph.D.  
(2) TYAP  Project: Acquisition of ABA Treatment Skills: In-Vivo vs. Video Modeling  
(3) Research Project: Generalization of Parent Training: A Comparison Study  
 Principal Investigator: Gerald Harris, Ph.D.  
(4) Research Project: Training and Generalizing Interaction Skills with Siblings of Children 
 with Autism  
 Principal Investigator: Gerald Harris, Ph.D.  
(5) Research Project: The Relationship of Parental Stress to Autism Treatment Type and 
Duration Principal Investigator: Gerald Harris, Ph.D.  
 
Dear Dr. Vailas:  
The Office of Human Research Protections has reviewed the University of Houston‘s 
(UH) March 2, 2006 and January 27, 2005 reports regarding the above referenced 
research and OHRP‘s inquiry regarding allegations of noncompliance with Department 
of Health and Human Services (HHS) regulations for the protection of human research 
subjects involving the above-referenced research.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
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(1) In its January 25, 2006 letter, OHRP made the following determination:   
HHS regulations at 45 CFR 46.103(a), 46.103(b)(4)(ii) and 46.103(b)(5) require that 
institutions have written institutional review board (IRB) procedures that adequately 
describe IRB operations with respect to:  
(a) determining which projects require review more often than annually and which need 
verification from sources other than the investigators that no material changes have occurred 
since previous IRB review, and  
(b) ensuring prompt reporting to the IRB, appropriate institutional officials, any Department or 
Agency head, and OHRP of (a) any unanticipated problems involving risks to subjects or others; 
(b) any serious or continuing noncompliance with 45 CFR Part 46 or the requirements or 
determinations of the IRB; and (c) any suspension or termination of IRB approval.  
 
OHRP found that the UH IRB Policies and Procedures supplied to OHRP do not contain 
specific procedures for how the IRB conducts these activities.  
Corrective Action: OHRP acknowledges that UH‘s IRB Policies and Procedures have 
now been revised to describe IRB operations adequately with respect to the above 
requirements under HHS regulations at 45 CFR 46.103(a), 46.103(b)(4)(ii), and 
46.103(b)(5).  
OHRP makes the following additional findings about the above-referenced research and 
projects:  
(2) HHS regulations at 45 CFR 46.109(a) require institutional review boards (IRBs) to review and 
have authority to approve, require modifications in (to secure approval), or disapprove all 
research activities covered by the HHS regulations. With respect to allegations that research was 
conducted without IRB review and approval and without legally effective informed consent, OHRP 
finds that this allegation cannot be substantiated. OHRP acknowledges UH‘s statements that (a) 
the IRB-approved study # 03-097 titled ―Investigation of Variables Involved in the Behavioral 
Treatment of Children with Autism‖ involves the collection of data from the clinical files of the 
investigator‘s private clients at the Texas Young Autism Project; (b) the second referenced project 
(hereinafter referred to as ―TYAP Project‖) is a presentation of activities conducted by TYAP and 
was not subject to UH IRB review or approval, and (c) the last three projects (two presentations 
and one poster) were not based on independent research, but utilized a subset of the research 
database created under the first, IRB-approved research project.  
(3) HHS regulations at 45 CFR 46.116 require investigators to obtain legally effective informed 
consent prior to the initiation of research. For research involving children, HHS regulations at 45 
CFR 46.408 require IRBs to determine that adequate provisions are made for soliciting the assent 
of children and the permission of each child‘s parents or  
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guardian. OHRP finds that when the UH IRB approved study #03-097, it reviewed and 
approved a parental permission form which contained all of the required elements of 
informed consent set forth under 45 CFR 46.116.  OHRP notes that there is no evidence in 
the IRB file to determine whether the UH IRB considered, as required by 45 CFR 
46.408(a), whether the child subjects involved in study #03-097 were capable of providing 
assent; however, OHRP acknowledges that UH IRB Policies and Procedures require 
assent from children capable of providing it, and describe appropriate criteria to include in 
assent forms.  
(4) HHS regulations at 45 CFR 46.111(a)(1)(i) state that, in order to approve research covered by 
the regulations, the IRB shall determine that risks to subjects are minimized by using procedures 
which are consistent with sound research design and which do not unnecessarily expose subjects 
to risk. OHRP questioned whether the UH IRB, in reviewing project #03-097, obtained sufficient 
information from the investigator regarding data recording technique and statistical method to 
determine that these regulatory requirements were satisfied.  
Corrective Action:  OHRP acknowledges that IRB project #03-097 involved only the collection of 
pre-existing data from TYAP files, and that the UH IRB identified the only significant risk of this 
research to be the possible loss of confidentiality. OHRP further acknowledges that UH modified 
its ―IRB Application To Conduct Research Using Human Subjects‖ form to request that 
investigators include a description of date recording techniques and/or statistical methods to be 
employed in the research.   
(5) HHS regulations at 45 CFR 46.110(c) require IRBs that use expedited review procedures to 
keep all IRB members advised of research proposals which have been approved via expedited 
review.  
 
OHRP finds that the UH IRB did not keep all IRB members advised of the approval of 
project # 03-097, as required by 45 CFR 46.110.  
Corrective Action: The UH IRB has modified its reporting procedures to ensure that the 
minutes for the expedited review subcommittee reflect subcommittee decisions 
regarding the research proposals it reviews under an expedited review procedure, and 
that these minutes are presented to the full IRB by one of the reviewing subcommittee 
members.    
(6) HHS regulations at 45 CFR 46.404-407 (subpart D) require specific findings on the part 
of the IRB for approval of research involving children.  OHRP expressed concern that the 
UH IRB file for project #03-097 provides no evidence that the IRB made the required 
Subpart D findings.  
Corrective Action: OHRP acknowledges UH‘s statement that, as a matter of policy and 
practice, the IRB reviews the requirements of subpart D for all research activities 
involving children. OHRP notes that UH initiated the following changes to  
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address OHRP‘s concern in this and future research activities: (a) the IRB application 
form now  
requires investigators seeking approval for research involving children to designate what 
they believe to be the category of the research under HHS regulations (45 CFR 46.404, 
46.405, or 46.406) and to explain how the regulatory criteria are met by the study; (b) a 
new reviewer‘s worksheet has been developed to require reviewers to identify the 
appropriate regulatory category for involvement of children in research and to ensure that 
child assent is obtained if appropriate, and (c) the regulatory category for involvement of 
children in research will now be noted in IRB meeting minutes.    
OHRP finds that the above corrective actions are adequate and appropriate under UH‘s FWA. As 
a result, there should be no need for further OHRP involvement in this matter, although you 
should notify OHRP if new information becomes available which might alter this determination.   
OHRP appreciates the continued commitment of your institution to the protection of human 
research subjects. Please do not hesitate to contact me should you have any questions.  
Sincerely,  
 
Carol J. Weil, J.D. Compliance Oversight 
Coordinator Division of Compliance Oversight  
 
 
 
cc: Ms. Debra Comeaux, Research Compliance Specialist,  
U Houston Dr. Merrill Hiscock, IRB Chair,  
U Houston IRB #2A and 2B  
Dr. Gerald Harris, U Houston  
Dr. Bernard Schwetz, OHRP  
Dr. Melody H. Lin, OHRP        
Dr. Michael Carome, OHRP  
Dr. Kristina Borror, OHRP  
Ms. Shirley Hicks, OHRP        
Dr. Irene Stith-Coleman, OHRP  
Ms. Pat El-Hinnawy, OHRP  
Ms. Janet Fant, OHRP  
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Appendix R 
 
List of Acronyms 
CARMA  Complementary Analysis Research Method Application  
CRS   Congress of Research Service 
DHHS   Department of Health and Human Services 
DL   Determination Letters 
FDA   Food and Drug Administration 
FWA   Federalwide Assurance 
HHS   Health and Human Services 
HRPP   Human Research Protection Program 
IRB   Institutional Review Board 
NBAC   National Bioethics Advisory Commission 
NCJJ   National Center for Juvenile Justice 
NIH   National Institutes of Health 
OHRP   Office of Human Research Protections 
OPRR   Office for the Protection of Research Risks 
SACHRP  Secretary's Advisory Committee on Human Research  
   Protections 
SSR   Social Science Research   
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Social/Behavioral IRB – Expedited Review 
Approval Notice 
 
NOTICE TO ALL RESEARCHERS: 
Please be aware that a protocol violation (e.g., failure to submit a  modification for 
any change) of an IRB approved protocol may result in mandatory remedial 
education, additional audits, re-consenting subjects, researcher probation, 
suspension of any research protocol at issue, suspension of additional existing 
research protocols, invalidation of all research conducted under the research 
protocol at issue, and further appropriate consequences as determined by the IRB 
and the Institutional Officer. 
 
 
DATE:  March 24, 2011 
 
TO:  Dr. LeAnn Putney, Educational Psychology 
 
FROM: Office of Research Integrity - Human Subjects 
   
RE:  Notification of IRB Action by  Charles Rasmussen Chair 
  Protocol Title: The Impact of Regulating Social Science Research with   
 Biomedical Regulations 
Protocol #: 1103-3762M 
  Expiration Date: March 23, 2012 
This memorandum is notification that the project referenced above has been reviewed and approved by the 
UNLV Social/Behavioral Institutional Review Board (IRB) as indicated in Federal regulatory statutes 45 
CFR 46 and UNLV Human Research Policies and Procedures. 
 
The protocol is approved for a period of one year and expires March 23, 2012.  If the above-referenced 
project has not been completed by this date you must request renewal by submitting a Continuing Review 
Request form 30 days before the expiration date.  
 
PLEASE NOTE:   
Upon approval, the research team is responsible for conducting the research as stated in the protocol most 
recently reviewed and approved by the IRB, which shall include using the most recently submitted 
Informed Consent/Assent forms and recruitment materials.  The official versions of these forms are 
indicated by footer which contains approval and expiration dates.  
 
Should there be any change to the protocol, it will be necessary to submit a Modification Form through 
ORI - Human Subjects.  No changes may be made to the existing protocol until modifications have been 
approved by the IRB.  Modified versions of protocol materials must be used upon review and approval. 
Unanticipated problems, deficiencies to protocols, and adverse events must be reported to the ORI – HS 
within 10 days of occurrence. 
If you have questions or require any assistance, please contact the Office of Research Integrity - Human 
Subjects at IRB@unlv.edu or call 895-2794. 
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